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iv ABSTRACT 
Oxytetracyline,  (OTC),  is  a  secondary  metabolite  antibiotic  produced  by  the 
actinomycete  Streptomyces  rimosus.  All  of  the  structural  genes  for  OTC  synthesis  are 
clustered  on  the  S.  rimosus  chromosome  and  flanked  by  resistance  determinants,  otrA 
and  otrB.  OtrA  mediates  resistance  through  non-covalent  modification  of  the 
bacterial  ribosome  whilst  otrB,  the  subject  of  this  thesis  acts  by  efflux  of  the  drug 
from  the  cell. 
At  the  outset  of  this  thesis  otrB  had  previously  been  cloned  and  sequenced. 
During  the  course  of  the  work  some  discrepancies  with  previously  published  data 
were  found,  parts  of  the  gene  were  then  re-sequenced  and  a  revised  otrB  sequence 
submitted  to  the  NCBI  database. 
The  OtrB  protein  is  a  transmembrane  protein  belonging  the  Major  facilitator 
Superfamily  (MFS).  Sequence  comparison  with  other  members  of  the  family  shows 
OtrB  to  be  part  of  a  subfamily  of  antibiotic  transporters  and  multi  drug  resistance 
proteins  made  up  from  14  transmembrane  helices  (6+2+6)  arrangement.  OtrB 
contains  many  conserved  motifs  typical  of  the  subfamily  and  of  the  MFS. 
otrB  was  cloned  into  E.  coli  and  expressed.  The  functional  activity  of  the 
cloned  gene  was  assessed  by  growth  on  various  concentrations  of  OTC.  Substrate 
specificity  was  investigated  using  TET  and  CTC  in  the  growth  media. 
Isolation  of  OtrB  from  E.  coli  as  a  polyhistidine  fusion  was  attempted, 
reasons  why  this  was  not  successful  are  discussed. 
Tetracycline  exporters  from  Gram-negative  bacteria  generally  contain  12 
transmembrane  helices  (6+6).  The  relevance  of  the  two  "extra"  helices  present  in 
OtrB  was  investigated  by  the  construction  and  expression  in  E.  coli,  of  a  deletion 
mutant  in  which  the  two  putative  central  helices  were  absent. CONTENTS 
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Chapter  I 
Introduction 
1.1  General  Introduction  to  the  Streptomycetes 
Streptomyces  are  a  group  of  Gram-positive,  aerobic,  filamentous  soil  bacteria.  Unlike 
many  bacteria  they  exhibit  a  complex  life  cycle.  The  Streptomyces  exist  in  the  soil  as 
part  of  a  large  community  of  organisms  including  fungi  and  other  bacterial  species 
which  recycle  complex  nutrients  such  as  lignin  and  celluloses  from  dead  plant  matter. 
These  soil  organisms  usually  exist  in  a  state  of  nutrient  limitation. 
This  type  of  competitive  existence  has  lead  to  various  organisms  evolving  adaptations 
to  enhance  their  competitiveness  over  the  others  which  share  the  same  nutrient 
sources;  the  complex  morphological  differentiation  of  the  Streptomyces  is  one  such 
example,  (Fig  I-  1).  The  filamentous  growth  of  these  organisms  bestows  upon  them  a 
competitive  advantage  by  enabling  the  bacteria  to  come  into  contact  with  fresh  sources 
of  nutrients  as  they  grow.  When  all  reachable  nutrient  sources  become  depleted, 
sporulation  is  triggered,  resulting  in  dispersion  to  new  locations  where  a  more 
nutritionally-rich  environment  will  hopefully  be  found.  In  this  environment,  spores 
germinate  and  new  hyphae  can  start  to  develop  once  again. 
1.2  Secondary  metabolites 
1.2.1  Function  &  evolution  of  secondary  metabolites 
Streptomyces  spp.,  like  many  Actinomycetes  produce  a  large  number  of  natural 
products  which  are  inessential  for  growth.  These  are,  by  this  definition,  secondary 
metabolites.  They  are  usually  produced  after  vegetative  growth,  in  conjunction  with 
differentiation.  In  1986  it  was  estimated  that  over  60%  of  the  known  bioactive 
compounds  at  that  time  were  produced  by  Streptomyces  species  (Omura,  1986) 
although,  with  the  high  throughput  screening  of  products  from  other  natural  sources 
taking  place  today,  this  figure  may  have  decreased  slightly  in  the  1990s.  There  is  one 
school  of  thought  which  holds  that  the  ability  of  the  Streptomyces  to  produce  so  many 
bioactive  secondary  metabolites  confers  a  selective  advantage  upon  them.  This 
argument  around  selective  pressure  has  three  main  points  as  follows: 
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1)  Secondary  metabolism  may  have  evolved  as  a  method  of  self  defence  for  organisms 
which  can  not  elicit  an  immune  response  (  Stone  &  Williams,  1992). 
2)  If  the  metabolites  produced  by  the  secondary  metabolism  conferred  no  selective 
advantage  upon  the  host,  their  biosynthesis  pathways  would  not  be  so  complex  and 
energetically  costly  to  the  host  (Katz  &  Demain,  1977). 
3)  As  so  many  secondary  metabolites  are  bioactive  and  inhibit  the  growth  of  other 
microbes,  they  should  be  involved  in  competition  between  microbes,  animals  and 
plants  in  their  natural  soil  habitat  (Demain,  1980). 
Another  school  of  thought  is  the  argument  that,  despite  bestowing  selectively 
advantageous  properties  on  the  host  cell,  secondary  metabolism  did  not  arise  primarily 
for  this  purpose.  Instead,  its  purpose  was  to  act  as  a  "shunf'  to  divert  intermediates  of 
primary  metabolism  and  prevent  their  build  up  to  toxic  levels  during  the  switch  from 
growth  to  stationary  phase  (Bu'Lock,  1980). 
There  is  also  a  third  theory  on  the  evolution  of  secondary  metabolites,  which  is 
that  the  structure  evolved  chemically  before  the  complex  pathways  for  their 
biosynthesis  had  developed.  The  low  weight  chemical  compounds  are  thought  by  some 
to  have  played  important  roles  early  on  in  the  evolution  of  biochemical  reactions, 
effecting  and  moderating  condensation  reactions  by  chemical  and  structural 
interactions  with  receptor  sites  on  simple  early  macromolecules  i.  e.,  secondary 
metabolites  are  suggested  to  have  evolved  as  pre-polypeptide  catalysts  which  were 
replaced  as  the  reactions  became  ever  more  complex  and  proteins  became  involved 
(Davies,  1990).  These  low  molecular  weight  "effectors"  now  interact  with  the  original 
receptor  sites  in  antagonistic  fashion,  thus  explaining  their  antibiotic  activity  (Davies 
et  al,  1992).  There  is  some  evidence  for  this  theory,  condensation  of  amino  acids  to 
form  oligo  and  polypeptides  is  now  undertaken  by  translation  on  the  ribosome. 
However,  the  theory  states  that  originally,  such  condensations  were  catalysed  by 
secondary  metabolites.  It  is  certainly  the  case  that  most  well  known  inhibitors  of 
protein  synthesis  are  extremely  specific  in  their  binding  to  ribosomal  target  sites, 
(Cundliffe,  1987)  and  the  complexes  formed  by  these  interactions  are  at  least  as  stable 
as  many  enzyme-substrate  interactions. 
Such  an  explanation  holds  well  for  antibiotics  which  inhibit  protein  synthesis 
However,  modification  of  the  antibiotic  or  it's  transport  into  and  out  of  the  cell  must 
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have  evolved  at  a  later  time  when  the  biosynthetic  pathways  that  result  in  secondary 
metabolite  formation  evolved.  For  this  theory  to  be  true  there  must  have,  at  one  time, 
been  a  switch  in  the  method  of  antibiotic  synthesis  from  a  non-enzymatic  reaction  to  a 
method  of  biosynthesis  similar  to  that  which  we  see  today  involving  several  proteins. 
When  and  why  then,  did  this  change  occur?  Obviously  after  the  antibiotics  had  given 
their  role  as  ribosomal  regulators  over  to  ribosomal  proteins  but  there  must  have  been 
some  impetus  to  develop  a  whole  new  biosynthetic  pathway  (Stone  &  Williams, 
1992). 
The  view  subscribed  to  by  the  majority  of  Streptomycete  biologists  seems  to  be 
the  first.  It  is  believed  that  secondary  metabolism  exists  to  protect  the  host  during 
those  points  of  the  life  cycle  when  its  metabolic  nutrients  could  be  scavenged  by  other 
microbes  in  the  vicinity.  The  theory  is  that  the  connection  between  morphological 
differentiation  and  the  onset  of  secondary  metabolite  production  is  not  one  of  chance- 
indeed  the  genetic  controls  for  the  two  processes  show  important  correlations 
(Hopwood,  1986). 
1.2.2  Control  of  secondary  metabolism 
The  discovery  that  N-acyl-homoserine-lactones  (HSLs)  act  as  a  cell  to  cell  signals 
amongst  some  Gram-negative  bacteria  in  the  phenomenon  known  as  "Quorum 
sensing"  (for  a  review  see  Swift  et  al,  1996)  means  that  we  should  look  again  at  the 
functions  of  antibiotics  and  the  secondary  metabolism  pathways.  Quorum  sensing  has 
been  defined  as,  "a  cell  to  cell  communication  device  to  regulate  transcription  of 
multiple  target  genes  in  concert  with  cell  density"  (Milton  et  al,  1997).  In  Gram- 
positive  bacteria  all  of  the  "pheremones"  so  far  identified  have  been  either  gamma- 
butyrolactones  or  post-translationally  modified  peptides  (Ji  et  al  1995;  Wirth  et  al, 
1996).  HSLs  and  their  counterparts  are  now  known  to  regulate  diverse  physiological 
processes  in  a  variety  of  bacteria,  including  secondary  metabolite  production  in  the 
plant  pathogen  Erwinia  carotovora  (Bainton  et  al,  1992,  Wirth  et  A  1996). 
In  Streptomycetes,  A-factor  which  is  a  structure  containing  gamma-butyrolactone 
has  been  shown  to  act  as  a  microbial  hormone  in  a  similar  way  to  the  HSL's-  A-factor 
was  originally  discovered  by  Khokhlov  (Khokhlov  et  al  1973,1967j  as  a  compound 
that  could  effect  the  sporulation  of  a  bld  mutant  of  S.  griseus  and  will  be  further Chapter  I 
discussed  below.  The  regulation  of  secondary  metabolism  and  morphological 
differentiation  in  the  Streptomycetes  is  complex  and  occurs  at  multiple  levels,  as  one 
might  expect,  in  order  to  effect  the  many  changes  which  occur  as  the  organisms  enter 
stationary  phase. 
Regulation  occurs  at  the  levels  of  transcription,  translation  and  at  the  post-translational 
level. 
1.2.2.1  Transcriptional  regulation: 
1.2.2.2  A-factor 
The  A-factor  mentioned  briefly  above  is  a  low  molecular  weight  metabolite  which  acts 
as  a  microbial  hormone  in  S.  griseus.  It  is  also  found  in  other  Streptomycetes  but  its 
function  in  these  organisms  is  unclear.  A-factor  was  first  found  in  S.  griseus  and  S. 
bikiniensis  by  Khokhlov  et  al  (1973).  It  is  essential  for  streptomycin  biosynthesis, 
streptommycin  resistance  and  spore  formation  in  these  organisms  (Hara  &  Bepu, 
1982).  A-factor  negative  mutants  of  S.  griseus  were  obtained  by  curing  treatments 
which  suggests  that  an  extra  chromosomal  element  is  involved  in  A-factor  synthesis 
(Hara  &  Beppu,  1982).  It  is  now  known  that  the  A-factor  determinant,  AfsA  is  located 
on  a  giant  circular  plasmid,  (15OOkb)  in  S.  griseus  (Horinouchi  &  Beppu,  1994).  In  S. 
coelicolor  this  is  not  the  case,  A-factor  is  stable  to  curing  treatments  and  has  been 
shown  to  be  situated  in  the  chromosome  (Hara  et  al,  1983). 
1.2.2.3  A-factor  in  S.  griseus 
In  S.  griseus,  A-factor  performs  it's  regulatory  function  by  binding  to  a  specific 
receptor  protein  which,  in  the  absence  of  A-factor,  acts  as  a  transcriptional  repressor 
for  genes  involved  in  morphological  and  physiological  differentiation.  In  the  presence 
of  A-factor,  the  receptor  protein  transfers  the  signal  to  the  upstream  activation 
sequence  of  the  strR  gene. 
1.2.2.4  A-factor  receptor  protein 
the  A-factor  receptor  protein  or  (A-factor  binding  protein)  of  S.  griseus  negatively 
controls  both  streptomycin  production  and  sporulation  (Miyake  et  al,  1990).  A  mutant 
was  isolated  which  did  not  require  A-factor  to  produce  streptomycin  under  normal 
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conditions  It  was  concluded  that  this  strain,  S.  griseus  2247  is  deficient  in  the  A-factor 
binding  protein  (Hara  &  Beppu,  1982).  As  strain  2247  was  not  deficient  for  A-factor 
but  could  produce  streptomycin  independently  of  it,  a  hypothesis  was  formulated.  This 
states  that  the  A-factor  binding  protein  in  the  wild  type  S.  griseus  acts  as  a  repressor- 
regulator  for  the  streptomycin  biosynthetic  cluster  and  that  that  the  repression  is 
released  when  it  binds  with  A-factor.  In  order  to  prove  this,  A-factor  negative  mutants 
of  S.  griseus  isolated  by  Horinouchi  et  al,  (1984)  were  further  mutated.  By  looking  for 
the  pseudoreversion  of  streptomycin  production,  strains  which  were  also  deficient  in 
the  A-factor  binding  protein  should  be  identified.  Three  such  mutants  were  isolated. 
On  examination  the  mutants  retained  their  A-factor  negative  phenotype  as  expected, 
they  were  able  to  sporulate  normally,  unlike  the  parent  strain,  and  displayed 
streptomycin  resistance  which  was  not  observed  for  the  parent  strain.  During  the 
course  of  these  investigations  it  was  observed  that  the  mutants  produced  streptomycin 
at  an  earlier  stage  of  growth  than  the  wild  type  S.  griseus,  after  two  days  rather  than 
after  three,  the  cell  masses  of  the  two  strains  were  almost  the  same.  The  amount  of 
drug  produced  by  the  mutants  was  about  10  times  higher  than  the  wild  type  yields.  It 
was  suggested  that  the  early  production  could  be  due  to  the  triggering  of  streptomycin 
synthesis  and  sporulation  being  linked  to  the  intracellular  concentration  of  A-factor. 
As  the  binding  factor  is  absent,  the  concentration  of  free  A-factor  will  build  up  to  the 
critical  level  earlier  on  in  the  life  cycle. 
1.2.2.5  A-factor  dependent  binding  protein  (AdpP). 
A41  kDa  protein  has  been  shown  to  bind  to  the  upstream  activation  sequence  of  the 
strR  regulatory  gene  (Vujaklija  et  al,  1993).  During  the  course  of  these  experiments 
Vujaklija  and  co-workers,  found  that  three  additional  proteins  also  bound  specifically 
to  the  region  near  the  upstream  activating  sequence  of  strR,  the  precise  functions  of 
these  proteins  are  not  known  but  it  is  suggested  that  they  may  play  regulatory  roles  in 
modulating  A-factor/UAS  binding.  The  A-factor  dependent  binding  protein  (AdpP), 
concerns  only  Streptomycin  production,  not  aerial  mycelium  formation  because 
transformants  of  wild  type  S.  griseus  containing  the  strR  promoter  on  a  high  copy 
number  plasmid  producing  little  or  no  Streptomycin  (Sm)  but  still  form  abundant 
spores.  This  is  in  accordance  with  the  hypothesis  that  AdpP  acts  as  an  activator  type 
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regulator,  the  lack  of  Sm  biosynthesis  being  due  to  titration  effect.  (Horinouchi  & 
Beppu,  1994). 
1.2.2.6  strR 
strR  encodes  an  activator  protein  for  genes  in  the  streptomycin  biosynthesis  cluster. 
There  is  more  than  a  10  fold  increase  in  strR  transcription  in  the  presence  of  A-factor. 
Work  done  by  Distler  et  al,  (1987)  identified  three  mRNAs  that  were  only  detectable 
in  the  presence  of  A-factor;  strR  a  regulatory  gene,  aphD  encoding  Sm-6- 
phosphtransferase  and  strB  encoding  aminocyclitol  amidinotransferase.  The  group  of 
Horinouchi  and  Beppu  then  conducted  experiments  to  determine  which  of  these  three 
promoters  is  directly  affected  by  A-factor.  This  work  showed  that  only  the  strR 
promoter  responded  directly  to  A-factor  and  that  the  transcript  encoding  qPhD  is 
produced  mainly  by  read  through  from  the  strR  promoter  (Vuj  aklija  et  al,  199  1).  As 
aphD  encodes  the  streptomycin  resistance  determinant  this  makes  sense. 
Cotranscription  ensures  that  resistance  is  induced  just  before  streptomycin 
biosynthesis  begins.  The  StrR  protein  is  then  thought  to  act  as  a  transcription  factor  for 
other  genes  in  the  Sm  biosynthetic  cluster.  StrR  has  been  shown  to  be  a  DNA  binding 
protein  that  functions  by  a  mechanism  that  is  not  yet  clear  (Distler  et  al,  1992). 
1.2.2.7  A  model  for  the  regulation  of  Sm  biosynthesis 
Taking  into  account  the  available  data,  a  model  for  the  way  in  which  A-factor 
regulates  streptomycin  biosynthesis  in  S.  griseus  has  been  presented  in  a  review  by 
Horinouchi  &  Beppu  (1994). 
At  an  early  stage  in  growth,  intracellular  concentration  of  A-factor  is  low.  At  this  time 
the  A-factor  receptor  protein  represses  the  transcription  of  an  (as  yet)  unidentified 
gene,  gene  X.  The  product  of  this  gene  should  be  involved  in  Sm  biosynthesis  and 
aerial  mycelium  formation  since  both  phenotypes  are  triggered  by  the  joint  action  of 
A-factor  and  A-factor  receptor  protein.  When  A-factor  reaches  a  critical  level  this  acts 
as  a  signal  for  Sm  biosynthesis  by  binding  to  the  A-factor  receptor  protein  which  is 
then  released  from  gene  X,  allowing  expression  of  the  gene  X  product.  This  protein 
product  then  induces  expression  of  AdpA,  the  transcription  factor  for  StrR.  Once  SUR Chapter  I 
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is  produced  it  can  act  as  a  transcription  factor  for  other  Sm  genes  including  strB  and 
strD  (A  flow  diagram  representing  these  processes  is  presented  in  Fig.  1-2). 
1.2.2.8  A-factor  in  S.  coelicolor 
A-factor  in  plays  no  known  regulatory  or  hormonal  function  in  S.  coelicolor.  It  is  one 
of  five  secondary  metabolites  produced  by  the  organism.  Secondary  metabolite 
production  is  controlled  and  regulated  by  a  large  inter-connected  network  of  genes 
which  is  now  beginning  to  be  understood. 
1.2.2.9  AbsA  and  AbsB 
Mutants  of  S.  coelicolor  which  are  totally  blocked  in  synthesis  of  all  four  antibiotics, 
absA  and  absB  mutants,  were  isolated  (Adamidis  et  al  1990).  The  global  control  of 
antibiotic  synthesis  in  this  organism  is  regulated  by  these  two  loci.  By  studying  the 
genes  and  gene  products  which  suppress  these  mutations,  information  about  the 
hierarchical  nature  of  the  regulatory  network  can  be  gleaned. 
1.2.2.10  AfsR  (AfsB) 
A  DNA  fragment  from  S.  coelicolor  which  controlled  streptomycin  biosynthesis  was 
isolated.  The  gene  afsB  was  identified  because  it  complemented  an  afsB  mutation  on 
the  chromosome  of  S.  lividans.  (Horinouchi  &  Beppu,  1983).  However,  this 
complementation  was  later  shown  not  to  be  a  direct  consequence  of  the  cloned  gene. 
Expression  of  the  gene  pl6otropically  and  positively  controls,  the  production  of  three 
metabolites,  A-factor,  actinorhodin  and  undecylprodigiosin.  These  three  metabolites 
are  unrelated  with  respect  to  structure.  The  AfsR  protein  is  important  in  it's  own  right, 
disruption  of  protein  function  resulting  in  a  loss  of  pigment  production.  When  afsR  is 
cloned  on  a  plasmid  into  S.  lividans,  which  contains  the  act  genes  but  does  not 
produce  actinorhodin  under  normal  physiological  conditions,  actinorhodin  synthesis  is 
induced  (Horinouchi  et  al  1984).  This  further  strengthens  the  case  for  its  function  as  a 
regulator.  afsR  was  cloned  and  sequenced  (Horinouchi  et  al,  1990).  The  deduced  AfsR 
protein  is  993  amino  acids  and  contains  A-and  B-type  ATP  binding  domains  in  the  N- 
terminal  portion  and  two  DNA  binding  concensus  sequences  in  the  C-terminal  part. 
When  either  of  the  two  ATP  binding  regions  was  mutated,  loss  of  pigment  formation 
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in  S.  lividans  was  observed.  A  similar  phenotype  was  observed  on  disruption  of  the 
chromosomal  afsR  gene  in  S.  coelicolor  indicating  that  AfSR  is  required  for  antibiotic 
synthesis.  The  presence  of  the  ATP  binding  motifs  led  researchers  to  assay  the  protein 
for  autophosphorylation.  Phosphorylation  did  not  occur  in  a  system  using  radiolabeled 
ATP  and  M902  but  was  observed  when  AfsR  was  incubated  with  the  S.  coelicolor 
cell  lysate.  Labelling  was  proportional  to  the  amount  of  AfsR  protein  (Hong  et  al, 
199  1).  A  similar  AfsR-phosphorylating  activity  was  observed  in  the  lysate  of  S. 
lividans.  It  was  suggested  by  Hong  et  al,  (199  1)  that  AfsR  may  be  part  of  a  two 
component  regulatory  system,  widespread  in  many  prokaryotes. 
1.2.2.11  AfsK 
In  fact  this  is  not  the  case,  AfsR  was  found  to  be  phosphorylated  by  a  eukaryotic  type 
protein  kinase,  AfsK  (Matsumoto  et  al,  1994). 
Kinase  activity  was  located  in  the  membrane  fraction  of  S.  coelicolor  when  a  plasmid 
containing  afsR  and  its  downstream  region  was  present.  This  suggested  that  afsK  was 
situated  downstream  of  afsR  and  that  AfsK  was  membrane  associated.  The  peptide 
sequence  of  AfsK  shows  remarkable  similarity  to  eukaryotic  serine/threonine  protein 
kinases.  Although  AfsK  phosphorylates  AfsR,  it  is  probably  not  the  only  protein  to  do 
so.  Disruption  of  the  chromosomal  afsK  gene  results  in  reduction  but  not  cessation  of 
actinorhodin  production  and  phosphorylated  AfsR  can  still  be  detected  in  the 
disruptant  (Matumoto  et  al,  1994). 
1.2.2.12  AfsR2 
Another  gene  at  the  afsR  locus  has  been  documented  for  S.  lividans  (Vogtli  et  A 
1994).  afsR2  is  situated  just  downstream  of  afsR  and  also  affects  the  production  of 
actinorhodin,  specifically  by  activating  transcription  of  the  actll-ORF4  regulatory  gene 
of  the  actinorhodin  biosynthetic  cluster.  AfsR2  also  stimulates  undecylprodigiosin 
production.  Even  though  overproduction  of  AfsR2  increases  actIl-ORF4  mRNA 
concentration,  it  is  not  required  for  expression  of  this  gene  since  actinorhodin  is 
produced  in  afsR  mutants  of  S.  lividans.  It  is  suggested  by  Vogtli  et  at,  (1994)  that 
some  of  the  stimulatory  effects  on  production  of  actinorhodin  previously  attributed  to 
afsR  are  in  fact  caused  by  afsR2  as  the  DNA  fragment  used  by  Horinouchi  et  at  in  the 
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afsR  studies  contained  some  downstream  DNA  now  known  to  encode  AfsR2.  The 
mode  of  action  of  AfsR2  is  not  clear.  There  is  similarity  between  a  segment  of  AfsR2 
and  a  domain  found  in  most  (Y  factors  but  Af:  sR2  is  unlikely  to  function  as  aa  factor 
by  itself  as  the  most  highly  conserved  region  amongst  other  cr  factors  is  not  present 
and  the  AfsR2  protein  is  considerably  smaller  than  most  a  factors. 
1.2.2.13  AfsQl-Q2 
AfsQ1  is  another  phosphorylated  protein  that  plays  a  role  in  regulating  antibiotic 
synthesis  in  S.  coelicolor.  The  gene  has  been  cloned  and  characterised.  (Ishizuka  et  al 
1992)  as  a  response  regulator  typical  of  the  prokaryotic  two  component  regulatory 
systems  previously  mentioned.  A  second  gene  afsQ2  downstream  of  qfsQ1  encodes  a 
sensory  histidine  kinase  which  is  thought  to  detect  environmental  signals  and 
transduce  such  signals  to  AfsQ  I  by  phosphorylation.  The  two  genes  are  transcribed 
polycistronically.  A  fragment  containing  these  two  genes  is  capable  of  conferring 
actinorhodin  production  on  S.  lividans  66HH2  1,  an  A-factor  deficient  mutant.  When 
afsQ]  is  truncated,  no  actinorhodin  biosynthesis  is  observed.  In  a  strain  of  S. 
coelicolor  in  which  the  afsQ]  and  2  genes  were  disrupted,  growth,  sporulation  and 
production  of  actinorhodin,  undecylprodigiosin  and  A-factor  were  comparable  with 
the  wild  type,  indicating  that  afsQ]  and  Q2  are  not  essential  for  these  phenotypes  in  S. 
coelicolor. 
Like  the  afsR  gene,  afsQl  was  found  to  complement  absA  mutants.  These  are 
mutants  that  result  in  a  global  block  of  antibiotic  synthesis  in  S.  coelicolor  (Adamidis 
&  Champness,  1992).  This  supports  the  hypothesis  that  the  afsQI/Q2  system  is 
involved  in  regulation  of  secondary  metabolite  production  and  is  part  of  a  network  of 
regulatory  genes  which  work  in  concert  with  some  genes  and  independently  of  others 
in  the  network.  It  is  thought  that  other  sensor/regulator  systems  may  be  present  in 
S.  coelicolor  (Ishizuka  et  al,  1992). 
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1.2.2.14  AbaA 
There  is  another  pleiotropic  regulatory  locus  present  in  S.  coelicolor,  which  like  the 
abs  and  afs  genes  acts  independently  of  sporulation.  abaA  was  identified  as  a  segment 
of  DNA  from  S.  coelicolor  that  increases  actinorhodin  synthesis  when  cloned  in  S. 
lividans  (Fernandez-Moreno  et  al,  1992a).  When  the  chromosomal  abaA  gene  is 
disrupted  by  prophage  insertion,  production  of  actinorhodin  is  abolished  and 
production  of  CDA  and  prodigiosin  is  greatly  reduced  while  methylenomycin 
production  is  not  significantly  affected.  These  phenotypes  are  very  similar  to  those  of 
afs  mutants  but  the  two  loci  have  different  positions  on  the  genetic  map  (Fernandez- 
Moreno  et  al,  1992b).  The  abaA  DNA  sequence  contains  at  least  two  ORFs;  ORF  A 
and  ORF  B.  ORF  B  is  implicated  in  control  of  antibiotic  production.  No  insertion 
mutants  of  ORFA  were  obtained  so  a  similar  role  for  it  cannot  be  ruled  out. 
1.2.2.15  Sigma  factors 
1.2.2.16  G, 
hiG 
Multiple  forms  of  RNA  polymerase  exist  in  Streptomyces  coelicolor.  At  least  nine 
sigma  factors  have  been  identified  and  six  of  these  play  a  role  in  regulating 
differentiation  and  secondary  metabolism. 
Most  of  the  work  concerning  Streptomyces  sigma  factors  involved  in  differentiation 
has  been  carried  out  using  S.  coelicolor  and  S.  griseus.  The  first  gene  identified  as 
encoding  a  sigma  factor  was  the  whiG  gene  of  S.  coelicolor  (Chater  et  A  1989). 
Mutations  at  the  whi  loci  are  so  called  because  they  block  the  formation  of  spores  in 
the  aerial  mycelium  which  therefore  stay  white  even  with  prolonged  incubation 
(Hopwood  et  al,  1970).  The  whiG  mutants  are  blocked  at  an  early  stage  in  this  process. 
They  display  very  long  straight  hyphae  that  lack  septation,  which  is  characteristic  of 
sporulation  in  the  wild  type. 
When  whiG  is  expressed  at  high  copy  number  in  S.  coelicolor,  increased 
sporulation  is  observed  (Mendez  &  Chater,  1987).  This  suggests  that  the  whiG  product 
positively  regulates  sporulation.  Studies  of  the  nucleotide  sequence  of  the  gene 
indicate  that  whiG  encodes  a  sigma  factor,  closely  related  to  028  from  Bacillus  subtilis 
which  regulates  motility,  chernotaxis  and  autolysis  (Helmann  et  at,  1988).  The  highest 
similarity  was  found  in  the  regions  which  encode  the  amino  acids  that  make  contact 
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with  the  DNA.  As  cýg  mutants  of  B.  subtilis  also  form  long  filaments,  it  is  possible 
that  both  factors  are  involved  in  transcription  of  autolysin  genes. 
Further  experiments  showed  that  ehiG  is  essential  for  sporulation  in  S.  coelicolor  but 
is  not  required  for  vegetative  growth  (Chater  et  al,  1989)  and  that  a  whiG  homologue 
is  present  in  most  streptomycetes.  The  S.  aureofaciens  homologue,  rpoZ  has  been 
cloned  (Kormanec  et  al,  1994)  Its  gene  product  shows  extensive  similarity  to  ehG, 
and  a28.  Similarities  have  also  been  observed  in  the  regions  upstream  of  these  genes, 
implying  that  the  two  genes  may  be  regulated  in  similar  ways. 
1.2.2.17  hrd  a  factors 
Four  further  sigma  factor  genes  were  cloned  independently  by  two  groups,  the  Buttner 
group  at  the  John  Innes  Centre  in  Norwich,  UK  (  Buttner  et  al,  1990)  and  the  group  of 
Tanaka  et  al  in  Tokyo  (Tanaka  et  al,  199  1).  The  hrd  genes,  hrdA  hrdB,  hrdC  and 
hrdD,  were  cloned  using  an  oligonucleotide  probe  based  on  conserved  residues  from 
E.  coli  and  B.  subtilis  sigma  factors  (Tanaka  et  al,  1988).  The  same  genes  were  cloned 
by  the  Buttner  group  using  a  different  probe,  the  rpoD  gene  from  Myxococcus  xanthus. 
As  hrdB  deletion  mutants  could  not  be  obtained,  (Buttner  et  al,  1990)  it  was  deduced 
that  HrdB  must  be  the  principal  vegetative  sigma  factor  in  S.  coelicolor.  This  was 
backed  up  by  sequencing  data  which  showed  HrdB  to  have  high  homology  with  the 
rpoD  gene  products  of  B.  subtilis  and  E.  coli  which  are  responsible  for  regulation  of 
housekeeping  genes  in  those  organisms.  Mutants  of  hrdC  and  hrdD  were  not  visibly 
different  in  phenotype  to  the  wild  type  S.  coelicolor  (Buttner  et  al,  1990)  and  hence 
these  genes  were  deduced  to  be  non-essential. 
Transcriptional  analysis  of  hrdB,  hdrC  and  hrdD  genes  was  carried  out  to 
provide  more  information  about  their  expression.  For  hrdD,  two  transcripts  were 
identified:  one  with  5'  end  365bp  upstream  of  the  putative  start  codon  and  the  other 
beginning  117  bp  upstream,  indicating  that  there  are  tandem  promoters  for  hrdD  in  S. 
coelicolor.  No  hrdC  transcripts  were  seen.  It  has  been  suggested  following  the 
construction  of  double  and  triple  hrd  mutants  that  hrdC  and  hrdD  may  have  identical 
or  overlapping  promoter  specificities  (Buttner  &  Lewis,  1992).  As  the  double  and 
triple  mutants  of  hrdA,  C  and  D  are  not  able  to  be  distinguished  phenotypically  from 
the  wild  type,  it  could  be  that  all  the  promoters  acted  upon  by  these  proteins  can  also 
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be  recognised  by  the  hrdB  gene  product  which  is  essential  for  growth  and 
differentiation  of  S.  coelicolor.  It  is  now  known  that  cy  hrdD  is  responsible  for 
transcription  of  the  reed  and  actlI-ORF4  genes  of  S.  coelicolor  in  vitro  (Fujii  et  al, 
1996).  These  genes  encode  regulators  required  for  biosynthesis  of  undecylprodigiosin 
and  actinorhodin.  There  is  a  possibility  that  these  promoters  may  be  recognised  in  vivo 
by  both  a  hrdD  and  OMB  .  Homologues  of  the  hrd  genes  have  been  found  in  other 
Streptomycetes  including  S.  lividans  and  S.  griseus  (Buttner  et  al,  1990)  and  S. 
aureofaciens  (Kormanec  &  Farkasovski,  1983)  but  only  hrdB  is  present  in  all  of  the 
species  so  far.  This  further  backs  up  the  hypothesis  that  hrdB  encodes  the  principal 
vegetative  sigma  factor  in  Streptomyces  spp.  The  work  of  Kormanec  and  Farkasovski 
has  shown  that  the  existence  of  tandem  promoters,  like  that  observed  for  hrdD  in  S. 
coelicolor,  is  more  widespread.  Four  hrd  genes  have  been  identified  in  S. 
aureofaciens,  hrd  A,  B,  D  and  E.  It  was  discovered  that  transcription  from  hrd 
promoters  depended  on  the  developmental  stage.  hrdA,  B  and  D  each  have  at  least 
two  promoters  with  the  downstream  promoter  being  weakest  in  all  three  cases.  hrdB  is 
transcribed  from  both  promoters  at  all  developmental  stages,  both  of  the  hrdD 
promoters  are  active  only  in  the  vegetative  stage  and  hrdA  is  transcribed  from  its 
tandem  promoters  at  the  time  corresponding  to  aerial  mycelium  formation.  No 
transcripts  were  identified  for  hrdE. 
Even  though  hrdA  was  transcribed  only  at  the  formation  of  aerial  mycelium,  there  was 
no  visible  phenotypic  difference  between  a  hrdA  mutant  and  the  wild  type  S 
aureofaciens. 
The  internal  promoter  of  the  essential  hrdB  is  of  interest,  tandem  promoters  were  not 
identified  in  the  S.  coelicolor  hrdB  gene.  Why  should  there  be  two  gene  products  if 
this  is  a  housekeeping  sigma  factor?  It  is  suggested  that  the  weaker  internal  hrdB-P  I 
promoter  may  be  able  to  respond  to  specific  physiological  conditions  (Kormanec  & 
Farkasowski,  1993).  This  phenomenon  of  two  polypeptides  encoded  by  the  same 
sequence  is  known  in  Streptomyces,  the  sporulation  gene  of  S.  griseus  encodes  two 
peptides  that  differ  at  their  N-termini  and  are  generated  by  temporal  control  of 
accumulation  of  the  transcript  (Babcock  &  Kendrick,  1990). 
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1.2.2.18  Cr 
F 
More  recently  another  sigma  factor  concerned  with  morphological  differentiation  has 
been  identified  (Potuckova  et  al,  1995).  sigF  was  cloned  from  S.  aureofaciens  using 
an  oligonucleotide  probe  derived  from  a  conserved  region  of  the  670  family.  The  sigF 
mutant  did  not  correspond  to  any  of  the  existing  whi  loci.  There  are  homologues  to 
sigF  in  other  Streptomycetes.  Sequencing  of  the  S.  coelicolor  sigF  showed  that  it 
encodes  a  peptide  with  high  similarity  to  other  sigma  factors.  Disruptants  of  sigF  were 
constructed  in  S.  coelicolor.  These  mutants  were  normal  for  vegetative  growth  but 
later  displayed  a  whi-like  phenotype.  Microscopic  analysis  revealed  that  this 
phenotype  was  not  the  documented  whi  phenotype  as  some  spores  were  produced  but 
they  were  small  and  deformed  compared  to  wild  type.  The  walls  of  the  mutant  spores 
were  thinner  and  sensitive  to  detergents,  unlike  the  wild  type.  These  observations  lead 
to  the  hypothesis  that  OF  controls  a  regulon  of  late  spore-specific  genes.  (Potuckova  et 
al,  1995).  There  is  now  enough  information  to  formulate  a  hypothesis  stating  that 
morphological  differentiation  in  the  streptomycetes  is  controlled  by  a  sigma  factor 
cascade.  Work  to  elucidate  the  hierarchy  of  this  cascade  is  now  being  carried  out. 
CY  whiG  is  epistatic  to  the  hrd  sigma  factors  and  does  not  depend  on  aF  or  any  of  the  six 
known  whi  genes  (whi  A,  B,  G,  H,  I  and  J)  required  for  sporulation  septum  formation 
(Kelemen  et  al,  1996).  This  puts  it  at  the  top  of  the  regulatory  cascade  that  controls 
spore  chain  development  in  S.  coelicolor.  Transcription  of  sigF  depends  on  all  of  these 
early  whi  genes  including  whiG  (Keleman  et  al,  1995.  The  dependence  of  CY  SigF  upon 
WhiH  and  WhiJ  may  not  be  absolute,  as  only  very  weak  signals  were  detected  in  S1 
nuclease  protection  analysis  (Keleman  et  al,  1995).  Transcription  of  sigF  is 
developmentally  regulated  as  transcripts  are  detected  only  at  the  time  of  sporulation- 
septum  formation.  No  transcripts  were  detected  in  the  vegetative  phase,  during  aerial 
mycelium  development  or  in  later  stages  of  spore  maturation.  Transcription  of  whiG 
carries  on  after  the  sigF  transcripts  cease  to  be  present.  whiG  transcripts  were  present 
throughout  all  developmental  phases  as  were  those  of  hrdB,  the  housekeeping  sigma 
factor,  that  was  used  as  a  positive  control.  As  transcripts  of  whiG  are  present  in  the 
vegetative  stage,  before  any  differentiation  has  occurred,  it  is  suggested  that  regulation 
of  WhiG  activity  is  at  the  post  translational  level.  WhiG  is  related  to  another  sigma 
factor  known  to  be  regulated  this  way,  ORA  from  S.  typhimurium.  This  is  involved  in 
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the  late  stages  of  flagellum  biosynthesis.  Another  protein,  FlgM,  binds  (;  FHA  until  the 
basal  body  hook  is  complete.  At  this  point,  FlgM  is  exported  through  the  hook,  freeing 
the  sigma  factor.  The  esp  locus  of  S.  coelicolor  whose  mutants  display  ectopic 
sporulation  is  suspected  of  encoding  a  FlgM  homologue  in  this  organism  (Keleman  et 
al,  1995). 
hiG  Although  transcription  of  sigF  depends  on  (;  ' 
,  the  transcription  of  the  sigF 
gene  is  not  carried  out  directly  by  the  E  (T,  hiG  polymerase  holoenzyme.  The  promoter 
region  of  sigF  shows  no  similarities  to  other  genes  transcribed  by  ehiG 
. 
The  hierarchy 
elucidated  so  far  has  (,  whiG  at  the  top  and  (;  F  controlling  the  late  events.  The  positions 
of  the  other  whi  genes  are  not  yet  determined  but  it  is  known  that  transcription  of  whiH 
is  directly  by  E  dwhiG  (Whatling  et  al,  in  preparation  (cited  in  Keleman  et  al,  1996)) 
and  that  whiB  transcription  does  not  depend  on  whiG. 
Fig  1.3  shows  the  hierarchy  of  sporulation-control  ling  genes  so  far  deduced  in  S. 
coelicolor  (Keleman  et  al,  1996). 
1.2.3  Post  -transcriptional  regulation 
1.2.3.1  Regulation  by  use  of  a  rare  tRNA 
bld  mutants  of  S.  coelicolor  were  first  characterised  as  being  defective  in  aerial 
mycelium  formation  and  sporulation  (Merrick,  1976).  bIdA  is  one  such  mutant.  This 
mutation  also  results  in  the  total  block  of  production  of  four  antibiotics  normally 
produced  by  the  strain:  actinorhodin,  undecylprodigiosin,  methylenomycin  and  the 
calcium  dependent  antibiotic  (CDA).  The  phenotype  of  bIdA  mutants  is  carbon  source 
dependent.  When  grown  on  rninimal  agar  containing  glucose  or  cellobiose  as  sole 
carbon  source  the  mutant  phenotype  is  seen  but  when  grown  with  maltose  or  melibiose 
as  the  carbon  source,  bIdA  mutants  produce  aerial  mycelia  and  sporulate  as  wild  type. 
However  the  production  of  antibiotics  is  not  restored.  There  are  however  a  class  of  bld 
mutants  known  as  the  pwb  mutants  which  can  (by  second  site  suppressor  activity) 
reinstate  the  production  of  antibiotics  from  the  red  or  act  clusters  but  not  both  (White 
&  Bibb,  1997,  Guthrie  et  al,  1998).  The  bIdA  gene  encodes  a  leucine  tRNA  for  the 
codon,  UUA  which  is  rare  in  the  G+C  rich  DNA  of  Streptontyces  spp  (Lawlor  et  al, 
1987). 
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Fig  1.3 
Heirarchy  of  genes  controlling  S.  coelicolor  sporulation.  Solid  arrows  indicate 
direct  biochemical  interaction,  broken  arrows  indicate  genetic  dependence 
which  could  be  direct  or  indirect  (taken  from  Keleman  et  A  1996). 
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Expression  of  several  genes  that  contain  a  TTA  codon  is  lost  or  reduced  in  bIdA 
mutants  (Leskiw  et  al,  199  1)  including  the  transcriptional  activator  for  actinorhodin 
biosynthesis  (Fernandez-  Moreno  et  al,  1991).  This  verifies  that  the  b1dA  gene  product 
is  the  principal  route  by  which  UUA  codons  are  translated  in  S.  coelicolor.  In  wild 
type  S.  coelicolor,  the  b1dA  encoded  tRNA  accumulates  at  the  time  of  aerial  myceliurn 
development-  It  is  just  prior  to  production  of  the  secondary  metabolites. 
Deletion  of  bIdA  had  no  obvious  effects  on  vegetative  growth  but  interfered 
with  mycelium  formation  and  sporulation  (Leskiw  et  al,  199  1).  It  was  originally 
thought  that  accumulation  of  the  b1dA  encoded  tRNA  was  temporally  regulated  as  it 
was  present  at  low  levels  during  the  early  stages  of  the  life  cycle  and  was  present  in 
increased  abundance  in  older  cultures.  It  is  now  thought  that  this  is  not  the  case  and 
SI  experiments  indicate  that  accumulation  is  not  temporally  regulated  (Leskwi  et  al, 
199  1).  Developmental  regulation  of  translation  of  UUA  codons  may  be  at  a  number  of 
different  levels:  processing  of  the  b1dA  RNA  transcript,  its  charging  of  the  tRNA  with 
the  leucine  residue,  or  possibly  its  access  to  the  ribosome.  It  has  also  been  shown  that 
some  genes  containing  UUA  codons  can  be  translated  at  an  extremely  low  level  in 
b1dA  mutants.  Two  genes  coding  for  antibiotic  modifying  (resistance)  enzymes 
(Leslaw  et  al,  199  1)  were  able  to  be  translated  in  a  b1dA  mutant,  hyg  encoding 
hygromycin  phosphotransferase  and  aad  encoding  aureomycin  adenyl  transferase. 
These  genes  contain  one  and  two  TTAs  respectively  (Hollingshead  et  al,  1985)  and 
were  able  to  be  translated  in  b1dA  mutants  (Leskwi  et  al,  199  1)  and  confer  resistance 
on  the  hosts.  Expression  may  be  due  to  insertion  of  another  amino  acid  in  place  of 
leucine,  if  the  codon/anticodon  interaction  is  weak. 
Data  compiled  from  coding  regions  from  100  Streptomyces  genes  (Bibb  et  al, 
1984)  have  shown  that  TTA  codons  are  rare  and  mostly  present  in  genes  required  for 
morphological  and  physiological  differentiation.  It  may  be  that  the  presence  of  TTA 
codons  confers  some  adaptive  benefit  but  such  benefits  are  not  obvious.  The  lack  of 
TTA  codons  in  genes  associated  with  vegetative  growth  may  just  be  due  to  the 
shedding  of  inefficient  codons  through  evolution. 
Actinorhodin  and  undecylprodigiosin  are  not  produced  by  b1dA  mutants,  the 
actIl  -ORF4  gene  which  regulates  actinorhodin  production  in  S.  coelicolor  contains 
TTA  codons  but  the  reed  gene,  which  plays  a  similar  role  in  the  red  synthetic  cluster 
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does  not.  It  has  therefore  been  suggested  that  a  second  pathway  specific  regulatory 
gene,  that  contains  a  TTA  codon  is  also  required  for  red  activation  (Guthrie  &  Chater, 
1990). 
1.2.3.2  Regulation  by  ppGpp  and  pppGpp. 
The  stringent  response  is  coupled  to  amino  acid  depletion  which  causes  the 
intracellular  accumulation  of  RNA  to  cease,  the  accumulation  of  guanosine  5'- 
diphosphate  3'  diphosphate  (ppGpp)  and  guanosine  5'-triphoshpate  3'  diphosphate, 
(pppGpp),  is  believed  to  be  responsible  for  the  onset  of  the  stringent  response  (Gallant, 
1979)  and  to  be  the  initiating  signal  for  secondary  metabolism  and  differentiation  in 
several  Streptomyces  strains  (Ochi  et  al,  1986b,  1987a).  It  was  observed  by  Ochi  in 
Streptomyces  MA406-A-1,  that  after  the  intracellular  accumulation  of  ppGpp  and 
pppGpp  that  follows  nutritional  shift  down,  initiation  of  antibiotic  synthesis  occurred. 
This  work  also  showed  that  ppGpp  inhibits  the  synthesis  of  GTP  and  so  is  indirectly 
involved  in  morphological  differentiation.  The  stringent  response  and  the 
accumulation  of  (p)ppGpp  has  been  studied  very  extensively  in  E.  coli,  where  the 
polyphosphorylated  nucleotides  are  synthesised  by  at  least  two  possible  routes. 
The  main  route  is  by  (p)ppGpp  synthetase  activity.  This  enzyme  is  encoded  by 
the  reIA  gene  (relA  mutants  do  not  exhibit  the  stringent  response  so  are  said  to  display 
a  relaxed  phenotype).  Under  conditions  of  amino  acid  deprivation,  the  synthetase  acts 
on  ribosomes  when  binding  of  uncharged  tRNAs  to  the  receptor  site  is  occurring.  This 
reaction  involves  transfer  of  pyrophosphate  from  ATP  to  GTP  or  GDP.  The  resulting 
transient  accumulation  of  (p)ppGpp  leads  to  complex  regulatory  reprogramming 
resulting  in  reduction  in  rate  of  transcription  of  stable  mRNAs  and  increased 
transcription  of  certain  amino  acid  operons.  re1C  mutants  have  defective  ribosomal 
(p)ppGpp  synthesis.  The  reIC  gene  encodes  the  LII  protein  in  the  50S  ribosomal 
subunit,  the  same  subunit  implicated  in  the  binding  of  the  ReIA  protein  (Parker  et  al, 
1976).  A  re1C  mutant  of  S.  coelicolor  has  been  isolated  (Ochi  et  al,  1990)  it  is 
deficient  not  only  for  the  stringent  response,  but  also  for  production  of  aerial  mycelium 
actinorhodin  and  undecylprodigiosin. 
The  minor  route  by  which  (p)ppGpp  is  synthesised  in  E.  coli  utilises  the  product  of  the 
spoT  gene,  the  ribosome  independent  (p)ppGpp  synthetase  11  (Sarrubi  et  A  1989).  The 
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activity  of  this  gene  product  was  deduced  due  to  the  lack  of  (p)ppGpp  accumulation  in 
reIA  spoT  double  mutants  (Xiao  et  al,  199  1),  compared  with  the  accumulation  of  the 
molecule(s)  in  strains  deleted  for  reIA  (Metzger  et  al,  1989). 
1.2.3.3  (p)ppGpp  and  antibiotic  sYnthesis 
That  (p)ppGpp  may  be  the  signal  that  links  the  onset  of  secondary  metabolism  to 
physiological  differentiation  is  an  attractive  theory,  and  although  the  work  of  Ochi  has 
provided  information  that  links  the  accumulation  of  (p)ppGpp  with  initiation  of 
secondary  metabolism  (Ochi,  1986a,  1986b),  no  such  direct  link  was  established  by 
others  (Strauch  et  al,  199  1;  Bascaran  et  al,  199  1;  Takano  et  al,  1992).  Work  by 
Martinez-Costa  et  al  (1996)  in  the  laboratory  of  Malpartida,  has  identified  reWspoT 
homologues  in  S.  coelicolor  and  S.  lividans.  Further  studies  using  the  S.  coelicolor 
gene  showed  that  it  was  important  in  activation  of  secondary  metabolism  as  it  could 
initiate  actinorhodin  production  when  transformed  into  S.  lividans  by  causing 
increased  transcription  of  the  actIl  ORF4  gene  which  acts  pleiotropically.  Deletion  and 
insertional  mutants  of  S.  coelicolor  were  made  to  investigate  further  the  importance  of 
the  relAlspoT  homologue.  The  insertion  mutants  unexpectedly  showed  no  apparent 
phenotypic  differences  from  the  parent  strain.  The  deletion  mutant  on  the  other  hand 
exhibited  slowed  growth,  poor  sporulation  and  abolition  of  actinorhodin  production. 
The  production  of  undecylprodigiosin  and  CDA  was  not  affected  by  the  mutation. 
The  lack  of  actinorhodin  production  in  the  deletion  mutant  is  due  to  transcription  of 
actH  ORF4  being  at  a  basal  level.  Production  was  restored  when  actIl  ORF4  DNA  was 
present  on  a  plasmid  or  when  the  plasmid  containing  the  re1A  homologue  was  present. 
In  tests  for  (p)ppGpp  from  ribosomes,  the  deletion  mutants  proved  negative. 
It  is  somewhat  surprising  that  undecylprodigiosin  production  was  unaffected  by 
deletion  of  the  re1A  homologue,  as  the  regulator  for  this  cluster  (redD),  shows  marked 
similarity  with  the  actlI-ORF4  gene  product.  A  regulatory  function  for  re1A  in  both 
antibiotic  pathways  cannot  be  ruled  out  as  extra  copies  of  the  gene  increases 
production  of  both  antibiotics  in  the  parent  strain  and  in  the  reL4  deletion  mutant 
(Martinez-Costa  et  al,  1996). 
The  Martinez-Costa  reWspoT  deletion  strain  shows  some  likeness  to  re1A  mutants  of 
S.  coelicolor  isolated  by  Ochi  et  al,  (1990).  The  Ochi  mutant  was  however  affected  in 
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its  ability  to  produce  undecylprodigiosin,  provoking  the  thought  that  there  may  be 
alternative  pathways  for  (p)ppGpp  production  in  S.  coelicolor. 
The  possible  link  between  accumulation  of  (p)ppGpp  and  initiation  of  antibiotic 
synthesis  is  not  yet  definitely  proved  or  disproved.  It  is  suggested  by  Bascaran  et  al, 
(1991)  that  sensing  of  growth  rate  may  be  a  critical  factor  in  regulating  the  start  point 
of  secondary  metabolite  biosynthesis. 
1.2.3.4  (p)ppGpp  and  morphological  differentiation 
As  well  as  linking  (p)ppGpp  accumulation  with  antibiotic  biosynthesis,  the  work  of 
Ochi  has  implicated  (p)ppGpp  indirectly  with  the  onset  of  aerial  mycelium  formation 
In  B.  subtilis,  sporulation  is  the  result  of  a  decrease  in  GTP  caused  by  the  stringent 
response  and  the  concomitant  production  of  antibiotics  is  a  consequence  of  the 
stringent  response  (Ochi  &  Oshawa,  1984;  Ochi,  1985).  The  same  phenomena  have 
been  observed  for  Streptomyces  MA406-A-  I  and  other  Streptomyces  spp  (Ochi, 
1986a).  Studies  on  GTP  synthesis  utilise  decoyinine,  a  specific  inhibitor  of  GMP  (and 
indirectly  GTP)  synthesis.  Four  Streptomyces  strains  studied  by  Ochi  developed  aerial 
mycelium  on  the  addition  of  decoynine.  These  findings  are  in  agreement  with  those  for 
B.  subtilis  which  underwent  sporulation  but  did  not  produce  antibiotics  when  treated 
with  decoynine. 
The  stringent  response  is  thought  to  affect  GTP  levels  in  the  cell.  S.  griseus  can 
be  induced  to  sporulate  by  transferring  cells  from  a  rich  to  a  nutritionally  poor  medium 
(Kendrick  &  Ensign,  1983).  Rel  mutants  produce  much  fewer  spores  than  wild  type 
cells  when  treated  in  this  way  (Ochi,  1987b).  Differences  in  the  ppGpp  levels  between 
the  two  strains  were  apparent:  rel  mutants  accumulated  10  times  less  of  the  molecule 
than  the  wild  type  which  also  showed  large  decreases  in  GTP,  not  seen  in  the  rel 
strain.  It  was  suggested  that  the  GTP  levels  undergo  this  transient  dramatic  decrease 
because  severe  amino  acid  deficit  leads  to  increased  numbers  of  uncharged  tRNA's 
and  hence  to  ppGpp  synthesis  in  wild  type,  but  not  rel,  cells. 
ppGpp  in  E.  coli  is  a  strong  inhibitor  of  IMP  hydrogenase,  the  first  enzyme  in 
the  purine  biosynthesis  pathway.  ppGpp  also  acts  in  this  way  in  S.  griseus  (Ochi, 
1987a).  Reduction  in  levels  of  GTP  could  also  result  directly  from  nutritional  shift 
down,  nitrogen  deficiency  may  curtail  the  purine  biosynthesis  pathway  resulting  in 
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lower  levels  of  GMP  and  GTP.  Studies  on  Streptomyces  clavuligerus  (Bascaran  et  al, 
199  1)  have  demonstrated  the  existence  of  a  burst  of  ppGpp  synthesis  triggered  by  the 
stringent  response  in  that  organism. 
1.3  Polyketide  Biosynthesis 
1.3.1  What  are  Polyketides? 
Polyketides  are  a  large  group  of  molecules,  all  of  which  are  synthesised  in  nature  as 
secondary  metabolites  from  small  carboxylic  acids  by  a  process  which  is  very  similar 
to  that  used  by  primary  metabolism  to  synthesise  fatty  acids.  Polyketide  derived 
compounds  are  common  in  both  prokaryotes  and  eukaryotes,  being  metabolites  of 
bacteria,  fungi  and  plants  (Fig  1.4).  Although  the  structures  of  these  compounds  vary 
in  size  and  complexity,  they  all  share  one  common  factor:  -  their  pattern  of 
biosynthesis,  which  is  discussed  in  section  1.3.2.  Polyketide  compounds  play  a  large 
number  of  roles,  including  antibiotics  (bacteria)  flavenoids  (plants)  and  mycotoxins 
(fungi).  Their  chemical  diversity  stems  from  the  programming  of  the  PKS  and  to  the 
huge  number  of  possible  modifications  that  can  occur  after  chain  assembly,  such  as 
aromatic,  ether  or  macrolide  ring  formation,  and  addition  of  different  functional 
groups.  Due  to  the  fact  that  secondary  metabolites  are  only  produced  under  certain 
environmental  and  physiological  conditions,  knowledge  relating  to  them  is  rather 
incomplete  and  anthropocentric.  The  most  well  studied  examples  are  those  which 
either  help  or  hinder  man,  the  most  obvious  example  being  the  vast  array  of 
antibiotics,  antitumor  and  antifungal  compounds.  Also  well  studied  are  the  polyketide 
derived  colours  of  flowering  plants  and  the  highly  poisonous  and  carcinogenic 
aflatoxins  produced  by  fungi. 
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Sherman,  (1990). 
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1.3.2  Polykefide  Biosynthesis 
Polyketide  biosynthesis  occurs  in  a  similar  manner  to  that  by  which  the  fatty  acids  are 
synthesised  in  primary  metabolism,  in  which  2-carbon  extender  units  are  added  to  a 
starter  acyl  group  via  a  cycle  of  condensation,  keto  reduction,  dehydration  and  eno- 
reduction.  Fatty  acid  biosynthesis  is  catalysed  by  enzyme  systems  called  fatty  acid 
synthases  (FAS)..  There  are  7  steps  in  fatty  acid  synthesis  (Fig  1.5)  Reactions  I  and  2 
are  priming  reactions  in  which  the  condensation  reaction  precursors,  malonyl  Co-A 
and  an  acetyl  group  linked  to  acetyl  carrier  protein  (ACP)  by  a  thioester  bond,  are 
loaded  onto  the  condensing  enzyme,  0  ketoacyl-synthase.  Reaction  3  is  the 
condensation  reaction  whereby  malonyl  ACP  is  decarboxylated,  the  resulting 
carbanion  then  attacks  the  acetyl-thioester  bond  to  form  0  ketoacyl-ACP.  Reaction  4  is 
a  reduction  step  catalysed  by  0  ketoacyl-ACP  reductase.  Reaction  5  is  a  deydration 
step  and  reaction  6  is  the  second  reduction  step,  this  time  an  enoy  I  -reduction. 
Reactions  2-6  are  then  repeated  six  times  to  give  a  final  product  of  16  carbon  chain 
length,  palmitoyl-ACP.  The  ACP  moiety  is  removed  by  palmitoyl  thioesterase  in  the 
seventh  and  final  step  to  form  palmitic  acid. 
1.3.2.1  Polyketide  Synthase  (PKS) 
The  PKS  systems  are  categorised  as  three  types,  Type  I  PKS's  are  large 
multifunctional  proteins  in  which  all  the  enzymatic  functions  are  carried  out  by 
various  domains  of  a  single  polypeptide.  The  products  of  Type  I  PKS  range  from 
simple,  6-methylsalcylic  acid  produced  by  Penicillium,  (Wang  et  al,  1990)  to  more 
complex,  e.  g.  erythromycin  from  Saccarospora  erythraea.  (Cortes  et  al,  1990).  In 
contrast  to  Type  L  Type  II  PKS's  consist  of  individual  enzymes,  each  one  a 
monofunctional  unit.  Several  of  the  aromatic  antibiotics  are  made  by  this  type  of 
system  e.  g.  actinorhodin  from  S.  coelicolor,  tetracenomycin  from  S.  glaucesens  and 
importantly  for  this  study,  oxytetracycline  from  S.  rimosus  (Hopwood  &  Sherman, 
1990).  Both  the  Type  I  and  H  PKSs  are  similar  to  FAS  in  that  they  act  in  conjunction 
with  acyl  carrier  protein  (ACP)  to  catalyse  addition  of  the  building  units. 
Type  III  PKS's  are  key  enzymes  for  the  biosynthesis  of  plant  metabolites. 
Interestingly  these  enzymes  are  unlike  PKS  Type  I  and  II  as  they  do  not  utilise  (ACP) 
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but  act  directly  on  coenzyme-A  (Hahlbrock,  198  1).  Chalcone  synthase  from  parsley  is 
an  example  of  such  a  system. 
In  the  biosynthesis  of  polyketides,  the  full  length  carbon  chain  is  generated  by 
addition  of  appropriate  extender  units  onto  a  starting  acyl  unit  as  in  fatty  acid  synthesis 
(Fig  1.5).  The  starter  for  polyketide  biosynthesis  does  not  have  to  be  acetyl  CoA. 
Oxytetracycline  biosynthesis  begins  with  malonamyl  CoA  (Thomas  &  Williams, 
1983),  daunorubicin  starts  with  propionyl  coA  (Kitamura  et  al,  198  1).  A  variety  of 
extender  units  are  also  used  in  the  biosynthesis  of  polyketides  although  most  use 
malonyl  CoA.  In  erythromycin  biosynthesis  however,  methylmalonyl  CoA  is  used  as 
an  alternative  extender  unit  (Omura  &  Tanaka,  1984).  When  the  chain  reaches  its  final 
length,  it  is  stabilised  by  cyclase  reactions  to  form  aromatic  or  macrolactone  rings. 
During  the  biosynthesis  of  fatty  acids,  the  FAS  has  only  a  limited  number  of  "choices" 
to  make.  The  final  chain  length  must  be  decided  and  in  a  few  versions,  a  choice  of 
starter  unit.  Also,  in  bacteria  where  unsaturated  fatty  acids  are  common,  unsaturation 
results  from  the  loss  of  the  eno-reduction  step  at  one  or  two  points  in  the  chain.  (In 
mammalian  fatty  acid  synthesis,  double  bonds  are  introduced  by  specific  desaturases 
once  the  chain  has  been  completed).  It  is  possible  that  components  of  the  FAS  and 
PKS  systems  could  be  shared  between  the  two  systems.  The  finding  that  the  malonyl 
transferase  gene  for  S.  coelicolor  lies  2.8  mega  bases  away  from  the  act  cluster  and 
next  to  an  ORF  whose  product  resembles  ketoacylsynthase  II  of  E.  coli  gives  weight  to 
this  hypothesis  (Revill  et  al,  1994).  Malonyltransferase  may  indeed  be  shared  between 
the  FAS  and  PKS  clusters  of  S.  coelicolor.  Polyketide  synthesis  can  be  thought  of  as 
an  extended  version  of  fatty  acid  synthesis  involving  a  much  larger  range  of  "choices" 
by  the  PKS.  Reflecting  this,  the  PKS  must  be  more  "highly  programmable"  (Hopwood 
&  Sherman,  1990).  The  unique  feature  of  the  PKS's  is  their  ability  to  chose  different 
starter  units  for  biosynthesis.  Fidelity  of  PKS  programming  is  not  absolute.  S. 
cinnamonensis  produces  the  polyketide  metabolite  monesin  A  as  its  major  polyether 
metabolite.  During  the  synthesis  of  this  molecule,  37  choices  are  required  to  be  made 
by  the  PKS  (Hopwood  &  Sherman,  1990).  Another  molecule,  monesin  B  is  also 
produced  by  the  organism  albeit  in  low  quantities.  Monesin  B  production  is  thought  to 
be  due  to  incorporation  of  propionate  instead  of  butyrate  as  the  fifth  extender  unit 
(Gorman  et  al,  1968). 
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Actinorhodin  produced  by  S.  coelicolor  is  the  best  studied  example  of 
polyketide  production  by  a  type  Il  PKS.  All  the  genes  for  actinorhodin  biosynthesis  lie 
on  a  22kb  stretch  of  the  S.  coelicolor  chromosome  (Malpartida  &  Hopwood,  1984; 
Malpartida  &  Hopwood,  1986).  Many  act  mutations  had  been  mapped  to  this  stretch 
of  DNA  which  complemented  act  mutants  of  class  I  and  III.  These  mutants  were 
deduced  to  be  blocked  in  backbone  building  as  they  did  not  secrete  any  actinorhodin 
intermediates  but  would  produce  actinorhodin  from  intermediates  secreted  by  later 
blocked  mutants  (Rudd  &  Hopwood,  1979).  DNA  from  this  region  was  used  to 
identify  PKS  genes  from  other  antibiotic  producing  Streptomyces  spp.  including  the 
gra  cluster  for  granaticin  production  from  S.  violaceoruber  (Sherman  et  al  1989),  the 
tcm  genes  from  the  tetracenamycin  producer  S.  glaucesens  (Bibb  et  al,  1989)  and  of 
special  interest  to  this  work,  the  otc  genes  from  S.  rimosus  which  encode  the 
oxytetracycline  PKS.  (Butler  et  al,  1989).  This  type  of  work  indicates  that  genes 
encoding  PKS  enzymes  occur  in  distinct  clusters  in  the  Streptomycetes.  This  is  true  for 
all  polyketide  antibiotic  genes  so  far  identified  and  also  for  other  types  of  antibiotic 
synthesis  enzymes.  The  regulatory  and  resistance  genes  are  also  present  within  these 
clusters. 
Polyketide  gene  clusters  share  a  common  aspect  of  their  organisation,  a  group 
of  three  open  readings  frames  that  show  marked  similarity  (Fig  1.6).  The  first  and 
second  ORFs  encode  P  ketoacylsynthase-like  peptides,  although  their  activity  as  such 
is  not  proven.  It  is  thought  that  they  are  translationally  coupled  to  produce  a 
heterodimeric  protein.  The  third  ORF  encodes  the  acyl  carrier  protein  (ACP).  This  is 
important  as  it  shows  that  formation  of  aromatic  polyketides  by  PKS's  is  by  a  pathway 
using  ACP  and  not  similar  to  the  plant  PKS's  which  do  not  require  an  ACP.  A  fourth 
ORF  is  also  present,  often  directly  downstream  of  these  three  well  conserved  regions. 
ORF  4  encodes  cyclase,  the  type  of  which  varies  between  the  different  clusters.  The 
FAS  systems  which  the  aromatic  PKS's  resemble  also  contain  acyl  transferase, 
required  for  transfer  of  the  malonyl  CoA  to  the  ACP  and  a  thioesterase  for  release  of 
the  completed  chain.  Neither  of  these  components  were  identified  in  a  study  of  12 
aromatic  PKS  systems  by  Katz  &  Donadio  (1993).  A  motif  typical  of  acyl  transferase 
function  has  been  identified  in  the  C  terminal  portion  of  ORF  I  (Fernandez-Moreno  et 
al  1992a)  but  whether  any  AT  activity  is  associated  with  ORF  I  remains  to  be  seen. 
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Linear  alignment  of  polyketide  synthase  genes  (Hopwood  &  Khosla,  1992). 
from  (a)  Type  11  PKS  (act,  actinorhodin;  gra,  granaticin;  tcm, 
tetracenomycin;  otc,  oxytetracycline  andfren,  frenolicin);  (b)  Type  I  PKS 
(ery,  erythromycin  and  6-MAS,  6  methylsalicylic  acid);  (c)  Type  III  PKS 
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1.3.2.2  The  Acyl  Carrier  Protein  (ACP) 
All  the  ACP's  from  fatty  acid  and  polyketide  synthesis  have  shown  substantial 
similarity  at  the  amino  acid  level  so  far  to  date.  The  highest  identity  is  found  around 
the  4'  phosphopantenylation  site  of  the  domains  or  subunits  characterised  by  a  highly 
conserved  serine  residue,  the  putative  site  of  pantenylation.  When  the  S.  coelicolor 
ACP  was  replaced  by  that  of  granaticin,  oxytetracycline  and  tetracenomycin  producers, 
a  functional  PKS  resulted  (Khosla  et  al,  1993).  The  products  of  this  PKS  were  similar 
to  actinorhodin  or  to  shunt  products  of  actinorhodin  production  made  by  various  act 
mutants.  The  amounts  of  the  different  compounds  produced  were  variable.  This  may 
be  because  of  differences  in  the  upstream  ribosome  binding  sites  of  the  hybrid 
constructs.  Thus  ACP  concentration  may  be  a  limiting  factor  in  polyketide 
biosynthesis.  This  hypothesis  is  backed  up  by  work  by  Grimm  et  al,  (1994)  which 
stated  that  daunorubcin  synthesis  could  be  reinstated  in  a  null  mutant  of  S.  peuticus  by 
introduction  of  the  tetracenomycin  ACP  on  a  high  copy  number  plasmid.  The  ACP  is 
essential  to  the  function  of  the  PKS  as  replacement  of  a  conserved  serine  residue  with 
an  alternative  amino  acid  resulted  in  loss  of  PKS  function  (Khosla  et  al,  1992). 
The  ACP  from  S.  glaucescens  was  purified  and  this  pure  form  was  found  to  behave  in 
a  similar  way  to  other  ACP's  from  bacteria  and  from  plants  (Summers  et  al,  1995). 
The  organisation  of  S.  glaucescensfabD,  H,  C  and  B  genes  was  shown  to  be  very 
similar  to  that  of  the  FAS  genes  of  E.  coli  (JabH,  D,  F,  G,  and  acpP).  This  suggests 
that  the  PKS  genes  of  S.  glaucescens  may  be  similar  to  those  involved  in  fatty  acid 
synthesis. 
1.4  The  OTC  cluster 
The  major  steps  in  biosynthesis  of  tetracycline  antibiotics  were  elucidated  in  the  late 
1960's  from  studies  on  the  chlortetracycline  producer,  Streptomyces  aureofaciens. 
(McCormick,  1966,1968).  At  that  time  the  genetics  of  industrial  Streptomyces  spp. 
were  not  well  established,  preventing  studies  on  the  biosynthesis  genes.  During  the 
1970's  genetic  investigations  of  Streptomyces  spp.  began  to  develop,  including  genetic 
analysis  of  the  oxytetracycline  producer  Streptomyces  rimosus  (Friend  &  Hopwood, 
197  1).  In  1979,  Pigac  &  Alacevic  showed  that  the  genes  for  OTC  biosynthesis  were 
located  on  the  chromosome  of  S.  rimosus.  By  the  early  1980's,  genetic  manipulation 
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of  Streptomyces  was  well  under  way.  In  1981,  Rhodes  and  his  coworkers  at  Pfizer,  UK 
isolated  a  series  of  OTC  production  negative  mutants  and  classified  them  into  nine 
separate  groups  according  to  the  results  of  cosynthesis  tests.  The  nine  groups  could 
then  be  further  subdivided  into  two  classes,  class  I  mutants,  which  were  the  convertors 
and  class  II  mutants  which  were  the  secretors.  Experiments  using  14C  labelled  acetate 
enabled  the  labelling  of  the  pool  of  OTC  precursors  within  the  cell.  This  myceliurn 
was  then  washed  and  transferred  to  media  containing  growing  unlabeled  mycelia  of 
the  other  non-producing  strain.  It  was  envisaged  that  if  cosynthesis  were  occurring  by 
transfer  of  an  intermediate  between  strains,  labelled  OTC  would  be  produced  when  the 
excretor  was  labelled  but  the  product  would  not  be  labelled  if  the  convertor  was  the 
labelled  strain. 
Previous  work  by  Miller  et  al  (1960)  had  shown  that  certain  S.  aureofaciens 
mutants  did  not  produce  chlortetracycline  because  they  lacked  a  flavin-like  cofactor, 
termed  Cosynthetic  factor  1,  (CSF1).  This  is  required  in  catalytic  amounts  for  the  final 
step  in  the  biosynthetic  pathway.  As  an  identical  step  also  occurs  in  OTC  biosynthesis, 
Rhodes  and  co-workers  investigated  the  importance  of  CSF  I  in  S.  rimosus.  Culture 
filtrate  from  a  CSF1  producing  strain  of  S.  aureofaciens  was  supplied  to  each  OTC 
mutant.  Results  showed  that  there  was  a  requirement  by  S.  rimosus  for  catalytic 
amounts  of  the  active  substance  (Rhodes  et  al,  198  1).  Further  studies  identified  the 
Class  I  mutants  as  being  defective  for  CSF  I  whilst  class  II  mutants  produce  their  own 
CSF  1.  Attention  was  then  switched  to  the  Class  11  OTC  mutants. 
In  order  to  determine  where  in  the  OTC  pathway  (Fig  1.7)  the  various  mutants 
were  blocked,  known  OTC  intermediates  were  added  to  liquid  cultures  of  all  the  class 
II  mutants.  When  the  supplied  compound  was  converted  to  OTC,  the  mutant  was 
presumed  to  be  blocked  at  the  previous  step  to  the  added  intermediate.  All  but  one  of 
the  class  11  mutants  (otc-25)  could  convert  7-chloro-dehydrotetracycline  (7-  chloro- 
DHTC)  to  7-  chloro-oxytetracycline  (7-  chloro-OTC)  via  7-  chloro-dehydro- 
oxytetracycline,  (7-  chloro-DHOTC).  This  mutant  was  assumed  to  be  unable  to 
perform  the  DHOTC  to  OTC  conversion  (step  9)  rather  than  being  blocked  in  the 
Previous  step.  As  DHTC  naturally  converts  to  tetracycline  (TET),  this  product  was  not 
identified.  This  mutation  was  assigned  to  a  locus  called  otcA.  Another  class  II  mutant 
(0tc-75)  could  carry  out  the  conversion  of  7-chloro-DHTC  to  7-chloro-OTC  but  not 
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ATC  to  OTC,  thus  it  was  blocked  in  the  C-6-hydroxylation  of  ATC  (otcC).  A  further 
mutant,  (otc-4)  was  able  to  convert  anhydrotetracycline  (ATC)  to  oxytetracycline  but 
not  4-amino  anhydrotetracycline  to  OTC  demonstrating  a  formation  of  4-amino-ATC 
this  mutant  was  assigned  to  locus  otcD.  None  of  the  mutants  that  appeared  to  be 
blocked  before  4-amino  ATC  (otc-20,  -90  and  -151)  could  convert  the  earlier 
precursors  6MPT  or  4-hydroxy-6MPT  to  OTC.  As  thse  mutants  could  cosynthesize 
with  each  other  they  were  deduced  to  be  blocked  at  different  steps  and  were  assigned 
to  loci  otcX,  Y  and  Z.  The  deduced  product  of  otcZ  shows  similarity  to  hydroxyindole 
o-methyl  transferases  and  to  the  carboxyl  domain  of  a  putative  o-methytransferase. 
Since  the  otcZ  mutant  was  blocked  somewhere  before  4-amino-ATC  (Rhodes  et  al, 
1981)  it  was  suggested  that  its  gene  product  was  involved  in  6-methylation  of  the 
pretetramid  structure  (polyketide  backbone).  However  as  the  mutant  could  convert 
neither  6MPT  or  4-amino-6MPT  to  OTC  the  implication  is  that  it  contains  mutations 
at  more  than  one  locus.  Transcriptional  analysis  (McDowall  et  al,  1991)  has  revealed 
the  existence  of  two  divergent  promoters,  one  which  directs  transcription  of  a 
polycistronic  message  containing  otcC-otcZ-otrA  and  the  other  direction  transcription 
of  otcX  genes.  The  product  of  otcX-ORFI  shows  similarity  to  actVA-ORF2  sequence 
of  actinorhodin  biosynthesis  (Caballero  et  al,  1991).  These  two  genes  are  likey  to  be 
involved  in  ring-hydroxylation  reactions. 
From  work  done  by  Aranthip  Thamchaipenet  in  this  laboratory,  it  is  now 
known  that  otcD  contains  two  ORF's,  otcD  ORF  I  which  encodes  a  putative 
cyclase/deydrase  enzyme  predicted  to  catalyse  one  or  more  of  the  aldol  cyclisations  of 
the  polyketide  chain  before  the  pretetramid  is  formed,  and  otcD  ORF2  which  lies 
directly  downstream  from  otcD  ORF  I  and  encodes  a  product  similar  to  several 
bacterial  hydroxylases  including  the  TcmG  hydroxylase  of  thq  tetracenomycin  cluster 
(Decker  &  Hutchinson,  1993).  This  protein  is  predicted  to  act  as  a  hydroxylase  either 
before  the  formation  of  4  amino  ATC  or  in  the  later  hydroxylation  step  at  the  fifth 
carbon  position  of  OTC.  These  findings  are  in  dispute  with  the  original  assignment  of 
otcD  as  a  methylase.  The  current  model  of  the  OTC  cluster,  (  Fig  1.8)  includes  two 
methylase  genes,  otcZ  as  discussed  above,  and  otcY  I  ORF5,  which  is  thought  to  fulfill 
the  second  methylation  requirement  of  OTC  biosynthesis  in  converting  4  amino  ATC 
to  ATC. 
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Further  work  by  Thamchaipenet  (1994)  has  also  gone  some  way  to  revealing 
the  functions  of  the  otcY  locus.  Initial  work  probing  S.  rimosus  genomic  DNA  with 
ketosynthase  genes  from  the  S.  coelicolor  act  cluster  showed  otcY  to  be  present  as  two 
clusters,  otcYl  and  otcY2  separated  by  8Kb  of  chromosome,  contrasting  with  the 
organisation  in  S.  coelicolor  where  the  genes  lie  adjacent  to  one  another.  The  otcY2 
region  was  sequenced  (Thamchaipenet,  1994)  revealing  the  presence  of  four  open 
reading  frames,  discussed  below. 
otcY2  orfl: 
Encodes  a  polypeptide  with  considerable  homology  to  the  actIll  gene  product  of  S. 
coelicolor,  the  putative  ketoreductase  enzyme  and  also  to  a  similar  peptide  from  the 
gra  cluster.  It  is  suggested  that  otcY2  orf  I  encodes  a  protein  that  catalyses  the 
ketoreduction  at  the  ninth  carbon  from  the  end  of  the  polyketide  chain. 
otcY2  orf2: 
The  deduced  peptide  sequence  of  this  gene  showed  some  similarities  to  the  P  subunit 
of  benzene  and  toluene  dioxygenase  from  P.  putida  and  also  to  the  actVI  andfren  orjX 
gene  products,  the  functions  of  which  are  not  known. 
otcY2  orf3: 
The  putative  product  of  this  gene  displayed  similarities  to  the  adenylate  forming 
enzyme  super-family,  members  of  which  originate  from  a  variety  of  sources.  This  gene 
is  thought  to  encode  a  malonamate-CoA  ligase,  probably  involved  in  malonamyl  CoA 
(starter  unit)  formation. 
otcY2  orM 
Lying  downstream  of  otcY2  or  f3,  otcY2  orN  encodes  a  small  protein,  highly  similar  to 
one  of  the  S.  aureofaciens  tetracycline  dehydrogenase  subunits.  This  subunit  is 
involved  in  the  final  step  of  antibiotic  synthesis  in  that  pathway.  A  similar  function 
can  be  postulated  for  the  otcY2  orf4  gene  product  in  the  OTC  pathway. 
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The  position  of  this  "late"  gene  amongst  genes  which  encode  rather  more  "early" 
functions  in  OTC  synthesis  is  interesting. 
Subsequent  to  this,  the  region  between  otcYl  and  otcY2  was  also  sequenced, 
(Thamchaipenet,  this  laboratory)  and  was  shown  to  contain  two  otcY  ORFs,  that  did 
not  hybridise  to  the  act  ketosynthase  probe,  otcY2-4  and  otcY2-5  are  thought  to 
encode  dehydrase  and  methylase  respectively.  Also  present  in  this  region  are  two 
further  otcYI  ORFs,  otcYI-4,  thought  to  encode  asparaginase  and  otcYI-5,  thought  to 
code  for  hydroxylase.  Once  all  the  sequencing  data  was  collated  it  became  apparent 
that  otcYI  and  otcY2  lie  next  to  each  other  on  the  chromosome  as  in  other  polyketide 
biosynthesis  cluster  found  in  Streptomyces 
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As  discussed  in  section  1.3,  polyketide  synthesis  genes  are  found  as  distinct  clusters. 
However,  initial  work  on  OTC  biosynthesis  genes  identified  two  clusters  of 
biosynthesis  genes,  the  4  o'clock  containing  otcD,  X,  Y  and  Z  and  the  10  o'clock 
containing  otcA  and  otcC,  so  named  because  of  their  position  on  the  S.  rimosus  genetic 
map  (Rhodes  et  al,  1984).  The  genes  of  the  4  o'clock  cluster  were  believed  to  be 
responsible  for  steps  up  to  the  formation  of  ATC  ("early"  genes)  and  the  10  o'clock 
cluster  genes  for  steps  after  this  point  ("late"  genes).  In  disagreement  with  this 
hypothesis,  otcC,  encoding  ATC  oxygenase  was  shown  by  reverse  genetics  to  map  to 
the  4  o'clock  cluster  (Binnie  et  al,  1989).  These  findings  were  augmented  by 
functional  evidence  in  the  form  of  complementation  tests  with  a  mutant  of  S.  rimosus 
deleted  for  the  entire  cluster.  This  complementation  led  to  the  question,  "were  all  the 
OTC  genes  located  on  the  4  o'clock  cluster?  "  This  was  indeed  shown  to  be  the  case.  A 
plasmid  carrying  this  cluster  on  a  34kb  fragment  of  S.  rimosus  chromosome  is  able  to 
confer  OTC  production  on  the  non  producers  S.  albus  and  S.  lividans  (Binnie  et  al, 
1989).  The  10  o'clock  cluster  probably  contains  genes  for  CSF1  biosynthesis. 
Early  studies  showed  the  OTC  cluster  to  be  linked  to  resistance  determinants 
(Rhodes  et  al  1981).  The  OTC  cluster  is  physically  linked  to  within  30kb  of  the 
genome  and  is  flanked  at  each  end  by  resistance  determinants  (Butler  et  al,  1989).  This 
was  deduced  by  the  isolation  of  OTC  resistant  clone  from  a  S.  rimosus  genetic  library, 
and  restriction  analysis  mapping  of  the  OTC  resistance  gene,  otrA  to  within  the  OTC 
cluster.  During  the  process  of  this  work  a  second  resistance  determinant,  quite 
different  from  otrA  was  identified  and  named  otrB.  Work  carried  out  independently  of 
that  of  Butler  and  co-workers  by  Ohnuki  et  al  (1985),  reciprocates  the  findings  that  the 
OTC  cluster  has  two  resistance  genes.  These  two  genes,  tetA  and  tetB  were  cloned 
from  S.  rimosus  and  expressed  in  the  non  OTC  producer,  S.  griseus,  in  which  they 
conferred  resistance  to  OTC  independently  of  each  other.  The  genes  tetA  and  tetB  are 
homologous  to  otrA  and  otrB  respectively  (Binnie  et  al,  1989).  Measurement  of 
polyphenylalanine  synthesis  using  purified  ribosomes  and  the  S  150  fraction  from  both 
host  and  tetA  transformants  indicated  that  the  resistance  specified  by  tetA  was  mainly 
in  the  ribosomal  fraction.  No  resistance  could  be  observed  once  ribosomes  has  been 
washed  in  ammonium  chloride.  Resistance  encoded  by  otrA  is  mediated  by  a 
cytoplasmic  factor  but  not  a  constituent  of  the  ribosome  (Ohnuki  et  al,  1985). 
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The  sequence  of  otrA  has  been  determined  (Doyle,  1987).  The  predicted  amino 
acid  sequence  shows  high  homology  with  TET  resistance  genes  from  other  bacteria 
that  mediate  their  resistance  through  non-covalent  modification  of  ribosomes,  e.  g. 
tetM  of  Streptococcus  and  tetO  from  Campylobacter  (  Doyle  et  al,  199  1).  The  N- 
terminal  domain  of  OtrA  shows  marked  similarity  with  the  GTP  binding  sites  of 
elongation  factors  required  for  protein  synthesis,  suggesting  that  GTP  hydrolysis  may 
be  important  in  the  function  of  OtrA.  Genes  homologous  to  tetM  and  tetO  are  present 
in  a  number  of  bacterial  spp.  (Salyers  et  al,  1990).  It  is  clear  that  they  are  all  related  to 
otrA  .  Indeed  it  has  been  speculated  that  resistances  of  this  type  found  in  clinical 
isolates  may  be  due  to  horizontal  transfer  at  some  point  in  the  past,  followed  by 
sequence  divergence  (Benveniste  &  Davies,  1973).  Promoter  analysis  of  otrA  has  lead 
to  the  finding  that  during  vegetative  growth,  otrA  is  transcribed  from  its  own  promoter 
otrA  pl  (Doyle  et  al,  1988),  with  the  transcription  start  127  nucleotides  upstream  of 
the  translational  start  site.  otrA  pl  is  similar  to  the  consensus  sequence  of  many  E.  coli 
promoters.  During  antibiotic  production  this  promoter  is  no  longer  used  and  otrA  is 
transcribed  as  part  of  a  polycistronic  transcript  which  also  includes  otcC  and  otcz. 
This  change  in  promoter  activity  may  reflect  the  use  of  multiple  sigma  factors  as  seen 
in  morphological  differentiation  of  other  Streptomyces  spp.  In  contrast  to  these  results, 
the  protein  synthesis  of  S.  griseus  carrying  the  tetB  gene  was  sensitive  to  OTC. 
Measurement  of  uptake  of  labelled  OTC  revealed  that  the  tetB  cells  accumulated  less 
intracellular  OTC  than  their  tetA  counterparts.  This  reduced  accumulation  was  also 
observed  for  S.  rinzosus.  It  was  then  suggested  that  otrB  (tetB)  encoded  a  protein 
responsible  for  the  reduced  accumulation  of  OTC  inside  the  cell. 
Efflux  as  a  tetracycline  resistance  mechanism  has  been  widely  studied  in  the 
enteric  bacteria  (McMurray  et  al,  1980;  Kaneko  et  al  1985;  Chopra,  1986). 
otrB  was  cloned  into  E.  coli  and  sequenced  as  tet347  (Reynes  et  al,  1988).  The 
deduced  347  amino  acid  peptide  sequence  shows  a  limited  but  significant  homology  to 
other  tetracycline  resistance  proteins  characterised  at  the  time.  Later  work  by 
MacGregor-Pryde  (1995)  in  this  laboratory  showed  that  this  sequence  was  truncated 
and  contained  some  mistakes.  This  work  also  presented  preliminary  analysis  of  the 
deduced  OtrB  product,  thought  to  be  a  transmembrane  protein  containing  14  membrane 
spanning  alpha  helices  (MacGregor-Pryde,  1995).  Further  work  to  clarify  sequence 
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details  is  presented  in  Chapter  3  of  this  thesis,  resulting  in  a  modified  otrB  sequence. 
(Fig  3.10).  The  otrB  gene  and  gene  product  are  discussed  more  thoroughly  in  the 
experimental  chapters  of  this  thesis. 
1.5.  Antibiotic  resistance 
Organisms  that  produce  antibiotics  must  somehow  render  themselves  resistant  to  their 
products  if  they  are  to  survive.  Early  ideas  on  antibiotic  production  were  that  such 
molecules  were  only  produced  once  the  growth  phase  comes  to  an  end.  However,  in 
some  organisms  antibiotic  production  overlaps  with  growth  phase,  even  though  the 
maximum  production  of  antibiotic  still  occurs  as  the  organisms  reach  stationary  phase. 
In  such  organisms,  expression  of  genes  that  encode  resistance  functions  should  be 
constitutive.  Although  many  producer  organisms  comply  with  the  early  hypothesis, 
constitutive  expression  of  resistance  genes  does  occur  in  some  organisms  (Cundliffe, 
1989).  Antibiotic  producers  have  a  range  of  defensive  options  open  to  them. 
Mechanisms  of  resistance  employed  by  producer  organisms  include,  (1)  Modification 
of  intracellular  drug  molecules  causing  inactivation,  (2)  Modification  of  the  target  site, 
(3)  Synthesis  of  novel  cellular  components  in  place  of  the  drug  target  and  (4)  Efflux  of 
the  drug  from  the  cell. 
The  mechanisms  of  resistance  discussed  below  are  all  taken  from  Streptonlyces  spp.  as 
befits  the  context  of  this  thesis. 
1.5.1  Modification  of  drug  molecules. 
Antibiotic  modification  in  producer  organisms  usually  occurs  due  to  one  of  two  main 
mechanisms,  N-acetylation  of  amino  groups  from  an  acetyl  CoA  donor  or  0- 
phosphorylation  of  hydroxyls  at  the  expense  of  ATP,  these  methods  of  resistance  are 
also  found  in  some  clinical  isolates.  Although  these  are  the  main  modification  steps 
other  methods  are  also  used-,  0-adenylation  is  common  amongst  clinical  strains  as  a 
resistance  mechanism  (Hollingshead  &  Vapnek,  1985)  but  has  not  been  found  in 
antibiotic  producers  (Cundliffe,  1989).  Another  modification  to  attain  drug  resistance 
is  the  0-acetylation  of  chloramphenicol.  Although  this  is  widespread,  both  in  Gram 
negative  and  positive  bacteria  including  Streptomyces  it  has  not  been  found  in 
organisms  that  produce  the  drug.  (Nakano  et  al,  1977).  Examples  of  drugs  that  are 
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inactivated  by  modification  are  the  aminoglycosides  neomycin  and  kanamycin. 
Streptomycin  is  another  example.  Neomycin  producers  such  as  S.  fradiae  have 
arninoglycoside  phosphotransferase  (APH)  and  acetyltransferase  (AAC)  activities.  The 
ribosomes  of  these  organisms  are  sensitive  to  the  drug  throughout  the  life  cycle.  It  is 
thought  that  the  two  modifying  enzymes  may  act  synergistically  to  bring  about  full 
resistance  as  strains  of  S.  lividans  expressing  only  one  of  the  genes  from  S.  fradiae 
were  less  resistant  than  strains  transformed  with  both  (Thompson  et  al,  1982). 
The  producer  of  kanamycin,  S.  kanamyceticus,  displays  AAC(6')  activity 
although  its  function  does  not  appear  to  be  resistance.  Activity  of  the  enzyme  is  at  a 
maximum  during  the  growth  phase  and  declines  just  prior  to  drug  production  (Satoh  et 
al,  1975).  Extra  copies  of  the  AAC  gene  resulted  in  higher  yields  of  kanamycin  and 
when  transformed  into  S.  fradiae,  in  higher  neomycin  yields,  even  though  this  activity 
is  not  normally  present  in  that  organism  (Crameri  &  Davies,  1986).  It  seems  then  that 
AAC  activity  may  be  involved  in  acetylation  of  intermediates  in  kanamycin 
production,  its  role  in  neomycin  production  is  unclear. 
In  S.  griseus  and  S.  bikiniensis,  streptomycin  phosphorylation  occurs.  The  principal 
enzyme  in  both  species  is  SPH(6),  originally  identified  as  the  product  of  the  aphD 
gene  of  S.  grisetts.  SPH  (3")  and  (Ya)  phosphotransferase  activities  have  also  been 
found  in  S.  griseus  and  S.  bikiniensis  respectively  (Walker  &  Skorvaga,  1973a, 
1973b).  Other  examples  of  antibiotic  inactivation  by  modifcation  are  the  7"-0- 
phosphorylation  of  hygromycin  B  in  S.  hygroscopicus  (Leboul  &  Davies,  1982)  and 
puromycin-N-acetyltransferase  activity  in  S.  alboniger  (Sugiyama  et  al,  1985). 
1.5.2  Modification  of  target  sites. 
Higher  levels  of  resistance  can  be  achieved  by  this  mechanism  than  are  reached  by 
antibiotic  inactivation  (Cundliffe,  1989).  One  of  the  most  well  documented 
modifications  of  cellular  components  in  producer  organisms  is  that  of  the  ribosome. 
Ribosomal  modification  is  common  in  those  Streptornycetes  that  produce  antibiotics 
whose  mode  of  action  is  inhibition  of  protein  synthesis  by  binding  to  ribosomes.  Not 
all  strains  that  produce  this  type  of  antibiotic  protect  themselves  by  ribosomal 
modification,  e.  g.  streptomycin  in  S.  griseus  as  discussed  above.  Analysis  by  Calcutt 
&  Cundliffe  (1989)  has  shown  that  ribosomal  resistance  is  most  often  due  to  some 
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property  of  the  rRNA.  Resistance  in  several  Streptomyces  strains  is  mediated  by 
methylation  of  the  rRNA.  In  most  of  the  organisms  identified,  ribosomal  resistance 
can  be  attributed  to  the  product  of  a  single  methylase  gene  acting  upon  a  single 
specific  site  in  the  rRNA  resulting  in  resistance  to  a  certain  antibiotic  or  group  of 
antibiotics  (Cundliffe,  1989).  There  are  however  exceptions:  S.  tenebrarius  has  two 
RNA  methylase  genes  and  displays  resistance  to  a  much  larger  array  of  drugs. 
Another  method  of  ribosomal  protection  in  Streptomycete  antibiotic  producers 
is  by  interaction  with  soluble  cytoplasmic  proteins,  as  exemplified  by  the  otrA  gene 
product  in  S.  rimosus.  The  exact  way  in  which  resistance  is  bestowed  on  the  ribosome 
by  these  interactions  is  not  yet  known.  The  72  kDa  OtrA  product  shows  similarity  to 
the  TetM  and  TetO  resistance  proteins  of  Gram-positive  bacteria.  These  three  peptide 
sequences  all  also  show  some  sequence  identity  with  the  GTP  binding  sites  of  known 
elongation  factors  EF-Tu  and  EF-G  (Doyle  et  al,  199  1;  Salyers  et  al,  1990).  However 
although  it  hydrolyses  GTP,  TetM  does  not  substitute  for  EF-Tu  in  Bacillus  subtilis  or 
E.  coli  (Burdett,  199  1). 
1.5.3  Syntliesis  of  novel  resistant  cellular  components 
This  type  of  antibiotic  resistance  is  typified  by  the  novobiocin  producer,  Streptomyces 
sphaeroides.  Novobiocin  acts  by  inhibiting  the  P  subunit  of  the  DNA  gyrase  enzyme. 
This  enzyme  is  a  heterodimer  comprising  C(2  02  subunits,  it  acts  as  a  topoisomerase, 
introducing  negative  supercoils  into  covalently  closed  circular  DNA.  The  target  of 
novobiocin  is  the  P  subunit,  an  ATPase  which  energises  the  nuclease  reaction  carried 
out  by  subunit  1.  In  S.  sphaeroides  there  is  a  novel  DNA  gyrase  P  subunit,  gyrB' 
whose  function  is  not  affected  by  novobiocin  and  is  induced  in  the  presence  of  the 
drug.  Peculiarly,  S.  sphaeroides  also  possesses  a  novobiocin  sensitive  0  subunit.  It  is 
unclear  why  this  has  not  been  superceded  in  the  cell  by  the  resistant  version  but  may 
concern  the  status  of  the  DNA  superhelicity.  Regulation  of  the  resistant  gyrB'  subunit 
is  controlled  by  a  promoter  that  is  sensitive  to  the  supercoiling  of  the  DNA  at  that 
locus,  gyrB'  is  induced  by  a  reduction  of  superhelicity,  a  phenomenon  that  can  result 
from  the  action  of  novobiocin. 
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1.5.4  Export  of  the  drug 
Each  organism  that  produces  an  antibiotic  possesses  a  mechanism  for  secretion  of  the 
final  product.  This  mechanism  can  also  be  looked  upon  as  a  resistance  mechanism 
exporting  any  molecules  which  have  re-entered  the  cell.  Export  as  a  resistance 
mechanism  is  prevalent  among  clinical  strains  and  very  well  documented  in  the 
literature,  see  section  1.6.2  for  a  discussion  of  tetracycline  efflux. 
Drug  efflux  in  the  Streptomyces  was  first  identified  in  S.  coelicolor,  which 
produces  a  number  of  antibiotics  including  methylenomycin.  The  methylenomycin 
biosynthetic  genes  are  entirely  plasn-dd-bome,  as  is  the  resistance  determinant  mmr. 
The  amino  acid  sequence  of  the  Mmr  protein  was  shown  to  have  many  similarities  to 
the  export  genes  of  Gram  negative  bacteria  (Neal  &  Chater,  1987).  It  is  now  known 
that  Mmr  and  several  other  Streptomyces  drug  exporters,  including  OtrB,  the  focus  of 
this  study,  belong  to  a  wide  ranging  and  rapidly  expanding  family  known  as  the  Major 
Facilitator  Superfamily  (  Paulsen  et  al,  1996).  The  MFS  and  its  members  are  discussed 
thoroughly  in  section  1.7. 
1.6  Tetracycline  &  Tetracycline  resistance. 
1.6.1  Tetracyclines 
Tetracyclines  are  a  group  of  polyketide  antibiotics  based  on  a  four  ring  structure  (tetra 
=  4),  all  of  which  are  produced  by  Streptomycetes  with  S.  aureofaciens  and  S.  rimostis 
being  the  most  commercially  important  producers.  S.  rimosus  is  the  producer  of 
oxytetracycline  S.  aureofaciens  strains  produce  tetracycline  and  chlortetracycline,  the 
ratio  of  which  can  be  varied  with  the  concentration  of  chloride  ions  present  in  the 
growth  media.  Tetracyline  are  important  broad  spectrum  antibiotics  that  are  still  in 
wide  use  today  despite  being  amongst  the  first  antibiotic  drugs  discovered.  As  well  as 
the  molecules  mentioned  above,  the  tetracycline  group  also  includes 
demethyltetracyclines  (McCorn-Lick  et  al,  1957)  and  decarboxymide  tetracycline 
derivatives,  (Hochstein  et  al,  1960).  Modern  semisynthetic  tetracycline  analogues 
include  doxycycline,  minocycline  and  the  group  of  drugs  known  as  the  glycylglycines 
(Fig  1-9).  As  well  as  being  active  against  Gram-positive  and  negative  bacteria, 
tetracyclines  are  also  used  to  combat  infections  by  spirochaetes,  mycoplasmas  and 
rickettsiae.  Although  they  are  all  closely  related  in  structure  they  differ  in 
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antimicrobial  activity  and  therapeutic  effect.  CTC  tends  to  be  used  on  Gram-positive 
cocci  whereas  TC  is  said  to  be  more  active  against  Gram-negative  bacilli 
(Durckheimer,  1975). 
The  mode  of  action  of  tetracyclines  is  the  inhibition  of  bacterial  protein  synthesis,  with 
the  target  site  of  the  drug  localised  on  the  ribosome.  The  drug  works  by  interfering 
with  binding  of  the  ternary  complex  aminoacyl-tRNA-EFru-GTP  on  the  acceptor  site 
of  the  30s  subunit  of  the  ribosome.  Atypical  tetracyclines  such  as  chelocardin  and 
anhydrotetracycline  exhibit  bactericidal  activity  but  are  poor  inhibitors  of  protein 
synthesis  (Chopra,  1994).  It  is  suggested  that  these  drugs  target  the  cytoplasmic 
membrane  rather  than  the  ribosome  (Oliva  et  al,  1992),  as  they  cause  alterations  in  cell 
morphology  and  trigger  the  release  of  P-galactosidase  from  the  cytoplasm.  As  would 
be  expected  the  well-documented  tetracycline  resistance  determinants  that  operate  by 
efflux  or  ribosomal  protection  do  not  impart  resistance  to  these  compounds  (Oliva  & 
Chopra,  1992).  Such  molecules  are  of  no  therapuetic  use  due  to  the  severe  side  effects 
experienced  by  users,  probably  because  the  action  of  such  drugs  on  the  membrane  is 
not  prokaryote-specif  ic  (Rogalski,  1985). 
Several  properties  of  the  drugs  make  for  near-perfect  therapuetic  agents, 
1)  They  are  active  against  a  broad  range  of  pathogens 
2)  They  are  well  absorbed  when  administered  orally 
3)  They  are  relatively  non-toxic 
4)  They  cause  few  allergic  reactions 
5)  They  are  cheap  to  produce 
These  properties  have  led  to  massive  use  of  the  drugs  for  over  40  years,  not  only  in 
medicine  but  also  as  food  supplements  in  animal  husbandry  and  fish  farming.  As  is  to 
be  expected,  due  to  the  selective  pressure  caused  by  such  extensive  use  a  growing 
number  of  bacterial  species  are  acquiring  resistance  to  tetracyclines. 
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Tetracycline  and  tetracycline  analogues;  Tetracycline,  Oxytetracycline, 
Doxycycline,  Minocycline  and  DMG-Mino  (a  member  of  the 
glycylglycine  group  of  drugs). 
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1.6.2  Resistance  to  tetracyclines 
Up  until  the  start  of  the  1990's,  reduced  accumulation  was  the  only  mechanism  of 
tetracycline  resistance  found.  Resistance  due  to  tetracycline  efflux  in  this  way  is  the 
most  dominant  resistance  mechanism  amongst  the  Enterobacteriacae  but  is  not  the 
main  method  of  resistance  in  other  groups  of  bacteria. 
There  are  three  mechanisms  of  tetracycline  resistance  observed  so  far  in  bacteria,  (1) 
reduced  cellular  accumulation  (efflux),  (2)  ribosomal  protection,  (3)  antibiotic 
inactivation.  Classification  of  tetracycline  resistance  proteins  is  based  on  the 
mechanism  of  resistance  with  each  tet  class  being  designated  a  capital  letter.  Proteins 
of  the  same  class  are  grouped  together  in  the  alphabet  (Levy  et  al,  1989).  Although 
resistance  determinants  of  producer  organisms  are  usually  physically  linked  in  the 
genome  to  biosynthesis  genes  this  is  obviously  not  the  case  in  non  antibiotic 
producers.  In  these  organisms,  resistance  genes  are  often  located  on  transposons, 
conjugative  plasmids  or  other  such  mobile  genetic  elements  (Roberts,  1994). 
1.6.2.1  Tetracyline  efflux 
There  are  presently  II  classes  of  tetracycline-specific  efflux  pumps,  TetA(B-E,  )  (G), 
(H),  K,  L,  P  and  OtrB.  (Table  3.1)  (TetA(B-E)  and  TetA(G)  and  (H)  occur  in  Gram- 
negative  bacteria,  the  amino  acid  identities  between  these  proteins  range  from  45-78%. 
TetK,  L,  P  and  OtrB  are  all  found  in  Gram-positives  but  show  only  slight  similarities 
in  their  amino  acid  sequences  (Sheridan  &  Chopra,  199  1).  These  proteins  do  not 
constitute  a  family  of  homologous  proteins,  although  members  of  the  TetK  and  TetL 
groups  do  show  significant  sequence  identity  with  each  other  (64-80%;  Ives  &  Bott, 
1990).  TetP  and  OtrB  on  the  other  hand  show  no  more  similarity  to  TetK/L  than  they 
do  to  the  Gram-negative  tet  proteins  (Sloan  et  al,  1994;  this  work). 
Efflux  determýinants  from  Gram-negative  bacteria  share  a  common  genetic 
organisation  in  that  tetR,  a  repressor  gene  is  located  next  to  tetA  in  a  divergent 
orientation.  The  TetR  protein  binds  to  two  tet  operator  sequences  located  in  the 
intergenic  region  in  the  absence  of  tetracycline  and  by  doing  so,  represses  transcription 
of  tetA  and  tetR.  When  tetracycline  is  present,  the  TetR-[TET-M  2+  ]  complex, 
consisting  of  the  repressor  protein,  tetracycline  and  a  metal  dication,  is  formed.  This 
allows  coinduction  of  tetA  and  tetR  expression. 
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It  was  thought  that  no  such  transcriptional  repressor  protein  existed  in  the  Gram- 
positive  tetracycline  resistant  bacteria  (Schnappinger  &  Hillen,  1996).  However, 
since  1991,  it  has  been  recognised  that  antibiotic  efflux  resistance  systems  from 
Streptomyces  spp.  probably  also  possess  resistance/repressor  systems  utilising 
resistance  and  repressor  genes  transcribed  divergently  from  overlapping  promoters 
(Neal  &  Chater,  199  1,  Cabellero  et  al,  199a,  Guilfbile  &  Hutchinson,  1992). 
The  upstream  region  of  the  otrB  resistance  determinant  from  S.  rimosus  was 
found  to  encode  a  repressor-like  protein  with  high  similarity  to  the  TcmR  protein 
from  S.  glaucesens  (MacGregor-Pryde,  1995).  TcmR  itself  is  similar  to  several  TetR 
repressor  proteins,  including  that  from  Tn]O.  Also  revealed  by  these  studies  is  the 
similarity  between  OtrR  and  the  marO  gene  product  of  Exo1i.  MarO  is  a  tetracycline 
inducible  multiple  resistance  protein.  All  of  these  proteins  contain  a  helix-turn-helix 
(HTH)  motif  similar  to  that  found  in  the  bacteriophage  434  repressors.  Analysis  of 
the  otrRlotrB  intergenic  region  by  MacGregor-Pryde  (1995)  revealed  similarity  to 
resistance/repressor  regions  from  other  antibiotic-producing  Streptomyces  a.  Several 
of  these  regions  contained  palindromic  sequences,  thought  to  be  operator  sequences. 
The  presence  of  these  putative  operator  sequences  coupled  with  the  similarity  of 
OtrR  to  other  HTH-containing  repressor  proteins  led  to  the  assignment  of  a  tet 
repressor  function  to  otrR. 
If  other  Gram-positive  Tet  proteins  are  not  repressor  regulated,  what  is  the 
mode  of  regulation?  TetK  and  TetL  mRNA's  show  sequence  similarity  to  mRNA's 
regulated  by  translational  attenuation,  which  has  been  suggested  as  the  most  probable 
regulatory  mechanism  for  expression  of  these  genes  (Speer  et  al,  1992).  The  method 
of  regulation  of  TetA(P)  however,  seems  to  be  different  again.  TET  resistance  from 
this  locus  is  inducible  but  mRNA  from  TetA(P)  shows  no  structures  typical  for 
proteins  regulated  by  attenuation.  TetA(P)  is  present  on  a  conjugative  plasmid.  As 
plasmids  that  contain  only  the  resistance  genes  mediate  constitutive  resistance, 
regulation  must  be  by  some  other  method.  Sequence  analysis  by  Sloan  et  al  (1994) 
revealed  no  putative  regulatory  gene  in  the  vicinity  of  tetA(P). 
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1.6.2.2  Gram-negative  TetA  proteins,  structure/function  studies 
Most  of  the  structure-function  studies  to  determine  the  molecular  basis  for 
tetracycline  resistance  by  such  resistance  "pumps"  have  been  carried  out  on  TetA(B) 
from  the  Exo1i  transposon,  TnIO.  There  is  now  a  wealth  of  information  concerning 
the  topology,  three  dimensional  structure  and  putative  substrate  binding  site  of  the 
protein  and  also  information  concerning  energisation  of  the  efflux  process,  much  of 
which  has  been  elucidated  by  the  group  of  Yamaguchi  and  co-workers  in  Japan. 
Much  of  the  knowledge  regarding  TetA(B)  can  also  be  applied  to  the  other  Gram- 
negative  tet  proteins. 
To  summarise,  these  proteins  are  a  group  of  membrane  proteins  comprised  of 
12  membrane  spanning  regions,  most  probably  (x  helices,  connected  by  cytoplasmic 
and  periplasmic  loops  (Eckert  &  Beck,  1989).  The  TetA  proteins  are  metal- 
tetracycline/proton  antiporters  that  pump  their  substrate  into  the  periplasm  (Thanassi 
et  al,  1995).  The  energy  required  for  this  process  is  provided  by  the  pH  gradient 
across  the  cytoplasmic  membrane  but  the  electrical  transmembrane  potential  is  not 
required.  (Kaneko  et  al,  1985).  These  observations  lead  to  the  reasoning  that 
tetracycline  efflux  by  the  TetA  group  of  resistance  proteins  is  an  electrically  neutral 
process. 
Residues  essential  to  tetracycline  binding  and  translocation  are  situated  in 
various  locations  in  the  protein  but  only  one  such  essential  amino  acid,  D66,  is found 
in  the  loop  regions  (Yamaguchi  et  al  1990).  D66  is  to  be  found  in  the  cytoplasmic 
loop  that  link  the  second  and  third  transmembrane  helices  (TMH2  and  TMH3).  This 
loop  contains  a  conserved  motif,  GXXXXRXGR  running  from  G62  -R7  1,  that  is 
common  not  only  to  the  tet  proteins  but  to  a  much  wider  series  of  transport  proteins, 
the  Multi-Facilitator  Superfamily  (see  section  1.7  and  Chapter  3  for  more 
information).  Mutational  analysis  of  this  loop  has  shown  that  only  R70  is  essential 
for  function  of  the  protein  (Yamaguchi  et  al,  1992a).  As  mutation  of  G62  or  G69  to 
amino  acids  that  have  a  low  propensity  to  form  0  turns  leads  to  reduced  activity  of 
the  protein,  it  is  thought  that  the  ability  of  loop  2-3  to  form  a0  turn  is  important  for 
protein  function  (Yamaguchi  et  al,  1992a).  The  Gram-negative  Tet  proteins  are 
hypothesised  to  have  evolved  from  a  gene  duplication  event  as  they  are  comprised  of 
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two  structurally  symmetrical  halves  (Rubin  et  at,  1990).  Loop  8-9  corresponds  to 
loop  2-3  according  to  this  hypothesis  (Yamaguchi  et  at,  1992b).  However  none  of  the 
residues  in  this  region  is  required  for  protein  function  (Yamaguchi  et  at,  1993;  1994) 
It  has  been  suggested  that  loop  2-3  and  loop  8-9  might  form  the  substrate  entrance 
gate  (Yamaguchi  et  at,  1990,1993).  Helix  3  is  thought  to  be  important  for  transport 
of  the  TET-M  2'  complex  as  substitution  of  S77  with  aC  residue  shows  no  transport 
activity.  (Yamaguchi  et  at,  1992c).  It  is  thought  that  side  chains  of  the  helix  3 
residues  protrude  into  the  [TET-M2+  ]  transport  channel.  Helix  7  is  thought  to  contain 
residues  important  for  substrate  recognition,  TetA(B)  variants  that  confer  resistance 
to  DMG-mino,  a  glycylglycine  type  drug  have  been  identified  (Guay  et  at,  1994). 
These  variants  contain  mutations  in  transmembrane  helices  7  and  10. 
In  summary,  residues  extending  over  the  whole  length  of  the  TetA  primary  sequence 
contribute  to  its  function  as  a  tetracycline  efflux  pump.  In  contrast  to  the  proton 
antiporter  activity  of  TetA(B),  TetA(C)  from  pSC  10  1  shows  potassium  uptake 
activity.  TetA(C)  mutants  which  lack  the  ability  to  supply  tetracycline  resistance  but 
still  transport  K'  have  been  used  to  indicate  some  residues  involved  specifically  with 
tetracycline  transport  (McNicholas  et  al,  1992).  Some  of  the  findings  are  different 
from  that  regarding  TetA(B),  e.  g.  mutations  that  abolish  tetracycline  efflux  have  been 
located  to  four  residues  of  connecting  loop  10-  11  (McNicholas  et  al,  1995).  There  is 
evidence  that  TET  resistance  proteins  of  Gram-negative  bacteria  function  as 
multimers  (Curiale  et  al,  1984).  A  multimerisation  domain  has  been  mapped  to  the  N 
terminal  half  of  TetA(B)  (McMurray  &  Levy,  1995),  suggesting  a  role  for 
oligomerisation  in  TetA  function.  A  model  of  the  two  dimensional  topology  of 
tetracycline  specific  efflux  pumps  is  shown  in  Fig  1.10 
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Two-dimensional  model  of  the  topology  of  tetracycline  specific  efflux  pumps. 
Amino  acids,  given  by  one  letter  abbreviations  are  given  for  positions  at 
which  mutations  result  in  at  least  80%  loss  of  activity  in  TetA(B)  (modified 
from  Schnappinger  &  Hillen,  1996). 
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1.6.2.3  Gram-positive  Tet  proteins 
Much  less  is  known  about  the  molecular  basis  of  TET  resistance  in  the  Gram-positive 
derived  exporters.  Studies  of  the  TetA(L)  protein  from  Bacillus  subtilis  have 
identified  marked  differences  to  the  Enterobacteriacae  TET  exporters.  TetA(L)  is 
chromosomally  encoded  and  will  only  confer  significant  levels  of  tetracycline 
resistance  on  the  cell  when  present  in  multiple  copies  after  an  amplification  event 
(Ives  &  Bott,  1990).  Studies  by  Guffanti  &  Krulwich  (1995)  show  that  TetA(L)  is  not 
a  specific  tetracycline/  H'  antiporter  but  also  antiports  KýNa+  and  K/H'  These 
antiport  activities  are  electrogenic  in  contrast  to  the  electroneutral  antiport  of  the 
Gram-negative  tet  proteins.  These  results  firmly  support  the  conclusion  that  TetA(L) 
is  a  multifunctional  antiporter.  It  is  suggested  that  the  protein  may  have  two  distinct 
binding  domains  for  its  metal  and  complex  organic  substrates. 
Studies  on  OtrB  have  shown  that  it  is  no  more  similar  to  the  Gram-positive  tet 
proteins  than  the  Gram-negative  tet  resistance  pumps,  showing  most  similarity  to 
other  Streptomyces  antibiotic  efflux  pumps  (MacGregor-Pryde,  1995;  this  work). 
OtrB  also  shows  high  similarity  to  some  multidrug  exporters,  raising  the  question 
that  it  too  may  be  a  multifunctional  antiporter  along  the  lines  of  Tet(Q. 
Tet(K)  is  also  capable  of  transporting  K*  ions  in  a  similar  way  to  the  TetA(Q  protein 
(Guay  et  al,  1993b).  It  was  postulated  from  hydropathy  profiles  that  the  Tet(K)  and 
Tet(L)  proteins  were  comprised  of  14  transmembrane  helices  in  contrast  to  the  12 
TMH  arrangement  of  the  Gram-negative  tet  proteins  (Guay  et  al,  1993a,  1993bj  This 
has  now  been  further  demonstrated  by  the  construction  and  analysis  of  phoA  Tet(K) 
fusions  which  firmly  demonstrate  the  presence  of  14  transmembrane  regions  (Ginn  et 
al,  1997).  Previously  little  work  detailing  mutagenesis  experiments  to  identify 
functionally  important  residues  of  any  Gram-positive  tet  proteins  had  been  published. 
However,  recent  work  in  the  Yamaguchi  laboratory  has  demonstrated  that  four 
transmembrane  glutamic  acid  residues  of  Tet(K),  located  in  helices  1,5  and  II  are 
functionally  important  and  can  be  compared  to  the  conserved  transmembrane  aspartyl 
residues  of  TetA(B)  (Fujihara  et  al,  1996).  It  is  important  to  remember  that 
information  gained  from  studies  of  Tet(K)  may  not  be  applicable  to  other  Gram- 
positive  tet  proteins  as  they  show  so  little  similarity  to  each  other. 
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1.6.2.4  Tetracycline  resistance  by  ribosornal  protection 
Ribosomal  protection  as  a  method  of  tetracycline  resistance  was  first  observed  in  the 
Streptococci  (Burdett,  1986).  Six  classes  of  proteins  that  confer  resistance  in  this  way 
are  now  known:  TetA(M),  (0)-(Q),  (S)  and  OtrA.  (Martin  et  al,  1986;  Taylor,  1986; 
LeBlanc  et  al,  1988;  Doyle  et  al,  199  1;  Dittrich  &  Schrempf,  1992;  Nikolich  et  al, 
1992;  Charpenteir  et  al,  1993;  Sloan  et  al,  1994).  Initial  work  on  this  group  of 
proteins  was  done  using  TetM.  Since  the  other  classes  in  the  group  have  sequence 
similarity  of  over  40%  (Sloan  et  al,  1994),  it  is  reasonable  to  expect  the  protection 
method  to  be  the  same  for  all  tet  proteins  that  act  by  ribosomal  protection. 
The  mechanism  of  ribosomal  protection  is  discussed  in  section  1.5.2.  In 
summary,  it  appears  that  these  TET  resistance  proteins  mediate  resistance  by 
inhibiting  the  binding  of  the  aminoacyl-tRNA:  EF  Tu:  GTP  complex  to  the  A  site  of 
the  ribosome.  The  exact  mechanism  of  inhibition  remains  to  be  determined  at  a 
molecular  level. 
1.6.2.5  Tetracycline  modification. 
A  third  mechanism  of  tetracycline  resistance  is  to  chemically  modify  the  antibiotic, 
rendering  it  non-toxic.  This  phenomenon  was  first  observed  by  Park  &  Levy  (1988) 
who  described  that  transposon  Tn4400  from  Bacteroidesfragalis  mediated  TET 
resistance  in  E.  coli  by  degradation  of  the  drug.  Independently  of  these  findings  it 
was  shown  that  a  closely  related  Bacteroides  transposon  Tn4351  also  carries  a  gene 
for  a  tetracycl  i  ne-  inactivating  enzyme.  Before  the  finding  of  tetracycline  modifying 
activity  from  Tn4400,  Park  et  al  had  previously  shown  that  Tn4400  mediated  TET 
resistance  by  an  efflux  mechanism  (Park  et  al,  1987)  and  had  designated  the  Tn4400 
encoded  TET  resistance  gene  Teff,  in  line  with  the  nomenclature  guideline  proposed 
by  Levy  et  al  (1989).  It  is  now  known  that  Tn4400  and  Tn4351  encode  tetracycline 
modifying  products,  which  require  NADP  and  oxygen  to  carry  out  the  modification 
reaction,  the  gene  was  re-named  tet(A)X  to  infer  a  new  class  of  resistance 
determinant.  TetX  is  presumed  to  be  an  NADP  requiring  oxidoreductase.  (Speer  et 
al,  199  1).  The  Tn4400  tetA(X)  provides  only  a  fifth  of  the  resistance  levels  of  that 
encoded  by  the  Tn4351  tetA(X).  This  is  thought  to  be  due  to  a4  base  difference  in 
their  upstream  regions  which  provides  Tn4351  with  a  better  -35  site,  presumably 
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leading  to  higher  levels  of  transcription  (Speer  et  al,  1991).  The  efflux  properties  of 
Tn4440  observed  by  Park  &  Levy  (1988)  are  encoded  on  a  separate  ORF  within  the 
Tn4400  sequence.  Although  the  product  of  this  gene  has  tetracycline  efflux  activity  it 
does  not  confer  TET  resistance  on  Exo1i  when  present  without  tet,  4(X)  (Speer  & 
Salyers,  1990).  The  two  genes  do  not  act  synergistically  as  the  resistance  levels 
attained  by  tetA(X)  alone  are  indistinguishable  from  those  observed  when  both  genes 
are  present  (Speer  &  Salyers,  1990).  The  efflux  activity  was  able  to  be  increased  to 
that  conferred  by  pBR328  (Manniatis  et  al,  1982)  by  cloning  the  region  into  a  high 
copy  plasmid.  Surprisingly,  despite  the  increased  efflux,  cells  were  still  sensitive  to 
tetracycline.  The  entire  efflux  determinant  present  on  Tn4400  is  thought  to  be 
included  in  an  insertion  element.  Tn4400  and  Tn4351  are  90%  homologous,  the 
difference  being  a  0.5kb  insertion  element  in  the  region  of  the  efflux  gene  of  Tn4400. 
Alternatively,  Tn4351  could  be  the  result  of  a  deletion  event  in  Tn4400  in  which  only 
part  of  the  efflux  gene  was  removed  (Speer  et  al,  1991). 
1.7  The  Mutifacilitator  Superfamily  (MFS) 
The  tetracycline  efflux  proteins  discussed  above  are  part  of  a  growing  and  very  wide 
-ranging  family  of  transport  proteins.  Located  in  the  cell  membrane,  members  of  the 
multifacilitator  superfamily  transport  a  variety  of  substrates,  from  sugars  to  Krebs 
cycle  intermediates.  Despite  the  differences  in  substrates  and  origin,  MFS  members 
have  been  observed  in  bacteria,  fungi,  plants  and  mammals. 
The  concept  of  a  superfamily  of  transport  proteins  was  suggested  in  1993  by  Marger 
&  Saier,  following  a  symposium  on  solute  transport  (Saier,  1990).  This  described  a 
number  of  classes  of  proteins  including  the  homologous  glucose  carriers  of 
prokaryotes  and  eukaryotes.  Homology  between  these  and  other  sugar  transporters  is 
well  documented  in  the  literature,  most  work  having  been  done  by  Henderson  and  co- 
workers  (Henderson  &  MacPherson,  1986;  Maiden,  1987;  Maiden  et  al,  1988,  Muiry, 
1989;  Henderson,  1990).  Initially,  extensive  similarities  were  identified  between 
passive  transporters  from  yeast  and  mammalian  cells  and  some  bacterial  proton/sugar 
symporters  (Baldwin  &  Henderson,  1989).  A  model  was  proposed  for  the  topology  of 
the  glucose  transporter  which  by  analogy  was  to  apply  to  the  AraE  and  XylE  proteins 
(Baldwin  &  Henderson  1989).  This  group  of  related  (Proton  motive  force)  dependent 
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proteins  was  extended  to  include  other  transport  proteins  from  Ecoli  including  the 
citrate  importer  and  tetracycline  antiporter  (Henderson  &  Maiden,  199o).  Some 
conserved  features  of  the  sequences  were  observed,  a  particularly  good  example  is 
the  motif  RXGRR,  where  R  can  be  substituted  by  K  and  X  is  often  a.  large 
hydrophobic  residue.  This  motif,  has  been  expanded  to  GXXXXRXGRR  and  is 
present  in  the  cytoplasmic  loop  connecting  TMH2  and  3  in  all  MFS  proteins 
(Paulsen  et  al,  1996).  These  early  comparative  analyses  provided  a  firm  background 
on  which  to  establish  the  existence  of  the  larger  multifacilitator  superfamily. 
Marger  &  Saier,  (1993)  identified  five  families  of  transport  proteins  which 
they  showed  by  extensive  statistical  analyses  to  be  members  of  one  large  superfamily 
(Fig  1.11). 
Class  1:  drug  resistance 
Class  2:  sugar  uptake 
Class  3:  uptake  of  Krebs  cycle  intermediates 
Class  4:  phosphate-ester/phosphate  antiport 
Class  5  oligosaccharide  uptake. 
Analysis  of  Class  I  proteins  gave  relatively  low  intraclustal  comparison  scores,  15- 
20SD's  (standard  deviations)  compared  with  scores  of  20-110  SD's  for  families  2  to 
5.  Thus,  members  of  family  I  show  the  lowest  degree  of  sequence  similarity.  To 
further  determine  the  phylogenetic  relationships  within  cluster  1,  analysis  was 
performed  on  the  seven  most  divergent  members  of  the  group:  NorA  (quinolone 
resistance  in  S.  aureus),  TetA  (tetracycline  resistance  in  E.  coli),  QacA  (antiseptic 
-resistance  in  S.  aureus),  MmrA  (methylenomycin  A  resistance  in  Streptomyces 
coelicolor),  Teffl  (tetracycline  resistance  in  Streptococcus  pneunioniae),  EmrA 
(multidrug  resistance  in  E.  coli)  and  Atr-l(aminotriazole  resistance  in  Saccharomyces 
cerevisiae).  The  outcome  of  this  revealed  that  the  drug  resistance  proteins  of  family 
1,  split  into  four  branches  (Fig  1.12),  with  NorA  and  TetA  the  first  branch,  MmrA 
and  EmrA  the  second  and  TetE  and  Atr-  I  the  third  and  fourth  respectively.  The 
greatest  similarity  between  the  seven  proteins  was  found  in  their  N-terminal  regions 
between  residues  100  and  160-  now  known  to  be  the  location  of  motif  C,  a  motif 
present  in  the  12  and  14  TMH  families  but  not  the  other  MFS  proteins  (Paulsen  et  al, 
1996).  Further  sequence  analyses  (Griffith  et  al,  1992;  Paulsen  &  Skurray,  1993)  led 
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to  a  revision  in  the  phylogeny  of  the  MFS  and  to  the  proposal  by  Paulsen  et  al  (1996) 
that  the  drug  exporter  family  should  be  further  sub-divided  into  two  groups,  those 
proteins  with  12  TMH's  being  one  group  and  those  comprised  of  14  TMH's  the 
other.  This  has  led  to  a  revised  phylogeny,  with  the  MFS  consisting  of  six  separate 
families.  (Figs  1.13  and  1.14)  each  of  which  contains  many  separate  transport 
proteins.  I 
With  the  publication  of  increasing  numbers  of  entire  genome  sequences,  the 
number  of  MFS  members  is  quickly  expanding,  although  many  of  these  proteins  are 
hypothetical  transporters  of  unknown  substrate  specificity.  The  number  of  proteins  in 
the  12  and  14  TMH  families  alone  was  reported  at  over  100  in  1996  and  has 
presumably  increased  considerably  since  then. 
Family  I  is  now  the  14  TMH  family.  Its  members  include  known  or  probable 
multidrug  efflux  proteins,  tetracycline  resistance  pumps  from  Gram-positive  bacteria 
and  vesicular  amine  transporters  from  higher  eukaryotes  (Lineal,  1993),  which  are 
involved  in  neurotransmission  but  can  also  mediate  drug  resistance  (Schuldiner, 
1994;  Schuldiner  et  al,  1995)  plus  other  hypothetical  or  as  yet  uncharacterised  12 
TMH  proteins.  Family  2,  the  12  TMH  family  has  members  which  include  a  number 
of  known  and  putative  multidrug  exporters  from  bacteria  and  fungi,  other  drug 
resistance  proteins,  many  from  Gram-positive  bacteria  including  antibiotic  producer 
organisms  and  as  in  Family  1,  a  number  of  uncharacterised  or  hypothetical  proteins 
identified  by  "sequence  gazing". 
Both  families  I  and  2  are  comprised  of  several  phylogenetically  distinct  groups. 
Family  I  is  divided  into  six  clusters  on  this  basis; 
a)  a  cluster  of  fungal  proteins,  b)  a  cluster  containing  various  bacterial  proteins 
including  the  multidrug  resistance  proteins  Bcr  and  EmrD  plus  two  hypothetical  yeast 
proteins,  c)  contains  monoamine  and  acetylcholine  transporters  from  higher 
eukaryotes,  d)  a  cluster  containing  two  bacterial  chloramphenicol  resistance  proteins 
plus  other  bacterial  transporters,  e)  the  Gram-negative  tet  cluster  which  as  well  as 
containing  tetA(B)-(E)  also  includes  three  multidrug  proteins  from  Gram-positive 
bacteria,  and  f)  this  cluster  contains  some  more  distantly  related  members  of  family  I 
such  as  the  multidrug  resistance  protein  LmrP  from  Lactococcus  lactis  (Bolhuis  et  A 
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1994).  Family  2  is  clustered  in  a  similar  way,  it  has  five  clusters;  a)  contains  several 
yeast  proteins  including  the  multidrug  efflux  protein  Sgel  (Amakasu  et  al,  1993). 
b)  is  a  small  cluster  containing  Atr-l,  a  yeast  multidrug  efflux  protein  (Kanazawa  et 
al,  1988)  c)  contains  two  Streptomyces  proteins,  the  oxytetracycline  resistance 
protein,  Tet347  (OtrB)  from  Streptomyces  rimosus  and  the  hypothetical  product  of 
the  Streptomyces  violaceoruber  SV-ORF4  gene  which  probably  encodes  granaticin 
resistance  (Hunter  pers.  comm),  d)  is  the  Gram-positive  tet  cluster,  containing  TetK, 
(Noguchi  et  al,  1986)  TetL,  (Hoshino  et  al,  1985)  and  a  Bacillus  subtilis  TET 
resistance  protein,  e)  is  a  large  cluster  of  bacterial  drug  resistance  proteins,  mostly 
from  Gram-positive  organisms  and  includes  several  drug  resistance/secretion  proteins 
from  antibiotic  producing  Actinomycetes  as  well  as  some  multidrug  exporters,  also 
from  Gram-positive  bacteria.  Lastly,  cluster  f)  contains  some  Gram-negative  derived 
14  TMH  proteins. 
From  the  information  presented  above  it  can  be  seen  that  clusters  usually 
appear  to  be  divided  on  the  basis  of  their  function/substrate  specificity,  although  both 
families  do  contain  a  numbers  of  proteins  as  yet  uncharacterised.  This  method  of 
division  however  does  not  account  of  the  fact  that  multidrug  resistance 
proteins/efflux  pumps  are  presented  in  many  of  the  various  lineages.  Lewis  (1994) 
suggested  that  the  multidrug  proteins  do  not  form  a  related  family.  The  phylogenetic 
analyses  of  Paulsen  et  al,  1996  and  Paulsen  &  Skurray,  1993,  echo  this  sentiment.  It 
is  proposed  that  multidrug  resistance  is  a  phenomenon  that  has  arisen  separately  on  a 
number  of  occasions.  Multidrug  resistance  could  possibly  arise  from  gradual  loss  of 
substrate  specificity  from  a  substrate  specific  transporter  (Lewis,  1994). 
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2.1  Introduction 
This  chapter  contains  the  general  procedures  used  in  the  experiments  which  were  the 
basis  of  this  thesis.  The  chapter  is  presented  as  five  sections,  bacterial  strains, 
plasmids  and  chemicals;  microbiological  techniques  and  standard  media;  DNA 
methods  ;  Protein  methods;  and  computer  methods. 
2.2  Bacterial  strains,  vectors  and  chemicals. 
Table  2.1.  Bacterial  strains 
Strain  Genotype  Source  /  Reference 
E  coli  Strain 
BL21(DE3)  (E.  coli  B)  F-ompTr-B  m-B 
(lambda  DE3  lysogen) 
(lambda  DE3  lambda  2  1;  in 
the  int  gene  of  lambda  is 
cloned  a  fragment  bearing 
lad  and  the  T7  polymerase 
gene  regulated  by  the 
lacUV5  promoter. 
DH5(x  endA  I  hsdRl  7(  r-K  M+K) 
supE44  thil  recAl  gyrA96 
relAl  A(LacZYA-  ArgF) 
U  169  (o8O  dlacZ  AM  15) 
deoR 
CB51  dam-3,  ara-14,  thi-1,  A 
(lac-pro  ) 
DS941 
ET12567 
StrePtontyces  rimosus  strains 
M15883 
recF  143,  proA  7,  str3  1,  thrl, 
leu6,  tsx33,  int  12,  his4, 
argE3,  lacY+,  IacZAM  15, 
laclq,  galK2,  ara  14,  supE44, 
XY15 
F  dain-  13::  Tn9,  dcin-6, 
IzsdM,  hsdR,  recF  143,  Tn  10, 
galK2,  galT22,  ara  14, 
lacY  I,  xyl-5,  leuB6,  thi-1, 
ton  A3  1,  rpsL  13  6,  It  isG4, 
tsx-78,  mil-  1,  gln44,  supE, 
lisdA5,  thi  A(lac  proA  B) 
OTCR 
Novagen 
Hanahan  (1983) 
C.  Boyd,  University  of 
Edinburgh 
D.  Sherrat,  University  of 
Glasgow 
MacNeil  (1988) 
Binnie  et  al.,  (1989) 
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M15883s  OTCS  Butler  et  al.,  (1989) 
StrePtomyces  albus  OTCS 
StrePtomyces  lividans  TK24  str6  Hopwood  et  al.,  (1985) 
Table  2.2.  nlasmids 
pGLW12  2.3kb  Pst  I  -Sac  I  otrB  L.  Woodward,  this  laboratory 
fragment  cloned  into  pIJ487 
(Ward  et  al,  1986) 
pGLW81  2kb  Sacl-BamHl  otrB  K.  Linton,  this  laboratory 
fragment  cloned  into 
pWHM3 
pIJ702  Streptomyces  cloning  vector  Katz  et  al  (1983) 
pUC18  Yanisch-Perron  et  al 
(1985) 
pIBI24  derived  from  pEMBL  Dente  et  al,  (1983) 
pMTL23  AmpR  col  EI  origin  Chambers  et  al 
cloning  vector  used  to  clone  (1988) 
PCR  product 
pT7-7  AmpR  col  EI  cloning  and  Tabor  &  Richardson 
expression  vector  allowing  (1985) 
positioning  of  the  cloned 
gene  in  frame  with  T7 
promoter 
pET2  Ib  AmpR  lacl  pMB  I  origin.  Novagen 
Cloning  vector  used  to 
create  C-terminal 
polyhistidine  fusions 
regulated  by  both  T7 
promoter  and  down  stream 
lac  operator 
pET15b  Amp  R  lacI  pMB  I  origin.  Novagen 
Cloning  vector  used  to 
create  N-terminal 
polyhistidine  fusions 
pIJ6017 
R  Kan 
, 
Streptomyces  Takano  et  al. 
expression  vector  regulated  (1995) 
by  Tsr  inducible  tipA 
promoter. 
pJJIBI  460pb  I  fragment  Chapter  3 
containing  start  of  otrB  ORF 
and  small  portion  of 
upstream  region  cloned  into 
pIBI24 
pJJ  1  2.1  kb  otrB  fragment  Chapter  4 
cloned  EcoRI  -  Hind  III  into 
pUC  18 
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pJJ  2  1.8kb  Nde  I-  Hind  III  Chapter  4 
fragment  cloned  into 
pMTL23 
pJJ  3  1.6kb  BsaB  I-  Hind  III  Chapter  4 
fragment  from  pJJ1  cloned 
into  pJJ2 
pJJ  4  1.8  kb  Nde  I  -Hind  III  Chapter  4 
fragment  from  pJJ3  cloned 
into  PT7-7 
pJJ  5  1.8kb  Nde  I-  Hind  III  Chapter  4 
fragment  from  pJJ4  cloned 
into  pET21b 
pJJ7  1.7kb  NdeI-EcoRl  PCR  Chapter  5 
product  cloned  into 
pMTL23 
PJJ8  1.66Kb  Ndel-Sacl  fragment  Chapter  5 
cloned  into  pET21b 
PJJ9  1.7kb  Ndel  -  EcoRI  Chapter  5 
fragment  cloned  into 
pET2  Ib 
pJJlO  0.5kb  PCR  product  cloned  Chapter  6 
Ndel-  EcoRI  into  pMTL23 
pJJ  11  0.8  kb  PCR  product  cloned  Chapter  6 
EcoRl-NdeI  into  pMTL23 
pJJ12  pJJ  10  insert  into  pET2  Ib  Chapter  6 
pJJ13  pJJ  It  insert  into  pET2  Ib  Chapter  6 
pJJ  14  0.8kb  OaI-EcoRl  fragment  Chapter  6 
from  pJJ  11  cloned  into 
pJJ12 
pJJ  17  pJJ  14  with  SacI  deletion  to  Chapter  6 
make  HisTag  fusion  at  C 
terminus 
pJJ18  1.8kb  NdeI-BatnHI  fragment  Chapter  5 
from  pJJ6  cloned  into 
pET  15b 
2.2.1  Chemicals  and  biochemicals 
Ampicillin  and  ethidiurn  bromide  were  supplied  by  Sigma  Chemical  Co.  (Poole, 
UK). 
Bactotryptone,  yeast  extract  and  Bactotryptone  (agar)  were  supplied  by  Difco 
(Detroit,  USA). 
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TEMED  (N,  N,  N',  N'-  tetramethylethylene  diamine)  and  Tris  buffer  were  supplied 
by  Boehringer  Mannheim  (Lewes,  UK). 
DMSO  was  supplied  by  BDH  Chemicals  (Poole,  UK). 
Agarose,  IPTG  (isopropyl-p-thiogalactoside)  were  supplied  by  BRL  (Gibco  Ltd., 
Paisley,  UK). 
Acrylamide,  bisacrylamide  and  SDS  were  supplied  by  FSA  laboratory  supplies 
(Loughborough,  UK). 
Oligonucleotides  were  synthesised  on  either  an  Applied  Biosystems  Model  280A 
DNA  synthesiser  at  the  Institute  of  Biomedical  and  Life  Sciences,  University  of 
Glasgow,  using  reagents  from  Cruachem  (Science  Park,  Glasgow  UK)  or  obtained 
from  BRL  (Gibco  Ltd.,  Paisley,  UK). 
All  other  chemicals  were  of  analytical  reagent  grade  and  were  supplied  from  one  of 
the  following  suppliers;  BDH  Ltd.,  Formachem  Ltd.,  Sigma  Chemical  Co.  Poole, 
UK). 
2.2.2  Enzynies  mid  kits 
All  restriction  enzymes,  T4  DNA  ligase,  alkaline  phosphatase  Pfu  and  Taq 
polymerases  were  supplied  by  BRL  or  Promega  Corporation. 
Purification  of  DNA  from  agarose  gels  was  performed  using  Qiaex  gel  extraction  kit 
from  Qiagen  Ltd.  (Germany). 
Plasmid  DNA  was  prepared  for  sequencing  using  plasmid  PURE  mini-prep  kit  from 
Sigma  -Aldrich.  (Dorset,  UK) 
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2.3  Standard  media  and  microbiological  techniques 
2.3.1  Media  for  the  growth  of  E.  coli 
Chemicals  of  good  quality  were  used  in  the  preparation  of  the  growth  media  and 
solutions  (AnaIR  grade  when  available).  The  source  of  many  of  the  chemicals  varied 
during  the  course  of  this  work.  The  most  common  suppliers  were  BDH  Chemicals 
Ltd.;  Difico  Laboratories  (Detroit,  Michigan,  USA)  and  Sigma  Chemical  Co.  Ltd. 
a)  L-broth 
I%  (w/v)  tryptone,  0-5%  (w/v)  yeast  extract,  0-5%  (w/v)  NaCl,  0.1%  (w/v)  glucose, 
0-002%  (w/v)  thymine,  made  up  in  distilled  water  and  adjusted  to  pH  7-0  with 
NaOH. 
b)  L-aRar 
As  L-broth,  but  without  glucose  and  with  the  addition  of  1-5%  (w/v)  bacto-agar. 
0  2xYT  medium 
1-6%  (w/v)  bacto-tryptone,  I%  (w/v)  bacto-yeast  extract,  0-5%  (w/v)  NaCl,  made  up 
in  distilled  water  and  adjusted  to  pH  7-0  with  NaOH. 
d)  Terrific  Broth. 
1.2%  (w/v)  bacto  tryptone,  2.4%  (w/v)  bacto  yeast  extract,  0.4%  (v/v)  glycerol, 
dissolved  in  900ml.  After  autoclaving  add  100  ml  of  a  solution  of  0.17mM  KH2P04 
and  0.72mM  K-)HP04- 
e)  Minimal  a-gar 
Agar  was  made  to  1.75%  with  water.  To  75  ml  of  this,  25  ml  of  D+M  salts  were 
added  and  glucose  and  thiamine  were  added  to  final  concentrations  of  2  mg/mI  and 
20  pg/ml,  respectively.,  4-:  1 
f)  SOC 
2%  tryptone,  0.5%  yeast  extract,  10  mM  NaCl,  2.5  mM  KCI  per  litre.  (pll  7)  After 
autoclaving,  add  M902  to  10  mM  and  glucose  to  20  mM 
Z)  Davis  and  Mingoli  (D+M)  Salts  (x4) 
2-8%  (w/v)  K2HP04,0*8%  (w/v)  KH2PO4,0-4%  (w/v)  (NH4)2SO4,0'  1%  (w/v) 
trisodium  citrate,  MgS04.7H20,  made  up  in  distilled  water. 
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2.3.2  Media  used  for  growth  of  Streptomyces 
a)  Soya  Mannitol  ARar  (SM) 
This  was  used  as  a  general  plating  medium  for  Streptomyces,  particularly  for 
production  of  spores.  It  consists  of  2%  (w/v)  mannitol,  2%  (w/v)  soya  bean  flour, 
and  1-6%  (w/v)  agar,  made  up  in  tap  water. 
b)  Yeast  extract-Malt  extract  (YEME) 
Used  for  the  growth  of  Streptomyces  lividans  It  consists  of  0-3%  (w/v)  Difco  yeast 
extract,  0.5%  (w/v)  Difco  bacto  peptone,  0.3%  (w/v)  Oxoid  malt  extract,  1%  (w/v) 
glucose,  34%  (w/v)  sucrose,  made  up  in  distilled  water.  To  prevent  pelleting,  and 
produce  a  well-dispersed  growth,  M902  was  added  to  a  final  concentration  of  5mM, 
and  glycine  to  a  final  concentration  of  0-5%  (w/v). 
c)  Tryptone  Soya  Broth.  (TSB) 
30g/l  in  distilled  water 
Used  for  the  growth  of  S.  albus  and  S.  rimosus. 
For  S.  albus  add  glycine,  (10%)  5  ml/I  andMgC12,  (100  mM)  5  ml/I 
d)  TSB  aRar. 
1.5%  acrar  in  TSB  broth 
Cý 
2.3.3.  Sterilisation  of  media 
All  growth  media  and  buffer  solutions  were  sterilised  by  heating  to  120"C  for  15 
minutes  in  an  autoclave.  Antibiotics  solutions  and  amino  acids  were  sterilised  by 
filtration  through  Nalgene  0.22gm  pore  membranes. 
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2.3.4  Antibiotics  and  indicators 
The  antibiotics  used  throughout  for  liquid  and  plate  selection  were  as  follows: 
Drug  Final  Stock  Storage  temp.  in 
concentration  in  concentration  0C 
[tg/ml  in  mg/ml 
Ampicillin  100  200  -20 
Chloramphenicol  34  34  -20 
Thiostrepton  50  10  -20 
Kanamycin  was  used  to  select  for  Streptomyces  lividans  transformed  with  pIJ6017 
based  plasmids,  100  gg/ml  was  used  for  selection  on  solid  media  and  5  gg/ml  used  in 
liquid.  When  these  plasmids  were  used  in  S.  albus,  a  concentration  of  200  gg/ml  was 
used  in  solid  media  and  100  gg/ml  in  liquid. 
2.3.5  Growth  of  Streptonzyces 
2.3.5.1  Growth  in  liquid  media 
Cultures  were  typically  grown  in  500  ml  conical  flasks  containing  100  ml  of  medium 
at  300C  on  an  orbital  shaker  at  200  rpm.  Expression  experiments  employed  TSB  or 
YEME  medium  which  produced  reproducible  and  rapid  growth.  Spores  from  frozen 
suspensions  or  suspensions  that  were  freshly-  prepared  from  a  frozen  slope  were  used 
to  inoculate  the  medium.  Cells  grown  on  YEME  could  be  harvested  after  48-72 
hours  and  stored  indefinitely  as  a  cell  pellet  at  -20  'C. 
2.3.5.2  Harvesting  of  mycelia 
After  growth,  mycelia  were  diluted  in  an  equal  volume  of  distilled  dH20,  recovered 
from  the  media  by  centrifugation  (10  minutes,  10000  g)  and  resuspended  in  dH20. 
2.3.6  Growth  of  E.  coli 
Liquid  cultures  of  E.  coli  strains  from  which  plasmids  were  to  be  isolated  were 
grown  in  L-  broth  with  the  appropriate  antibiotic  selection  (typically  ampicillin  at 
100  gg/ml  and/or  chloramphenicol  at  34  gg/ml).  The  volume  of  broth  inoculated 
depended  on  the  quantity  of  plasmid  required.  Routinely  1.5  ml  and  3  ml  culture 
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were  used  for  Doly  and  Sigma  plasmid  preparations  respectively.  (sections  2.4.2.1 
and  2.4.2.2). 
For  the  preparation  of  membrane  fractions  and  the  preparation  of  competent  cells,  E 
coli  were  grown  in  Terrific-broth.  To  maximise  aeration  of  the  culture,  the  volume  of 
the  Erlenmeyer  flask  used  was  at  least  five  times  that  of  the  broth.  All  cultures  were 
incubated  at  37'C  in  an  orbital  shaker  at  ca.  250  rpm. 
2.3.6.1  Expression  of  cloned  genes  in  E.  coli  using  IPTG. 
Liquid  cultures  of  E.  coli  strains  in  which  cloned  genes  were  to  be  expressed  from  an 
expression  vector  containing  the  T7  promoter  were  inoculated  from  overnight 
cultures  and  grown  in  800  ml  Terrific-broth  with  the  appropriate  antibiotic  selection. 
Cultures  were  monitored  for  growth  by  spectrophotometry  of  I  ml  samples  at  600 
nm.  On  reaching  OD600=  0.6,  cultures  were  induced  to  express  protein  by  the 
addition  of  0.4  mM  IPTG  and  grown  for  a  further  2.5  hours.  Cultures  were  then 
harvested  by  centrifugation  in  Beckman  J2-21  M/E  centrifuge  using  a  JA14  rotor  at 
5000  xg  for  5  minutes. 
2.3.7  Preparation  of  Streptonzyces  spores 
2.3.7.1  Preparation  and  storage  of  stispensions 
Concentrated  spore  suspensions  were  required  for  inoculating  liquid  cultures  of  S. 
rimosus,  S.  albus  or  S.  lividans.  The  protocol  described  by  Hopwood  et  al.  (  1985) 
was  followed  with  minor  modifications: 
A  boiling  tube  containing  a  slant  of  SM  agar  (produced  by  pouring  ca.  20  ml  of 
molten  agar  into  the  tube  and  allowing  it  to  solidify  with  the  tube  held  at  +5"  from  the 
horizontal)  was  inoculated  with  150  VI  of  a  spore  or  mycelial  fragment  suspension 
and  incubated  at  30"C.  After  5-  10  days  the  surface  of  the  culture  was  covered  in  a 
dark  grey  mass  of  spores.  The  slant  was  then  sealed  using  parafilm  and  frozen  at  - 
20"C.  Spores  could  be  harvested  immediately  or  stored  indefinitely  at  -20"C.  The 
spores  were  harvested  by  adding  5  ml  of  dH 
20 
to  the  frozen  slant  and  rubbing  the 
surface  of  the  slant  with  a  10  ml  glass  syringe.  Contaminating  agar  or  mycelial 
fragments  were  removed  by  a  single  passage  -through  a  cotton  wool  filter,  as 
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described  in  Hopwood  et  al.  (1985).  The  filtered  spore  suspension  was  then  either 
used  fresh  to  inoculate  YEME  or  TSB  media  or  frozen  at  -20'C. 
2.3-7.2  Spore  counts 
Colony  forming  units  were  determined  by  plating  suitably  diluted  spore  samples  on 
Soya  plates.  Counts  of  the  number  of  colonies  were  made  after  incubation  at  30'C 
for  5  days. 
2.3.8  Preservation  of  E.  coli  strains 
E-coli  strains  were  stored  in  glycerol.  An  800  pI  aliquot  of  an  overnight  culture  was 
mixed  with  an  equal  volume  of  40%  (v/v)  glycerol,  2%  peptone  (w/v)  and  frozen  at  - 
700C  The  strains  were  revived  by  scraping  the  surface  of  the  frozen  suspension  with 
a  toothpick  and  either  inoculating  liquid  broth  or  streaking  onto  agar  to  isolate  a 
single  colony. 
2.3.9  Introduction  of  plasmid  DNA  into  E.  coli 
2.3.9.1  Preparation  of  competent  cells 
a)  CaCl,  method. 
Cells  prepared  by  this  rnethod  have  an  efficiency  of  ca.  Ix  10-5  cfu  per  Rg  of  plasmid 
DNA  so  were  used  for  moving  plasmids  from  strain  to  strain. 
An  overnight  culture  of  the  recipient  strain  was  inoculated  1:  100  into  fresh  L-broth 
with  antibiotic  if  appropriate  and  incubated  with  shaking  at  37'C  for  90  -  120 
minutes  to  a  density  of  approximately  108  MI-I  cells  (OD  600  0.4  -  0.6)  The  cells  were 
harvested  by  pelleting  in  a  bench  top  centrifuge  @  10,000  x  g,  for  5  minutes  and 
resuspended  in  half  the  original  culture  volume  of  ice  cold  50  m.  M  CaC12.  The  cells 
were  pelleted  again  and  resuspended  in  I  ml  ice-cold  50  mM  CaC12  for  every  30  ml 
of  original  culture  volume  and  stored  on  ice  for  at  least  20  minutes  before  use.  The 
competent  cells  prepared  by  this  method  were  used  the  same  day. 
b)  Hanahan's  method 
Cells  prepared  by  this  method  have  an  efficiency  of  ca.  Ix  10  6-  1X  107  CfU  per  gg  of 
plasmid  DNA  so  were  used  for  transformation  of  ligations. 
Cells  were  prepared  by  a  modified  method  of  Hanahan,  (1983). 
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An  overnight  culture  of  the  recipient  strain  was  inoculated  1:  100  into  2xYT  with 
antibiotic  if  appropriate.  The  culture  was  incubated  at  37"C  with  shaking  (as  above) 
until  OD  600  reached  0.4  -  0.6.  Cells  were  pelleted  in  a  bench  top  centrifuge  and 
resuspended  in  2.5  ml  ice  cold  TFB  buffer  for  every  30  ml  of  culture.  The  cells  were 
left  on  ice  for  15  minutes.  100  gI  of  DMSO  was  added  after  5  minutes,  after  a  further 
10  minutes  100  gI  of  DTT/KAc**  was  added.  After  another  5  minutes  a  further 
100gl  of  DMSO  was  added.  After  a  further  5  minutes,  the  cells  were  divided  into  200 
gI  aliquots  and  were  ready  to  transform.  Competent  cells  prepared  by  this  method 
were  used  the  same  day. 
TFB  buffer:  10  mM  MES*  pH6.3,45  mM  MnC12AH20,10  mM  CaC12.2H20,100 
mM  KCI,  3  mM  cobalt  chloride. 
*A  IM  stock  of  MES  was  prepared  by  dissolving  19.52  g  of  MES  in  80  ml  of 
distilled  H20,  pH  was  adjusted  to  6.3  with  5M  KOH,  add  dH20  to  100  ml  and  filter 
sterilised. 
**  DTT/KAc:  2.25  M  DTT,  40  mM  Potassium  acetate,  pH6. 
b)  Electrocompetence  method 
Cells  prepared  by  this  method  have  an  efficiency  of  ca.  Ix  10'9  cfu  per  [tg  of  plasmid 
DNA  so  were  used  for  transformation  of  ligations  in  lower  efficiency  strains 
An  overnight  culture  of  the  recipient  strain  was  inoculated  1:  100  into  500  ml  fresh  L 
broth  and  incubated  for  3-3.5  hours  until  OD  600  reached  0.4  -  0.6.  The  cells  were 
then  harvested  by  pelleting  in  a  Beckman  centrifuge  @  15000  xg,  4'C  for  15  mins 
and  resuspended  in  250  ml  ice  cold,  sterile  dH20,  the  cells  were  pelleted  again  and 
resuspended  in  50  ml  of  ice  cold,  sterile,  10%  glycerol  and  pelleted  again.  The  cells 
were  finally  resusupended  in  0.8  ml  ice-cold  sterile  10%  glycerol,  and  40gl  aliquots 
dispensed  into  0.5  ml  microcentrifuge  tubes  on  dry  ice  before  storage  at  -80'C.  These 
cells  can  be  stored  for  months  once  prepared. 
2.3.9.2  Transformation  procedures 
aLCaCL12  transformation  L-L- 
Transformations  were  carried  out  in  sterile  1.5  mi  microcentrifuge  tubes.  An  aliquot 
(maximum  volume  10  [d)  of  ligation  mix  or  plasmid  DNA  was  added  to  100  91 
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aliquot  of  competent  cells,  mixed  gently  and  incubated  on  ice  for  at  least  20  minutes. 
The  DNA/  cell  mixture  was  heat  shocked  at  42  'C  for  90s.  I  ml  of  L  broth  was  added 
and  the  transformation  mix  incubated  at  37  T  with  shaking,  for  45  minutes  to  allow 
any  antibiotic  resistance  to  express  before  being  plated  onto  L-  agar  containing  the 
appropriate  antibiotic  /  chromogenic  substances  and  incubated  at  37  T  overnight. 
b)  Hanahan's  method 
As  above  but  using  0.8  ml  SOC  in  place  of  L-broth  before  incubation. 
c)  Electrotransformation 
An  aliquot  of  competent  cells  was  removed  from  -80"C  and  thawed  on  ice,  to  this 
was  added  no  more  than  2.0  gl  ligation  mix  or  plasmid  DNA  the  mixture  was 
incubated  on  ice  for  I  minute.  The  mixture  was  transferred  to  a  pre  chilled 
electrotransformation  cuvette,  the  cuvette  was  dried  and  placed  in  dried,  prechilled 
cuvette  holder  and  subjected  to  a  pulse  of  25OkV  (resistance  200n)  using  a  Biorad 
pulse  controller.  I  ml  of  ice  cold  SOC  liquid  media  was  added  to  the  cuvette  and 
mixed  using  a  Pasteur  pipette.  The  mix  was  incubated  at  37  T  for  45  minutes  to 
allow  expression  of  antibiotic  resistance  before  plating  onto  L-agar  as  the  previous 
method. 
2.3.9.3  Selection  of  pUC  derived  recombinant  clones 
a)  Ampicillin 
Stock  solutions  (200  mg/ml  made  up  in  water)  were  added  to  molten  agar  (cooled  to 
55'Q  to  a  final  concentration  of  50  gg/ml. 
b)  Xgal  (  5-bromo-4-chloro-3-indolyl-D-D-galactosida.  se) 
This  was  used  in  conjunction  with  IPTG  (indolyl-P-D  galactoside)  to  identify  the  E. 
coli  clones  containing  pUC-based  vectors  with  inserts  in  their  polylinker  cloning 
sites.  Recombinants  containing  inserts  are  generally  white  whilst  those  with  no  insert 
are  blue.  X-gal  was  stored  at  a  concentration  of  20  mg/mI  in  dimethy1formamide 
(DMF)  at-20'C.  IPTG  stock  was  at  24  mg/ml  in  dH20  and  stored  at  -200C.  Final 
concentrations  in  agar  were  20  gg/ml  and  50  gg/ml  respectively. 
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2.3.10  Introduction  of  plasmid  DNA  into  Streptomyces 
Plasmids  were  introduced  into  protoplasts  of  Streptomyces  species  using  the 
polyethylene  glycol  method  described  by  Hunter  (1985). 
2.3.10.1  Protoplast  method  of  Transformation 
Reagents. 
Medium  P:  5-73  g  N-tris[hydroxymethyllmethyl-2-aminoethanesulfonic  acid  (TES), 
103  g  sucrose,  2-93  9  M9023H20,0-5  g  K2SO4,3-68  g  CaC12.2H20,2  ml  trace 
element  solution-,  adjusted  to  pH  7.4  with  NaOH  and  made  up  to  I  litre  in  distilled 
water. 
Lysozyme  solution:  10%  (w/v)  sucrose,  25  mM  TES  buffer  (pH  7-2),  2.5  mM 
K2SO4,2  ml  trace  elements  (Hopwood  et  al.,  1985),  2.5  mM  MgC12,2-5  m.  M 
CaC12.  KH2PO4  (0-005%  [w/vl)  and  lysozyme  (0-3  mg/ml)  were  added  immediately 
prior  to  use. 
PEG  solution:  Ig  of  polyethylene  glycol  1540  (supplied  by  BDH)  was  melted  in  a 
microwave  (600  W)  for  10  seconds  on  the  reheat  setting  and  then  mixed  with  3  ml  of 
medium  P. 
2.3.10.2  Preparation  of  protoplasts 
30  ml  cultures  were  grown  in  the  appropriate  medium  at  30'C.  The  optimal  time  to 
harvest  the  mycelium  in  order  to  recover  the  most  competent  protoplasts  was 
species-dependent  (i.  e.  S.  lividans  mycelia  were  harvested  after  65  hours  and  S. 
rimosus  and  S.  albus  after  48  hours,  respectively).  The  mycelium  was  pelleted  at 
12000  g  for  10  minutes  and  washed  twice  in  10.3%  (w/v)  sucrose.  The  pellet  was 
then  resuspended  in  4  ml  of  lysozyme  solution  and  incubated  at  37'C  for  15-30  min. 
The  formation  of  protoplasts  was  monitored  using  a  microscope,  and  the  reaction 
terminated  by  adding  5  ml  of  P  medium. 
The  protoplasts  were  then  filtered  through  cotton  wool  (Hopwood  et  al.,  1985)9 
pelleted  using  a  centrifuge  (12000  g  for  10  minutes)  and  washed  twice  in  P  medium. 
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Finally,  they  were  resuspended  in  2  ml  of  medium  P,  dispensed  into  100  VI  aliquots 
and  frozen  at  -700C. 
2.3.10.3.  Transformation  of  protoplasts. 
The  protoplasts  were  thawed  on  ice.  DNA  was  added  in  a  volume  of  less  than  10  PI 
and  the  mixture  incubated  on  ice  for  30  seconds.  400  pl  PEG  solution  was  added, 
the  solution  incubated  on  ice  for  a  further  I  minute  and,  finally,  800  VI  medium  P 
was  added.  Dilutions  of  the  transformation  mix  were  then  made  in  medium  P  and 
plated  onto  regeneration  medium. 
2.3.10.4  Regeneration  of  transformed  protoplasts 
Selection  of  transformants,  due  to  plasmid-borne  resistance  markers,  was  performed 
by  overlaying  the  regeneration  plates  with  I  ml  of  a  10-3%  (w/v)  sucrose  solution 
containing  a  suitable  antibiotic  after  16-20  hours  of  non-selective  growth  at  30'C. 
The  antibiotics  used  in  this  work  for  plasmid  selection  in  Streptomyces  were 
thiostrepton  (obtained  from  E.  R.  Squibb,  New  Jersey,  USA)  and  kanamycin. 
Thiostrepton  was  dissolved  in  DMSO  to  make  a  1%  (w/v)  stock  solution. 
Kanamycin  was  dissolved  in  distilled  HO  at  25  mg/ml  Transformed  protoplasts  were 
selected  by  overlaying  with  220pg/ml  thiostrepton  or  2  mg/ml  kanamycin  for  S. 
lividans,  5  mg/ml  for  S.  albus 
2.4  General  DNA  Methods 
2.4.1  Commonly  used  buffers 
a)  TE  buffer  (10x) 
100  mM  Tris-HCI  pH8,10  mM  EDTA,  Sterilised  at  120  'C  and  20  psi  using  an 
autoclave  and  stored  at  room  temperature,  used  as  aIx  solution 
haALhUffeLM) 
4.48%  (w/v)  Tris,  1.64%  (w/v)  sodium  acetate,  0-36%  (w/v)  Na2EDTA.  2H20,  made 
up  in  distilled  water,  pH  adjusted  to  8-2  with  glacial  acetic  acid,  used  as  a  Ix 
solution. 
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c)  VHind  III  DNA  markers 
X  c1857  S7  DNA  was  obtained  from  BRL.  This  DNA  was  cleaved  with  the 
restriction  enzyme  Hind  III  and  resulting  DNA  fragments  diluted  to  a  final 
concentration  of  27  ng/pl  in  TE  (final  concentration  I  x)  with  loading  buffer  added  to 
Ix  concentration.  Typically,  10  V1  was  used  on  agarose  gels  as  markers  for 
comparing  the  size  and  concentration  of  bands  in  samples. 
d)  ARarose  Rel  loadiniz  buffer 
0.5  %  (w/v)  bromophenol  blue,  0.05  %  (w/v)  xylene  cyanol,  50  %  Ficoll,  I%  (w/v) 
SDS,  100  mM  EDTA. 
2.4.2  Preparation  of  plasmid  DNA 
2.4.2.1  Reagents  for  isolation  of  plasmid  DNA 
Protocols  based  on  the  alkaline  lysis  method  (Birnboim  and  Doly,  1979)  were  used 
for  the  isolation  of  plasmid  from  small  (5  ml)  cultures  of  E.  coli.  An  alternative 
alkaline  lysis  developed  by  Kieser,  was  used  for  isolation  of  plasmid  DNA  from 
Streptomyces. 
a)  Birnboim  Doly  I  (BDI) 
50  mM  glucose,  25  mM  Tris-HCl  pH  8.0,10  mM  EDTA.  If  streptomycete  plasmids 
were  being  isolated,  lysozyme  was  added  immediately  before  use  to  a  final 
concentration  of  5  mg/ml. 
b)  Birnboim  Doly  11  (BDII) 
0-2  M  NaOH,  1%  (w/v)  SDS  which  was  stored  in  a  plastic  container. 
c)  Birnboim  Doly  III  (BDIII) 
Prepared  by  mixing  60  ml  5M  CH3COOK  with  11.5  ml  glacial  acetic  acid  and  28.5 
ml  dH20.  The  resultant  solution  is  3M  with  respect  to  potassium  and  5M  with 
respect  to  acetate. 
d)  DNase-free  RNase 
Pancreatic  RNase  (RNase  A)  was  dissolved  at  a  concentration  of  10  mg/ml  in  dH20, 
heated  to  1000C  for  15  mins  and  allowed  to  coot  slowly  to  room  temperature.  The 
RNase  was  then  aliquoted  and  stored  at  -200C. 
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e)  Acid  phenol/chloroform 
50  g  phenol  was  dissolved  in  50  ml  chloroform  and  10  ml  dH20.  Hydroxyquinoline 
was  added  as  an  anti-oxidant 
f)  Alkaline  SDS 
M  NaOH,  2%  (w/v)  SDS. 
2.4.2.2  Small-scale  plasmid  preparation  from  E.  coli 
Routinely,  plasmids  were  isolated  from  1-5  ml  of  E.  coli  cultures.  The  cells  were 
pelleted  by  centrifugation  in  a  1-5  ml  microfuge  tube  (12000  g  for  30  secs)  and 
resuspended  in  100  V1  of  BDI,  containing  lysozyme  at  a  concentration  of  I  mg/ml, 
using  a  vortex  mixer.  This  was  followed  by  the  addition  of  200  P1  of  BDII  and 
repeated  inversion  of  the  microfuge  tube  to  thoroughly  mix  the  suspension. 
Immediately  afterwards,  150  pl  of  pre-chilled  BDIII  was  added  to  the  viscous 
bacterial  lysate,  mixed  gently  on  the  vortex  mixer  and  placed  on  ice  for  5-10  mins. 
The  cell  debris  and  most  of  the  chromosomal  material  were  harvested  by 
centrifugation  (12000  g,  4"C  for  10  min)  in  a  microfuge.  The  supernatant  was 
transferred  to  a  fresh  tube  and  extracted  with  half  volumes  of  phen  o  I/chloro  form  and 
chloroform.  The  nucleic  acid  was  then  precipitated  by  the  addition  of  2  volumes  of 
ethanol  and  allowed  to  stand  at  room  temperature  for  5  mins.  The  precipitate  was 
harvested  by  centrifugation  in  a  microfuge  (12000  g,  4'C  for  at  least  15  mins).  The 
resulting  pellet  was  rinsed  twice  with  70%  (v/v)  ethanol  before  it  was  allowed  to  dry 
by  leaving  the  tube  open  on  the  bench.  The  nucleic  acid  was  then  resuspended  in  50 
pI  dH20  containing  DNase-free  RNase  (20  pg/ml). 
If  further  purification  of  the  DNA  was  required  (for  example  for  double-stranded 
sequencing  reactions),  the  pellet  was  resuspended  in  16  gI  of  Ix  TE,  to  which  4  [tI  of 
4M  NaCl  and  20  gI  of  13%  PEG  were  added,  followed  by  incubation  on  ice  for  20 
mins.  Centrifugation  for  15  mins  at  4  "C  produced  a  pellet,  which  was  washed  in  70% 
ethanol,  and  resuspended  in  Ix  TE. 
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2.4.2-3.  Preparation  of  plasmid  DNA  by  the  "Kieser"  niethod 
(HOPwood  et  al.,  1985) 
UP  to  I  ml  of  Streptomyces  culture  was  diluted  1:  1  with  dH20  and  pelleted  by 
centrifugation.  The  pellet  was  washed  in  TES  buffer,  resuspended  in  500  Rl  TES 
buffer  (containing  2  mg/ml  lysozyme),  and  incubated  at  37'C  for  up  to  30  mins.  250 
41  of  alkaline  SDS  was  added,  the  solution  homogenised  immediately,  and  incubated 
at  70"C  for  15  mins.  After  cooling  to  room  temperature,  the  solution  was  mixed  with 
90  W  of  acid  phenolkhloroform,  centrifuged,  and  the  supernatant  isolated.  This  step 
was  repeated  using  80  gl  of  chloroform,  and  the  supernatant  added  to  60  gl  3M 
sodium  acetate  and  600  gl  isopropanol.  The  solution  was  mixed  and  left  at  room 
temperature  for  10  mins,  followed  by  centrifugation.  The  pellet  was  washed  in  70% 
ethanol,  and  resuspended  in  Ix  TE. 
2.4.3  Precipitation  of  DNA 
DNA  solutions  were  precipitated  by  the  addition  of  1/10  volume  of  5M  NaCI  and  2 
volumes  of  cold  ethanol  or  an  equal  volume  of  isopropanol.  After  mixing,  the  DNA 
was  pelleted  by  centrifugation  (27000  g,  4  'C,  30  mins  for  volumes  of  7-5-20  ml,  or 
12000  g,  4  "C,  15  mins  for  small  volumes  in  microfuge  tubes).  The  pellet  was 
washed  in  70%  (v/v)  ethanol  and  dried  briefly  in  a  vacuum  desiccator,  or  in  an  open 
tube  on  the  bench. 
2.4.4  Spectrophotometric  measurement  of  nucleic  acid 
Nucleic  acid  concentrations  were  determined  spectrophotometrically  at  260  nm.  In  a 
I  cm  path  length  an  absorbance  value  of  1.0  corresponds  to  50  Vg/ml  for  double- 
stranded  DNA,  33  pg/ml  for  single-stranded  DNA  and  20  pg/ml  for  oligonucleotides. 
2.4.5  Digestion  of  DNA  with  restriction  enzymes 
Restriction  digests  were  carried  out  using  the  BRL  restriction  enzymes  and  REact 
buffers  which  were  provided  with  each  batch  of  enzyme.  There  are  ten  different 
REact  buffers  with  a  range  of  salt  concentrations,  each  one  suitable  for  a  range  of 
enzymes.  Alternatively,  digests  were  performed  using  New  England  Biolabs 
restriction  enzymes  and  the  accompanying  restriction  buffers.  Analytical  digests  were 
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carried  out  in  a  volume  of  20  pI  at  37"C.  Preparative  digests  were  carried  out  in  larger 
volumes.  When  DNA  was  digested  with  two  restriction  enzymes,  the  endonuclease 
requiring  the  lower  salt  buffer  was  used  first.  After  the  recommended  duration  of 
digestion,  the  salt  concentration  was  adjusted  and  the  second  enzyme  added. 
2.4.6  Ligation  of  DNA  fragments 
The  ligation  of  DNA  fragments  was  carried  out  usually  at  a  DNA  concentration  of  6 
gg/ml.  The  molar  ratio  of  insert  fragment  to  vector  was  3:  1,  when  the  vector  could 
not  ligate  to  itself  (for  example  when  using  a  vector  that  has  been  dephosphorylated 
or  has  been  cut  with  two  non-complementary  enzymes).  A  molar  ratio  of  10:  1  was 
used  when  the  ends  of  the  vector  could  ligate  to  each  other.  Ligations  were 
performed  usually  in  20  pl  of  lx  ligation  buffer  provided  by  BRL,  containing  IU  of 
T4  ligase  per  pg  of  DNA.  The  reactions  were  incubated  for  4  hours  at  room 
temperature  or  overnight  at  4*C 
2.4.7  Removal  of  the  5'  phosphate  from  linearised  DNA 
lOx  CIP  Buffer:  200  mM  Tris-HCl  pH  8.0,10  mM  M902,10  mM  ZnC12  and  0-5 
mg/ml  Bovine  Serum  Albumin. 
Procedure:  Calf  Intestinal  Alkaline  phosphatase  (CIP)  was  used  to  remove  the  5' 
phosphate  from  DNA.  Around  5  pmoles  of  5'-terminal  phosphorylated  DNA  with  5' 
protruding  ends  (approximately  7  Vg  of  a5  kb  molecule)  were  incubated  in  Ix  CIP 
buffer,  containing  0.1  U  of  CIP  at  37  'C  for  60  mins.  The  reaction  was  terminated  by 
heating  to  65  'C  in  Ix  gel  loading  buffer  for  10  mins.  The  S-terminal 
dephosphorylated  DNA  was  recovered  from  an  agarose  gel  after  electrophoresis. 
(2.4.10) 
2.4.8  Filling  in  of  5'  overhanging  bases  resulting  from  restriction  digests. 
After  digestion,  8gl  of  dNTP's  at  a  1.25  mM  concentration  and  2-3U  of  T4  DNA 
polymerase  was  added  to  the  20gl  reaction  and  incubated  for  a  further  I  hour  at  37 
'C.  The  dNTP's  were  removed  by  electrophoresis  and  gel  purification  before  further 
manipulation. 
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2.4.9  Addition  of  linkers  to  blunt  ended  fragments 
The  molar  ratio  of  linker  to  blunt  ended  vector  must  be  200:  14  ptl  of  5x  ligation 
buffer  and  200  ng  of  vector  DNA  (0.6  pmol)  were  added  to  22.5  pmol  of  kinased 
linker  and  IU  T4  DNA  ligase  in  a  20  gl  reaction  volume  and  incubated  at  4  *C 
overnight. 
2.4.10  Removal  of  excess  linker  after  ligation. 
The  reaction  was  heated  to  65  'C  for  10  minutes  to  stop  the  reaction.  The  DNA  was 
precipitated  (2.4.4)  and  reconstituted  in  8  gI  Ix  TE  to  which  was  added  IgI  of 
suitable  ReAct  buffer  and  IU  of  restriction  enzyme.  The  restriction  digest  was  carried 
out  as  normal  (2.4.6.  )  The  excess  DNA  was  removed  by  electrophoresis  and  gel 
purification,  whereupon  the  fragment  was  religated  to  itself  and  transformed  before 
further  manipulation. 
2.4.11  Agarose  gel  electrophoresis 
2.4.11.1  Preparation  of  agarose  gels 
DNA  was  visualised  on  horizontal  neutral  agarose  gels.  Although  0-9  %  (w/v)  gels 
were  most  commonly  used,  1-2  %  (w/v)  gels  were  occasionally  used  to  separate 
fragments  of  <1-5  kb.  Gels  were  routinely  prepared  and  run  in  TAE  buffer.  %-Hind 
III  markers  were  used  on  all  gels  as  size  markers  and  for  quantification  of  the  amount 
of  DNA  by  comparing  the  intensity  of  bands  to  those  of  the  samples  (2.4.1  c). 
a)  MinLgels 
BRL  model  H6  gel  kits  were  used  for  the  rapid  analysis  of  DNA  after  digestion  with 
restriction  enzymes  or  precipitation  steps.  0.  IS  g  agarose  was  added  to  20  ml  of  Ix 
TAE,  boiled,  and  then  cooled  to  600C.  The  molten  agarose  was  poured  into  a  7-6  cm 
x  5-1  cm  gel  caster  with  an  8  well  slot  former  (4-1  x  0-8  mm  wells).  Alternatively, 
smaller  gels  were  made  by  pipetting  8-12  ml  of  molten  agarose  onto  a  7.6  cm  x  5.1 
cm  glass  slide,  wells  were  formed  with  a  modified  8  well  slot  former.  After  the  gel 
had  set,  the  slot  former  was  removed  and  the  gel  placed  in  the  tank  with  500  ml  of  Ix 
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TAE.  Depending  on  the  time  available  and  the  level  of  resolution  required,  the  DNA 
was  separated  by  electrophoresis  for  30-60  mins  with  an  applied  voltage  of  2-10 
V/cm.  1/10  volume  loading  buffer  (2.4.1d)  was  added  to  the  DNA  samples  before 
they  were  loaded  onto  the  gel.  The  separated  DNA  molecules  were  visualised  on  a 
302  nm  UV  transilluminator 
b)  Large  gels 
200  ml  gels  were  also  used  to  ensure  good  separation  of  DNA  fragments  for  accurate 
sizing  They  were  made  by  pouring  200  ml  of  molten  agar  into  a  16.5  x  23  cm  gel 
former  with  a  14  space  slot  former.  The  gels  were  run  overnight  at  20  V  in  Ix  TAE 
buffer.  DNA  samples  were  mixed  with  1/10  volume  of  lOx  loading  buffer  (2.4.1d) 
before  loading  onto  the  gel. 
2.4.11.2  Staining  of  gels  with  Ethidium  Bromide 
Gels  were  stained  by  placing  in  a  solution  of  EtBr  dissolved  in  Ix  TAE  or  distilled 
H20  at  0.5  gg/ml  for  10-20  minutes.  Background  staining  caused  by  unbound  EtBr 
was  removed  by  soaking  in  Ix  TAE. 
2.4.11.3  Photography  of  agarose  gels 
Gels  stained  with  ethidium  bromide  were  viewed  on  a  302  nm  UV  transilluminator 
and  photographed  using  Polaroid  type  67  land  film  Alternatively,  pictures  were 
obtained  using  a  Mitsubishi  video  copy  processor  attached  to  a  UVP  video  camera. 
2.4.12  Recovery  of  DNA  from  agarose  gels 
Using  Qiaex-susj2ension 
A  Qiaex  gel  extraction  kit  was  obtained  from  Qiagen,  Germany.  The  gel  slice 
containing  the  excised  DNA  fragment  was  mixed  with  3  vols.  QX  I  solubilisation 
buffer  and  Qiaex-suspension  (10  pl  per  5  pg  DNA).  The  gel  slice  was  incubated  at 
50"C  for  10  mins  with  frequent  mixing  to  solubilise  the  gel  and  allow  the  DNA  to 
absorb  to  the  Qiaex-suspension.  The  suspension  was  pelleted,  washed  twice  with 
500  pl  QX  I  wash  buffer,  and  twice  with  500  pl  PE  wash  buffer.  The  suspension  was 
pelleted  and  air-dried  for  10-15  mins,  followed  by  resuspension  in  Ix  TE  buffer  or 
water,  10  mins  incubation  at  59'C  with  frequent  mixing  and  pelleted  again.  The 
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DNA  was  contained  in  the  supernatant,  in  a  condition  ready  for  any  subsequent 
manipulations. 
2.4.13  DNA  sequencing 
Plasmid  DNA  was  sequenced  automatically  by  Mr.  R.  Tate  at  the  Molecular  Biology 
Laboratory,  Department  of  Physiology  and  Pharmacology,  University  of  Strathclyde 
using  an,  ABI  (Applied  Biosystems)  373A  automated  sequencer  run  using  dye 
terminators  and  Amplitaq  FS  DNA  polymerase  (Cycle  sequencing). 
2.4.13.1  Preparation  of  plasmid  template  for  sequencing 
Plasmid  DNA  was  prepared  for  sequencing  using  a  plasmidPURE  kit  (Sigma). 
2.4.13.2  Preparation  of  sequencing  primers. 
Oligonucleotide  primers  for  sequencing  were  obtained  from  BRL  (Paisley,  UK) 
as  a  dry  pellet,  primer  was  reconstituted  with  200  gI  Ix  TE  this  was  used  as  a  stock 
and  stored  at  -20"C.  The  DNA  concentration  of  the  stock  was  determined 
spectro  photo  metrically,  (2.4.4).  Stock  was  diluted  with  sterile  distilled  H20  to  a 
suitable  concentration  for  the  sequencing  reaction. 
2.4.14  Polyrnerase  Chain  Reaction. 
The  Polymerase  Chain  Reaction  (PCR)  was  employed  several  times  in  this  work  to 
introduce  mutations  into  DNA.  Conditions  must  be  optimised  for  each 
primer/template  combination  but  a  general  protocol  is  given  below. 
a)  PCR_Mjýiýients. 
5-10  ng  plasmid  template 
100  pmole  primer  I 
100  pmole  primer  II 
5  gl  DMSO 
2.5  MM  M9CI2 
1.25  mM  dNTP's 
5  gl  IN  buffer 
total  volume  to  50  gl  with  dH20 
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b)  Reaction  conditions. 
step  1.  Denature  DNA  at  94'C  for  4  minutes  add  0.5  Units  Taq  or  Pfu  polymerase 
(I  gl)  plus  I  drop  of  mineral  oil  to  prevent  evaporation  from  top  of  tube. 
step  2.94  'C  for  30s 
step  3.  Tn,  *  -5  'C  for  60s 
step  4.72  *C  for  120s 
Repeat  steps  2-  4  for  30  cycles. 
*T.  is  calculated  by  the  equation: 
Tm  =  59.9  +  41  [%  G+C]  -  657/  Lp 
(where  Lp  is  length  of  primer  in  bases) 
2.4.14.1  PCR  Primers 
Several  primers  were  employed  during  work  presented  in  this  thesis. 
5'CCCAGTCACGACGTTGTAAAACG3' 
Universal  (forward)  M  13/pUC  Primer 
5'AGCGGATAACAATTTCACACAGG3' 
Universal  (reverse)  M  13/pUC  Primer 
5'GATCCTGACGCATATGTCGGGACTGCT3' 
Custom  primer  1,  includes  Ndel  site,  underlined  (4.4.2) 
5'CGGAATTCCTCGAGTCAGAGCTCCCAGGCGTCCGACGCGGG3' 
Custom  primer  2,  changes  otrB  stop  codon  to  TGG,  encoding  tryptophan  (5.2.2) 
5'CCCGGAATTCTAGGTATCGATGCCGACCATGCGGTGCTCGCGCCG3' 
Custom  primer  3,  creates  N-terminal  half  of  truncated  otrB  when  used  with  universal 
forward  primer  (5.8) 
80 Chapter  2 
5'CATATGGGCATCGATACCCTGCGGCGCGGCGAC3' 
Custom  primer  4,  creates  C-terminal  half  of  truncated  otrB  when  used  with  reverse 
primer  (5.8) 
2.5  General  protein  methods 
2.5.1  Preparation  of  crude  protein  extracts 
Cell  pellets  were  resuspended  in  ice  cold  extraction  buffer,  (100  MM  potassium 
phosphate  buffer  pH7.0  [6.15  ml  IM  K2P04,3.85  ml  IM  KH2PO4  in  100  ml],  5 
mM  EDTA,  I  mM  benzamidine,  0.4  mM  DTT;  benzamidine  and  DTT  added 
immediately  before  lysis)  and  lysed  by  passage  through  an  automatic  French  Pressure 
cell  under  750  psi  pressure  or  by  use  of  a  constant  systems  model  40/AA  cell 
disrupter.  The  suspension  was  centrifuged  at  10,000  xg  for  15  minutes  at  4'C  and  the 
supernatant  isolated. 
2.5.2.  Preparation  of  membrane  fractions 
2.5.2.1  Disruption  of  cells 
Cell  pellets  were  resuspended  in  not  more  than  30  ml  20  niM  Tris,  pH8,0.5  mM 
EDTA  and  French  pressed  as  above.  After  French  pressing  the  cells  were  centrifuged 
to  bring  down  whole  cells  and  cell  debris  using  a  Beckman  JA20  rotor  at  13750  rpm, 
(1500  x  g)  for  30  minutes.  The  supernatant  was  decanted  off  and  ultra-centrifuged  in 
a  Beckman  Ti60  rotor  at  45,000  rpm,  (  13  1,000  x  g)  for  90  minutes  to  pellet  the 
mixed  inner  and  outer  membranes.  The  membrane  pellets  were  each  resuspended  in  4 
ml  50  mM  sodium  phosphate  buffer,  pH8  and  quick  frozen  on  dry  ice  and  ethanol. 
These  membrane  samples  can  be  stored  at  -200C. 
2.5.2.2  Solubilisation  of  membranes 
Membrane  pellets  were  thawed  on  ice  and  resuspended  in  a  total  of  8  ml 
solubilisation  buffer,  50  mM.  sodium  phosphate,  pH8,10%(v/v)  glycerol,  20  mM 
imidazole  pH8,1%  (w/v)  dodecylmaltoside  (DDM)  using  a  blue  tip  at  first  then 
sequentially  finer  needles.  The  suspension  was  mixed  on  a  rocker  for  2  hours  at  40C. 
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After  mixing,  the  membrane  samples  were  centrifuged  in  a  Beckman  SW  50  rotor  at 
290,000  xg  for  90  minutes. 
2.5.3  Isolation  of  His-tagged  protein 
2.5.3.1  Preparation  of  HisResin 
4  ml  of  HisResin  (Novagen)  equivalent  to  2  ml  settled  bed  volume,  was  washed 
twice  with  distilled  H20  then  charged  with  50  ml  400  mM  NiS04  by  rocking  for  8 
hours  at  4'C. 
After  this  time  the  tubes  were  left  upright  for  30  minutes  for  the  agarose,  resin 
to  settle,  the  supernatant  was  then  removed.  The  resin  was  then  washed  twice  in 
denaturing  equilibration  buffer,  50  mM  sodium  phosphate,  pH8,10%(v/v)  glycerol, 
20  mM  imidazole,  pH8,0.  l%  DDM,  6M  urea. 
2.5.3.2  Binding  of  HisTagged  proteins  to  resin 
Solubilised  membrane  fractions  were  added  to  the  settled  resin  and  the  volume  made 
up  to  50  ml  with  denaturing  equilibration  buffer  in  falcon  tubes.  The  tubes  were 
rocked  overnight  at  4  'C  in  order  that  the  HisTagged  protein  would  bind  to  the  Ni- 
resin. 
2.5.3.3  Column  purification  of  HisTagged  proteins. 
The  resin  from  the  overnight  binding  reaction  was  left  to  settle  in  the  tubes  and  then 
loaded  into  a  column  made  from  2.5  ml.  syringe  with  a  glass  wool  frit.  The  resin  was 
left  to  settle  in  the  column  which  was  washed  through  with  the  remaining  volume 
from  the  50  ml  of  equilibration  buffer. 
The  column  was  then  washed  with  10  volumes  of  elution  buffer  1,50  mM  sodium 
phosphate  buffer,  pH8,20  mM  imidazole,  pH8,10%  (v/v)  glycerol,  0.1% 
(w/v)DDM,  6M  urea.  1.5  ml  fractions  were  collected  in  eppendorf  tubes. 
The  column  was  then  washed  through  with  10  volumes  of  elution  buffer  IL  as  above 
but  with  200  mM  imidazole  in  place  of  20  mM.  1.5  ml  fractions  were  again 
collected. 
The  final  wash  was  done  using  citrate  buffer,  100  mM  sodium  citrate,  pH4,10% 
(v/v)  glycerol,  0.1%  (w/v)  DDM,  6M  urea.  1.5  ml  fractions  were  collected  in 
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eppendorfs  as  before.  The  column  purification  should  be  carried  out  at  a  low 
temperature  but  4  'C  may  cause  the  urea  to  precipitate. 
2.5.4  Protein  Assays 
The  amount  of  protein  in  membrane  samples  was  measured  prior  to  gel 
electrophoresis  using  the  bicinchoninic  acid  assay  for  soluble  protein. 
2.5.4.1  BCA  assay 
REAGENTS 
Reagent  A:  1%  BCA-Na2,2%  Na2CO3.  H20,0.16%  Na2  Tartrate,  0.4%  NaOH  and 
0.95%  NaHC03.  (Adjust  to  pH  11.25  by  the  addition  of  solid 
NaHC03)- 
Reagent  B:  4%  CUS04.5H20  in  sterile  distilled  H20. 
Working  Reagent:  100  vol.  Reagent  A+2  vol.  Reagent  B. 
BSA  Protocol 
A  series  of  BSA  (Bovine  Serum  Albumin)  standards  ranging  from  0  Pg/ml  to  1000 
gg/ml  was  prepared.  To  100  gl  of  standard  or  suitably  diluted  sample,  2  ml  of 
working  reagent  was  added.  The  tubes  were  then  incubated  at  37'C  for  30  minutes  Zý 
after  which  the  absorbance  was  measured  at  562  nm  against  a0  gg/ml  BSA  blank. 
2.5.4.2  DC-  protein  assay  of  column  cluates 
As  column  eluates  contained  6M  urea  and  0.1%  DDM,  the  Detergent  Compatible 
assay  system  from  BioRad  was  used  to  assay  for  protein  in  these  samples.  This  is 
compatible  with  4M  urea.  BSA  standards  were  prepared  in  4M  urea  in 
concentrations  ranging  from  0  to  250  gg/ml.  To  200  gl  of  standard  or  suitably 
diluted  sample  (4  M  urea),  100  gl  solution  A'  and  800  [il  of  solution  B  from  the  kit 
were  added.  The  tubes  were  incubated  at  room  temperature  for  20  minutes  after 
which  the  absorbance  was  measured  at  655  nm  against  a  blank  containing  4M  urea. 
2.5.5  Denaturing  polyacrylamide  gel  clectrophoresis  of  proteins  (SDS 
PAGE) 
2.5.5.1  Reagents  for  SDS  PAGE 
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a)  4x  load  buffer  62.5  mM  Tris.  HCI  (pH8.6),  5%  glycerol,  1.6%  (w/v)  SDS, 
0.0025%  (w/v)  bromophenol  blue.  immediatley  prior  to  use  add  3  RI 
mercaptoethanol  per  100  gl 
b)  Anode  buffer.  0.302%  (w/v)  Tris  base,  1.44%  (w/v)  glycine,  0.1%  (w/v)  SDS 
0  Cathode  buffer,  0.302%  (w/v)  Tris.  HCl  (pH8.4). 
d)  Molecular  weight  standards.  Supplied  as  a  prestained  mixture  of  six  proteins  by 
Biorad,  (Hemel  Hempstead,  UK).  Contains;  Rabbit-muscle  Phosphorylase  B,  97,400 
Da,  Bovine  Serum  Albumin,  66,200  Da,  Hen  Egg  White  Ovalbumin,  45,000  Da, 
Bovine  Carbonic  Anhydrase,  3  1,000  Da,  Soybean  Trysin-inhibitor,  2  1,000  Da,  Hen 
Egg  White  Lysozyme,  14,400  Da. 
2.5.5.2  Apparatus  for  SDS  PAGE 
5x  17  cm  gels  were  cast  between  glass  plates  with  1.5mm  thick  spacers  and  a  20 
tooth  1.5  mm  thick  teflon  comb.  Electrophoresis  was  performed  using  a  model  15- 
17  vertical  gel  electrophoresis  apparatus  from  BRL,  Paisley,  UK  or  using  the  Atto 
mini  gel  system  from  Genetic  Research  Instrumentation  Ltd.  Dunmow,  Essex,  UK. 
This  system  used  90  mm  x  80  mm  x  Imm  glass  plates  with  a  12  well  0.8  mm  thick 
teflon  comb. 
2.5.5.3  Protocol  for  SDS  PAGE 
Electrophoresis  of  the  supernatant  from  the  cell  lysate,  inner  membrane  fraction  or 
eluate  from  the  purification  column  was  performed  in  the  presence  of  0-  1%  (w/v) 
SDS  in  a  4%  (w/v)  stacking  gel  and  a  15%  (w/v)  running  gel.  A  ratio  of  8.6  :I 
acrylamide  :  bis-acrylamide  was  used  in  the  gel,  and  polymerisation  was  induced  by 
the  addition  of  0.1  %  (w/v)  fresh  ammonium  persulphate  and  0.1  %  (vIv)  TEMED. 
When  using  the  minigel  apparatus,  the  gel  was  made  up  as  a5%  (w/v)  stacking  gel 
and  10  %  (w/v)  resolving  gel  at  a  ratio  of  3.75  :I  acrylamide:  bisacrylamide. 
I  volume  of  4x  protein  loading  buffer  was  added  to  three  volumes  of  sample,  and  the 
mixture  denatured  at  37C  for  20  minutes.  10-30  gI  of  the  sample  was  loaded  onto 
the  gel,  and  the  get  electrophoresed  at  a  constant  current  of  200  mA.  A  prestained 
molecular  weight  ladder  was  also  run  on  the  gel  to  allow  estimation  of  subunit 
Molecular  weight  and  later  to  determine  extent  of  transfer  of  proteins  to  membrane. 
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2.5.6  Staining  of  polyacrylamide  gels 
The  gel  was  stained  after  electrophoresis  by  either  the  Coomassie  method  or  the 
silver-stain  method. 
a)  Coomassie  method. 
The  gel  was  placed  in  Coomassie  blue  stain,  (0-25%  (w/v)  Coomassie  brilliant  blue 
R250  in  105  (v/v)  acetic  acid,  45%  (v/v)  methanol  for  30  mins,  and  destained  in  10% 
(v/v)  acetic  acid,  45%  (v/v)  methanol. 
b)  Silver  Stain  method  (Heukshoven  &  Dernick.  1989). 
I)The  gel  was  fixed  in  30%  (v/v)  ethanol,  10%  (v/v)  acetic  acid  for  3  hours  or 
overnight. 
2)  The  gel  was  washed  in  10%  (v/v)  ethanol  for  5  minutes 
3)  The  gel  was  washed  three  times  in  deionised  H,  O  for  10  minutes  each  time. 
4)  The  gel  was  placed  in  Farmer's  reagent  for  I  minute. 
Farmer's  reducing  reagent:  0.3%  (w/v)  Na,  S,  O 
3,5H20,0.15 
%  (w/v)  KFe  (CN),, 
0.005%  (w/v) 
NaC03. 
5)  The  gel  was  washed  three  times  in  deionised  H,  O  for  10  minutes  each  time. 
6)  The  gel  was  placed  in  0.1%  (w/v)  AgNO,  for  30  minutes. 
7)  The  gel  was  quickly  washed  in  deionised  H,  O,  (10-20  seconds). 
8)  The  gel  was  placed  in  developer  made  from  2.5%  (w/v)  Na  2CO31 
0.02%  (w/v) 
Formaldehyde  until  colour  developed,  (ca.  5  mins). 
9)  The  reaction  was  stopped  by  placing  the  gel  in  30%  (v/v)  methanol,  10%  (v/v) 
acetic  acid  for  30  minutes. 
2.5.7.  Transfer  of  proteins  to  nitro-cellulose  membrane  (Western  blotting). 
2.5.7.1.  Transfer  Buffer 
a)  Transfer  Buffer  was  prepared  by  the  method  of  Towbin  et  al  (1979) 
25  mM  Tris,  192  mM  glycine.  The  buffer  was  measured  for  pH  which  should  be  8.5 
depending  on  the  quality  of  reagents.  The  pH  was  not  adjusted  with  acid  or  base  as 
this  affects  the  conductivity. 
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2.5.7.2  Apparatus  for  transfer 
The  transfer  was  performed  using  a  model  2005  Transfer  tank  from  LKB  Bromma 
for  large  gels  or  a  Biorad  mini  trans-blot  tank  for  small  gels. 
2.5.7.3  Protocol  for  transfer 
Following  electrophoresis,  the  gels  were  rinsed  for  15  m  inutes  in  transfer  buffer  to 
remove  electrophoresis  buffer  salts  and  detergents,  during  this  time  the  buffer  was 
changed  3  times. 
A  piece  of  nitro-cellulose  membrane  (Hybond-C,  Amersham,  UK)  cut  to  the 
dimensions  of  the  gel  was  slid  slowly  at  an  angle  of  450  into  transfer  buffer,  abrupt 
wetting  was  avoided  as  this  can  lead  to  formation  of  bubbles  within  the  matrix. 
Two  pieces  of  filter  paper,  (Whatman  3  mm)  per  gel  were  cut  to  the  dimensions  of 
the  gel  and  saturated  with  transfer  buffer,  the  sponge  pads  from  the  apparatus  were 
also  completely  saturated  with  transfer  buffer. 
The  apparatus  tank  was  half  filled  with  pre  chilled  transfer  buffer  and  the 
cooling  system,  set  to  12  'C  and  pre-run  for  30  mins  before  the  start  of  blotting. 
The  gel  sandwich  was  built  up  on  one  plate  by  placing  a  pre-wetted  sponge  pad, 
followed  by  a  pre-wetted  filter  paper,  followed  by  the  equilibrated  polyacrylamide 
gel.  The  wetted  membrane  was  lowered  on  top  of  the  gel  using  forceps,  making  sure 
all  air  bubbles  were  excluded,  and  a  second  piece  of  filter  paper  placed  on  top,  this 
was  followed  by  the  second  pre-wetted  sponge  pad,  finally  the  second  plate  was 
added  to  the  sandwich  and  clipped  firmly  into  place.  Good  contact  was  maintained 
throughout. 
The  whole  gel  holder  was  then  placed  inside  the  blotting  tank  in  the  correct 
orientation,  (membrane  towards  the  positive  electrode  )and  the  tank  topped  up  with 
pre-chilled  transfer  buffer.  The  transfer  was  run  at  60  V(  about  500  mA  )  for  5  hours 
or  at  30  V  overnight  (16-18  hours)  for  the  large  gels  or  for  1.5  hours  at  constant 
current  of  200  mA  when  using  the  Bio-Rad  mini  trans-blot  equipment.  Following 
transfer,  if  not  blocked  straight  away,  membranes  were  removed  from  the  sandwich 
using  forceps 
,  washed  briefly  (1-2  minutes)  in  transfer  buffer  and  air  dried.  Once 
dried,  the  membranes  were  stored  between  two  sheets  of  filter  paper  in  sealed  plastic 
bags  at  4'C  until  required. 
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2.5.8  Immunodetection 
2.5.8.1  Reagents  for  immunodetection 
a)  TBS  buffer:  50  mM  Tris-HCI,  pH7.5,150  mM  NaCl. 
b)  TB  S-Tweeno  buffer:  50  mM  Tris-HCI  pH7.5,150  rnM  NaCl,  0.1%  Tweeno  20 
c)  Primary  antibody:  Anti  -PentaHistidine,  Mouse  Ascites  fluid,  Mouse  IgG  (Qiagen, 
UK). 
d)  Chemiluminescence  Western  blotting  kit,  (  Boehringer  Mannheim,  Lewes,  UK) 
contains  luminol  substrate  with  enhancer,  starting  solution,  Blocking  reagent, 
Secondary  antibody:  Anti-mouse  IgG-POD,  Fab  fragments. 
e)  Primary  blocking  buffer,  10%  marvel  in  TBS-Tween-208 
2.5.8.2  Protocol  for  immunodetection 
The  following  washing  and  incubation  steps  were  carried  out  at  room  temperature  on 
a  shaking  platform. 
1)  Blocking 
The  membrane  was  placed  in  a  trough  with  the  side  that  had  been  in  contact  with  the  C) 
gel  uppermost.  50ml  of  primary  blocking  buffer  was  added  to  the  trough  to  cover  the 
membranes  and  the  blocking  reaction  was  carried  out  overnight  at  room  temperature. 
2)  Addition  of  primary  antibody 
The  blot  was  overlaid  with  50  ml  of  primary  antibody  at  a  dilution  of  1:  2000  in 
blocking  buffer  and  incubated  overnight  at  4DC. 
3)  Washing 
The  membrane  was  washed  twice  for  10  minutes  each  in  at  least  50  ml  TBS/Tween 
and  then  twice  for  10  minutes  each  in  a  similar  volume  of  TBS. 
4)  Addition  of  secondary  antibLody 
The  membrane  was  incubated  for  30  mins  with  20  ml  (125gl  of  solution  per  cm  2  of 
membrane)  of  secondary  antibody  at  a  dilution  of  40  mU/mI  in  0.5%  blocking  buffer 
from  the  kit  (or  in  10%  Marvel  solution  as  step  2) 
5)  Washing 
As  step  3. 
6L]2etection. 
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Transparent  plastic  roll  was  cut  and  formed  into  a  bag  slightly  bigger  than  the  size  of 
the  membrane,  the  membrane  was  placed  inside  the  bag.  The  bag  was  sealed  on 
three  sides  using  a  vacuum  sealer.  The  premixed  detection  reagent  (100  volumes  of 
solution  A  to  I  volume  of  solution  B  as  directed  by  the  kit)  was  added  to  the  bag  at 
20  gl/cm  2  (between  1.5  to  3.0  ml  depending  on  size  of  membrane)  The  bag  was 
sealed  after  eliminating  air  bubbles  and  incubated  for  60  seconds.  The  membrane  was 
removed  from  the  bag  and  was  placed  protein  side  uppermost  between  two  acetate 
sheets  into  a  film  cassette. 
In  a  dark  room,  a  photographic  film  was  placed  on  top  of  the  bag  and  exposed  for  60 
seconds.  The  film  was  then  developed.  A  second  film  was  placed  in  the  cassette  and 
exposed  for  a  suitable  time  period  estimated  by  intensity  of  initial  signal. 
2.6  Computer  methods 
The  DNA  and  protein  sequences  in  this  thesis  were  analysed  using  the  Sequence 
Analysis  Software  package,  Version  8  from  the  Genetics  Computer  Group  at  the 
University  of  Wisconsin  (GCG)  (Devereux  et  al,  1984). 
BIBBPROGAC 
analysis;  uses  the  algorithm  of  Bibb  et  al  (1984)  to  find  potential  coding  regions  in 
the  nucleotide  sequences  of  Streptomycetes. 
GAP:  uses  the  algorithm  of  Needleman  &  Wunsch,  (1970)  to  find  the  alignment  of 
two  complete  sequences  that  maximises  the  number  of  matches  and  minimises  the 
number  of  gaps. 
PEPPLOT: 
plots  measures  of  protein  secondary  structure  and  hydrophobicity  in  parallel  panels  of 
the  same  plot.  Uses  a  choice  of  10  panels  ,  the  analysis  done  in  this  thesis  used  the 
algorithm  of  Goldman,  Engelman  and  Steitz,  (Engelman  et  al,  1986)  and  the 
hydropathy  measure  of  Kyte  and  Doolittle  (Kyte  &  Doolittle,  1982)  to  identify 
nonpolar  transbilayer  helices  over  a  window  of  9  residues. 
PILEUP: 
creates  a  multiple  sequence  alignment  from  a  group  of  related  sequences  using 
progressive,  pairwise  alignments.  It  can  also  plot  a  tree  showing  the  clustering 
relationship  used  to  creatd  the  alignment. 
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CHAPTER3 
otrB  gene  and  gene  product 
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Chapter  3. 
The  otrB  gene  and  gene  product. 
3.1  Introduction. 
The  30  kb  otc  cluster  lies  550-670  kb  from  one  of  the  chromosomal  ends  and  is 
known  to  be  flanked  by  resistance  determinants,  otrA  and  otrB,  with  the  otrB  gene 
being  closer  to  the  chromosome  end  (Garven,  1994;  Peric  &  Hranueli  unpublished 
results).  Initially  otrA  was  shown  to  specify  resistance  to  OTC  mainly  in  the 
ribosomal  fraction.  OtrA  shows  considerable  homology  to  the  TetM  and  TetO  gene 
products  of  Streptococcus  and  Campylobacter.  It  is  suggested  that  the  product  of 
otrA  confers  resistance  by  means  of  a  noncovalent  modification  of  the  ribosome.  At 
the  onset  of  this  work  the  otrB  gene  had  been  cloned  on  3  separate  occasions  (Rhodes 
et  al,  1984;  Ohnuki  et  al,  1985  and  Reynes  et  al  1988).  The  function  of  the  gene 
product  had  been  demonstrated  on  two  separate  occasions  (Ohnuki  et  al,  1985; 
Butler  et  al  1989).  Ohnuki  showed  that  the  protein  synthesis  machinery  of  S.  griseus 
carrying  the  tetB  (  otrB  )  resistance  determinant  on  a  plasmid  was  sensitive  to 
tetracycline  and  by  the  use  of  inverted  membrane  vesicles  demonstrated  that  this 
strain  exhibited  reduced  uptake  of  tritium  labelled  tetracycline.  As  reduced  uptake  is 
equivalent  to  increased  export  when  using  inverted  vesicles  it  was  proposed  that  the 
function  of  the  otrB  gene  product  is  to  implement  transport  of  the  produced  antibiotic 
from  the  cell. 
Two  sequences  for  otrB  were  available,  (Reynes  et  al,  1988;  and  MacGregor- 
Pryde,  1995).  Reynes  et  al  named  the  gene  tet  347,  as  sequencing  had  revealed  that 
the  gene  product  was  347  amino  acids  in  length.  Studies  showed  that  the  protein  was 
membrane  associated  and  supported  the  hypothesis  that  it  was  involved  in 
tetracycline  transport.  The  amino  acid  sequence  of  Tet347  showed  similarity  to  the 
exporter  families  but  was  smaller  than  the  usual  size  for  a  membrane  transporter  and 
did  not  appear  to  have  an  upstream  repressor  gene.  For  this  reason,  tet  347  was  given 
its  own  branch  of  the  evolutionary  tree  (Sheridan  &  Chopra,  199  1).  This  hypothesis 
was  contested  by  the  MacGregor-Pryde  (1995)  sequence  which  clearly  identifies  an 
upstream  ORF,  otrR  reading  divergently  from  otrB.  Analysis  of  this  sequence 
revealed  that  the  gene  product  of  this  ORF  is  a  putative  repressor  belonging  to  the 
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family  of  mcr  resistance/  repressor  genes  and  that  a  putative  helix-turn-helix  DNA 
binding  motif  is  present  in  the  upstream  sequence.  The  inverted  and  direct  repeats  of 
the  intergenic  region  show  similarity  to  the  operator  sequence  of  bacteriophage  434 
as  do  all  of  the  resistance  repressor  gene  systems  considered  by  MacGregor-Pryde 
(1995). 
Analysis  of  the  otrB  sequence  by  MacGregor-Pryde  identified  one  large  open 
reading  frame  of  1611  bp,  encoding  a  537  amino  acid  product  which  shows  high 
sequence  similarity  to  the  tcmA  gene  product  (Guilfbile  &  Hutchinson,  1992).  This 
implies  that  the  OtrB  protein  acts  as  an  export  pump  powered  by  the  transmembrane 
electrochemical  gradient.  Studies  of  the  deduced  otrB  gene  product  using  hydropathy 
profiling  and  comparison  analysis  indicate  that  the  protein  is  a  member  of  the  major 
facilitator  superfamily  (MFS),  showing  most  similarity  with  members  of  the  class  III 
family.  These  and  other  data  from  the  thesis  of  MacGregor-Pryde  suggest  that  the 
Reynes  sequence  was  erroneous  and  that  the  otrB  gene  product  does  conform  to 
known  Gram-positive  families  of  tetracycline  export  proteins  and  also  shows 
similarity  to  other  Streptomycete  antibiotic  export  genes. 
3.2  Aims  of  this  chapter 
During  the  course  of  this  work  it  was  discovered  that  the  MacGregor-Pryde  sequence 
also  contained  some  errors.  For  this  reason,  a  region  at  the  5'  end  of  the  gene  was 
cloned  into  pIB124  and  resequenced.  The  data  resulting  from  this  allowed  a  modified 
amino  acid  sequence  for  OtrB  to  be  deduced.  The  aims  of  this  chapter  were: 
(1)  To  elucidate  the  definitive  sequence  of  the  otrB  gene. 
(2)  Analysis  of  the  amino  acid  sequence  with  respect  to  other  tetracycline  resistance 
determinants  and  other  members  of  the  Major  Facilitator  Superfamily. 
3.3  Re-sequencing  of  parts  of  otrB 
3.3.1  Sequencing  strategy 
In  order  to  express  the  OtrB  protein  in  E.  coli  it  was  necessary  to  engineer  an  Nde  I 
(CATATG)  site  into  the  ATG  start  codon  of  the  gene.  This  was  done  using  PCR 
mutagenesis  with  a  mutagenic  oligonucleotide  primer  (4.4.3).  As  the  PCR  reaction 
was  performed  using  Taq  polymerase  it  was  important  to  sequence  the  PCR  product 
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and  compare  the  sequence  to  the  known  otrB  sequence  to  eliminate  mistakes  made 
by  the  enzyme,  which  has  no  proof  reading  activity.  The  PCR  product  was  cloned 
using  restriction  enzymes  Nde  I-  Hind  111,  into  pMTL23  which  has  annealing  sites 
for  universal  and  reverse  sequencing  primers  just  outside  of  the  polylinker  region  and 
sequenced  from  the  5'  end  using  an  ABI  automated  sequencer  to  give  c  300  bp  of 
sequence  at  the  start  of  the  gene.  When  this  sequence  was  compared  to  the 
MacGregor-Pryde  sequence,  a  number  of  differences  were  immediately  apparent. 
The  number  of  differences  was  thought  to  be  too  high  to  be  due  to  the 
infidelity  of  Taq  polymerase  activity.  The  lack  of  proof  reading  activity  of  the 
enzyme  results  in  some  mis  incorporation  of  bases.  The  fidelity  of  Taq  polymerase 
has  been  reported  to  be  2x  10-4,  error/bp  i.  e.  a  mistake  every  5  Kb,  (  Saiki  et  al, 
1988),  although  later  reports  are  that  the  error  rate  is  actually  slightly  lower  at  8.9  x 
10-6  errorlbp  (Cline  et  al,  1996).  In  order  to  rule  out  PCR  mistakes,  it  was  decided 
that  the  PCR  template  itself  should  be  sequenced  .  However,  direct  sequencing  of 
pJJ1  was  impractical  because  the  1.6  kb  otrB  gene  was  present  within  a  larger  2.34 
kb  SacI-BamHI  fragment  on  pJJ  I  with  500  bp  of  DNA  upstream  of  the  ATG  start  site 
(Fig  3.1  a  ). 
The  460  bp  Apa  I  fragment  containing  the  start  codon  and  401  bp  of  otrB  was 
cloned  into  p113124  to  create  pJJIBI  and  sequenced.  This  sequence  also  showed  some 
differences  to  the  previous  work. 
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Introduce  NdeI  site  at  ATG  codon  by  PCR. 
I 
Clone  PCR  product  into  pMTL23  to  create  pJJ2. 
I 
Sequence  from  NdeI  end  using  universal  primer. 
I 
Compare  sequence  data  with  that  of  MacGregor-Pryde  (1995). 
Diff  ren  es  observed 
Mistakes  in  M-P  sequence  ?  ýP  ?,  errors  ? 
Sequence  PCR  template,  subcloning  required. 
Subclone  genomic  Apal  fragment  int  plB124,  creating  pJJIBI  and  sequence  from 
both  ends  using  universal  and  reverse  primers. 
I 
Mistakes  in  M-P  sequence-.  [ 
I 
Compare  M-P  sequence  and  Reynes  sequence  with  new  sequence  data. 
I 
PCR  mistake  found  in  pJJ3. 
I 
Fresh  pJJ3  clone  sequenced,  thought  to  have  no  PCR  mistakes,  this  is  named 
pJJ6. 
I 
Design  sequencing  primers  to  determine  sequence  in  positions  where  M-P,  Reynes 
and  new  data  do  not  agree.  Analyse  these  data  and  produce  definitive  otrB  sequence 
Fijz  3.1b 
Plan  of  work  for  Chapter  3. 
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3.3.2  Analysis  of  sequence  data 
DNA  sequence  data  were  analysed  using  the  "Sequence  analysis  software  package, 
version  9"  from  the  University  of  Wisconsin,  (  GCG  9;  Devereux  et  al  1984).  This 
package  contains  a  series  of  programs  written  specifically  for  molecular  geneticists 
requiring  to  compile  and  analyse  sequence  data  quickly  and  with  accuracy.  The 
programmes  used  in  this  analysis  are  listed  below.  Further  information  can  be  found 
in  the  previous  chapter  (2.6).  The  GCG  programs  used  to  analyse  sequence  data 
were;  BESTFIT,  TRANSLATE,  PILEUP  and  COMPARE. 
3.4  Comparison  of  sequence  data  for  otrB. 
The  sets  of  sequence  data  were  compared  using  the  GCG  program  BESTFIT. 
335  bases  of  pJJ3  were  sequenced,  the  pJJ3  sequence  differing  from  the  MacGregor- 
Pryde  sequence  at  24  positions  of  the  335,  more  than  be  attributed  to  polymerase 
infidelity.  Comparing  the  pJJIBI  sequence  to  that  of  pJJ3  ,  the  two  sets  of  data  were 
in  agreement  apart  from  one  deletion  in  pJJ3,  this  was  presumed  to  be  a  PCR 
mistake.  A  second  pMTL  based  clone,  pJJ6,  was  chosen  at  random  and  sequenced  in 
the  same  way.  The  pJJ6  data  was  compared  to  the  pJJIBI  sequence  and  no 
differences  were  found  in  the  first  266  bases  of  the  otrB  open  reading  frame  (Fig  3.2), 
supporting  the  theory  that  the  deletion  in  pJJ3  was  due  to  infidelity  of  the  taq 
polymerase.  The  new  otrB  sequence  was  then  compared  to  the  tet347  sequence 
(Reynes  et  al,  1988)  and  to  otrB  (MacGregor-Pryde,  1995).  (Figs  3.3  and  3.4.  ). 
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1  ATGTCGGGACTGCTGCTGGCCGTGTTCCTCGCGGCCCTGGACCAgACGGT  50 
1  ATGTCGGGACTGCTGCTGGCCGTGTTCCTCGCGGCCCTGGACCAGACGGT  50 
51  CATCGCCACCGCGATGCGCACCATCGCGGACGACCTCCACGGCCAgACCG  100 
51  CATCGCCACCGCGATGCGCACCATCGCGGACGACCTCCACGGCCAgACCG  100 
101  AGCAGGCATGGGCGACGACGGGCTACCTCATCGCCTCCGTCCTGGCGATG  150 
101  AGCAGGCATGGGCGACGACGGGCTACCTCATCGCCTCCGTCCTGGCGATG  150 
151  CCGTTCTACGGCAAGCTGTCCGACATCTACGGGCGCAAGCCCATGTACCT  200 
151  CCGTTCTACGGCAAGCTGTCCGACATCTACGGGCGCAAGCCCATGTACCT  200 
201  GATCTCCATCGTGGTGTTCATCGGCGGCTCGGTGCTGTGCGGCACGGCCG  250 
201  GATCTCCATCGTGGTGTTCATCGGCGGCTCGQTGCTGTGCGGCACGGCCG  250 
251  GCTCGATGTGGGAGCT  266 
251  GCTCgATGTGGGAGCT  266 
FiR  3.2 
BESTFIT  of  the  wild  type  otrB  sequence  from  pJJIBI  (top)  against 
sequence  from  the  PCR  product  in  pJJ6  (bottom). 
96 Chapter  3 
1  ATGTCGGGACTGCTGCTGGCCGTGTTCCTCGCGGCCCTGGACCAGACGGT  50 
1  ATGTCGGGACTGCTGCTGGCCGTGTTCCTCGCGGCCCTGGACCAGACGGT  50 
51  CATCGCCACCGCGATGCGCACCATCGCGGACGACCTCCACGGCCAGACCG  100 
51  CATCGCCACCGCGATGCGCACCATCGCGGACGACCTCCACGGCCAGACCG  100 
101  AGCAGGCATGGGCGACGACGGGCTACCTCATCGCCTCCGTCCTGGCGATG  150 
101  AGCA%j%j--.  z%,,.  ý,,,,,  GACGACGGGCTACCTCATCGCCTCCGTCCTGGCGATG  150 
151  CCGTTCTACGGCAAGCTGTCCGACATCTACGGGCGCAAGCCCATGTACCT  200 
151  CCGTTCTACGGCAAGCTGTCCGACATCTACGGGCGCAAGCCCATGTACCT  200 
201  GATCTCCATCGTGGTGTTCATCGGCGGCTCGGTGCTGTGCGGCACGGCCG  250 
201  GATCTCCATCGTGGTGTTCATCGGCGGCTCGGTGCTGTGCGGCACGGCCG  250 
251  GCTCgATGTGGGAGCTGGCCCTCTTCCGGGCCGTCCAAGGGACTGGGCGG  300 
251  GCTCGATGTGGGAGCT.  GCCCTCTTCCGGGCCGTCC.  AGGGACTGGGCGG  298 
301  CGGCGGGCTGATGTCCCTGCCCACCGCGGTGGTCGCCGACCTCGCCCCGG  350 
299  CGGC.  GGCTGATGTCCCTGCCCACCGCGGTGGTCGCCGACCTCGCCCCGG  347 
351  TGCG.  CGAGCGCGGCCGCTACTTCGCC  376 
348  TGCGCCGAGCGCGGCCGCTACTTCGCC  374 
Fijz  3.3 
Sequence  comparison  of  the  pJJ6  otrB  PCR  product  (top)  with  tet347 
sequence  (Reynes  et  al,  1988)  (bottom). 
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1  ATGTCGGGACTGCTGCTGGCCGTGTTCCTCGCGGCCCTGGACCAGACGGT  50 
291  ATGTCGGGACTGCTGCTGGCCGTGTT.  CTCGCG..  CCCTGACCAGACGGT  337 
51  CATCGCCACCGCGATGCGCACCATCGCGGACGACCTCCACGGCCAGACCG  100 
338  CATCGCCA 
...  CGATGCGCACCATCGCGGACGACCTCCACGGCCAGACCG  384 
101  AGCAGGCATGGGCGACGACGGGCTACCTCATCGCCTCCGTCCTGGCGATG  150 
385  AGCAGGCATGGGCGACGACGGGCTACCTCATCGCCTCCGTCCTGGCGATG  434 
151  CCGTTCTACGGCAAGCTGTCCGACATCTACGGGCGCAAGCCCATGTACCT  200 
Hill  111111111 
435  CCGTTCTACGGCAAGCTGTCCGACATCTACGCGCGCA 
...  GCATGTACCT  481 
201  GATCTCCATCGTGGTGTTCATCGGCGGCTCGGTGCTGTGCGGCACGGCCG  250 
482  GATCTCCATCGTGGTGTTCATCGGCGGCTCGGTGCTGTGCGGCACGGCCG  531 
251  GCTCgATGTGGGAGCTGGCCCTCTTCCGGGCCGTCCAAGGGACTGGGCGG  300 
II1  1111111  Hill 
532  GCTCGATGTGGGAGCTGGCCCTCTTCGGCGTC 
.....  AGGGACT.  GGCGG  575 
301  CGGCGGGCTGATGTCCCTGCCCACCGCGGTGGTCGCCGACCTCGCCCCGG  350 
576  CGGCGGGCTGATGT.  CCTGCCCACCGCGGTGGTCGCCGACCTCGCCCCGG  624 
351  TGCGCGAGCGCGGCCGCTACTTCGCC  376 
625  TGCGCGAGCGCGGCCGCTACTTCGGU  b5u 
Fig  3.4 
Sequence  comparison  of  the  pJJ6  otrB  PCR  product  (top)  against  the  original 
otrB  sequence  (bottom)  (MacGregor-Pryde,  1995).  It  should  be  noted  that  the 
original  MacGregor-Pryde  sequence  contains  sequence  upstream  of  otrB  and 
that  the  otrB  ORF  begins  at  position  29  1. 
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3.4.1  Outcome  of  initial  sequence  analysis 
As  tet347,  otrB  (MacGregor-Pryde,  1995)  and  the  sequence  of  the  PCR  product  in 
pJJ3  showed  aG  at  position  255,  it  appeared  that  the  A  from  the  automated  sequence 
of  the  pJJ6  insert  was  a  mistake,  mis-naming  of  bases  was  resolved  by  careful  study 
of  the  chromatogram.  (bases  which  have  been  re-called  or  were  un-named  (N's)  in  the 
original  chromatogram  are  denoted  in  lower  case  in  Figs  3.2  -  3.4.  ) 
The  mistakes  were  often  due  to  peaks  being  spaced  unevenly  and  overlapping  each 
other  or  peaks  being  so  small  that  they  were  easily  confused  with  the  background 
noise. 
From  the  BESTFITs  of  tet347  against  the  pJJ6  sequence,  there  appear  to  be 
three  frameshifts  in  the  Reynes  sequence.  These  occur  at  positions  288,305  and  355. 
tet347  has  an  A  missing  at  288,  aC  missing  at  305  and  aC  inserted  at  355  (Fig  3.3). 
The  C  at  355  is  not  present  in  the  pJJ6,  pJJIBI  or  MacGregor-Pryde  sequences.  The 
presence  of  the  bases  at  288  and  305  in  the  other  three  sequences  plus  analysis  of 
codon  usage  using  BIBBPROGAC,  (2.6)  was  evidence  that  the  two  bases  at  289  and  4n 
305  were  actually  present  in  the  gene  and  not  sequencing  artefacts  and  that  the 
inserted  C  at  355  is  also  a  mistake 
BESTFIT  analysis  of  the  later  parts  of  otrB  (MacGregor-Pryde,  1995)  and 
tet347  shows  that  the  two  sequences  are  in  agreement  apart  from  insertion  of  aC 
residue  at  787  and  3  GC  inversions  at  650,700  and  1060  in  the  otrB  sequence  of 
MacGregor-Pryde.  These  residues  correspond  to  bases  497,359,409  and  765  of  the 
coding  sequence  from  the  MacGregor-Pryde  data.  By  using  BIBBPROGAC  it  can  be 
shown  that  the  "extra"  C  residue  is  required  at  base  497  to  maintain  codon 
preference  in  the  reading  frame. 
At  this  stage  it  became  apparent  that  further  sequencing  was  required  to  resolve  the 
three  remaining  differences  (359,409,765)  between  the  MacGregor-Pryde  and 
Reynes  sequence  data. 
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3.5  Second  stage  sequencing  strategy. 
As  initial  sequencing  data  of  the  5'  terminal  region  of  from  pJJIBI  and  pJJ6  (see 
above)  was  not  in  agreement  with  that  presented  by  MacGregor-Pryde  (1995)  or 
Reynes  and  co-workers  (1988)  further  sequencing  was  carried  out  to  resolve  these 
differences  and  the  three  differences  found  further  downstream  between  the 
MacGregor-Pryde  and  Reynes  data  (Fig  3.5). 
3.5.1  Primer  design 
Oligonucleotide  primers  for  DNA  sequencing  were  designed  against  the  MacGregor- 
Pryde  sequence  using  the  programs,  Oligo  4.0-se  (distributed  for  MedProbe  for  NBI, 
Europe)  and  GeneRunner,  version  3.5  (Hastings  software).  These  programs  analyse 
the  template-primer  duplex  for  annealing  temperature,  stable  bond  formation  and  G- 
C  clamps.  Three  primers  were  designed,  the  first  (Primer  1),  being  a  20-mer  which 
read  forward  from  base  294  the  second  (Primer  2),  an  18-mer,  reading  forward  from 
base  587,  the  third  (Primer  3)  also  an  18-mer,  reading  in  reverse  from  base  600.  All 
are  shown  in  Fig  3.5. 
Following  the  discovery  of  a  GC  inversion  at  position  1469  late  on  in  the 
project  (See  Section  5.12),  it  became  necessary  to  sequence  the  remainder  of  the  otrB 
gene.  This  step  had  not  been  taken  before  as  the  Reynes'  and  MacGregor-Pryde 
sequences  were  in  agreement  apart  from  the  anomalies  mentioned  above.  Four 
further  sequencing  primers  were  designed,  (Primers  4  to  7).  These  are  also  shown  in 
Fig  3.5 
3.5.2  Sequencing  results 
Data  from  the  sequencing  reaction  using  Primer  I  showed  that  the  sequence  at  base 
359  was  CC  as  in  the  Reynes'  sequence  and  not  GC  as  written  by  MacGregor-Pryde. 
The  data  from  Primer  3  resolved  the  differences  at  base  409,  in  this  case  in  agreement 
with  the  MacGregor  -Pryde  (GGCGG)  and  not  the  Reynes  sequence  (GCGGC).  The 
sequence  from  the  reaction  performed  with  Primer  2  gave  data  in  agreement  with  the 
Reynes  sequence  at  base  765,  i.  e.  GC.  not  the  MacGregor-Pryde  data,  CG. 
The  data  from  primers  4  to  7  gave  the  otrB  sequence  from  base  287  to  the  end  of  the 
gene.  BESTFIT  analysis  was  performed  against  the  previously  compiled  sequence. 
100 Chapter  3 
Several  differences  to  the  Reynes/  MacGregor-Pryde  sequence  were  found  in  the 
region  not  previously  sequenced  for  this  thesis;  an  extra  C  at  position  1157,  a  deleted 
G  at  position  1168,  a  C-G  inversion  at  1296  and  the  previously  mentioned  GC-CG 
inversion  at  1469.  Later  in  the  project  sequencing  of  the  far  end  of  the  gene  was 
verified  using  T7  terminator  primer,  a  reverse  primer  which  read  into  the  gene  from  a 
cloning  vector  (section  5.13). 
3.5.3  BIBBPROGAC  analysis 
In  order  to  verify  that  the  sequence  contained  no  frame  shift  mutations,  the  nucleotide 
sequence  was  translated  into  peptide  sequence  to  check  for  stop  codons,  and  run 
through  a  codon  analysis  check  using  BIBBPROGAC.  Both  analyses  showed  that  no 
frame  shifts  were  apparent  in  the  new  sequence.  The  BIBBPROGAC  results  are 
presented  as  Fig  3.6.  The  revised  otrB  sequence  was  deposited  as  AF061335  (Fig 
3.7). 
3.6  Results  of  peptide  analysis 
As  noted  above,  the  nucleotide  sequence  generated  from  resequencing  was  translated 
into  peptide  sequence,  this  was  done  using  the  GCG  program  TRANSLATE  (Fig 
3.7).  When  the  peptide  sequence  was  available,  several  types  of  analysis  were 
possible.  A  hydropathy  profile  of  a  peptide  sequence  can  be  formed  using  the  GCG 
program,  PEPPLOT.  This  program  utilises  the  hydrophobicity  measure  of  Kyte  and 
Doolittle.  From  the  hydropathy  profile  of  OtrB  (Fig  3.8)  It  can  be  clearly  seen  that 
there  are  14  strongly  hydrophobic  segments,  deduced,  from  their  length  and 
composition,  to  form  transmembrane  alpha  helices  (TMH's). 
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ATGTCGGGACTGCTGCTGGCCGTGTTCTCGCG  =  TGACCAGACGGTCATCGCCACGATG 
1  ------------------------------------------------------------  60 
TACAGCCCTGACGACGACCGGCACAAGAGCGCGGGACTGGTCTGCCAGTAGCGGTGCTAC 
CGCACCATCGCGGACGACCTCCACGGCCAGACCGAGCAGGCATGGGCGACGACGGGCTAC 
61  ------------------------------------------------------------  120 
GCGTGGTAGCGCCTGCTGGAGGTGCCGGTCTGGCTCGTCCGTACCCGCTGCTGCCCGATG 
CTCATCGCCTCCGTCCTGGCGATGCCGTTCTACGGCAAGCTGTCCGACATCTACGCGCGC 
121  ------------------------------------------------------------  180 
GAGTAGCGGAGGCAGGACCGCTACGGCAAGATGCCGTTCGACAGGCTGTAGATGCGCGCG 
AGCATGTACCTGATCTCCATCGTGGTGTTCATCGGCGGCTCGGTGCTGTGCGGCACGGCC 
181  ------------------------------------------------------------  240 
TCGTACATGGACTAGAGGTAGCACCACAAGTAGCCGCCGAGCCACGACACGCCGTGCCGG 
Primer  4 
GGCTCGATGTGGGAGCTGGCCCTCTTCGGCGTCAGGGACTGGCGGCGGCGGGCTGATGTC 
241  ------------------------------------------------------------  300 
CCGAGCTACACCCTCGACCGGGAGAAGCCGCAGTCCCTGACCGCCGCCGCCCGACTACAG 
Primer  I 
CTGCCCACCGCGGTGGTCGCCGACCTCGCCCCGGTGCGCGAGCGCGGCCGCTACTTCG-Qc 
301  ------------------------------------------------------------  360 
GACGGGTGGCGCCACCAGCGGCTGGAGCGGGGCCACGCGCTCGCGCCGGCGATGAAGCCG 
(See  Fig  3.1) 
361  ----------------------------  --  ------------------  420 
AAGGAGGTCTACCGCACCCACCAGCGGTC  AGCICCCGG  GACCGCCCGCCGAAGAAG  GC 
4 
GCGGAGGCGGGCCAGGTCTTCGGCATCGACGGCTGGCGCTGGGTGTTCCTGCTCAACGTA 
421  ------------------------------------------------------------  480 
CGCCTCCGCCCGGTCCAGAAGCCGTAGCTGCCGACCGCGACCCACAAGGACGAGTTGCAT 
CCGCTGGGCCTGCTGG-CCCTGGTCACCGTGCGCAAGGCCCTGAACCTGCCGCACGAACGG 
481  ------------------------------------------------------------  540 
GGCGACCCGGACGACCGGGACCAGTGGCACGCGTTCCGGGACTTGGACGGCGTGCTTGCC 
Primer  5P  rimer  2 
CGCGAGCACCGCATGGACGTACTGGGCGCGGCGGCGCTGGCGCTGTTCCTGGTGCCCCTG 
541  ------------------------------------------------------------  600 
GCGCTCGTGGCGTACCTGCATGACCCGCGCCGCCGCGACCGCGACAAGGACCACOOGGAC 
Primer  3 
CTGATCGTCGCCGAACAGGGCCGGACCTGGGGCTGGGGCTCGCCGGCCGCCCTCGCCCTC 
601  ------------------------------------------------------------  660 
GACTAGCAGCGGCTTGTCCCGGCCTGGACCCCGACCCCGAGCGGCCGGCGGGAGCGGGAG 
TTCGCGCTCGGCGCGGCCGGGCTGGCGGTCTTCATCCCCGTCGAGCTGCGGCGCGGCGAC 
661  ------------------------------------------------------------  720 
AAGCGCGAGCCGCGCCGGCCCGACCGCCAGAAGTAGGGGCAGCTCGACGCCGCGCCGCTG 
GAGGCCATCCTGCCGCTGGGGCTCTTCCGGCGCGGCAGCATCGCQCTGTCGTCCGCGGTC 
721  ------------------------------------------------------------  780 
CTCCGGTAGGACGGCGACCCCGAGAAGGCCGCGCCGTCGTAGCGCGACAGCAGGCGCCAG 
Primer  6 
AACTTCACCATCGGCGTCGGCATCTTCGGCACGGTCACCACCCTGCCGCTGTTCCTCCAG 
781  ------------------------------------------------------------  840 
TTGAAGTGGTAGCCGCAGCCGTAGAAGCCGTGCCAGTGGTGGGACGGCGACAAGGAGGTC 
ATGGTGCAGGGGCGGACCCCGACCCAGGCCGGACTGGTGGTCATCCCGTTCATGCTGGGC 
841  ------------------------------------------------------------  900 
TACCACGTCCCCGCCTGGGGCTGGGTCCGGCCTGACCACCAGTAGGGCAAGTACGACCCG 
ACCATCGCCTCGCAGATGGTCTCCGGCAAGCTCATCGCGTCCTCGGGCCGGTTCAAGAAA 
901  ------------------------------------------------------------  960 
TGGTAGCGGAGCGTCTACCAGAGGCCGTTCGAGTAGCGCAGGAGCCCGGCCAAGTTCTTT 
CTGGCGATCGTGGGCCTGGGCTCGATGGCCGGGGCGCTGCTGGCCATGGCCACCACCGGC 
961  ------------------------------------------------------------  1020 
GACCGCTAGCACCCGGACCCGAGCTACCGGCCCCGCGACGACCGGTACCGGTGGTGGCCG 
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GCGACGACCCCGATGTGGGGCATCGTCCTGATCGTCCTCTGGCTCGGCGTCGGCATCGGC 
1021  ------------------------------------------------------------ 
1080 
CGCTGCTGGGGCTACACCCCGTAGCAGGACTAGCAGGAGACCGAGCCGCAGCCGTAGCCG 
Primer  7 
CTGTCCCAGACCGTCATCACCTCGCCCATGCAGAACTCGGCCCCCAAGAGCCAGCTCGGC 
1081  ------------------------------------------------------------  1140 
GACAGGGTCTGGCAGTAGTGGAGCGGGTACGTCTTGAGCCGGGGGTTCTCGGTCGAGCCG 
0 
GTGGCGAACGGCGCCT.  QGGCCTGTGCCQGGCAGATCGGCGGCTCCACCGGCATCGCGGTT 
1141  ------------------------------------------------------------  1200 
CACCGCTTGCCGCGGAGCCGGACACGGCCCGTCTAGCCGCCGAGGTGGCCGTAGCGCCAA 
CTGTTCTCCGTGATGTTCGCGGTGGCGCTCGGCCGCCTCGCCGACCTGCTGCACACCCCG 
1201  ------------------------------------------------------------  1260 
GACAAGAGGCACTACAAGCGCCACCGCGAGCCGGCGGAGCGGCTGGACGACGTGTGGGGC 
CGCTACGAGCGCCTCCTGACCGACCCGGCGATCACCGGCGACCCCGCCAACCACCGCTTC 
1261  ------------------------------------------------------------  1320 
GCGATGCTCGCGGAGGACTGGCTGGGCCGCTAGTGGCCGCTGGGGCGGTTGGTGGCGAAG 
CTTGACATGGCCGAGTCCGGGCAGGGCGCGGGGATCAACCTTGACGACACGTCCCTGCTG 
1321  ------------------------------------------------------------  1380 
GAACTGTACCGGCTCAGGCCCGTCCCGCGCCCCTAGTTGGAACTGCTGTGCAGGGACGAC 
AACGGCATCGACGCCCGGCTGATGCAGCCGGTGACGGATTCCTTCGCCCACGGCTTCCAC 
1381  ------------------------------------------------------------  1440 
TTGCCGTAGCTGCGGGCCGACTACGTCGGCCACTGCCTAAGGAAGCGGGTGCCGAAGGTG 
ATCATGTTCCTGCCCGGCGGCGTGGTGCTGCTGGCCGGGTTCGTCATGACCTGGTTCCTG 
1441  ------------------------------------------------------------  1500 
TAGTACAAGGACGGGCCGCCGCACCACGACGACCGGCCCAAGCAGTACTGGACCAAGGAC 
CGCGAACTCCAGGAGGAGACCGCGCCGGAGGAGGAGCGGCCGGCCGAGAGCGGCGCCGGG 
1501  ------------------------------------------------------------  1560 
GCGCTTGAGGTCCTCCTCTGGCGCGGCCTCCTCCTCGCCGGCCGGCTCTCGCCGCGGCCC 
GCGAAGAACGGGCCGCTGCCCGCGTCGGACGCCTGA 
1561  ------------------------------------  1596 
CGCTTCTTGCCCGGCGACGGGCGCAGCCTGCGGACT 
Fig  3.5 
MacGregor-Pryde  otrB  sequence  and  primers  designed  against  it.  Numbering  refcrs 
to  the  otrB  ORF,  and  not  the  whole  otrB  sequence.  Primers  were  used  to  determine 
definitive  sequence  over  regions  with  sequence  anomalies.  The  seven  sequencing 
primers  (arrows)  are  shown  with  their  annealing  positions.  Anomalies  between  the 
three  sets  of  sequence  data,  (this  work,  MacGregor-Pryde,  1995  and  Reynes  et  al, 
1988)  are  underlined.  Also  shown  (boxed)  is  the  second  Apal  sit  (Fig  3.1).  DNA 
sequence  upstream  of  this  is  discussed  in  section  3.4.  Later  in  the  project  sequencing 
was  also  performed  at  the  far  C-terminal  end  of  the  gene  reading  in  from  vector 
sequence  using  T7  terminator  primer  (section  5.13). 
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16  0.700  0.300  0.900  811  0.400  0.400  1.000 
31  0.900  0.300  1.000  ...  826  0.500  0.500  1-000 
46  0.700  0.500  1.000  841  0.600  0.400  1.000 
61  0.400  0.600  1.000  856  0.800  0.300  1.000 
76  0.700  0.400  1.000  871  0.700  0.600  1.000 
91  0.900  0.300  1.000  886  0.700  0.500  0-900 
106  0.600  0.700  0.900  901  0.700  0.300  0.900 
121  0.500  0.700  0.900  916  0.500  0.500  1-000 
136  0.600  0.400  1.000  931  0.400  0.500  1-000 
151  0.500  0.400  1.000  946  0.400  0.500  1.000 
166  0.400  0.300  1.000  961  0.400  0.500  0.900 
181  0.500  0.400  1.000  976  0.600  0.400  0.900 
196  0.400  0.400  1.000  991  0.700  0.500  1.000 
211  0.400  0.200  1.000  1006  0.800  0.600  1.000 
226  0.600  0.400  1.000  1021  0.700  0.700  1.000 
241  0.600  0.800  1.000  1036  0.400  0.800  1.000 
256  0.600  0.700  1.000  1051  0.500  0.600  1.000 
271  0.700  0.400  1.000  1066  0.600  0.300  1.000 
286  0.900  0.500  0.900  1081  0.700  0.400  1.000 
301  0.800  0.600  0.900  1096  0.700  0.500  1.000 
316  0.700  0.600  1.000  1111  0.400  0.500  1.000 
331  0.900  0.500  1.000  1126  0.400  0.600  1.000 
346  1.000  0.500  1.000  1141  0.600  0.500  1.000 
361  0.800  0.600  1.000  1156  0.700  0.500  1.000 
376  0.600  0.400  1.000  1171  0.700  0.700  1.000 
391  0.600  0.400  1.000  1186  0.600  0.700  1.000 
406  0.800  0.600  1.000  1201  0.600  0.600  0.900 
421  0.800  0.600  1.000  1216  0.500  0.400  0.900 
436  0.800  0.600  1.000  1231  0.600  0.300  1.000 
451  0.800  0.400  1.000  1246  0.900  0.500  1.000 
466  0.600  0.500  1.000  1261  0.900  0.500  1.000 
481  0.600  0.400  0.900  1276  0.800  0.400  1.000 
496  0.800  0.200  0.900  1291  0.800  0.500  1.000 
511  0.900  0.400  1.000  1306  0.700  0.600  1.000 
526  0.700  0.400  1.000  1321  0.600  0.500  1.000 
541  0.800  0.400  0.900  1336  0.700  0.300  0.900 
556  0.900  0.400  0.900  1351  0.800  0.500  0.900 
571  0.900  0.400  0.900  1366  0.700  0.500  0.900 
586  1.000  0.500  0.900  1381  .  0.600  0.300  0.900 
601  0.900  0.400  1.000  1396  0.600  0.400  1.000 
616  0.800  0.200  0.900  1411  0.700  0.400  1.000 
631  0.700  0.500  0.900  1426  0.600  0.400  0.900 
646  0.600  0.900  1.000  1441  0.600  0.400  0.900 
661  0.800  0.800  1.000  1456  0.600  0.300  1.000 
676  0.900  0.600  1.000  1471  0.700  0.300  1.000 
691  0.900  0.600  1.000  1486  0.900  0.400  1.000 
706  0.800  0.400  1.000  1501  0.500  0.400  1.000 
721  0.800  0.400  1.000  1516  0.600  0.300  0.900 
736  0.900  0.500  1.000  1531  0.900  0.400  0.900 
751  0.800  0.400  1.000  1546  0.900  0.600  1.000 
766  0.700  0.600  1.000  1561  0.900  0.700  1.000 
781  0.600  0.700  1.000  1576  0.700  0.700  1.000 
796  0.400  0.500  1.000  1591  0.700  0.600  1.000 
FiR  3.6 
BIBBPROGAC  analysis  of  revised  otrB  sequence 
The  analysis  shows  that  the  average  G+C  composition  of  column  I  is  around  70% 
while  for  column  2  it  is  over  50%,  column  3  displays  a  G+C  composition  of  over 
90%.  This  is  consistent  with  an  open  reading  frame  starting  at  base  1.  (Percentages  are 
displayed  as  decimals  where  1 
. 000  =  100%).  Columns  represent  codon  positions  1,2 
and  3  for  a  30  base  window,  step  length  is  15  bases.  (Refer  to  section  2.6) 
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ATGTCGGGACTGCTGCTGGCCGTGTTCCTCGCGGCCCTGGACCAGACGGTCATCGCCAC 
1  ------------------------------------------------------------  60 
TACAGCCCTGACGACGACCGGCACAAGGAGCGCCGGGACCTGGTCTGCCAGTAGCGGTGG 
MSGLLLAVFLAALDQTVIAT 
GCGATGCGCACCATCGCGGACGACCTCCACGGCCAGACCGAGCAGGCATGGGCGACGACG 
61  ------------------------------------------------------------  120 
CGCTACGCGTGGTAGCGCCTGCTGGAGGTGCCGGTCTGGCTCGTCCGTACCCGCTGCTGC 
AMRTIADDLHGQTEQAWATT 
GGCTACCTCATCGCCTCCGTCCTGGCGATGCCGTTCTACGGCAAGCTGTCCGACATCTAC 
121  ------------------------------------------------------------  180 
CCGATGGAGTAGCGGAGGCAGGACCGCTACGGCAAGATGCCGTTCGACAGGCTGTAGATG 
GYLIASVLAMPFYGKLSDIY 
GGGCGCAAGCCCATGTACCTGATCTCCATCGTGGTGTTCATCGGCGGCTCGGTGCTGTGC 
181  -----------------------------------------------------------  -  240 
CCCGCGTTCGGGTACATGGACTAGAGGTAGCACCACAAGTAGCCGCCGAGCCACGACACG 
GRKPMYLISIVVFIGGSVLC 
GGCACGGCCGGCTCGATGTGGGAGCTGGCCCTCTTCCGGGCCGTCCAGGGACTGGGCGGC 
241  ------------------------------------------------------------  300 
CCGTGCCGGCCGAGCTACACCCTCGACCGGGAGAAGGCCCGGCAGGTCCCTGACCCGCCG 
GTAGSMWELALFRAVQGLGG 
GGCGGGCTGATGTCCCTGCCCACCGCGGTGGTCGCCGACCTCGCCCCGGTGCGCGAGCGC 
301  ------------------------------------------------------------  360 
CCGCCCGACTACAGGGACGGGTGGCGCCACCAGCGGCTGGAGCGGGGCCACGCGCTCGCG 
GGLMSLPTAVVADLAPVRER 
GGCCGCTACTTCGCCTTCCTCCAGATGGCGTGGGTGGTCGCCAGCGTCGCGGGCCCGCTG 
361  ------------------------------------------------------------  420 
CCGGCGATGAAGCGGAAGGAGGTCTACCGCACCCACCAGCGGTCGCAGCGCCCGGGCGAC 
GRYFAFLQMAWVVASVAGPL 
GCGGGCGGCTTCTTCGCGGAGGCGGGCCAGGTCTTCGGCATCGACGGCTGGCGCTGGGTG 
421  ------------------------------------------------------------  480 
CGCCCGCCGAAGAAGCGCCTCCGCCCGGTCCAGAAGCCGTAGCTGCCGACCGCGACCCAC 
AGGFFAEAGQVFGIDGWRWV 
TTCCTGCTCAACGTACCGCTGGGCCTGCTGGCCCTGGTCACCGTGCGCAAGGCCCTGAAC 
481  ------------------------------------------------------------  540 
AAGGACGAGTTGCATGGCGACCCGGACGACCGGGACCAGTGGCACGCGTTCCGGGACTTG 
FLLNVPLGLLALVTVRKALN 
CTGCCGCACGAACGGCGCGAGCACCGCATGGACGTACTGGGCGCGGCGGCGCTGGCGCTG 
541  ------------------------------------------------------------  600 
GACGGCGTGCTTGCCGCGCTCGTGGCGTACCTGCATGACCCGCGCCGCCGCGACCGCGAC 
LPHERREHRMDVLGAAALAL 
TTCCTGGTGCCCCTGCTGATCGTCGCCGAACAGGGCCGGACCTGGGGCTGGGGCTCGCCG 
601  ------------------------------------------------------------  660 
AAGGACCACGGGGACGACTAGCAGCGGCTTGTCCCGGCCTGGACCCCGACCCCGAGCGGC 
FLVPLLIVAEQGRTWGWGSP 
GCCGCCCTCGCCCTCTTCGCGCTCGGCGCGGCCGGGCTGGCGGTCTTCATCCCCGTCGAG 
661  ------------------------------------------------------------  720 
CGGCGGGAGCGGGAGAAGCGCGAGCCGCGCCGGCCCGACCGCCAGAAGTAGGGGCAGCTC 
AALALFALGAAGLAVFIPVE 
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CTGCGGCGCGGCGACGAGGCCATCCTGCCGCTGGGGCTCTTCCGGCGCGGCAGCATCGCG 
721  ------------------------------------------------------------ 
780 
GACGCCGCGCCGCTGCTCCGGTAGGACGGCGACCCCGAGAAGGCCGCGCCGTCGTAGCGC 
RRGDEAILPLGLFRRGSIA- 
CTGTGCTCCGCGGTCAACTTCACCATCGGCGTCGGCATCTTCGGCACGGTCACCACCCTG 
781  ------------------------------------------------------------ 
840 
GACACGAGGCGCCAGTTGAAGTGGTAGCCGCAGCCGTAGAAGCCGTGCCAGTGGTGGGAC 
LCSAVNFTIGVGIFGTVTTL 
CCGCTGTTCCTCCAGATGGTGCAGGGGCGGACCCCGACCCAGGCCGGACTGGTGGTCATC 
841  ------------------------------------------------------------  900 
GGCGACAAGGAGGTCTACCACGTCCCCGCCTGGGGCTGGGTCCGGCCTGACCACCAGTAG 
PLFLQMVQGRTPTQAGLVVI 
CCGTTCATGCTGGGCACCATCGCCTCGCAGATGGTCTCCGGCAAGCTCATCGCGTCCTCG 
901  ------------------------------------------------------------  960 
GGCAAGTACGACCCGTGGTAGCGGAGCGTCTACCAGAGGCCGTTCGAGTAGCGCAGGAGC 
PFMLGTIASQMVSGKLIASS 
GGCCGGTTCAAGAAACTGGCGATCGTGGGCCTGGGCTCGATGGCCGGGGCGCTGCTGGCC 
961  -----------------------------------------------------------  1020 
CCGGCCAAGTTCTTTGACCGCTAGCACCCGGACCCGAGCTACCGGCCCCGCGACGACCGG 
GRFKKLAIVGLGSMAGALLA- 
ATGGCCACCACCGGCGCGACGACCCCGATGTGGGGCATCGTCCTGATCGTCCTCTGGCTC 
1021  -----------------------------------------------------------  1080 
TACCGGTGGTGGCCGCGCTGCTGGGGCTACACCCCGTAGCAGGACTAGCAGGAGACCGAG 
MATTGATTPMWGIVLIVLWL 
GGCGTCGGCATCGGCCTGTCCCAGACCGTCATCACCTCGCCCATGCAGAACTCGGCCCCC 
1081  -----------------------------------------------------------  1140 
CCGCAGCCGTAGCCGGACAGGGTCTGGCAGTAGTGGAGCGGGTACGTCTTGAGCCGGGGG 
GVGIGLSQTVITSPMQNSAP 
AAGAGCCAGCTCGGCGTGGCGAACGGCGCCTCCGGCCTGTGCCGGCAGATCGGCGGCTCC 
1141  -----------------------------------------------------------  1200 
TTCTCGGTCGAGCCGCACCGCTTGCCGCGGAGGCCGGACACGGCCGTCTAGCCGCCGAGG 
KSQLGVANGASGLCRQIGGS 
ACCGGCATCGCGGTTCTGTTCTCCGTGATGTTCGCGGTGGCGCTCGGCCGCCTCGCCGAC 
1201  -----------------------------------------------------------  1260 
TGGCCGTAGCGCCAAGACAAGAGGCACTACAAGCGCCACCGCGAGCCGGCGGAGCGGCTG 
TGIAVLFSVMFAVALGRLAD- 
CTGCTGCACACCCCGCGCTACGAGCGCCTCCTGACGGACCCGGCGATCACCGGCGACCCC 
1261  -----------------------------------------------------------  1320 
GACGACGTGTGGGGCGCGATGCTCGCGGAGGACTGCCTGGGCCGCTAGTGGCCGCTGGGG 
LHTPRYERLLTDPAITGDP- 
GCCAACCACCGCTTCCTTGACATGGCCGAGTCCGGGCAGGGCGCGGGGATCAACCTTGAC 
1321  -----------------------------------------------------------  1380 
CGGTTGGTGGCGAAGGAACTGTACCGGCTCAGGCCCGTCCCGCGCCCCTAGTTGGAACTG 
ANHRFLDMAESGQGAGINLD 
GACACGTCCCTGCTGAACGGCATCGACGCCCGGCTGATGCAGCCGGTGACGGATTCCTTC 
1381  -----------------------------------------------------------  1440 
CTGTGCAGGGACGACTTGCCGTAGCTGCGGGCCGACTACGTCGGCCACTGCCTAAGGAAG 
TSLLNGIDARLMQPVTDSF- 
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GCCCACGGCTTCCACATCATGTTCCTCGCCGGCGGCGTGGTGCTGCTGGCCGGGTTCGTC 
1441  -----------------------------------------------------------  1500 
CGGGTGCCGAAGGTGTAGTACAAGGAGCGGCCGCCGCACCACGACGACCGGCCCAAGCAG 
AHGFHIMFLAGGVVLLAGFV- 
ATGACCTGGTTCCTGCGCGAACTCCAGGAGGAGACCGCGCCGGAGGAGGAGCGGCCGGCC 
1501  -----------------------------------------------------------  1560 
TACTGGACCAAGGACGCGCTTGAGGTCCTCCTCTGGCGCGGCCTCCTCCTCGCCGGCCGG 
MTWFLRELQEETAPEEERPA 
GAGAGCGGCGCCGGGGCGAAGAACGGGCCGCTGCCCGCGTCGGACGCCTGA 
1561  ---------------------------------------------------  1611 
CTCTCGCCGCGGCCCCGCTTCTTGCCCGGCGACGGGCGCAGCCTGCGGACT 
ESGAGAKNGPLPASDA*- 
FiR  3.7 
The  revised  nucleotide  sequence  for  otrB,  deposited  as  AF061335  and  the 
translated  peptide  sequence. 
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Fig  3.8 
Hydropathy  plot  for  OtrB  obtained  using  PEPPLOT. 
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3.6.1  Hydropathy  profile  of  OtrB 
The  plot  (2.6.  for  details  and  reference)  produced  is  a  curve  which  is  the  average  of  a 
residue-specific  hydropathy  index  over  a  window  of  nine  residues.  A  curve  drawn  in 
the  upper  half  of  the  frame  indicates  a  hydrophobic  region  and  when  in  the  lower  a 
hydrophilic  region  is  indicated.  The  hydropathy  plot  for  OtrB  is  shown  in  Fig  3.8 
Von  Heijne  (1986)  made  observations  that  the  distribution  of  certain  amino 
acids  is  biased  with  respect  to  the  topology  of  membrane  proteins.  Hydrophobic 
residues  (F,  I,  L,  V  and  M)  are  twice  as  likely  to  appear  in  membrane  spanning 
regions  as  in  cytoplasmic  or  periplasmic  loops.  The  "positive  inside  rule"  says  that 
the  cytosplasmic  and  periplasmic  loops  may  be  differentiated  by  the  fact  that 
positively  charged  residues,  R  and  K  appear  four  times  as  frequently  in  cytoplasmic 
loops  as  they  do  in  the  periplasmic  variety.  The  putative  positions  of  the  14  TMH's 
within  the  OtrB  sequence  are  shown  in  Fig  3.9. 
3.6.2  Major  facilitator  superfamily 
The  deduction  of  14  putative  TMH's  of  OtrB  its  function  as  an  antibiotic  exporter 
lead  to  its  assignment  within  a  rapidly  expanding  group  of  proteins,  the  Major 
Facilitator  Superfamily  (for  a  review  see  Paulsen  et  al,  1996).  This  family  contains 
membrane  transport  proteins  from  all  forms  of  life,  from  bacteria  to  higher 
eukaryotes  and  has  more  than  300  members  (1.7). 
The  MFS  was  originally  sub-divided  into  5  families  on  the  basis  of  substrate 
(Marger  &  Saier,  1993);  transporters  for,  (i)  drug  export,  (ii)  sugar  uptake,  (iii) 
uptake  of  Krebs  cycle  intermediates,  (iv)  phosphate-ester/phosphate  antiport,  and  (v) 
oligosaccharide  uptake.  Family  (i)  which  contained  proteins  with  both  12  and  14 
TMS's  is  now  further  divided  into  the  12  TMH  exporters  and  the  14  TMH  exporters, 
(Paulsen  et  al,  1996).  A  phylogenetic  tree  was  shown  in  Fig  1.14.  OtrB  is  presumed 
to  be  a  member  of  the  14  TMH  exporter  sub-family.  The  best  way  to  assess  the 
relationship  of  OtrB  to  other  transport  proteins  was  to  use  the  GCG  program, 
PILEUP  (2.6). 
Several  PILEUP  analyses  were  performed.  Fig  3.10  shows  the  conserved 
residues  between  several  Streptomycete  14  TMH  drug  exporters.  Fig  3.11  shows  a 
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MSGIfTL-AV-FLAALDQTVIAT  AMRTIAD  GQTEQ 
PFYGKLSDIYIGRKPf4YLISI  VVFIGGSVLC  GTAGS"ELA  LFfUW-QG3LGG 
GGILL!  M!  ýLffAV  VADLAPVRER  GRYF7ýýQMAýWVVAýSV'ýAGPL,  --A-C;  qFFAEAGQ 
VFGIDGfqRWV  FLLNVPLGLL  ALVTVRKALq  LPHERREHW  DVLGAAALAL 
FLVPL17IVA-E  QGRTWGVFSP  AALALFALGA  AGLAVFIPVE  ---  LIRRGDEAILP 
LGLFRRGSIA  FCSAVNFTIG  VGIFGTVTTL-PILFLQMVQGR  TPTQFOý37ývvl 
PFMLGTIASP  MVSGKLIASS  GRFKKLIIVG  LGSMAGALLA  MATTPATTfM- 
WGIVLIVLWL  GVGIGLSQT  SPMQNSAP  KSQLGVANGA  SGLCRQFI-GGS 
TGIAVLFSVM  FAVALGRLAD  LLIJTPRYERL  LTDPAITGDP  ANHRFLDMAE 
SGQGAGINLD  DTSLLNGIDA  RLMQPVTDSF  AHGFHIMFLA  GGVVLLAGFV 
MTIFLRELQE  ETAPEEERPA  ESZ;  ýýP  LPASDA 
i 
R0.9 
Shows  the  putative  OtrB  transmembrane  regions  (boxed).  Residues  in  bold 
type  belong  to  conserved  motifs  of  the  MFS  family  (Paulsen  et  al,  1996). 
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1  so 
OTRB  ----------  ----------  ----------  MSG.  LLLAVF  LAALDQTVIA 
CTRB-NEND  MANATSQTGE  AVADEAGGPA  GFTHRQIITA  LSG.  LLLAVL  LAALDQTIVS 
SVORF4  ---  MTDTANR  RSATPDSGAD  AVDKRRIRLI  MTGLLLLGLF  MAALDQTIIS 
CMCT  ---------  M  TSVRGASKTG  RTSKTSTATT  ALVLACTAHF  LVVFDTSVIT 
PUR8  ----  MARKPD  ISAVPVESAA  CQGPDPRRWW  GLVVILAAQL  LVVLDGTVVN 
ACTVA  ---------  M  TANPGRPGGP  ADQGHPRRWA  ILGVLVLSLV  GIILDNTVLN 
PTR  ---------  M  TATTTETSKA  PSGGHPQRWL  ILGVICLAQL  TVLLDNTVLS 
TCMA  --MSTETHDE  PSGVAHTPAS  GLRGRP..  WP  TLLAVAVGVM  MVALDSTIVA 
MMR  ---  MTTVRTG  GAQTAEVPAG  GRRDVPS.  GV  KITALATGFV  MATLDVTVVN 
LDxTvxn 
51  100 
OTRB  TAMRTIADDL  HGQ  ....  TEQ  AWATTGYLIA  SVLAMPFYGK  LSDIYGRKPM 
CTRB  TALRTIGDQL  HGQ  ....  TVQ  AWVITGYLVS  STIAMPFYGK  LSDIYGRKPL 
SVORF4  AALRTIADDL  NGL  ....  SEQ  AWANTSYMIT  SVIMTALYGK  LSDIYGRRPV 
CMCT  VALPSV  ...  R  ADLGFAPASL  QWVVNSYTLA  FAGLLLFGGR  LADIHGHRRV 
PURB  IALPSV  ...  Q  RDLGMSDTSR  QWVITAYTLA  FGGLLLLGGR  VADAFGRRRI 
ACTVA  VTLRTLTDPE  QGLGASHSQV  EWVLSAYTLA  FAATLFTWGV  LGDRLGRRRV 
PTR  VAIPSLT  ...  RELHASTADI  QWMINAYSLV  QSGLLLTAGN  AADRYGRRKM 
TCMA  IANPAI  ...  Q  QDLHASLADV  QWITNGYLLA  LAVSLITAGK  LGDRFGHRQT 
MMR  VAGATI  ...  Q  ESLDTTLTQL  TWIVDGYVLT  FASLLMLAGG  LANRIGAKTV 
vAIP  M  (motif  D)  Gx  LaDrxGrkxx 
101  150 
OTRB  YLISIVVFIG  GSVLCGTAGS  MWELALFRAV  QGLGGGGLMS  LPTAVVADLA 
CTRB  YLAAIAVFIV  GSAACAMANS  METLAIARVL  QGFGGAGLMS  LPTAVIADLA 
SVORF4  YCTAVGVFVL  GSVLCGLAQS  MTTLAVFRG.  QGIGAGGLMS  LAFAILTDLV 
CMCT  FLGGLAVFTL  TSLIGGLATS  PASLIAARAG  QGAGAAVLAP  LAVTMLTTSF 
PUR8  FAVGILGFGL  ASLLGGAAPD  PGTLFLARAL  QGVFAAALAP  AALALINTLF 
ACTVA  LLLGLGLFGL  SSLAGAYAGS  PEQLIAARAC  MGVSGAAVLP  STLATIAAVF 
PTR  LVAGLALFGI  GSLAAGLAQT  SGQLIAARAG  MGVGGALLMT  TTLAVVVQVF 
TCMA  FLVGVAGFAV  TSAAIGLSGS  VAAIVVFRVL  QGLFGALMQP  SALGLLRVTF 
MMR  YLWGMGVFFL  ASLACALAPT  AETLIAARLV  QGAGAALFMP  SSLSLLVFSF 
XL  (motif  A)  lxxxRx  qGxgaa  (motif  B) 
151  200 
OTRB  PV.  RERGRYF  AFLQMAWVVA  SVAGPLAGGF  FAEAGQVFGI  DGWRWVFLLN 
CTRB  PV.  RERGRYF  SYLMMAWVAA  SVLGPLVGGL  FAGAGEILGV  TGWRWAFLIN 
SVORF4  PL.  AERSRYQ  AWFGAVFGVS  AVVGPVAGGF  FAGLDSFLGA  SGWRWAFFIN 
CMCT  AEGPRRTRAL  TISTAVALVG  GASGNLLGGV  FTEF  ......  LSWRSVLLVN 
PUR8  TEPGERGKAF  GVYGAVSGGG  AAVGLLAGGL  LTEY  ......  LDWRWCLYVN 
ACTVA  PL.  RERPKAL  GIWAASVGFA  LGIGPVTGGI  LLAH  ......  FWWGSVLLVN 
PTR  DE.  TERVKAI  ALWSTVSSLG  FAAGPLIGGV  MLEH  ......  YWWGAIFLIN 
TCMA  PPGK.  LNMAI  GIWSGVVGAS  TAAGPIIGGL  LVQH  ......  VGWEAVFFIN 
MMR  PEKRQRTRML  GLWSAIVATS  SGLGPTVGGL  MVSA  ......  FGWESIFLLN 
g  xxxGPxxGG  1(motif  C)  WxwxFlIN 
201  250 
OTRB  VPLGLLALVT  VRKALNLPHE  R  ...  REHRMD  VLGAAALALF  LVPLLI.  VAE 
CTRB  VPLGLVALLS  VRKALNLPHR  R  ...  VDHPID  FRGALTLALC  LVPLLI.  VAE 
SVORF4  VPIGVAGALI  IAALVRVQPG  R  ...  AQHKFD  IAGLLALIAC  LLPLLF.  AVE 
CMCT  VPIGIPVLFL  AARVLAGPRK  RPWGR.  VRLD  LPGAVLATAG  LTLLTLGVSQ 
PUR8  APVALLAL.  L  GCRLL..  PRD  RRTGRAVRLD  LPGTLLGCGG  LVAIVYAFAE 
ACTVA  VPLMAGCL.  V  AVVLVVPETR  GTAGR..  RVD  AAGLLLSIAG  VVPLVYAIIE 
PTR  IPVAVIGL.  V  AVVLLVPESK  NPQGD..  RPD  LLGAVLSTIG  MTAVVYAII. 
TCMA  VPVGLAALVA  GLVILTDARA  ERAPK..  SFD  VSGIVLLSGA  MFCLVWGLIK 
MMR  LPIG..  AIGM  AMTYRYIAAT  ESRAT..  RLA  VPGHLLWIVA  LAAVSFALIE 
VPig  (motif  H)  D  xxGXKL  (motif  E) 
251  300 
OTRB  QGRTWGWGSP  AALALFALGA  AGLAVFIPVE  LRRGDEAILP  LGLFRRGSIA 
CTRB  EGLDWGWGSA  RSLTLFAVSL  IGLVLFVLAE  RARGLEAMVP  LRLFRRGGIT 
SVORF4  QGPAWGWTDP  GTLVLFGLGA  VGLVLFSLAQ  KRAADAALLP  TPMFRNPLFS 
CMCT  T.  HEHGWGEA  AVAVPLAGGL  LALLAFVVVE  ARFAASPLIP  PRLFGLPGVG 
PUR8  A..  ESGWGDP  LVVRLLVLGV  LMLVAFALVE  RR.  VQDPLLP  PGVVAHRVRG 
ACTVA  AGRSGGVTRP  AVWAAGLAGL  GLLLVFLWHE  RR.  TPEPSLE  LGFFRMKAFS 
PTR  SGPDHGWTST  QVLASAALGA  LFLGAFVFWE  LR.  IPYPMLD  MHFFRNQRFI 
TCMA  APAWGWGDL  RTLGFLAAAV  LAFAGFTLRE  SR.  ATEPLMP  LAMFRSVPLS 
MMR  GPQLGWTAG  PVLTAYAVAV  TAAALLALRE  HR.  VTNPVMP  WQLFRGPGFT 301  350 
OTRB  LCSAVNFTIG  VGIFGTVTTL  PLFLQMVQGR  TPTQAGLVVI  PFMLGTIASQ 
CTRB  MTTAVNFTIG  VGIFGTVSTL  PLFLQLVQGR  SATVAGLVII  PVMTGAIVSQ 
SVORF4  VYNGVNVLVG  AAVFGALSVL  PLYLQMVKGL  SPTQAGLIM  PQTLGIVVAG 
CMCT  WGNLAMLLAG  ASQVPVWFFL  TLSMQHVLGY  SAAQAGLGFV  PHALVMLVVG 
PUR8  GSFLVVGLPQ  IGLFGLFLFL  TYYLOGILDY  SPVLTGVAFL  PLGLGIAVGS 
ACTVA  TAVAAVGFVS  FAMMGFLFFS  AFYLQSVRGY  TPLQAGGCTV  ALAVANVVCG 
PTR  GAVAGAILVA  FGMTGSLFLL  TQHLQFVLGY  GALDAGLRTA  PLALTVVALN 
TCMA  AGTVLMVLMA  FSFIGGLFFV  TFYLQNVHGM  SPVESGVHLL  PLTGMMIVGA 
MMR  GANLVGFLFN  FALFGSTFML  GLYFQHARGA  TPFQAGLELL  PMTIFFPVAN 
351  400 
OTRB  MVS.  GKLIAS  SGRFKKLAIV  GLGSMAGALL  AMATTGATTP  MWGIVLI  ... 
CTRB  TIC.  AKIIKK  WNRYKKPAIV  GLGSMAGALL  SLSAAGADTP  LAVIVVI  ... 
SVORF4  RIA.  RPYVTR  TGRYKAVLLS  GLVLMVVATF  WFGVLTADTS  LWQTGVA  ... 
CMCT  LR.  VVPWLMR  HVQARVLIAA  GAAIGALGFW  WQSLLTPDS.  AYLGGILGP 
PURS  SL.  IAARLLP  RTRPRTLIVG  ALLAAA-AGMA  LLTRLEPDTP  QVYLTHLLPA 
ACTVA  ..  PLSTVLVR  SIGPRNVCAA  GMLAVTASLC  GVTFVTQHAP  VWLILVLF.. 
PTR  LTGMGARLLR  IFGTPVTIAV  GMALVSGGLA  AIAVLGAGGY  NGMLLGL... 
TCMA  P..  VSGIVIS  RFGPGGPLVV  GMLLTAASLW  GMSTLEADSG  MGITSLWF.. 
MMR  I..  VYARISA  RFSNGTLLTA  FLLLAGAASL  SMVTITASTP  YWVVAVAV.. 
401  450 
OTRB  VLWLGVGIGL  SQTVITSPMQ  NSAPKSQLGV  ANGASGLCRQ  IGGSTGIAVL 
CTRB  AAWLGFGIGL  SQTVITLAIQ  SSAPKSELGV  ANAASGLFRQ  LGGTSGAAVF 
SVORF4  AGVMGFGIGL  CWQVMLIAIQ  TGVAPQYMGA  GMGSFTFFRQ  IGGTGRHRVF 
CMCT  AVLISIGGGL  VGTPLARTVT  SGVGPLDAGA  ASGLMNTTRQ  FGGAFGLAVL 
PURB  QILIGLGIGC  MMMPAMHTAT  ARVAPHEAGA  AAAVVNSAQQ  VGGALGVALL 
ACTVA  AALGAGVAC  VMPTAAVSIM  NAIPREKAGV  ASAMNNTVRQ  LGGALGVAVL 
PTR  VVMGAGVAL  SMPAMANAIM  SAIPPEKAGV  GAGINGTLAE  FGNGLGVAVL 
TCMA  VLLGLGLAP  VMVGTTDVIV  SNAPAELAGV  AGGLQQSAMQ  VGGSLGTAVL 
MMR  GVANIGAGI  ISPGMTAALV  DAAGPENANV  AGSVLNANRQ  IGSLVGIAA 
LgxxxGxavx 
451  500 
OTRB  FSVMFAVALG  RLA  ....  DLL  HTPRYERLLT  DPAITGDPAN  HRFLDMAESG 
CTRB  MSVLFGVAAG  RLD  ....  GAD  PDEAVRRALS  DPDSTGG.  LS  ASAVDAFTSG 
SVORF4  LSMFFGAVGE  KVAAAYRGAA  SDPAYTAAVN  DPAVTGQAAN  KVLL  .....  G 
CMCT  LTVTGSGTSG  SPAELASHYG  DAFVGIAVFM  LAIAVLTPVL  PALARSTPPG 
PURB  NTVSTGATAA  YLADHGTSPA  ATVDGTVHG  YTVAIAFAVG  VLLLTAVLAW 
ACTVA  GSLMGAAYRR  GIEDELAVLP  PSARHQAGES  LDATLLAATR  LGESGLVGPA 
PTR  GAVLNSRF  ........  AALV  PAA..  VGATS  LPAALAAADD  AGERARISDA 
TCMA  GVLMASRVGD  VFPDKWAEAN  LPRVGPREAA  AIEDAAEVGA  VPPAGTLPGR 
MMR  GVVLHSTSD.  ..  WDHGAAIS  FLAVGLAYLL  GGLSAWRLIA  RPERRSAVTA 
gxl  (Motif  F) 
501 
OTRB  QGAGINLDDT 
CTRB  FDTMFLVGGL 
SVORF4  PGRRVGLDNS 
CMCT  VIHVSPVAR- 
PUR8  VLIDSRTEAA 
ACTVA  RQAFLDAMHL 
PTR  FASGLETSQL 
TCMA  HAGTLSEVVH 
MMR  AT  -------- 
550 
SLLNGIDARL  MQPVTDSFA  HGFHIMFLAG  GVVLLAGFVM 
ILAVGFLLTF  PLRELRDEE  -  ----------  ---------- 
SFLDHADPRL  A.  KPFLEGLA  EAMQTVFVVS  GVMLLIALVL 
----------  ----------  ----------  ---------- 
DETGSASVTP  ARPR  ------ 
AAGAAAAVAL  VGALAVLRWL 
V..  GAVAVLA  GGLLAALLLR 
SSFISGMGLA  FTVAGAVALV 
----------  ---------- 
----------  ---------- 
PSSVTTPTPP  AGAVPGREHS 
RAERADPPAK  A  --------- 
AAAVALFTRK  AEPDERAPEE 
----------  ---------- 
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551  585 
OTRB  TWFLRELQEE  TAPEEERPAE  SGAGAKNGPL  PASDA 
CTRB  ----------  ----------  ----------  ----- 
SVORF4  AAVPKEKPPR  AGRRFAGRRK  ETGKQPAAKK  ----- 
CMCT  ----------  ----------  ----------  ----- 
PUR8  ----------  ----------  ----------  ----- 
ACTVA  DHLKVQGS  --  ----------  ----------  ----- 
PTR  ----------  ----------  ----------  ----- 
TCMA  FPVPASTAGR  G  ---------  ----------  ----- 
MMR  ----------  ----------  ----------  ----- 
Fifz  3.10 
Alignments  between  a  series  of  Streptomycete  14  TMH  drug,  exporters. 
CmcT,  the  cephamycin  transporter  from  Nocardia  lactamdurans  is  also 
included. 
Conserved  motifs  of  the  MFS  family  are  denoted  in  bold  type  below  the 
PileUp.  Upper  case  residues  denote  the  amino  acid  is  conserved  in  over  70% 
of  proteins,  lower  case  letters  denote  conservation  of  the  residue  in  over  40% 
of  proteins.  (Motif  concensus  sequences  taken  from  Paulsen  &  Skurray,  1996) 
Residues  in  bold  type  within  the  PileUp  diagram  are  motifs  found  to  be  well 
conserved  amongst  the  drug  transporters  of  Streptomyces  spp. 
For  accession  numbers  and  references  for  these  proteins,  see  Table  3.1. 
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1  50 
TetK  MFSLYKKFKG  LFYSVLFWLC  ILSFFSVLNE  MVLNVSLPDI  ANHFNTTPGI 
TetL  MNTSYSQSNL  RHNQILIWLC  ILSFFSVLNE  MVLNVSLPDI  ANDFNKPPAS 
OtrB  ----------  -----  MSGLL  LAVFLAALDQ  TVIATAMRTI  ADDLHGQTEQ 
51  100 
TetK  TNWVNTAYML  TFSIGTAVYG  KLSDYINIKK  LLIIGISLSC  LGSLIAFIGH 
TetL  TNWVNTAFML  TFSIGTAVYG  KLSDQLGIKR  LLLFGIIINC  FGSVIGFVGH 
OtrB  A-WATTGYLI  ASVLAMPFYG  KLSDIYGRKP  MYLISIVVFI  GGSVLCGTAG 
101  150 
TetK  NHFFILIFGR  LVQGVGSAAF  PSLIMVVVAR  NITRKKQGKA  FGFIGSIVAL 
TetL  SFFSLLIMAR  FIQGAGAAAF  PALVMVVVAR  YIPKENRGKA  FGLIGSIVAM 
OtrB  SMWELALF.  R  AVQGLGGGGL  MSLPTAVVAD  LAPVRERGRY  FAFLQMAWVV 
151  200 
TetK  GEGLGPSIGG  IIAHY 
.....  ...  IHWSYLL  ILPMITIVTI  PFLIKVMVPG 
TetL  GEGVGPAIGG  MIAHY 
.....  ...  IHWSYLL  LIPMITIITV  PFLMKLLKKE 
OtrB  ASVAGPLAGG  FFAEAGQVFG  IDGWRWVFLL  NVPLGLLALV  TVRKALNLPH 
201  250 
TetK  KSTKNTLDIV  GIVLMSISII  CFML  ......  ...  FTTNYNW  TFLILFTIFF 
TetL  VRIKGHFDIK  GIILMSVGIV  FFML  ......  ...  FTTSYSI  SFLIVSVLSF 
OtrB  ERREHRMDVL  GAAALALFLV  PLLIVAEQGR  TWGWGSPAAL  ALFALGAAGL 
251 
TetK  VIFIK.  HISR  VSNPFINPKL 
TetL  LIFVK.  HIRK  VTDPFVDPGL 
OtrB  AVFIPVELRR  GDEAILPLGL 
301 
TetK  MKTIYHVNVA  TIGNSVIFPG 
TetL  MKDVHQLSTA  EIGSVIIFPG 
OtrB  LQMVQGRTPT  QAG.  LVVIPF 
300 
GKNIPFMLGL  FSGGLIFSIV  AGFISMVPYM 
GKNIPFMIGV  LCGGIIFGTV  AGFVSMVPYM 
FRRGSIALCS  AVNFTIGVGI  FGTVTTLPLF 
350 
TMSVIVFGYF  GGFLVDRKGS  LFVF.  ILGSL 
TMSVIIFGYI  GGILVDRRGP  LYVL.  NIGVT 
MLGTIASQMV  SGKLIASSGR  FKKLAIVGLG 
351 
ý400  TetK  SISISFLTIA  FFVEFS.  MWL  TTFMFIFVMG  GLSFTKTVIS  KIVSSSLSEE 
TetL  FLSVSFLTAS  FLLETT.  SWF  MTIIIVFVLG  GLLFTKTVIS  TIVSSSLKQQ 
OtrB  SMAGALLAMA  TTGATTPMWG  IVLIVLWLGV  GIGLSQTVIT  SPMQNSAPKS 
401  450 
TetK  EVASGMSLLN  FTSFLSEGTG  IAIVGGLLSL  QLINRKLVLE  FINYSSGVYS 
TetL  EAGAGMSLLN  FTSFLSEGTG  IAIVGGLLSI  PLLDQRLLPM  EVDQSTYLYS 
OtrB  QLGVANGASG  LCRQIGGSTG  IAVLFSVMFA  VALGRLADLL  H  ....  TPRYE 
451  500 
TetK  NILVAMAILI  ILCCLLTIIV  FKRSEKQFE  -  ----------  ---------- 
TetL  NLLLLFSGII  VISWLVTLNV  YKHSQRDF  --  ----------  ---------- 
OtrB  RLLTDPAITG  DPANHRFLDM  AESGQGAGIN  LDDTSLLNGI  DARLMQPVTD 
501  550 
TetK  ----------  ----------  ----------  ----------  ---------- 
TetL  ----------  ----------  ----------  ----------  ---------- 
OtrB  SFAHGFHIMF  LAGGVVLLAG  FVMTWFLREL  QEETAPEEER  PAESGAGAKN 
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551 
TetK  -------- 
TetL  -------- 
OtrB  GPLPASDA 
Fijz  3.11 
Alignment  of  OtrB  with  TetK  and  TetL,  two  tetracycline  exporters  from 
Gram-positive  bacteria.  For  accession  numbers  and  references  for  these 
proteins,  see  Table  3.1. 
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1 
50 
L 
ýA 
LPT  L 
TetA(A)  MKPNIPLfII  LSTVAL-LDAVG  IGLIMPVLPG  L  LVHSNDJVT  LLA 
LDAVG  LPG] 
T  JA  LL  Im  LPT  LE  ýL  p 
AALLI  LIM  LPS  L 
FL  LDAMG 
LDAMG 
LD;  ýG 
LD  G  LF 
LI  LI  T 
A  JA  LG 
ýL  pL 
TetA(C)  MKSNNALIVI  LGTVTLDAVG  IGLVMPVLPG  L  IVHSDS  IAýSHHYYGGV  A 
TetA(G)  --VRSSAIIA  LLLIVGLDAMG  LGLIMMPPVVLPT  L  LVPAEQIVAGHYGALLS  L 
TetA(B)  --MNSSTFIA  LVVIITTLLDAMG  IGLI.  MMPPVVLLPT  L  EFIASEDIIANHFGVLLA 
L"  IGLI  I 
LL 
TetA(D)  --MNKPAVJIA  LVVIITTLLDAMG  IGLIMMPVVLPS  L  YLPEADIVANHYGILLA 
Lj  IGLV 
s 
LT 
TetA(E)  --MNRT  LVVIIIIFLDAMG, 
ýý 
IGII.  MPýVýLPA  L  EFVGKANIVAENYGVLLA 
OtrB  ----------  MSGLLLAVFL  AALDOTVIAT  AMRTIADDLH  GQTEQAWA= 
51  00 
m. 
TetA(A)  LYALVQFACA  PVL  SDRF  GRRPILLVSL  AGATVDYAIM  ATAPPFL'  Y 
SDRF  GRPPVLLASL  LGATIDYAIM  ATT2  TetA(C)  LYALMQFLCA  PVL  k  P2  LY 
TetA(G)  LYALMQVVFA  PML  LSDSY  GRPPVLLASL  AGAAVDYTIM  ASAPPVL  -y 
01 01 
p 
L 
PVL  L  L' 
TetA(B)  LYALMQVIýFA 
JPWL 
SDRF  GRFPVLLLSL  IGASLDYLLL  AFSSSAL 
I; 
y 
ýFA  PýL  W  NVL 
FA  PML  L  VL 
FA  PLL  W 
TetA(D)  LYAVMQVCFA  PLL  WSDKL  GRFPVLLLSL  AGAAFDYTLL  ALSNNVL  y 
VA  PML  L 
TetA(E)  LYAMMQVIiFA  PLL  WSDRI  GRIPVLLLSL  LGATLDYALM  ATAS  Y 
PVL 
JL 
OtrB  GYLIASVLAM  PFYGKLSDIY  GRKPMY  ISI  VV  LA 
101  150 
TetA(A)  IGIý:  VAGI.  T  GATGAVAGAY  IADI  DER  ARI-FGFMSAC  FGFGMVAGPV 
TetA(C)  AGR:  VAGI.  T  GATGAVAGAY  IADITDGEDR  ARWGLMSAC  FGVGMVAGPV 
TetA(G)  IGRVSGV.  T  GATGAVAAST  IADST3EGSR  ARVFGYMGAC  YGAGMIAGPA 
TetA(B)  LGRiLSGI.  T  GATGAVAASV  IADTTSASQR  VKVFGWLGAS  FGLGLIAGPI 
TetA(D)  LGR[ISGI.  T  GATGAVAASV  VADSTAVSER  TAVFGRLGAA  FGAGLIAGPA 
TetA(E)  LGREIAGI.  T  GATGAVA-AST  IADVT[PEESR  THV4FGMMGAC  FGGGMIAGPV 
OtrB  LF  VRER  GRYFAFLOMA 
151  200 
TetA(A)  LGGLMC:;  FSP  HA?  FFAAAAL  NGLNFLTGCF  ESHKGER  RPLRREALNP 
TetA(C)  AGGLLCAISL  HA?  FLAAAVL  NGLNLLLGCF  LMQESHKGER  RPMPLRAFNP 
TetA(G)  LGGMLC3ISA  HA?  FIAAALL  NGFAFLLACI  FLKETHHSHG  GTGKPVRIKP 
TetA(B)  IGGFACEISP  HS?  FFIAALL  NIVTFLVVMF  WFRETKNTRD  NTDTEVGVET 
TetA(D)  IGGLACDISP  HL?  FVIAAIL  NACTFLMVFF  IFKPAVQTEE  KPADE..  KQE 
TetA(E)  IGGFACQLSV  QA?  FMFAAAI  NGLAFLVSLF  ILHETHNANQ  VSDELKNETI 
OtrB  AQQFFAEAGQ  VF  GIDGWRWV  FLU  PLGLL  A  VTVRKALN-LPHERREHRM 
201 
TetA(A)  LSFVRWARGM  TvrVAALMAV  FFIMQLVGQV  PAALWVIFG3  DRFHWDArTI 
TetA(C)  VSSFRWARGM  TIVAALMTV  FFIMQLVGQV  PAALWVIFG:  3  DRFRWSArmI 
TetA(G)  FVLLRLDDAL  R3LGALFAV  FFIIQLIGQV  PAALWVIYG:  3  DRFQWNTNTV 
TetA(B)  QSNSVYI.  TL  FKrmpILLII  YFSAQLIGQI  PATVWVLFT3  NRFGWNSAMV 
TetA(D)  SAGISFI.  TL  LKPLALLLFV  FFTAQLIGQI  PATVWVLFT3  SRFAWDSkAV 
TetA(E)  NETTSSIREM  ISELS  LLVV  FFIIQLIGQI  PATLWILFCJE  ERFAWDqVW 
OtrB  DVLGAAALAL  F..  LVPLLIV  AEQGRTWGWG  SPAALALFAL  QAAQL-P&-F-f 
251 
TetA(A)  GISLAAFGIL  HSLAQAMITC  PVAARLGERI  ALMLGMIADG  TGYILLAFPT 
TetA(C)  GLSLAVFGIL  HALAQAFVTC  PATKMEKý  AIIAGMAADA  LGYVLLAFPT 
TetA(G)  GLSLAAFGAT  HAIFQAFVTC  PLSSRLGEPR  TLLFGMAADG  TGFVLLAFzT 
TetA(B)  GFSLAGLGLL  HSVFQAFVAC-RIATKWGEK"r  AVLLGFIADS  SAFAFLAFIS 
TetA(D)  GFSLAGLGAM  HALFQAVVAC  ALAKRLSEFr  IIFAGFIADA  TAFLLMSAIT 
TetA(E)  GVSLAVFGLT  HALFQGLAAd  FIAKHLGE*  AIAVGILADG  CGLFLLAVAT 
OtrB  kYELRRGDEA  ILPLGLFRRG  SIALCSAVNF  TIGVGIFGTV  TTLPLFLQMV 
301  350 
TetA(A)  RG  AFPIMV  LLASGGIGMP  AMQUýML  RQV  DEERQGQLQG  3LAALTSLTS  WF 
L: 
RQV 
TetA(C)  RGWýMFPIMI  LLASGGIGMP  AL^  "Rv  DDDHQGQLQG  3LAALTSLTS 
TetA(G)  QG4WFPILL  LLAAGGVGMP  ALQ  LSNNV  SSNKQGALQG  rLTSLTNLSS 
TetA(B)  EG*VFPVLI  LLAGGGIALP  ALQ3VMSIQT  KSHQQGALQG  ZVSLTNATG 
TetA(D)  SG  PVLI  LLAGGGIALP  ALQ:;  IISAGA  SAANQGKLQG  JLVSLTNLTG 
TetA(E)  QS=PVLL  LLACGGITLP  ALC31ISVRV  GQVAQGQLQG  VLTSLTHLTA 
OtrB  QGR-PTQAGL  VVIPVMLGTI  MVSGKLI  ASSGRFK... 
351  400 
TetA(A)  IVGPLLFTIAI  Y  SITT  G  WAWIAGAkALY  LLCLPALRRG  SGAGQRAD 
.  Aj  y 
k] 
VT 
FT 
FA 
'A 
, Fp 
.  AL  y  PL  pIL 
'IAT  A  Ts  Pm 
TetA(C)  ITGPLIVTAI  Y  SAST  G  LAWIVGAALY  LVCLPALRRG  kA  VCLPALRRG  SRATST-- 
ýVj  I  IWIIGL 
FL  YTG 
ýWJJGC 
ýFj  FS  VWLIGTALY  GLL 
LAFY  CII  LSMT 
TetA(G)  IAGPLG 
, 
FTAL  Y  TAGAIG 
: 
WIVGAILY  LICL 
CGLY  VVALI  IL 
RRP  TSLV---- 
IF 
IL  F  TetA(B)  VIGPLLFAVI  SLPI  WIWIIGLAFY  CIIILLSMTF  TPQAQGSK 
LAICLL 
TS  PM 
TetA(D)  VAGPLLFAFI  F  TQQS  TVWLIGTALY  GLLLAICLLI  PAPVAATC  I 
TetA(E)  VIGPLVFAFL  Y  TRET  G  WVWIIGCGLY  VVALIILRFFIH  GRVIHPIN 
OtrB  MAGALLýAMAT  ATTP  TS  PMQNSAPKSQ 
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401  450 
TetA(A)  R  ---------  ----------  ----------  ----------  ---------- 
TetA(C)  ----------  ----------  ----------  ----------  ---------- 
TetA(G)  ----------  ----------  ----------  ----------  ---------- 
TetA(B)  QETSA  -----  ----------  ----------  ----------  ---------- 
TetA(D)  ----------  ----------  ----------  ----------  ---------- 
TetA(E)  KSDVQQRI  --  ----------  ----------  ----------  ---------- 
OtrB  LGVANGASGL  CRQJ  =  TGT  AVLFSVMFAV  ALGRLADLLH  TPRYERLLTD 
451  500 
TetA(A)  ----------  ----------  ----------  ----------  ---------- 
TetA(G)  ----------  ----------  ----------  ----------  ---------- 
TetA(C)  ----------  ----------  ----------  ----------  ---------- 
TetA(B)  ----------  ----------  ----------  ----------  ---------- 
TetA(D)  ----------  ----------  ----------  ----------  ---------- 
TetA(E)  ----------  ----------  ----------  ----------  ---------- 
OtrB  PAITGDPANH  RFLDMAESGQ  GAGINLDDTS  LLNGIDARLM  QPVTDSFAHG 
501  550 
TetA(A)  ----------  ----------  ----------  ----------  ---------- 
TetA(G)  ----------  ----------  ----------  ----------  ---------- 
TetA(C)  ----------  ----------  ----------  ----------  ---------- 
TetA(B)  ----------  ----------  ----------  ----------  ---------- 
TetA(D)  ----------  ----------  ----------  ----------  ---------- 
TetA(E)  ----------  ----------  ----------  ----------  ---------- 
OtrB  FHIMFLAGGV  VLLAGFVMTW  FLRELOEETA  PEEERPAESG-AGAKNGPLPA 
551 
TetA  (A)  --- 
TetA(G)  --- 
TetA(C)  --- 
TetA(B)  --- 
TetA  (D)  --- 
TetA(E)  --- 
OtrB  SDA 
Fi.  iz  3.12 
Alignment  of  OtrB  with  12  TMH  Tetracycline  resistance  proteins  from 
Gram-negative  bacteria.  The  12  TMH's  of  the  TetA  group  are  marked, 
residues  in  bold  type  indicate  conservation  between  OtrB  and  the  TetA  group. 
Underlined  regions  denote  the  putative  14  TMH's  of  OtrB 
For  accession  numbers  and  references  for  these  proteins  see  Table  3.1. 
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PILEUP  for  OtrB  and  Tetracycline  resistance  proteins  with  14  TMH's  from  other 
Gram-positive  bacteria.  It  should  be  noted  that  all  tet  exporters  from  Gram-positives 
are  so  far  thought  to  be  made  up  from  14  TMH's  whilst  those  from  Gram-negatives 
seem  to  consist  of  12  TMH's.  Fig  3.11  shows  that  although  OtrB  and  the  TetK,  Tetl, 
proteins  both  contain  14  TMH's  ,  TetK  and  Tetl,  are  much  more  closely  related  to 
each  other  than  they  are  to  OtrB.  OtrB  shows  much  more  homology  with  the  proteins 
in  the  previous  PileUp. 
OtrB  and  some  Gram-negative  TET  exporters  are  compared  in  Fig  3.12.  The 
proteins  from  Gram-negatives  show  very  high  homology  to  each  other,  the  positions 
of  the  12  TMH's  of  the  TetA  group  are  marked,  it  can  be  seen  that  all  but  two  of  the 
residues  conserved  between  OtrB  and  the  TetA  group  occurs  in  the  first  6  helices  of 
the  proteins.  The  remaining  two  conserved  residues  occur  within  TMHlO  of  both 
proteins.  It  is  possible  that  this  motif,  present  as  ALQ  in  the  TetA  group  and  as  ASQ 
in  OtrB  are  linked  to  substrate  recognition  as  there  is  no  conservation  of  these 
residues  within  the  Streptomycete  transporter  group  whose  members  transport  varied 
substrates.  However  if  this  were  the  case,  the  motif  might  be  expected  also  to  appear 
in  the  TetK  and  TetL  proteins,  no  such  motif  can  be  observed. 
3.6.3  Conserved  motifs 
Within  the  members  of  the  MFS,  certain  conserved  regions  known  as  motifs  have 
been  identified  (Henderson  &  Maiden,  1990;  Griffith  et  al  ,  1992;  Marger  &  Saier, 
1993;  Paulsen  &  Skurray,  1993).  Some  of  these  motifs  are  conserved  throughout  the 
entire  superfamily  (motifs  A  and  B)  whilst  another  is  found  only  in  the  12  and  14 
TMH  families  (motif  C  and  D,  although  there  is  some  variation  in  motif  D  between 
the  2  families).  Other  motifs  were  identified  as  being  exclusive  to  either  the  12  TMH 
(motif  G)  or  the  14  TMH  families  (motifs  E  and  F)  (Paulsen  &  Skurray,  1993).  In  a 
review  by  Paulsen  et  al  (1996)  these  motifs  have  been  refined  using  extensive 
multiple  sequence  alignments.  Also  presented  in  that  review  is  an  additional  motif 
(motif  H).  This  is  present  in  the  14  TMH  family  but  can  also  be  seen  in  a  somewhat 
diverged  format  in  some  12  TMH  transporters.  The  consensus  sequences  of  motifs 
presented  here  are  taken  from  Paulsen  et  al,  (1996). 
Many  of  these  motifs  can  be  clearly  identified  in  OtrB,  (  Fig  3.10). 
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Motif  A 
GxLaDrxGRkxxxL 
Initially  identified  as  a  motif  from  certain  sugar  and  tetracycline  transporters,  by 
Rouch  et  al  (1990)  as  GXXSDR/KSGR/ER/K  and  by  Henderson  &  Maiden  (1990)  as 
RXGRR,  motif  A  is  located  in  the  cytoplasmic  loop  between  the  second  and  third 
TMH's.  The  motif  is  conserved  in  all  four  families  of  the  MFS,  has  been  postulated 
to  act  as  a  substrate  entrance  gate  (Yamaguchi  et  al,  1990)  and  is  thought  to  form  a 
turn  of  the  protein.  In  OtrB  the  motif  has  been  totally  retained  and  can  be  seen  as 
GkLsDiyGRKpmyL  where  upper  case  letters  denote  residues  in  agreement  with  the 
motif  sequence  (Fig  3.10).  The  residues  of  motif  A,  which  is  the  most  highly 
conserved  loop  in  the  N-terminal  half  of  the  MFS  proteins,  have  been  well- 
characterised  and  the  two  glycine  residues  are  essential  for  function.  Studies  of  TetB 
have  led  to  the  postulation  that  they  are  involved  with  a  gating  function  (Yamaguchi 
et  A  1990;  Yamaguchi  et  A  1992a).  It  is  also  possible  that  they  may  act  to  promote 
global  conformational  changes  in  the  protein  that  enable  the  substrate  to  cross  the 
membrane.  The  aspartic  acid  residue  and  arginine  residue  are  also  essential  most 
likely  playing  a  structural  role,  (Jessen-Marshall  et  al,  1995).  This  second  postulation 
is  supported  by  the  fact  that  second  site  suppressor  mutations  which  retain  function 
have  been  identified  and  these  mutations  occur  at  various  sites  all  over  the  protein 
(Yamaguchi  et  al,  1995,  Someya  et  al  1995).  The  SD  (serine,  aspartate)  motif  within 
motif  A  shows  absolute  conservation  in  tetracycline  transporters  of  the  12  and  14 
TMH  families  (Chopra,  1986).  This  observation,  made  more  than  10  years  ago,  has 
been  borne  out  in  sequences  published  since  that  time. 
Motif  C 
gxxxGPxxGGxl 
This  motif  ,  located  in  TMH  5  of  the  12  &  14  TMH  antiporter  families  is  not  found 
in  the  symport  proteins  of  the  other  MFS  families.  This  suggests  a  role  in  the  linking 
of  proton  translocation  to  the  antiport  but  not  the  symport  of  a  substrate  (Griffith  et 
al,  1992;  Paulsen  &  Skurray,  1993).  Mutagenesis  studies  of  the  glycine  residue  at 
Position  5  in  the  motif  in  TetC  have  been  carried  out  and  it  is  suggested  by  Varela  et 
al  (1995)  that  the  residues  of  motif  C form  a  bend  in  TMH5.  This  invites  the 
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speculation  that  motif  C  may  determine  the  positioning  of  the  unoccupied  substrate 
binding  site  and  therefore  control  transport  direction  of  the  substrate. 
In  OtrB,  motif  C  is  conserved  as  avsaGPlaGG  (Fig  3.10). 
Motif  Di 
lDxTvxnvAlP 
As  with  motif  C,  motif  D  is  only  found  within  the  12  &  14  TMH  families  and  it  is 
slightly  different  in  each  of  these.  The  motif  is  known  as  Di  in  the  14  TMH  proteins 
and  Dii  in  the  12  TMH  proteins.  The  conserved  residues  which  make  up  the  motif 
occur  within  the  first  TMH  of  the  transporter.  The  role  of  this  motif  has  not  as  yet 
been  investigated.  Motif  Di  appears  in  OtrB  as,  LDqTViatA.  (Fig  3.10). 
Motifs  E  and  F 
DxxGxxL  and  lgxxxGxavxGxl 
Motifs  E  and  F  are  only  conserved  among  members  of  the  14  TMH  family.  At  this 
time  there  are  no  published  data  regarding  their  function  although  it  should  be  noted 
that  within  motif  E  there  is  a  highly  conserved  intramembranous  charged  residue, 
namely  the  aspartate  at  position  I  of  the  motif.  Motif  E  sits  within  the  TMI-17  whilst 
motif  F  is  positioned  within  TMH  13. 
In  OtrB,  both  motifs  have  been  conserved  to  some  extent.  Motif  E  is  seen  as  DvIGaaa 
and  motif  F  as  iGgstGiAVIfsv  (Fig  3.10) 
Motif  H 
WxwxFLINPig 
This  motif  occurs  in  the  sixth  helix  of  the  14  TMH  exporters  but  can  also  be 
recognised  in  a  divergent  form  in  some  of  the  members  of  the  12  TMH  family.  Like 
motifs  E  and  F,  there  is  little  known  of  its  functional  significance.  In  OtrB  the  motif 
is  very  well  conserved  and  appears  as  WcWvFLINVPIG.  (Fig  3.10) 
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There  are  a  number  of  other  well  conserved  residues  among  the  14  TMH  family, 
identified  by  Paulsen  et  aL,  (1996)  which  are  not  present  as  part  of  motifs,  the  OtrB 
protein  contains  many  of  these  conserved  residues.  (Fig  3.10). 
PILEUP  analysis  has  also  shown  up  two  regions  that  are  extremely  well  conserved 
amongst  the  Streptmoycete  drug  transporters.  A  conserved  Glu  (E)  residue  at  the  end 
of  the  eighth  TMH  and  a  conserved  Leu-Gln  (LQ)  motif  in  the  cytoplasmic  loop 
connecting  TMH's  9  and  10.  The  conserved  E  is  present  in  8  out  of  the  8 
Streptomyces  drug  transporters  analysed  and  the  LQ  motif  present  in  7  of  the  8.  In 
Mmr,  the  methylenmycin  transporter  from  Streptomyces  coelicolor,  the  L  is  replaced 
by  an  F  (Phe),  both  are  nonpolar  amino  acids. 
3.6.4  Relationship  to  other  MFS  members 
From  the  results  of  the  PILEUP  analysis,  it  can  be  seen  that  OtrB  shares  more 
similarity  with  other  streptomycete  transport  proteins  than  it  does  with  tetracycline 
pumps  from  other  bacteria,  be  they  Gram-positive  or  negative.  Although  the  OtrB 
protein  is  more  closely  related  in  its  topology  to  the  Gram  positive  than  the  Gram 
negative  Tet  exporters,  the  results  of  these  PILEUP's  show  that  more  residues  are 
conserved  between  TetA(B)  (Gm-ve)  and  OtrB  than  between  TetK  and  OtrB. 
A  different  method  of  assessing  "relatedness"  of  proteins  is  to  use  the  TblastN  search 
from  the  NCBI  (National  Center  for  Biotechnology  Information).  This  toot 
enables  the  peptide  sequence  of  a  query  protein  to  be  compared  against  various 
databanks  of  nucleotide  sequences  and  outputs  a  list  of  the  most  closely  related 
peptides  by  virtue  of  the  number  of  conserved  residues  between  the  two.  A  table  of 
relatedness  (Table  3.2)  was  compared  using  data  from  such  an  analysis  on  the  otrB 
nucleotide  sequence  When  the  OtrB  sequence  was  looked  at  in  this  way,  tile  two 
most  closely  related  peptides  were,  CtrB,  the  chlortetracycline  determinant  from  S. 
aureofaciens  and  the  product  of  SvOrf4  from  the  granatacin  cluster  of  S. 
violaceoruber,  for  which  the  substrate  is  probably  granatacin  The  third  most  closely 
related  peptide  was  not  from  a  Streptomycete  nor  was  it  a  single  drug  transporter  but 
the  macronuclear  DNA  from  Bacillus  subtilis  that  encodes  a  protein  responsible  for 
multidrug  resistance  in  that  organism. 
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Table  3.  L  Shows  names,  substrates,  sources,  accession  numbers  and  references  of 
proteins  used  in  PILEUP  analyses. 
Protein  Organisni  substrate  Accession  no.  References 
OtrB  Streptomyces  rimosus,  OTC  AF061335  This  work 
CtrB  Streptomyces  CTC  GB  132939  Ryan  et  al, 
aureofaciens  1997 
SvOrf4  Streptomyces.  Granaticin  (?  )  GB  L37334  Bechthold  et  at 
violaceoruber  unpublished.  cited 
in  Paulsen  et  at, 
1996 
CrncT  Nocardia  Cepharnycin  SWQ04733  Coque,  et  al 
lactamdurans  1993 
Pur8  Streptomyces.  puromycin,  N-  GBX76855  Tercero  et  al, 
lipmanii  acetyl  puromycin  1993 
ActVa  Streptonzyces.  Actinorhodin  GBX58833  Cabellero  et  al, 
coelicolor  1991b 
Ptr  Streptomyces.  Pristinamycin  GBX84072  Blanc  et  al, 
pristinaespiralis  1,11,  rifarnpin  1995 
TcrnA  Streptonzyces.  Tetracenomycin  GBM80674  Guilfoile  & 
glaucesns  C  Hutchinson, 
1992 
Mrnr  Streptomyces.  Methylenomycin  GBM18263  Neal  &  Chater, 
coelicolor  A  1987 
TetK  Staph.  aureus  TET  EMM  16217  Noguchi  et  al, 
1986 
TetL  Bacillus  TET  SWP07561  Hoshino  et  al, 
Stearothermophillus  1985 
TetA  Escherichia  coli  TET  EMX00006  Waters  et  al, 
(A)  1983 
TetA  Escherichia  coli  TET  EMJ01830  Nguyen  et  al, 
(B)  1983 
TetA  Pseudomonas  TET  EMJO  1749  Peden,  1983 
(C)  aeruRinosa 
TetA  Salmonella  ordonezi  TET  EMX65876  Allard  et  al, 
(D) 
-  - 
1993 
TetA  Fs 
cherichia  coli  TET  SWQ07282  Allard  & 
_LE) 
Bertrand,  1993 
TetA  Vibrio  anguilarium  TET  GBS52437  Zhao  &  Aoki, 
_LG)  1  1  1992 
TetA  Pateurella  maltocida  TE  GBU00792  Hansen  et  al, 
(H) 
- 
1  1 
1993 
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As  the  nucleotide  databases  are  continually  updated,  slightly  lower  scoring  peptides 
with  similarity  to  OtrB  are  often  displaced  down  the  list  by  new  additions  to  the 
growing  family  of  MFS  members.  The  data  presented  here  were  obtained  by 
comparing  otrB  to  all  non  redundant  GenBank  translations  plus  the  PDB,  Swissprot 
PIR  protein  databases  using  the  basic  (un-gapped)  blast  search,  TblastN  on  13.10.97. 
The  fourth  most  significant  alignment  was  with  a  presumed  multidrug  transporter 
protein  from  Mycobacterium  tuberculosis  cosmid  Y  180  and  the  next  but  one  highest 
scorer  was  the  ErmB  homologue  from  B.  subtilis.  None  of  the  remaining  members  of 
the  "top  ten"  were  from  bacteria  but  were  all  from  yeasts.  Indeed,  II  out  of  the  top  20 
scores  are  proteins  from  these  eukaryotic  organisms. 
Other  streptomycete  exporter  genes  are  brought  up  by  the  search.  These  are  the 
actinorhodin  exporter  actIlOrf4  from  S.  coelicolor  at  position  17,  tcmA  from  S. 
glaucesens  at  position  22,  actVa  also  from  S.  coelicolor  at  29,  lmrA  which  encodes 
lincomycin  resistance  in  S.  lincolnensis  at  position  39.  Finally  the  gene  encoding  S. 
albonigerpur8  protein,  a  puromycin  exporter,  which  is  even  less  well  related  was  at 
position  83. 
It  is  pertinent  to  note  that  other  tetracycline  resistance  determinants  come 
fairly  far  down  the  list.  Only  TetA(B)  from  TnI0  is  present  in  the  first  100,  at 
position  65.  This  is  interesting  as  the  TetK  protein  from  S.  aureus  does  not  appear  in 
the  top  100  most  closely-related  proteins  even  though  it  is  made  up  from  14  TMH's 
(Guay  et  al,  1993a,  Ginn  et  al,  1997)  as  is  OtrB  and  is  encoded  by  a  Gram-positive 
organism  whilst  TetA(B)  is  a  member  of  the  12TMH  subfamily  and  is  encoded  by  a 
Gram-negative  organism,  Exo1i.  These  findings  will  be  discussed  further  in  section 
3.7. 
Most  of  the  similarities  between  closely-related  members  of  MFS  families 
and  subfamilies  occur  in  the  N-terminal  portion  of  the  protein  rather  than  in  the  C- 
terminal  portion  (Griffith  et  al  1992,  Marger  &  Saier,  1993,  Paulsen  &  Skurray, 
1993,  Rouch  et  al,  1990).  It  has  been  suggested  therefore  that  the  N-terminal  halves 
of  these  proteins  are  primarily  concerned  with  energisation  of  transport  whilst  the 
more  diverged  C-terminal  regions  are  involved  in  recognition  of  the  wide  variety  of 
substrates  transported. 
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Table  3.2 
20  most  high  scoring  nucleotide  coding  sequences  to  otrB.  Data  from  TblastN 
analysis  performed  13/10/97. 
Accession  No.  Organism  gene  /  protein  Score 
1  gbD38215  Streptomyces  aureofaciens  ctrB  1057 
2  gbL37334  Streptomyces  violaceoruber  sv0  rf4  352 
3  dbjD50098  Bacillus  subtillus  MDR  331 
4  embZ97193  Mycobacterium  tuberculosis  MDR*  289 
5  embZ68144  Schizosaccharomyces  pombe  MDR*  342 
6  dbjD50453  Bacillus  subtillis  ErmB  homologue  311 
7  embZ36162  Saccharomyces  cerevisiae  unknown  function  229 
8  gbZ49259  Saccharomyces  cerevisiae  unknown  function  234 
9  gbLI1640  Saccharontyces  cerevisiae  unknown  function  229 
10  gbL24961  Yeast  MDR*  229 
11  embX77765  Saccharomyces  cerevisiae  NORI  229 
12  gbU02077  Saccharonzyces  cerevisiae  unknown  function  229 
13  gbU25841  Saccharoinyces  cerevisiae  unknown  function  229 
14  embZ28330  Saccharomyces  cerevisiae  unknown  function  209 
15  embZ80226  Mycobacterium  tuberculosis  unknown  function  191 
16  embZ73009  Saccharomyces  cerevisiae  unknown  function  216 
17  gbM64683  Streptomyces  ceolicolor  ActIl  0rf4  159 
18  gbU32771  Haemophilus  influenzae  unknown  function  183 
19  embX87941  Saccharomyces  cerevisiae  unknown  function  216 
20  gbU51164  Propionibacterium 
freudenreichi 
unknown  function  152 
*  MDR  denotes  gene  encoding  putative  multidrug  resistance  protein. 
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3.7  Discussion. 
3.7.1  Sequencing  results. 
The  nature  of  the  Streptomyces  genome  (>70%  G+Q,  has  the  consequence  that 
manual  DNA  sequencing  of  Streptomyces  genes  can  prove  difficult.  Compressions  of 
bands  in  the  polyacrylamide  gel  occur  due  to  the  formation  of  secondary  structures  by 
the  DNA  GC  clamps  and  hairpin  loops  occur  often  with  G+C  rich  DNA.  This  may 
offer  an  explanation  for  the  discrepancies  between  the  otrB  sequences  presented  by 
MacGregor-Pryde  (1995),  Reynes  et  al,  (1988)  and  that  presented  in  this  thesis, 
which  was  obtained  using  automated  DNA  sequencing  methods.  The  advent  of 
automated  sequencing  introduced  computerised  technology  for  the  analysis  of 
sequencing  gels.  This,  coupled  with  the  increase  in  the  length  of  DNA  that  can  be 
sequenced  in  one  run  and  the  reduction  in  the  time  taken  to  obtain  the  final  results, 
means  that  multiple  runs  can  be  performed,  analysed  and  compared  with  each  other 
in  shorter  periods  of  time  and  with  considerably  less  expense  than  traditional  manual 
radiolabelling  methods. 
3.7.2  OtrB  within  theMajor  Facilitator  Superfamily 
The  volume  of  information  on  the  MFS  and  its  members  has  grown  considerably  in 
the  last  few  years  which  has  enabled  a  thorough  analysis  of  the  OtrB  peptide 
sequence  with  respect  to  other  like  proteins. 
The  analysis  undertaken  in  this  chapter  gives  much  evidence  to  support  the 
designation  of  OtrB  in  the  14  TMH  subfamily  of  the  Major  Facilitator  Superfamily. 
A  phylogenetic,  tree,  taken  from  Paulsen  et  al,  (1996)  shows  that  within  the  14  TMH 
group,  several  distinct  clusters  can  be  discerned  (Fig  1.13).  OtrB  (shown  as  Tet347) 
is  present  within  a  small  cluster  containing  itself  and  SvOrf4.  CtrB  is  also  presumed 
to  be  a  member  of  this  cluster.  As  previously  mentioned,  most  of  the  similarity 
between  these  transporters  is  in  the  N-terminal  region,  and  is  believed  to  indicate  that 
this  region  is  involved  with  energisation  of  membrane  transport.  Through  the  work  of 
Yamaguchi  and  colleagues,  the  TetA(B)  protein  of  E.  coli  has  been  studied 
extensively  by  mutation  analysis,  and  essential  and  functionally  important  residues 
identified  (  1.6.2  ).  Although  TetA(B)  is  not  the  most  closely  related  protein  to  OtrB, 
it  is  interesting  to  investigate  which,  if  any,  of  these  residues  are  conserved. 
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Some  of  the  motifs  are  conserved  fairly  well  across  the  whole  MFS  superfamily  and 
are  believed  to  be  functionally  important  with  respect  to  transport.  There  are  also 
some  residues  identified  by  Yamaguchi  et  al  which  are  conserved  across  the  Gram 
negative  Tet  exporters.  Some  of  these  observations  do  not  apply  to  other  families 
such  as  OtrB,  or  TetK/TetL  but  others  can  be  applied.  The  aspartate  (D)  residue 
within  motif  A  (located  between  helix  2  and  3)  is  conserved  across  the  whole  MFS 
and  the  preceding  residue  is  often  an  alanine  (A)  residue.  However,  in  the  Gram- 
negative  Tet  exporters  this  residue  is  conserved  as  a  serine  (S).  This  is  also  the  case 
in  the  Gram  positive  Tet  exporters,  TetK,  TetL  and  OtrB.  Yamaguchi  et  al  have 
proposed  that  these  two  residues  may  act  as  a  substrate  gate  (Yamaguchi  et  al.,  1990) 
and  not  as  a  substrate  binding  site  as  originally  suggested  by  Chopra  (1986).  The 
work  of  the  Yamaguchi  group  has  also  shown  that  the  other  serine  residue  in  this 
loop  towards  the  N-terminus  is  also  well  conserved  among  Gram-negative  Tet 
exporters  and  is  thought  to  be  important  in  formation  of  a  gating  channel  in  TMH  3 
along  with  S91  and  D84  (Yamaguchi  et  al,  1992a). 
A  histidine  residue  H257,  located  in  TMH  8  of  TetA(B)  was  demonstrated  by 
Yamaguchi  et  al  (199  1)  to  be  essential  for  proton  translocation.  When  mutated  to 
alanine  (A)  or  asparagine  (N)  the  protein  loses  its  antiporter  activity  and  becomes  a 
uniporter.  As  OtrB  has  14  TMH's  this  observation  cannot  be  extended  to  it. 
It  would  be  more  interesting  to  look  at  those  residues  believed  to  be  involved 
in  substrate  recognition  in  TetA(B).  The  aspartate  residue  D84  was  thought  to  play 
some  role  in  substrate  recognition  in  TetA(B)  along  with  D  15  and  D285  by  virtue  of 
their  negative  charges  (Yamaguchi  et  al,  1992b)  as  it  was  conserved  in  all  the  Gram 
negative  Tet  proteins  , 
but  as  this  aspartic  acid  has  now  been  shown  to  be  part  of  a 
motif  observed  in  all  families  of  the  MFS,  the  hypothesis  that  it  is  involved  in 
substrate  specificity  seems  somewhat  outdated.  Two  residues  have  been  implicated  in 
substrate  recognition.  Guay  et  al  (1994)  showed  that  mutations  in  two  codons  of 
TetA(B),  namely  codon  W231  and  codon  L308,  resulted  in  increased  resistance  to 
the  novel  tetracycline  9-(dimethylgycylamido)-minocycline,  (DMG-Mino)  with  a 
concurrent  decrease  in  tetracycline  resistance.  Both  amino  acids  altered  in  DMG- 
Mino  resistant  mutants  are  located  in  transmembrane  regions  of  the  protein,  W231  in 
TMI-19  and  L308  in  TMH  11.  It  is  proposed  that  the  side  chains  at  positions  231  and 
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308  point  into  a  channel  that  is  involved  in  tetracycline  recognition  (Guay  et  al, 
1994).  It  is  also  suggested  is  that  these  two  residues  may  interact,  as  they  are 
positioned  at  around  the  same  depth  within  the  helix.  The  fact  that  both  mutations  are 
needed  to  severely  affect  tetracycline  resistance  is  consistent  with  the  hypothesis  that 
both  residues  are  important.  Both  residues  deemed  to  be  important  for  substrate 
recognition  are  located  in  the  C-terminal  half  of  TetA(B).  This  is  consistent  with  the 
fact  that  transport  proteins  show  most  homology  with  each  other  in  their  N-terminal 
portions  which  may  be  involved  in  energisation  of  the  transport  function  whist  the  C 
terminal  halves,  being  less  similar  may  have  evolved  to  specifically  recognise  a 
particular  substrate. 
The  comparison  analysis  shown  in  this  Chapter  has  indicated  that  OtrB  is  less 
closely  related  to  most  other  tetracycline  pumps  than  it  is  to  the  proton/drug 
antiporters  from  other  antibiotic  producing  8treptomycetes.  Also,  OtrB  is  more 
closely  related  to  some  multidrug  exporters  than  it  is  to  these  narrow  specificity 
proton  antiporters.  This,  coupled  with  the  fact  that  tetracycline  exporters  appear  in 
different  branches  of  the  MFS  phylogeny,  suggests  that  tetracycline  transporters  have 
evolved  separately  in  the  various  lineages  of  the  MFS.  It  has  been  suggested  that  the 
Gram  negative  TET  resistance  pumps  evolved  from  a  shared  ancestor  in  the 
producer  organisms,  Streptoniyces  (  Benveniste  &  Davies,  1973). 
Multidrug  resistance  within  the  MFS  has  occurred  independently  on  a 
number  of  occasions  (Paulsen  et  al  1996).  This  conclusion  is  drawn  as  the  broad 
specificity  members  of  the  MFS  are  no  more  related  to  each  other  than  they  are  to 
other  members  of  their  respective  families  (Lewis,  1994).  OtrB  seems  to  share  more 
sequence  similarity  with  various  multidrug  exporters  including  many  from  yeasts 
than  it  does  with  TET  proteins  from  other  species  of  bacteria.  The  upstream  region 
encodes  the  putative  repressor  protein  OtrR,  which  has  more  in  common  with  the 
upstream  repressors  of  multidrug  transporters  than  it  does  to  those  of  the  TET  family. 
Whether  or  not  OtrB  can  transport  more  diverse  compounds  has  yet  to  be 
investigated.  At  this  point  we  should  remember  that  Streptonzyces  were  once 
classified  alongside  the  fungi  and  share  some  characteristics  of  fungal  organisms:  - 
complex  life-cycle,  production  of  secondary  metabolites  etc.  So  perhaps  this 
relationship  is  not  as  strange  as  it  first  appears. 
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It  can  be  speculated  that  TET  resistance  has  evolved  in  other  species  of 
bacteria,  especially  the  medically  important  bacteria,  as  a  result  of  the  huge  use  of  the 
drug  world-wide.  This  selective  pressure  may  have  driven  the  spread  of  TET 
resistance  genes  via  horizontal  transfer,  resulting  in  a  large  and  wide-ranging 
population  of  bacteria  resistant  to  the  drug.  Also  it  has  been  shown  that  OtrB  will 
give  resistance  against  a  wider  range  of  substrates  when  expressed  in  E.  coli  than  is 
observed  for  S.  rimosus  (4.4).  So  possibly  the  host  strain  also  exerts  some 
evolutionary  pressure  on  the  protein  because  the  kinetics  of  drug  binding  may  be 
different  in  the  Gram-negative  and  Gram-positive  strains  owing  to  their  physiological 
differences.  Over  time,  residues  which  result  in  different  kinetic  constants  for  drug 
recognition  and  transport  maybe  selected  for. 
3.8  Future  Work 
In  order  to  know  more  about  the  topology  of  OtrB,  its  functional  motifs,  its  position 
within  the  MFS  and  the  complex  evolutionary  history  thereof,  there  are  several 
questions  that  should  be  asked  and  experiments  that  should  now  be  performed. 
1)  Regarding  the  14  TMH's  presumed  to  make  up  the  OtrB  protein,  the  presence  and 
exact  positioning  of  the  transmembrane  regions  could  be  determined  by  employing  a 
fusion  strategy,  using  fusions  to  reporters  such  as  alkaline  phosphatase  or  beta- 
lactamase  which  show  different  phenotypes  in  periplasmic  and  non  periplasmic 
domains.  This  approach  has  been  used  successfully  on  TetA(C)  (Allard  &  Bertrand, 
1993)  and  recently  on  TetK  (Ginn  et  al,  1997). 
2)  Site-directed  substitution  mutagenesis  to  elucidate  which  residues  are  essential  and 
to  give  clues  as  to  their  function. 
3)  Resistance  and  specificity  studies  of  CtrB,  in  order  to  investigate  its  relationship  to 
OtrB. 
4)  Studies  to  investigate  any  cross-resistance  between  OtrB  and  the  SvOrf4  gene 
product  using  Granatacin  and  Oxytetracycline  as  the  substrates,  also  further  studies 
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on  the  substrate  specificity  of  OtrB  in  order  to  assess  its  possible  function  as  a 
multidrug  transporter. 
The  specificity  of  OtrB  when  expressed  in  E.  coli  was  broader  than  when  the 
plasmid-borne  otrB  gene  was  present  in  Streptomyces  spp.  that  did  not  contain  the 
OTC  cluster.  (  Section  4.2).  This  observation  became  the  basis  for  the  specificity 
studies  carried  out  in  Chapters  4  and  5  of  this  thesis.  The  observation  that  Gram 
negative  TET  resistant  bacteria  have  efflux  pumps  of  12  TMH's  and  that  14  TMH  s 
are  present  in  the  TET  efflux  pumps  of  Gram  positive  bacteria  was  also  followed  up. 
This  work  is  detailed  in  Chapter  5  and  involves  deletion  of  the  two  central  putative 
helices  of  OtrB  and  the  expression  of  the  truncated  gene  in  E.  coli. 
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CHAPTER4 
Expression  of  otrB  in  Streptomyces  and  E.  coli. 
4.1  Introduction. 
OtrB  has  been  known  to  be  an  oxytetracycline  resistance  determinant  since  initial 
work  on  the  cluster  in  the  1980's  (Ohnuki  et  al.,  1985,  Butler  et  al.,  1989).  Since 
then,  OtrB,  (as  Tet347  (Reynes  et  al,  1988)  has  been  classified  as  a  member  of  the 
rapidly  expanding  Major  Facilitator  Superfamily  of  transmembrane  transport  proteins 
(Paulsen  et  al  1996;  Paulsen  &  Skurray,  1993). 
The  host  organism,  Streptomyces  rimosus  possesses  at  least  two  other 
resistance  determinants,  otrA  (Ohnuki  et  al,  1985)  which  modifies  the  ribosome  and 
so  prevents  translational  arrest  (  Doyle  et  al,  1991),  and  otrC  (Hunter,  unpublished 
results)  about  which  little  is  known  at  this  time.  It  is  also  reported  that  there  is 
evidence  for  a  second  "silent"  OTC  cluster  on  the  Streptontyces  rinzostis  chromosome 
(Marsic  (this  laboratory)  unpublished  results).  For  these  reasons,  the  level  of 
resistance  to  oxytetracycline  offered  by  OtrB  cannot  be  measured  in  the  host 
background. 
The  otrB  gene  has  previously  been  subcloned  and  sequenced  in  this 
laboratory,  (MacGregor-Pryde,  1995).  Two  plasmids  were  used  in  this  study, 
pGLW81  (  K.  J.  Linton,  this  laboratory)  contains  the  otrB  gene  on  a  Streptonlyces-E. 
coli  shuttle  vector  and  pGLW  12  (  Fig  4.1)  which  contains  otrB  and  part  of  otrR  ,a 
regulatory  gene  upstream  of  otrB  that  is  thought  to  be  a  repressor  (MacGregor- 
Pryde,  1995). 
To  determine  the  contribution  of  OtrB  to  the  cell's  overall  OTC  resistance, 
the  plasmids  mentioned  above  were  transformed  separately  into  the  heterologous  host 
Streptomyces  albus,  which  is  not  a  producer  of  oxytetracycline  and  has  not  been 
shown  to  contain  OTC  production  or  resistance  genes.  The  plasmids  were  also 
transformed  into  S.  rimosus  strain  15883s.  This  strain  is  deleted  for  the  OTC  cluster 
including  both  otrA  and  otrB  (Butler  et  al,  1989),  enabling  evaluation  of  OTC 
resistance  in  the  host  background. 
Expression  of  the  oIrB  gene  in  E.  coli  was  important  for  two  main  reasons,  the  first 
being  that  there  are  a  number  of  well-characterised,  easily  available  systems  for  the 
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Plasmids  pIJ702,  pGLW12  and  pGLW8.  References  are  given  in  Table  2.2 
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over-expression  of  foreign  proteins  in  this  host.  By  developing  a  system  which 
produces  reasonable  quantities  of  the  protein  it  should  be  possible  in  the  future  to  use 
immunoblotting  techniques  to  quantify  the  amount  of  OtrB  produced  under  different 
conditions  and  to  set  up  systems  to  investigate  the  transport  of  OTC  and  presumably 
protons  across  the  E.  coli  membrane.  By  over-expressing  otrB,  purification  of  the 
protein  product  for  structural  determination  should  be  achievable.  Secondly,  by 
expressing  the  OtrB  protein  which  has  the  characteristic  14  putative  transmembrane 
helices  of  Streptomycete  transport  proteins,  in  this  Gram-negative  background  ,a 
comparison  can  be  drawn  between  it  and  the  Tet  proteins  of  Gram-negative  bacteria. 
These  proteins  consist  of  12  such  helices  (Eckert  &  Beck,  1989).  The  best  studied  of 
these  proteins  is  TetA  from  transposon  Tn10  of  E.  coli. 
4.2  Aims  of  this  chapter 
1.  To  determine  the  level  of  resistance  to  oxytetracycline  provided  by  otrB  in 
Streptomyces  rhnosus  15883s,  and  Streptomyces  albus. 
2.  To  express  the  otrB  gene  in  the  heterologous  host,  Escherichia  coli  and  determine 
the  level  of  resistance  provided  in  this  foreign  host. 
3.  To  investigate  the  specificity  of  OtrB  for  oxytetracycline  and  whether  it  is  able  to 
provide  any  resistance  against  the  related  compounds  tetracycline  and 
chlortetracycline. 
4.3  Initial  expression  of  otrB  in  Streptontyces. 
4.3.1  Plasmid  constructs  containing  otrB. 
Both  plasmid  pGLW12  and  pGLW8  I  contain  the  part  of  the  region  of  DNA  known 
to  encode  the  divergent  otrBlotrR  promoter  region  (Fig  4.1).  pGLW  12  contains  DNA 
encoding  86  of  the  151  amino  acids  of  the  putative  regulator  protein  OtrR  and  the 
promoter  region.  It  maybe  that  the  expression  of  otrB  from  this  promoter  will  be 
affected  in  some  way  by  a  product  of  the  partial  otrR  gene  upstream.  pGLW81 
contains  the  promoter  region  and  only  24  bases  of  otrR  meaning  that  gene  expression 
from  this  construct  is  probably  not  subject  to  regulation  by  OtrR.  This  could  have  an 
effect  on  the  level  of  resistance  shown  by  organisms  containing  this  plasmid. 
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4.3.2  Expression  in  S.  rimosus  strain  15883s. 
Plasmids  pGLW  12  and  pGLW81  were  transformed  into  protoplasts  of  S.  rimosus 
strain  15883s  (  2.3.10  for  methodology).  A  spore  suspension  of  the  strain  was  serially 
diluted  and  100gl  aliquots  spread  on  to  TSB  plates.  The  dilution  which  gave  a 
countable  number  of  colonies,  i.  e.  between  50  and  200,  was  chosen  for  the  resistance 
tests.  The  spore  suspension  was  streaked  onto  TSB  plates  containing  increasing 
concentrations  of  oxytetracycline.  Colonies  growing  on  the  OTC  plates  were  counted 
and  compared  to  the  number  of  colonies  on  the  control  plate.  The  concentration  at 
which  no  colonies  were  visible  was  taken  as  the  MIC  (minimum  inhibitory 
concentration).  Hence  the  concentration  below  this  was  the  equivalent  to  the  level  of 
resistance  provided  by  otrB  in  any  particular  strain.  As  a  control,  plasmid  pIJ702 
(Fig  4.1)  which  does  not  contain  the  otrB  gene  was  transformed  into  both  S.  ritnosus 
15883s  and  S.  albus  and  tests  carried  out  as  before  (Table  4.1).  Tests  were  also 
carried  out  on  plates  containing  tetracycline  and  chlortetracycline  to  investigate  the 
specificity  of  OtrB.  Results  are  given  in  Table  4.1 
4.3.3  Expression  of  OtrB  in  S.  albits 
As  mentioned  above,  there  is  evidence  to  suggest  that  there  is  a  third  oxytetracycline 
resistance  determinant  otrC,  in  S.  rinzosus.  For  this  reason  it  was  pertinent  to  repeat 
the  tests  carried  out  above  in  a  strain  negative  for  OTC  production.  Plasmids 
pGLW12  and  pGLW81  were  transformed  into  protoplasts  of  S.  albus  and  the  tests 
performed  as  for  S  rimosus  strain  15883s.  Control  plasmid  pIJ702  was  included  as  in 
the  previous  section  (Table  4.1). 
Plasmid  pGLW81  conferred  the  highest  levels  of  OTC  resistance  when 
present  in  both  S.  rimosus  1583s  and  S.  albus,  giving  resistance  up  to  12  and  IORg/ml 
respectively.  The  resistance  conferred  by  pGLW  12  was  lower  at  5[tg/ml  in  both  S. 
rimosus  15883s  and  in  S.  albus.  As  expected,  the  control  plasmid  pIJ702  which  does 
not  contain  otrB  confers  no  OTC  resistance  on  either  host.  pGLW12  contains  part  of 
the  putative  repressor  gene  otrR.  However,  pGLW81  contains  only  a  few  bases  of 
this  gene.  It  is  conceivable  that  the  absence  of  the  repressor  deregulates  otrB 
expression,  resulting  in  elevated  levels  of  OTC  resistance.  There  was  no  resistance  to 
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tetracycline  or  chlortetracycline  by  any  of  the  strains  tested,  indicating  high 
specificity  of  OtrB  for  oxytetracycline  when  expressed  in  a  Streptomycete 
background. 
Table  4.1  Results  of  streak  tests  in  Streptomyces  s,  2. 
OTC  conc. 
Rg/ml 
S.  rimosus  15883s  S.  albus 
pGLW12  pGLW8  I  pIJ702  pGLW12  pGLW81  pIJ702 
0  +*  +  +  +  +  + 
2  +  +  +  + 
4  +  +  +  + 
5  +  +  +  + 
6  +  + 
8  +  + 
10  +  + 
12  + 
15 
*  denotes  growth 
**  -  denotes  lack  of  growth 
4.4.  Expression  of  otrB  in  E.  coli. 
4.4.1  The  T7  expression  system. 
The  T7  expression  system  works  by  expressing  the  gene  of  choice  from  the  viral  T7 
promoter,  present  on  an  ampicillin-resistant  vector.  This  is  recognised  by  viral  T7 
RNA  polymerase,  hence  the  T7  RNA  polymerase  gene  must  be  present  in  the  host 
cell.  The  strain  used  as  host  is  E.  coli  BL21  (DE3).  As  aB  strain,  BL21  has  the 
potential  advantage  that  it  is  deficient  in  the  Ion  protease  and  the  OmpT  outer 
membrane  protein  that  can  degrade  proteins  during  purification.  DE3  is  a  lambda 
derivative  that  contains  a  DNA  fragment  containing  the  lacI  gene,  the  lacUV5 
promoter  and  the  gene  for  T7  RNA.  polymerase  (Studier  &  Moffat,  1986).  This 
fragment  is  inserted  into  the  int  gene,  because  when  this  gene  is  then  inactivated  the 
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lysogen  is  very  stable  and  requires  a  helper  for  excision  from  the  chromosome.  The 
only  promoter  which  directs  transcription  of  the  T7  RNA  polymerase  gene  in  this 
strain  is  the  IPTG  inducible  lacUV5  promoter.  The  expression  of  the  gene  of  choice 
is  induced  by  the  addition  of  0.4  mM  IPTG  to  a  log  phase  culture.  Some  proteins 
may  be  toxic  to  the  cell  if  expressed  at  a  high  level.  This  is  especially  true  for 
membrane  proteins.  If  a  toxic  protein  is  expressed  constitutively,  albeit  at  low 
levels,  the  host  cells  become  "sick"  and  growth  is  affected.  To  alleviate  this 
problem,  T7  lysozyme  may  be  expressed  in  the  cell.  This  enzyme  inhibits 
transcription  by  T7  RNA  polymerase  (Inouye  et  al,  1973;  Moffat  &  Studier,  1987; 
Studier,  1991).  When  produced  from  the  cloned  gene,  relatively  high  levels  of  T7 
lysozyme  can  be  tolerated  by  E.  coli,  apparently  because  the  protein  is  unable  to  pass 
through  the  inner  membrane  to  reach  the  peptidoglycan  layer.  Any  basal  levels  of  T7 
polymerase  present  in  the  ceil  prior  to  induction  will  be  prevented  from  transcribing 
the  gene  of  choice  by  the  action  of  the  lysozyme.  However,  when  the  cells  are 
induced,  the  levels  of  T7  RNA  polymerase  are  increased  so  that  the  lysozyme  is 
swamped,  allowing  expression  of  the  chosen  gene.  The  lysozyme  gene  is  present  on 
a  plasmid,  pACYC184,  (Chang  &  Cohen,  1978)  which  also  carries  chloramphenicol 
resistance.  There  are  two  versions  of  this  plasmid,  pLysE  and  pLysS.  pLysE 
expresses  T7  lysozyme  from  the  pACYC184  to  promoter.  Cells  carrying  this 
plasmid  accumulate  fairly  high  levels  of  T7  lYsozyme.  Cells  carrying  pLysE  display 
a  reduced  growth  rate.  A  plasmid  containing  the  fragment  in  the  opposite  orientation 
where  it  is  transcribed  from  the  03.8  promoter  is  known  as  pLysS;  cells  carrying  this 
plasmid  accumulate  much  lower  levels  of  T7  lysozyme  and  do  not  show  any 
decrease  in  growth  rate.  There  are  a  number  of  vectors  commercially  available  for 
this  system  (pET  system  from  Novagen,  Qiaexpress  system  from  Qiagen). 
4.4.2  Construction  of  expression  plasmid  pJA 
pJJ4  is  based  on  the  expression  vector  pT7-7  (Tabor  &  Richardson,  1985). 
The  otrB  gene  encoding  the  oxytetracycline  efflux  protein  from  S.  rimosus  (on  a 
2.3kb  EcoR  I-  Hind  III  fragment  from  pGLW81)  was  cloned  into  pUC18  to  create 
PJJI.  This  was  the  template  in  the  polymerase  chain  reaction  using  a  mutagenic 
primer  to  introduce  an  NdeI  site  (CATATG  )  at  the  N-terminus.  The  product  of  this 
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reaction  with  engineered  Nde  I  site  was  digested  with  Nde  I  and  Hind  III  and  ligated 
into  similarly  digested  pMTL23  to  create  pJJ2. 
The  first  250  bases  of  the  otrB  PCR  product  were  sequenced  from  pJJ2.  To 
compare  these  sequence  data  with  wild  type  otrB  sequence,  a  0.46kb  Apa  I  fragment 
from  pJJ  I  beginning  70bp  upstream  of  the  otrB  start  site  was  cloned  into  pIB124  to 
create  pJJIBI  and  sequenced  using  a  ABI  automated  sequencer  and  universal  forward 
primer.  Both  the  PCR  product  and  the  wild  type  sequence  showed  differences  to  the 
otrB  sequence  presented  by  MacGregor-Pryde  (1995).  This  is  discussed  fully  in 
Chapter  3.  (3.4.1).  To  circumvent  mutations  due  to  Taq  polymerase  further 
downstream  of  the  sequenced  region,  pJJ2  isolated  from  CB51  cells  (dam-)  was 
restricted  with  Bsabl  and  HindIII  to  remove  the  region  which  had  not  been 
sequenced.  pJJ  I  was  similarly  restricted  and  the  C-terminal  1.669kb  fragment  of  wild 
type  otrB  was  ligated  with  the  2.7kb  pJJ2  (vector  and  small  insert)  to  create  pJJ6. 
pJJ6  was  restricted  with  NdeI  and  HindIII  and  the  I.  Skb  oIrB  fragment  ligated  with 
similarly-cut  pT7-7  to  create  pJJ4  (Fig  4.2). 
A  second  expression  construct,  was  created  using  the  5.4  Kb  Novagen  vector 
pET21b,  the  NdeI  -  HindIH  fragment  from  pJJ4  was  ligated  with  similarly  cut  vector 
to  create  pJJ5.  (Fig  4.3).  pJJ5  does  not  express  the  HisTag  present  on  this  vector. 
4.4.3  Expression  of  pJJ4  and  pJJ5. 
The  plasmids  were  transformed  into  three  strains  of  E.  coli  BL21(DE3),  BL21(DE3) 
pLysE  and  BL21(DE3)  pLysS.  All  induction  experiments  were  carried  out  as 
described  in  2.3.6.1.  Streaks  of  induced  and  uninduced  culture  were  plated  on  L-agar 
containing  increasing  concentrations  of  OTC  either  with  or  without  the  addition  of 
0.4mM  IPTG  to  the  cooled  molten  agar.  Growth  on  oxytetracycline  was  taken  as  a 
measure  of  the  level  of  expression  of  the  otrB  gene.  Results  of  the  tests  for  pJJ4  and 
pJJ5  are  presented  in  Figs  4.4  and  4.5  respectively. 
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Table  4.2  Results  of  specificity  tests 
drug 
concentration 
in  gg/ml 
pJJ4  BL2  I  (DE3)pLysS 
induced 
pJJ5  BL21(DE3)pLysS 
induced 
tetracycline  chlortetracycline  tetracycline  chlortetracycline 
0  +*  +  +  + 
2.5  +  +  +  + 
5  +  +  + 
7.5  +  +  + 
10  +  +  + 
12  -  -  + 
15  -  -  + 
20  -  -  + 
25  -  -  + 
30 
1-  I-  I-  -I 
*  denotes  growth 
**  -  denotes  lack  of  growth 
4.5  Discussion. 
4.5.1.  Discussion  of  resistance  levels  of  pJJ4 
The  pT7-7  based  plasmid,  pJA  shows  more  robust  growth  on  plates  that  do  not 
contain  IFITG  than  on  those  with  IPTG.  This  is  true  for  induced  and  uninduced 
cultures,  whether  or  not  OTC  is  present.  This  second  point  shows  poor  control  of 
expression  of  the  target  gene  in  this  vector.  The  fact  that  all  cultures  containing  pJA 
show  more  robust  growth  on  plates  without  the  inducer  could  be  because  the  culture 
is  already  expressing  the  OtrB  protein  at  the  maximal  level  which  can  be  tolerated  by 
the  cells'  physiology  and  further  increasing  amounts  of  the  inducer  cause  expression 
of  the  protein  to  reach  levels  that  are  lethal  to  the  cell. 
When  streaked  onto  plates  that  contained  OAmM  IPTG,  cultures  of 
BL21(DE3)/pJJ4 
, 
induced  or  uninduced,  did  not  grow  at  oxytetracycline 
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concentrations  above  20gg/ml  whilst  strains  BL21(DE3)  pLysS  and  BL21(DE3) 
pLysE  transformed  with  pJJ4  both  had  a  minimum  inhibitory  concentration  of 
12gg/ml  induced  or  uninduced.  The  difference  between  strains  can  be  explained  by 
the  fact  that  the  pLys  plasmids  encode  T7  lysozyme  which  inhibits  transcription  of 
the  otrB  gene  leading  to  reduced  levels  of  the  protein  in  the  cells. 
When  streaked  onto  plates  that  did  NOT  contain  the  inducer  IPTG,  strains 
BL21(DE3)/pJJ4  and  BL21(DE3)  pLysE  /pJJ4  both  grew  at  30gg/ml.  However  when 
the  strains  were  induced,  BL21(DE3)  pLysE  was  not  able  to  grow  at  OTC 
concentrations  above  15gg/ml,  once  again  this  is  probably  due  to  expression  levels 
becoming  toxic  when  IPTG  was  added  to  the  culture.  Strain  BL21(DE3)  pLysSIpJJ4 
would  not  grow  at  concentrations  higher  than  15gg/ml  whether  induced  or 
uninduced. 
4.5.2  Discussion  of  OTC  resistance  levels  conferred  by  pJJ5 
The  unsatisfactory  control  of  expression  using  T7-7  as  an  expression  vector  lead  to 
the  use  of  another  expression  system.  The  pET  vector  series  is  widely  used  in  the 
expression  of  prokaryote  and  eukaryote  proteins  in  E.  coli  (Aukhil  et  al,  1993; 
Campbell,  1992;  Dietrich  et  al,  1991)  With  the  pET  system  the  control  of  expression 
should  be  more  tightly  regulated  than  when  using  the  pT7-7  vector.  There  are  a 
number  of  different  pET  vectors  suitable  for  different  purposes.  The  vector  chosen 
for  this  work  was  pET21-b,  this  vector  gave  the  option  of  creating  a  C-terminal 
polyhistidine  fusion  to  OtrB. 
pJJ5  was  a  more  suitable  construct  for  evaluating  levels  of  OTC  resistance 
provided  by  OtrB.  Maximal  resistance  with  this  construct  was  to  more  than  40  gg/ml, 
higher  than  the  maximum  levels  observed  for  pJJ4  which  showed  some  growth  at  30  Cý 
gg/ml  but  none  at  35  [tg/ml.  The  regulation  was  well  controlled  as  there  was  always 
little  or  no  resistance  in  the  uninduced  samples  from  all  three  strains.  Growth  of 
induced  samples  was  not  observed  on  plates  containing  oxytetracycline  without 
IPTG.  This  shows  that  in  the  absence  of  the  inducer,  expression  of  otrB  is  switched 
off.  Little  or  no  growth  of  uninduced  samples  was  observed  on  plates  containing 
oxytetracycline  whether  or  not  they  also  contained  0.4  mM  IPTG.  Uninduced  cells 
have  not  expressed  otrB  and  so  are  killed  by  the  oxytetracycline  before  any  IPTG  that 
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may  be  present  in  the  agar  can  activate  T7  polymerase  and  turn  on  the  expression  of 
otrB. 
For  samples  that  have  been  induced  with  IPTG  and  grown  for  some  time  to  allow 
expression  of  the  OtrB  protein,  the  subsequent  levels  of  resistance  to  OTC  depend  on 
the  strain.  In  this  situation,  BL21(DE3)  pLysS  was  found  to  be  the  optimal 
background,  giving  resistance  to  up  to  50  gg/ml  of  the  drug.  Presumably  this  is 
because  levels  of  OtrB  in  BL2  I  (DE3)  become  too  toxic  for  the  cell  after  some  time 
and  in  BL2  I  (DE3)  pLysE,  the  level  of  otrB  expression  is  reduced  considerably  by  the 
inhibitory  actions  of  the  T7  lysozyme.  As  T7  lysozyme  is  expressed  from  a  tet 
promoter  in  pLysE,  it  could  be  that  this  promoter  is  further  activated  by  the  presence 
of  OTC  in  the  media  leading  to  very  high  levels  of  T7  lysozyme  expression,  which 
then  inhibit  T7  polymerase  even  when  the  cells  are  induced. 
4.5.3  Discussion  of  specificity  tests. 
All  specificity  tests  were  carried  out  in  E.  coli  BL2  I  (DE3)  pLysS  as  this  gave  the 
highest  resistance  to  oxytetracycline.  Results  of  the  tests  are  shown  in  Table  4.2. 
The  pJJ4  construct  gave  resistance  to  tetracycline  (TET)  to  the  same  levels  as  with 
the  natural  substrate  oxytetracycline  (10  [tg/ml).  However,  pJJ4  conferred  resistance 
to  only  1/4  of  the  concentration  of  chlortetracycline  (CTC)  (2.5gg/ml).  These  levels 
were  the  same  whether  the  cells  were  induced  with  IPTG  or  not. 
pJJ5  conferred  most  resistance  to  oxytetracycline  (50  pg/ml),  giving  resistance  to  half 
this  level  of  tetracycline  and  one  quarter  of  this  level  of  chlortetracycline.  Uninduced 
cells  would  not  grow  in  the  presence  of  any  of  the  three  drugs. 
When  these  results  are  compared  to  the  tests  performed  with  pGLW12  and 
pGLW81  in  Streptomyces  sp.  it  should  be  noted  that  the  OtrB  gene  product  is  not  as 
substrate  specific  when  expressed  in  E.  coli  as  it  is  when  expressed  in  its  natural  host. 
There  are  a  number  of  possible  explanations  for  this. 
(1)  The  differences  could  be  due  to  the  variation  in  the  structure  of  the  cytoplasmic 
membrane  between  Gram  positive  and  negative  bacteria  which  may  then  affect  the 
conformation  which  OtrB  adopts.  The  Km  of  OtrB  maybe  more  similar  for  the  three 
different  drugs  when  it  is  present  in  the  E.  coli  membrane  whereas  the  configuration 
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of  OtrB  in  Streptomyces  could  mean  the  Km  for  OTC  is  significantly  smaller  than  for 
CTC  or  TET 
(2)  It  is  possible  that  in  the  natural  host,  the  protein  is  produced  at  much  lower  levels 
than  it  is  in  the  E.  coli  expression  system  which  is,  by  its  design,  maximising  the 
levels  of  protein  produced.  Higher  copy  number  of  the  protein  may  lead  to  an 
increased  rate  of  transport,  even  for  a  poor  substrate. 
(3)  The  metal  dication  (M2+)  component  of  the  transported  complex  may  be  different 
between  the  two  types  of  bacteria,  this  would  cause  a  change  in  the  character  of  the 
substrate  which  could  possibly  affect  the  specificity  of  the  protein. 
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CHAPTER  5 
Construction  of  polyhistidine  fusion,  expression  and  isolation. 
5.1  Introduction 
Fusion  proteins  containing  a  peptide  tag  can  be  used  to  facilitate  purification  of 
proteins  of  interest  from  prokaryotic  and  eukaryotic  organisms.  A  fragment  of  DNA 
containing  the  gene  of  interest  is  cloned  into  a  plasmid  vector  with  a  strongly 
regulated  promoter.  The  gene  is  cloned  in  frame  with  a  sequence  of  nucleotides 
encoding  a  protein  tag.  The  tag  can  be  positioned  at  the  N-  or  C-terminus  of  the 
protein.  The  tag  should  exhibit  a  strong  affinity  to  the  complementary  ligand  used  in 
the  main  separation  process.  If  the  protein  of  interest  is  to  be  secreted,  a  signal 
sequence  should  be  included.  Also  a  peptide  cleavage  site  may  be  introduced 
between  the  protein  of  interest  and  the  tag.  This  enables  the  desired  protein  to  be 
obtained  in  its  native  state.  Whereas  the  purification  tag  must  be  a  peptide  or  protein, 
the  complernntary  ligand  may  be  derived  from  any  biological  or  chemical  source. 
Examples  of  such  pairings  are  antigen  &  antibody,  enzyme  or  enzyme  binding  site  & 
substrate  or  substrate  analogue,  hormone  &  receptor,  binding  protein  &  binding 
ligand,  polyhistidine  &  metal  chelate  ligand  and  charged  peptide  &  charge  ligand  or 
ion  exchangers.  The  ideal  affinity  tag  should  be  able  to  form  a  stable  complex  with 
an  inexpensive,  chemically  stable  and  easily  available  ligand  with  an  absolute 
specificity,  yet  should  dissociate  under  mild  conditions.  Commonly  used  tags  are, 
maltose  binding  protein,  the  FLAG  TM  tag  and  poly-histidine  peptide. 
FLAG 
TM  Fusions 
This  affinity  tag  developed  by  International  Biotechnologies  Inc.  consists  of  an  8 
arr9no  acid  sequence,  AspTyrLysAspAspAspAspLys  which  is  used  as  an  N-terminal 
fusion  (Hopp  et  al,  1989).  The  first  four  residues  make  up  the  antigen  by  which  the 
fusion  protein  is  recognised  by  the  mouse  anti-FLAG  monoclonal  antibody.  The  last 
four  amino  acids  make  up  the  cleavage  site  for  enterokinase  which  can  be  used  to 
remove  the  tag  from  the  purified  protein.  Although  separation  is  achieved  by  use  of 
an  antibody-antigen  complex  (usually  very  strongly  associated),  dissociation  is  easily 
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achieved  because  the  interaction  depends  on  the  presence  of  calcium  ions.  When 
calcium  ions  are  withdrawn  the  complex  dissociates. 
Maltose  BindinR  Protein  (MBP)  Fusions 
Fusions  with  MBP  are  commonly  used  to  induce  secretion  of  the  protein  into  the  E. 
coli  periplasm.  The  fusion  protein  adsorbs  onto  cross-linked  starch.  Elution  may  be 
acheived  by  adding  maltose  which  binds  with  a  higher  specificity  than  the  starch  and 
so  displaces  it.  A  disadvantage  of  this  system  is  the  high  MW  of  MBP  (about 
41  kDa).  However  for  large-scale  purifications  it  remains  a  good  system  due  to  its  use 
of  an  inexpensive  ligand. 
Poly-Histidine  Fusions 
Chelating  ligands  used  with  the  polyhistidine  system  include  IDA  (iminodiacetic 
acid),  TED  (N,  N,  N'-Tris  (carboxymethyl)  ethylene  diamine  and  NTA  (nitrilotriacetic 
acid)  (Flaschel  &  Friehs,  1993).  Metal  ions  which  have  been  used  include  Cul*,  Ni', 
Co'  or  Zn'+.  The  Ni  (II)-NTA  group  is  suited  to  complexing  proteins  containing  a 
run  of  several  histidine  residues  (Hochuli,  1988)  whilst  other  metal-chelate 
combinations  best  complex  proteins  with  only  one  or  two  histidine  residues. 
Histidine  is  a  rare  amino  acid  in  many  proteins,  therefore  a  run  of  several  histidines 
in  sequence  is  extremely  uncommon.  The  Ni  (II)-NTA  system  has  thus  become  the 
system  of  choice  for  purification  of  poly-histidine  fusions,  the  strategy  being  to 
separate  the  tagged  protein  of  interest  from  the  bulk  of  other  bacterial  proteins  by 
metal  affinity  chromatography  (  Hochuli  et  al,  1988  ).  This  is done  by  passing  a  cell 
extract  through  a  column  that  contains  NTA-nickel-agarose.  The  tagged  protein  binds 
to  the  matrix  through  interactions  with  the  divalent  cations  and  can  then  be  eluted 
with  high  levels  of  imidazole,  competing  metal  ions  or  by  lowering  the  pH  to  a  value 
where  binding  cannot  occur. 
The  proteins  produced  by  this  method  are  often  pure  enough  to  be  subjected 
to  further  analyses  such  as  NMR  and  CD  studies  that  can  determine  structural 
identity.  The  histidine  tag  could  also  be  used  to  determine  the  level  of  expression  of 
the  protein  of  interest.  It  is  known  that  for  the  E.  coli  TetA(B)  protein,  the  level  of 
tetracycline  resistance  supplied  by  the  gene  on  a  plasmid  is  not  always  directly 
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related  to  the  level  of  gene  expression  (Walmsley  pers.  com.  ).  If  this  were  also  to  be 
the  case  for  OtrB,  HisTagging  would  be  a  suitable  method  of  monitoring  expression 
levels  by  the  use  of  anti-His  antibodies.  Fusions  at  the  amino  terminus  although 
proven  useful  in  the  isolation  of  many  cytoplasmic  fusion  proteins,  may  interfere 
with  the  folding  of  membrane  proteins  and  may  affect  positioning  in  the  bacterial 
membrane  and  hence  the  activity  of  the  protein.  Successful  isolation  of  membrane 
proteins  has  been  achieved  using  fusions  to  the  C-terminus  of  the  protein,  (Aldema  et 
aL,  1996)  As  OtrB  is  a  membrane  protein,  the  fusion  product  was  designed  with  the 
HisTag  at  the  carboxy  terminus.  A  second  construct  with  an  amino  terminal  HisTag 
was  made  later  to  investigate  any  difference  in  activity  with  respect  to  positioning  of 
the  HisTag. 
5.2  Construction  of  OtrB  fusion  plasmids 
In  order  to  construct  a  plasmid  that  would  express  otrB  fused  to  the  polyhistidine  tag, 
it  was  first  necessary  to  create  an  intermediate-stage  construct  from  the  cloning 
vector  pMTL23  and  the  otrB  PCR  product  containing  a  mutation  at  the  C-terminal 
end  which  replaces  the  stop  codon  with  a  coding  version.  The  mutated  otrB  was  4ý1 
subcloned  from  this  plasmid  into  the  expression  vector  pET15b  and  the  resulting 
fusion  product  expressed  in  E.  coli. 
5.2.1  Construction  of  pJJ7 
pJJ7  was  constructed  by  cloning  the  product  of  a  PCR  reaction  that  used  pJJ6  as  the 
template,  the  mutagenic  oligonucleotide,  primer  2(2.4.14)  at  the  carboxy  terminus 
and  universal  reverse  primer  at  the  amino  terminus  (Fig 5.1). 
The  mutagcnic  primer  changes  the  original  otrB  stop  codon  to  TGG,  which 
codes  for  tryptophan,  following  this  are  a  Sacl  site,  a  TGA  stop  codon,  an  Xho  I  site 
and  an  EcoRI  site.  The  PCR  product  was  cut  with  Nde  I  and  Eco  RI  and  cloned  into 
similarly  cut  pMTL23.  The  PCR  reaction  was  carried  out  using  pfu  polymerase 
which  has  a  fidelity  of  1.3x  10-6  ,  approximately  six  times  less  error  prone  than  Taq 
polymerase  (Cline  et  al,  1996).  The  1.63  Kb  PCR  product  was  not  expected  to 
contain  any  mistakes,  hence  the  PCR  product  was  cloned  in  entirety  (  Fig  5.1).  As 
otrB  activity  is  manifested  as  OTC  resistance,  the  activity  of  the  otrB  PCR  product 
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can  be  measured  as  expression  of  the  gene. 
5.2.2  Construction  of  PJJ8  and  PJJ9 
In  order  to  create  the  His  fusion  construct  pJJ8,  the  mutated  otrB  gene  was  removed 
from  pJJ7  using  Nde  I  and  Sac  I  and  cloned  into  the  expression  vector  pET2  I  b.  (Fig 
5.2).  This  cloning  strategy  enables  the  T7  polymerase  to  read  through  the  otrB  gene, 
past  the  tryptophan  codon,  into  the  region  of  vector  DNA  encoding  the  polyhistidine 
tag.  A  control  plasmid,  pJJ9,  was  made  by  cloning  the  insert  from  pJJ7  into  pET21b 
on  NdeI  -EcoRI  ends,  translation  terminates  at  the  introduced  stop  codon  after  the 
SacI  site,  resulting  in  a  non-His-tagged  product. 
5.2.3  Construction  of  pJJ18 
The  amino  terminal  HisTagged  OtrB  construct  was  made  by  ligating  the  pJJ6  derived 
Ndel,  BamHI  fragment  (3.3.1)  containing  otrB  with  similarly  cut  pET  I  5b.  This 
results  in  a  plasmid,  pJJ18  in  which  the  HisTag  is  translated  just  prior  to  and  in  frame 
with  the  ATG  start  codon  of  the  otrB  gene  (Fig.  5.3). 
5.3  Levels  of  OTC  resistance 
5.3.1  pJJ8  and  pJJ9  results. 
The  plasmids  pJJ8  and  pJJ9  were  transformed  separately  into  the  E.  coli  expression 
strains  BL21(DE3),  BL21(DE3)  pLysS,  The  pLysE  strain  was  not  used  as  with 
previous  constructs  because  the  highest  levels  of  resistance  were  shown  to  be  with 
the  pLysS  strain.  Induction  with  IPTG  and  streak  tests  in  the  presence  of  increasing 
concentrations  of  oxytetracycline  were  carried  out  as  described  in  the  previous 
chapter.  The  highest  level  of  OTC  resistance  was  observed  for  pJJ8/9  in  BL2  I  (DE3) 
pLysS  (Fig  5.4). 
A  parallel  control  induction  experiment  was  performed  with  the  two  strains 
alone  and  also  transformed  with  pET21b.  All  controls  grew  on  plates  that  did  not 
contain  oxytetracycline,  whether  or  not  the  plates  also  contained  0.4  MM  IPTG.  None 
of  the  controls  showed  growth  at  any  concentration  of  oxytetracycline  tested 
irrespective  of  the  presence  of  IPTG,  the  lowest  being  2.5  ýtg/ml- 
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5.3.2  Oxytetracycline  resistance  conferred  by  pJJ18 
As  for  previous  constructs,  pJJ  18  was  transformed  into  E.  coli  BL2  I  (DE3)  and 
BL21(DE3)  pLysS.  Cultures  were  grown  to  log  phase  and  induced  by  the  addition  of 
0.4  mM  IPTG.  The  cultures  were  grown  for  a  further  2.5  hours  and  then  harvested. 
OTC  resistance  was  determined  by  streaking  samples  of  each  culture  onto  agar  plates 
containing  increasing  OTC  concentrations.  For  each  OTC  concentration  two  plates 
were  streaked,  one  plate  containing  0.4mM  IPTG,  the  other  containing  no  IPTG. 
Plasmid  pJJ18  conferred  resistance  to  a  maximum  OTC  concentration  of 
lOgg/ml.  This  level  was  the  same  for  both  induced  and  uninduced  cultures  of  either 
BL2  I  (DE3)  or  BL2  I  (DE3)  pLysS  when  plated  on  0.4  mM  IPTG.  When  induced  or 
uninduced  cultures  of  either  strain  were  streaked  out  on  plates  containing  OTC  but  no 
IPTG,  the  levels  of  resistance  were  lower.  The  maximum  resistance  levels  observed 
for  pJJ  18  (Fig  5.5)  were  five  times  lower  than  for  the  pET2  I  -b  based  OtrB 
constructs,  pJJ5  and  pJJ8/9  (4.5.2,5.3.1)  suggesting  that  the  N-terminal  HisTag 
might  be  affecting  protein  folding. 
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5.4  Attempts  to  isolate  HisTagged  fusion  protein. 
Isolation  of  the  HisTagged  fusion  protein  was  attempted  from  BL21(DE3)  /  pJJ8- 
Although  the  pLysS  strain  had  produced  higher  resistance  levels,  purification  was  not 
attempted  from  this  strain.  The  T7  lysozyme  produced  by  this  strain  causes  the  cells 
to  lyse  after  thawing  frozen  pellets.  Lysis  produces  a  viscous  sample  that  is 
unsuitable  for  use  with  the  cell  disrupter  or  French  press.  A  large  scale,  (800  ml) 
induction  run  was  carried  out  (2.3.6.1)  and  the  membrane  fraction  prepared  (2.5.2). 
The  membrane  fractions  were  assayed  for  protein  content  and  samples  were  run  on 
an  SDS  PAGE  gel  which  was  then  stained  using  Coomassie  Blue  (Fig  5.6).  The 
membranes  were  solubilised  in  a  buffer  containing  I%  dodecylmaltoside  and  the 
solubilised  extract  was  then  bound  overnight  in  the  presence  of  20  mM  in-ddazole  to 
HisBind  resin  (Novagen)  to  which  Ni"  had  been  previously  bound.  The  resin  was 
then  packed  under  gravity-flow  into  a  column  and  the  extract  put  through  this 
column.  By  washing  the  column  with  increasing  concentrations  of  imidazole,  any 
unbound  proteins  should  be  eluted,  leaving  the  fusion  protein  bound  to  the  nickel  by 
it's  affinity  tag.  To  ensure  the  fusion  protein  was  eluted,  a  final  wash  with  buffer 
containing  100  m.  M  citrate,  pH4  was  used.  I  ml  fractions  were  collected  as  the 
column  was  washed  with  the  various  buffers.  Samples  from  the  first  two  fractions 
were  subjected  to  SDS  PAGE,  (2.5.5.3).  No  well  over-expressed  band  was  readily 
visible  in  any  of  the  lanes  corresponding  to  column  eluates  when  the  gel  was  stained 
by  either  the  Coomassie  method  (Fig 5.7)  or  the  silver  stain  method  (Fig  5.8). 
Although  this  was  the  case,  the  OtrB  fusion  protein  could  well  be  present  in  low 
quantities.  The  initial  gel  (Fig 5.6)  run  using  whole  membrane  fractions  and  stained 
by  the  Coomassie  method  had  shown  a  number  of  bands  present  in  the  induced 
fractions  which  were  not  present  in  the  non-induced  samples. 
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SDS  PAGE  of  solubilised  whole  membrane  fractions  from  indUced  and 
uninduced  (Ind,  Un)  samples  of  E.  coh  131,21  (DE3)  transformed  with 
pJJ8.  Lanes  2-5  contain  10ýil  of  membrane,  lanes  6-9  contain  20pl  of 
membrane. 
Lanes  I  and  10  contain  size  markers  at,  66,200  Da,  4  5,000  Da,  36,000  Da, 
29,000  Da,  24,000  Da,  20,100  Da  and  14,200  Da 
The  gel  was  stained  by  the  Cooniassie  niethod  (2.5.6). 
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SDS  PAGE  of  colunin  cluates  1,2  and  I  of0tril-I  11"  from  1111111duced  (I'llics 
1-3)  and  uninduced  (lanes  4-6)  samples  ofE.  coli  111,2  1  (1)1,  ',  3)  tralistornied 
with  plasmid  pJJ8.15[d  ofeach  eltiate  were  loaded  per  lane.  Lane  8  contains 
13.2ýtg  AFAR-His  as  a  positive  control.  Lane  10  contains  size  markers  at 
97,4000  Da,  66,200  Da,  45,000  Da,  3  1,000  Da,  2  1_500  Da,  and  14,400  Da. 
The  gel  was  stained  by  the  Cooniassie  method  (2.5.6). 
Protein  concentrations  of  the  variOLIS  eluates  are  given  In  Table  5.1. 
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Fig  5.8 
SDS  PAGF  ofinduced  and  uninduced  Column  eluates  from  E.  coli 
BI-21(Dl,  '3)  transformed  with  pJJ8.  Underhný,  -d  lanes  indicate  indUCed 
samples,  those  which  are  not  underlined  contain  Uninduced  samples.  Numbers 
refer  to  the  fraction  of  eluate  analysed.  Lanes  14-16  contain  either  whole 
membrane  fraction  (sol)  or  a  suspension  of  the  pellet  that  remained  after  tile 
solubilisation  step  (non).  10-  15  ýLg  of  protein  was  loaded  per  lane  after  BCA 
assay  of  the  four  samples. 
Lane  I  contains  size  markers  at  66,000  Da,  45,000  Da,  36,000  Da,  29,000  Da, 
24,000  Da,  20,000  Da  and  14,2000  Da. 
The  get  was  stained  by  silver  staining  (2.5.6b) 
Protein  concentrations  of  the  various  eluates  are  given  in  Table  5.1 
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Table  5.1 
Protein  concentrations  of  column  eluate  fractions  from  induced  BL2  1  (DE3)  /pJJ8 
Determined  by  BioRad  DC-  Bradford  assay. 
Fraction  number  Wash  buffer  gg  /gI  protein 
1  1  (20  rnM  imidazole)  4.3 
2  1  4.08 
3  1  1.23 
4  1  0.93 
5  1  0.655 
6  2  (200  rnM  imidazole)  2.320 
7  2  0.660 
8  2  0.795 
9  2  0.710 
10  2  0.705 
11  2  0.700 
12  2  1.286 
13  2  not  available 
14  3  (100  rnM  citrate)  1.635 
15  3  1.800 
16  3  1.855 
17  3  1.79 
18  3  1.7 
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5.5  Assay  for  OtrB  fusion  using  immunodetection 
As  the  results  of  the  affinity  column  did  not  demonstrate  the  presence  of  a  purified 
fusion  protein,  the  next  step  was  to  screen  for  OtrB-His  using  immunodetection 
techniques  (Western  blotting)  as  described  in  2.5.7 
Anti-His  monoclonal  antibodies  raised  against  the  hexahistidine  tag  (Qiagen, 
UK)  were  used  to  assay  for  low  levels  of  OtrB-His  that  might  be  present  in  the 
eluates.  These  antibodies  are  available  in  three  forms,  1)  Anti-  RGS-His,  (this 
antibody  is  raised  against  proteins  cloned  using  a  Qiagen  vector  which  encodes  three 
amino  acids,  arginine,  glycine  and  serine  just  prior  to  a  HisTag.  The  "tail"  is  included 
to  mobilise  the  HisTag  in  order  that  it  may  be  well  presented  to  the  affinity  resin)  2) 
Anti  PentaHis  and  3)  Anti  TetraHis.  As  it  can  not  be  predicted  which  of  the  three 
would  give  the  best  results,  all  three  forms  were  used  initially  to  assay  for  OtrB-His. 
Samples  of  column  eluates  from  the  induced  OtrB  sample  were  subjected  to 
SDS  PAGE  along  with  an  N-terminal  HisTagged  positive  control,  Aflatoxin- 
Aldehyde-Reductase  (AFAR-His)  kindly  donated  by  Dr.  Elizabeth  Ellis,  University 
of  Strathclyde.  This  control  had  been  shown  previously  to  be  detected  by  the  method 
described  (E.  Ellis  pers.  com.  ).  After  running  the  gel  (Fig  5.6),  the  proteins  were 
transferred  to  a  nitrocellulose  membrane  and,  after  blocking,  the  membrane  soaked  in 
a  solution  containing  the  primary  AntiHis  antibody.  At  this  stage,  the  antibodies 
should  bind  to  any  OtrB-His  present  on  the  membrane.  Membranes  were  then  washed 
to  remove  non-specific  binding  and  soaked  in  a  second  antibody  solution  containing 
the  secondary  anti-mouse  antibody  (  Mannheim,  Germany).  The  secondary  antibody 
is  conjugated  to  horseradish  peroxidase,  which  in  the  presence  of  hydrogen  peroxide, 
catalyses  the  oxidation  of  a  diacy1hydrazide  substrate.  An  activated  intermediate 
reaction  product  is  formed  which  decays,  emitting  light.  The  light  emission  can  be 
enhanced  using  4-iodophenol  which  acts  as  a  radical  transmitter  between  the  oxygen 
radical  and  the  substrate.  The  presence  of  fusion  protein  is  detected  on  photographic 
film  as  light  emitted  (Fig  5.9). 
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Protein  concentrat  lolls  of  the  various  fractions  are  given  ill  Table  5.1. 
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5.6  Discussion 
5.6.1  pJJ8  and  pJJ9  results 
The  levels  of  expression  of  pJJ8  and  pJJ9  were  essentially  identical,  this  indicates 
that  the  presence  of  the  series  of  histidine  residues  at  the  C-terminus  is  not  affecting 
the  activity  of  the  protein  as  it  can  still  protect  the  cell  from  oxytetracycline.  This 
implies  that  there  are  no  problems  with  protein  folding  due  to  the  presence  of  the 
HisTag.  No  difficulties  were  expected  with  the  carboxy-terminal  fusion. 
The  highest  concentration  of  oxytetracycline  at  which  strains  containing  these 
constructs  would  grow  was  50  gg/ml  for  the  pre-induced  BL21(DE3)  pLysS  strain 
and  10  gg/ml  for  the  pre-induced  BL21(DE3)  strain  when  both  strains  are  growing  on 
plates  that  contain  0.4mM  IPTG  in  addition  to  the  drug.  The  resistance  of  strains 
carrying  pJJ5/  pJJ8/  pJJ9  to  50  gg/ml  OTC  is  higher  than  resistance  levels  observed 
for  the  12  transmembrane  helix  TnIO  TetA  protein  (Walmsely  pers.  com.  ).  This 
could  feasibly  relate  to  an  increase  in  copy  number,  expression  levels  or  activity  of 
OtrB  compared  to  TetA.  The  strains  which  were  not  preinduced  are  much  less 
protected  against  oxytetracycline  than  their  pre-induced  counterparts,  which  shows 
that  the  control  of  gene  expression  is  similar  to  the  previous  construct,  pJJ5.  Indeed, 
the  plasmids,  pJJ5  and  pJJ8/9  have  altogether  similar  resistance  profiles.  This  is 
evidence  that  the  PCR  step  which  mutated  the  carboxy  end  of  the  gene  in  order  to 
create  the  fusion  product,  did  not  introduce  any  other  mutations  to  essential  or 
important  residues,  i.  e.  the  functional  activity  remains  the  same. 
5.6.2  pJJ18  results 
In  direct  contrast  to  the  above  findings,  the  results  from  the  resistance  tests  of  the 
induced  pJJ18  strains  show  much  lower  resistance  to  oxytetracycline.  The  highest 
concentration  at  which  growth  was  observed  was  I  Ogg/ml  for  both  the  pre-induced 
BL2  I  (DE3)  and  BL2  I  (DE3)  pLysS  strains,  this  is  20%  of  the  resistance  level  of  the 
carboxy  tagged  construct  pJJ8,  the  control,  pJJ9  and  the  original  pET21b  construct, 
pJJ5.  The  cultures  of  the  two  strains  containing  pJJ  18  that  were  not  pre-induced  with 
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0.4mM  IPTG  in  liquid  culture  show  resistance  at  lOgg/ml  which  is  a  similar  level  to 
non  pre-induced  samples  of  the  other  three  plasmids.  The  reason  for  the  80% 
reduction  in  resistance  is  presumed  to  be  due  to  ntisfolding  of  the  protein  caused  by 
the  presence  of  the  amino-terminal  HisTag. 
5.7  Deletion  of  the  two  putative  central  helices. 
As  previously  discussed  in  Chapter  3,  the  OtrB  protein  is  predicted  to  be  formed 
from  14  transmembrane  alpha  helices  connected  by  alternate  cytoplasmic  and 
periplasmic  loops.  The  tetracycline  resistance  pumps  from  Gram-negative  organisms 
have  been  shown  to  consist  of  only  12  such  loops.  The  work  of  Yamaguchi  and 
colleagues  has  given  us  much  information  about  one  such  exporter,  namely  the  TetA 
(B)  /  H'  antiporter  from  transposon  TnIO  of  E.  coli.  Conserved  motifs  have  been 
identified  which  place  TnIO  in  the  Major  Facilitator  Superfamily  as  discussed  in 
Chapter  3.  Residues  essential  for  tetracycline  export  have  also  been  identified 
(Yamaguchi  et  al,  1990,1992a,  1992b,  1993). 
To  investigate  the  importance  of  the  two  central  helices  present  in  the 
exporters  of  Gram-positive  bacteria  when  expressed  in  a  Gram-negative  host,  DNA 
encoding  the  two  putative  central  helices  from  OtrB  was  deleted.  The  two  halves  of 
the  gene  were  then  joined  using  DNA  encoding  a  large  central  cytoplasmic  loop 
modelled  on  that  of  TetA(B).  This  "E  coli  friendly"  protein  was  then  expressed  in  the 
Gram-negative  host  and  the  resistance  of  cells  expressing  this  mutated  otrB  gene 
was  assessed. 
5.8  Construction  of  truncated  otrB  gene 
5.8.1  Construction  of  pJJ10  and  pjJ1I 
To  construct  the  shortened  otrB  gene,  the  two  halves  of  the  mutated  gene  were 
prepared  separately  by  PCR  based  site  directed  mutagenesis.  The  template  for  both 
PCR  reactions  was  plasmid  pJJ7,  (5.2.1). 
For  reaction  1,  the  product  of  which  was  the  DNA  encoding  the  N-terminal 
half  of  OtrB,  the  primers  used  were  universal  forward  primer  and  a  custom  reverse 
primer,  primer  3  (2.4.14).  The  primer  contains  EcoRI  and  Cal  sites,  and  introduces 
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For  PCR  reaction  II,  which  produced  the  DNA  encoding  the  C-terminal  half  of  the 
truncated  OtrB,  the  primers  used  were  universal  reverse  and  a  custom  forward 
primer,  Primer  4.  This  primer  contains  ClaI  and  I-Ide-I  sites  and  introduces  two 
amino  acids  into  the  new  cytoplasmic  loop.  The  0.5kb  product  of  PCR  reaction  I  and 
the  0.8  kb  product  of  reaction  II  were  cut  with  NdeI  and  EcoRL  The  fragments  were 
then  ligated  separately  with  pMTL23  that  had  also  been  restricted  with  NdeI  and 
EcoRL  The  ligation  products  were  pJJ  10,  which  contained  PCR  product  I  and  pJJ1  1, 
which  contained  PCR  product  II  (  Fig.  5.10). 
5.8.2  Design  of  PCR  primers 
When  designing  PCR  primers  to  create  the  cytoplasmic  loop  between  the  two  halves 
of  the  OtrB  deletion  mutant,  the  basis  of  design  was  the  TetA  protein  from 
transposon  TnIO  (Fig  5.11).  This  middle  cytoplasmic  loop  consists  of  33  amino 
acids,  which  makes  it  considerably  longer  than  the  other  cytoplasmic  and  periplasmic 
loops  in  the  protein,  a  longer  middle  loop  appears  to  be  characteristic  for  many 
members  of  the  Multi  Facilitator  Superfan-dly. 
In  the  otrB  gene,  the  fragment  of  DNA  encoding  the  two  middle 
transmembrane  helices,  helices  7  and  8,  begins  at  base  571  (G)  and  ends  at  base  781 
(C).  It  was  this  DNA  that  was  deleted  to  make  the  truncated  otrB  gene.  In  order  to 
join  the  two  PCR  products  a  new  cytoplasmic  loop  was  constructed  using  the  "tails" 
of  the  PCR  primers  As  already  stated,  the  TetA  central  cytoplasmic  loop  consists  of 
33  amino  acids.  After  helices  7  and  8  have  been  removed  from  the  otrB  DNA,  28 
residues  remain  to  make  up  the  new  cytoplasmic  loop,  II  from  loop  6-7  and  17  from 
loop  8-9.  Five  extra  amino  acids  were  added  by  incorporating  their  codons  into  the 
primer  tails,  tails  also  had  to  contain  restriction  sites  to  clone  them  initially  as  two 
separate  parts  and  then  join  them. 
The  middle  five  amino  acids  of  TetA  are,  valine  (V),  glycine  (G),  valine  (V), 
glutarnic  acid  (E)  and  threonine  (T).  The  DNA  sequence  which  encodes  these  amino 
acids  was  incorporated  into  the  design  of  the  primers,  taking  account  of  the  high  G 
C  content,  around  70%,  of  the  Streptomycete  genome.  This  was  in  order  with  the 
long-term  aim  to  express  otrB  from  an  expression  vector  in  Streptontyces.  The  codon 
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long-term  aim  to  express  otrB  from  an  expression  vector  in  Streptomyces.  The  codon 
bias  figures  used  were  compiled  from  67  Streptomyces  genes  by  Taylor,  (1992) 
(Table  5.2). 
From  these  figures,  the  DNA  sequence,  GTC  GGC  GTC  GAG  ACC  was 
chosen  to  encode  these  amino  acids  in  the  primers,  However,  this  sequence  does  not 
contain  a  suitable  restriction  site  to  join  together  the  two  PCR  products.  By  changing 
the  valine  to  isoleucine  (1)  and  the  glutamic  acid  to  aspartic  acid  (D),  the  sequence  is 
changed  to  GTC  GGC  ATC  GAT  ACC  which  introduces  a  CIaI  site,  (underlined) 
whilst  retaining  the  character  of  the  amino  acids.  Valine  and  isoleucine  both  have 
non-polar  side  chains,  aspartic  acid  and  glutamic  acid  both  have  negatively-charged 
side  chains. 
5.9  Construction  of  pJJ12,  pJJ14  and  pJJ17. 
The  N-terminal  fragment  of  otrB  was  subcloned  into  pET2  Ib  from  pJJ  10  (5.8.1)  to 
create  pJJ12  (Fig  5.12).  pJJ1O  was  restricted  with  NdeI  and  EcoRI  and  ligated  with 
similarly  cut  pET21b.  pJJ12  was  then  restricted  with  Cal  and  EcoRI  and  ligated 
with  the  C-terminal  fragment  of  otrB  which  had  been  removed  on  MI,  EcoRI  ends 
from  pJJ  11  (5-8.1).  The  product  of  this  ligation  was  named  pJJ  14  (Fig  5.13).  pJJ  14 
was  therefore  a  pET21b-based  plasmid  which  contained  the  truncated  otrB  gene. 
In  pJJ  14,  the  fragment  containing  otrB  was  cloned  using  EcoRI  at  the  C-terminal 
end,  thus  the  insert  had  a  SacI  site,  a  stop  codon  and  an  Xhol  site  upstream  of  the 
vector  DNA  encoding  the  HisTag.  Downstream  of  the  EcoRI  site,  the  vector 
polylinker  contains  another  Sacl  site.  By  cutting  pJJ  14  with  Sacl  and  re-ligating,  the 
small  SacI  fragment  was  removed.  This  creates  a  fusion  with  the  HisTag,  pJJ  17  (Fig 
5.13).  To  demonstrate  that  this  fragment  had  been  removed,  pJJ17  was  restricted  with 
EcoRl.  As  this  site  had  been  removed,  the  plasmid  remained  uncut.  As  a  control, 
pMTL23  was  included  in  the  restriction  mixture,  this  linearised  with  EcoRl, 
showing  that  the  enzyme  was  active  (Fig  5.14)  and  that  the  EcoRI  site  in  pJJ  17  had 
been  removed. 
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Universal  Primer 
0 
571bp  Mutagenic  "tail" 
h/  *ý'ýP  imer  4 
otrB  1611bp 
4--\ 
Primer  3T 
Mutagenic  "tail" 
Ndel  Clal  EcoRl 
PCR  product  I 
Encodes  TMH  1-6 
721bp  Reverse  Primer 
Nde  I  Clal 
Eco  RI 
PCR  product  2 
Encodes  TMH  9-12 
Fig-5.10 
Positioning  of  mutagenic,  Universal  and  Reverse  primers  on  the  otrB 
template  and  the  products  of  the  PCR  reactions. 
169 Chapter  5 
TetA(B)  central  cytoplasmic  loop 
F  RETKNTRDNTDTEV  GV  ET  OS  NS  VYITL  F  KTM 
otrB  sequence  CAC  CGC  ATG  GTC  GGC  GTC  GAG  ACC  CTG  TGC  TCC 
MVGVETLC 
II 
ID 
A'ýC  GAT 
Clal  site 
LPHERREHRMVG  I  DTLCS  AV  NFTI  GVG  IF 
Peptide  sequence  of  new  OtrB  central  cytoplasmic  loop. 
Fig  5.11 
Cytoplasmic  loop  joining  TMH6  and  the  six  C-terminal  TMH's  of  OtrB. 
showing  the  peptide  sequence  of  TetA(B)  central  cytoplasmic  loop,  (top 
line),  with  the  5  residues  to  be  conserved  in  the  new  OtrB  loop  shown  within 
the  box.  The  codons  chosen  from  the  codon  bias  table  are  shown  in  bold  type 
on  the  second  line  with  original  otrB  nucleotides  in  normal  type.  The  two 
residues  substituted  to  introduce  the  restriction  site  are  shown  by  arrows 
along  with  the  DNA  that  encodes  them.  The  bottom  line  shows  the  final 
cytoplasmic  loop  introduced  into  OtrB  in  place  of  the  deleted  region. 
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Table  5.2 
Codon  preference  table  for  67  Streptomycete  genes 
G  A  T  c 
G  Gly  19  Glu  81  Val  39  Ala  33  G 
Gly  10  Glu  19  Val  2  Ala  4  A 
Gly  8  Asp  4  Val  4  Ala  3  T 
Gly  64  Asp  96  Val  56  Ala  59  c 
A  Arg  6  Lys  95  Met  100  Thr  30  G 
Arg  I  Lys  5  Ile  3  Thr  3  A 
Ser  3  Asn  4  Ile  5  Thr  2  T 
Ser  28  Asn  96  Ile  92  Thr  65  c 
T  Trp  100  END  14  Leu  3  Ser  26  G 
END  83  END  3  Leu  0  Ser  3  A 
Cys  13  Tyr  5  Phe  I  Ser  I  rr 
Cys  87  Tyr  95  Phe  99  Ser  39  c 
C  Arg  36  Gln  93  Leu  55  Pro  52  G 
Arg  5  Gln  7  Leu  0  Pro  2  A 
Arg  7  His  6  Leu  2  Pro  3  T 
Arg  46  His  94  Leu  39  Pro  43  c 
N.  B.  a)  The  first  nucleotide  of  each  codon  is  provided  in  the  left  hand  column;  the 
second  nucleotide  is  shown  in  the  top  row;  the  third  nucleotide  is  shown  in  the  right 
hand  column. 
b)  The  figures  show  the  relative  codon  uses  (expressed  as  a  percentage  of 
each  nucleotide  triplet)  in  encoding  each  amino  acid  in  the  67  genes  analysed. 
Data  taken  from  Taylor,  1992. 
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5.10  Expression  and  Resistance  results 
5.10.1  Expression  of  pJJ14  and  pJJ17 
Plasmids  pJJ  14  and  pJJ  17  were  transformed  separately  into  E.  coli  BL2  I  (DE3)  and 
BL2  I  (DE3)  pLysS.  Induction  with  IPTG  was  carried  out  as  for  other  strains  (2.3.6.1). 
Cultures  were  streaked  onto  agar  plates  containing  increasing  concentrations  of 
oxytetracycline,  both  with  and  without  IPTG.  Controls  were  the  same  as  in  previous 
induction  experiments.  Untransformed  and  vector-only  strains  did  not  grow  in  the 
presence  of  2  gg/ml  OTC. 
Table  5.3 
Results  of  pJJ  14  and  pJJ  17  resistance  tests. 
OTC 
gg/ml 
B  L2  I  (DE3)/pJJ  14  or  pJJ  17  BL2  I  (DE3)  pLysS/pJJ  14  or  pJJ  17 
pre-induced  uninduced  pre-induced  uninduced 
I 
IPTG  no  IPTG  IPTG  no  IPTG  IPTG  no  IPTG  IPTG  no  IPTG 
0  +  +  +  +  +  +  +  + 
3.0  I.  g.  I.  g.  I.  g.  I.  g. 
5.0 
10.0 
indicates  growth 
-  indicates  no  growth 
I.  g.  indicates  light  growth 
pJJ  14  and  pJJ  17  exhibited  similar  oxytetracycline  resistance  profiles,  both  displaying 
resistance  to  a  maximum  of  3gg/ml  OTC.  No  difference  between  the  two  strains  was 
expected  as  the  results  for  expression  and  resistance  of  earlier  plasmids  demonstrate 
that  the  HisTag  does  not  appear  to  make  any  difference  to  the  OTC  resistance  of  the 
host.  Resistance  to  OTC  was  only  observed  when  the  plasmids  were  expressed  in  E. 
coli  BL21(DE3)  pLysS.  Strains  lacking  the  pLysS  plasmid  could  not  grow  in  the 
presence  of  2.0gg/mI  OTC  as  is  the  case  for  the  controls.  The  OTC  resistance 
exhibited  by  the  truncated  protein  was  not  increased  by  induction  with  lVrG  during 
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Amp 
PCR  using  2  sets  of  primers,  universal  +  Primer  3  and  reverse  +  Primer  4 
Each  primer  has  a  tail  designed  to  mimic  the  central  cytoplasmic  loop  from  TetA(B) 
Clone  the  two  products  separately  into  pMTL23  to  create  pJJ10  and  pJJ1  1 
Suclone  from  these  plasmids  into  pET21  b  to  create  pJJ1  2  and  pJJ1  3 
E  co  [I 
V  14 
Fig  5 
Construction  of  pJJ  12  and  pJJ  13 Chopter  5 
Cut  both  pJJ12  and  pJJ13  with  Clal  &  EcoRl.  Ligate  large  fragment 
of  pJJ12  to  0.8kb 
f  ragment  of  PJJ  13  to  create  pJJ  14 
STOP 
I  co 
,  -! 
tA7, 
-ý",  sacl 
pJJ14  -Velices9-12 
6.70  Kb 
Amp 
helices  1-6 
T7  promoter 
NNdel 
Restrict  withSacl  and  re-ligate 
in  order  to  remove  STOP  codon 
and  create  polyhistidine  fusion 
his  -t(-](  I 
Ai  T  ij 
F  ig,  5.13 
('011',  ti-LICtion  ot'pJJ  14  and  pJ.  1  17 
9-11) 
lal 
sl-6 
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X/EcoRl  Y,  Fco  RI  7-lEco  RI  ?J  11111  XINde  I  YINde  I  Z,  'A'(/,,  l 
pJJ17  pJJ17 
Fig  5.14 
Agarose  electrophoresis  of  restriction  digests  to  screcii  lor  p.  1.1  17. 
Lanes  1-3  are  EcoRl  restrictions,  lanes  5-7  are  Nele  I  restrictions. 
Lane  I  contains  uncut  clone  X4  linearised  pMT1,23,  lane 
-'  shows  a  sccond 
similar  clone  (clone  Y)  4-  finearised  pMT1.23,  lane  3  shows  plasmid  frolli  a 
third  transformant(clone  Z)  4-  uncut  IM11121,  Restriction  ol'the  pM'1T23 
control  has  not  occurred  in  this  sample  so  no  conclusions  can  be  drawn.  Lalic 
4  contains  ý,  /  Hind  III  size  markers.  Lanes  5-7  contain  Wel  digests  ol'  clone 
X,  clone  Y  and  clone  Z.  Clone  Z  DNA  was  ofpoor  quality,  did  not  rcstrict 
with  either  enzyme  and  was  discarded,  clones  X  ýjjid  y  showcd  11  St  -icti  o  re  ii  ion 
withEcoRI.  Clone  X  was  named  p.  1.1  17. 
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growth  of  the  inoculum  and  no  difference  was  observed  between  samples  plated  in 
the  presence  or  absence  of  0.4  m.  M  IPTG. 
5.11  Discussion  of  resistance  supplied  by  truncated  OtrB 
The  OTC  resistance  exhibited  by  the  two  BL2  I  (DE3)  pLysS  strains  containing  pJJ  14 
or  pJJ17  is  low,  ca.  4%  of  that  shown  by  plasmid  pJJ8  in  which  the  full  length  otrB 
gene  fused  to  the  polyhistidine  tag  is  expressed.  Nevertheless,  some  resistance  is 
provided  by  the  construct  as  cells  containing  no  plasmid  and  those  transformed  with 
vector  only  are  unable  to  survive  at  a  lower  concentration  of  2  Pg/n-d  OTC.  Although 
resistance  is  not  completely  lost,  the  deleted  region  thought  to  contain 
transmembrane  helices  7  and  8  must  be  important  to  the  function  of  the  protein  as  the 
greatly  reduced  resistance  levels  demonstrate. 
It  is  highly  probable  that  the  reduced  resistance  activity  is  attributable  to 
differences  in  the  way  the  protein  folds  and  assembles  in  the  membrane  when  it  is 
truncated  in  this  way.  What  cannot  be  deduced  from  this  study  is  whether  the 
attempts  to  mimic  the  loop  character  of  the  Gram-negative  TetA(B)  protein  make  any 
positive  contribution  to  the  resistance  levels  in  these  strains  or  whether  merely 
maintaining  the  length  of  the  loop  at  33  amino  acids  would  have  resulted  in  similar 
OTC  resistance.  The  importance  of  the  length  of  cytoplasmic  loops  is  not  known  as 
regards  insertion  into  the  membrane.  Although,  length  of  periplasmic  loops  is 
thought  to  be  important.  Proteins  containing  cytoplasmic  loops  shorter  than  c.  25 
amino  acids  are  thought  to  be  able  to  insert  into  the  inner  membrane  independently  of 
the  cellular  Sec  system  (Kuhn,  1988,  Andersson  &  Von  Heijne,  1993).  The  Sec 
system  is  the  machinery  that  enables  secretion  of  certain  proteins  out  of  the  cell. 
(Schatz  &  Beckwith,  1990).  Sec  independent  proteins  may  insert  into  the  membranes 
by  a  method  known  as  the  "helical  hairpin"  method,  the  helical  hairpin  structure 
being  composed  of  a  pair  of  anti-parallel  alpha  helices  from  neighbouring  odd  and 
even-numbered  transmembrane  regions.  The  reason  for  formation  of  such  structures 
is  thought  to  be  a  thermodynamic  one  as  formation  may  increase  the  overall 
hydrophobicity  of  the  sequence  sufficiently  enough  to  drive  polar  loop  residues 
across  the  lipid  bilayer  and  provide  a  way  of  masking  interior  hydrophilic  residues 
via  association  of  relatively  polar  faces  of  the  helices  (Engelman  &  Steitz,  198  1).  The 
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TetA(C)  protein  from  pBR322  has  been  indicated  to  insert  by  this  mechanism  (Guo 
et  al,  1996).  The  work  presented  by  Guo  and  co-workers  also  shows  that  efficient 
insertion  of  odd  numbered  transmembrane  helices  requires  the  presence  of  the  next 
even  numbered  segment. 
As  both  the  truncated  and  wild  type  form  of  OtrB  contain  a  large  putative 
periplasn-&  loop  between  transmembrane  regions  13  and  14  it  is  unclear  which 
method  of  insertion  into  the  membrane  is  used.  Proteins  may  insert  by  utilising  both 
systems.  Lac  permease,  a  12  segment  membrane  protein  can  assemble  in  the 
membrane  as  an  active  protein  when  contiguous  fragments  separated  within 
periplasmic  loops  I  and  4  are  co-expressed  in  E.  coli  (  Zen  et  al,  1994).  Possibly 
OtrB  inserts  in  a  similar  manner  as  some  transmernbrane  segments  require  the  sec 
machinery  whilst  others  form  helical  hairpins.  The  periplasmic  loops  of  OtrB  have 
not  been  affected  by  the  deletion  apart  from  the  absence  of  loop  7-8.  The  loops  that 
are  present  are  intact  and  have  not  been  mutated  in  any  way.  Insertion  by  helical 
hairpin  formation  should  remain  unaffected  in  the  truncated  protein.  However,  the 
deletion  of  TMI-17  may  affect  the  folding  of  the  following  six  helices.  It  is  thought 
that  the  N-terminal  half  of  TetA(B)  assembles  in  the  membrane  independently  of  the 
C-terminal  half  whilst  the  insertion  of  the  C-terminal  half  is  affected  by  the  presence 
of  the  N-terminal  portion  (Yamaguchi  et  al,  1993).  Vesicles  containing  the  two 
halves  of  TetA(B)  expressed  separately,  showed  about  40%  of  the  transport  activity 
per  C-terminal  as  those  containing  the  wild  type  protein.  These  results  suggest  that 
the  C-terminal  half  of  the  protein  is  important  for  correct  insertion  of  TetA(B)  into 
the  membrane.  This  may  also  be  the  case  in  OtrB,  removing  TMH7  which  is  part  of 
its  N-terminal  half  could  well  result  in  incorrect  folding  of  the  C-terminal  portion. 
Although  the  presence  of  the  N-terminal  region  is  important  for  insertion  of  the  C- 
terminal,  it  is  not  essential  as  some  C-terminal  fragments  were  detected  in  the 
membrane.  This  is  in  contrast  to  similar  work  carried  out  using  the  lac  permease 
where  the  presence  of  the  C-terminal  fragment  was  not  detected  in  the  membrane  in 
the  absence  of  the  N-terminal  fragment  (Bibi  &  Kaback,  1990).  It  can  be  concluded 
that  the  low  OTC  resistance  of  E.  coli  strains  expressing  the  truncated  OtrB  protein  is 
probably  due  to  misfolding  of  the  C-terminal  portion  of  the  protein. 
Yamaguchi  et  al  (  1993)  also  found  that  vesicles  containing  only  one  of  the  two 
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halves  of  TetA(B)  had  no  active  transport  activity.  This  is  also  thought  to  be  the  case 
with  OtrB  as  when  pJJ  12  or  pJJ  13  were  expressed  in  BL2  I  (DE3)  or  BL2  I  (DE3) 
pLysS  the  level  of  OTC  resistance  observed  was  identical  to  that  of  untransfomed 
and  vector-only  controls. 
5.12  Lack  of  detection  of  OtrB-His 
Attempts  to  isolate  OtrB-His  by  the  NTA-nickel  agarose  column  were  assumed  to  be 
unsuccessful.  This  conclusion  was  reached  after  no  over-expressed  band  was  seen  on 
SDS-PAGE  gels  of  the  membrane  fractions  or  the  column  eluates  and  no  signal  was 
observed  when  a  Western  blot  of  column  eluates  was  probed  with  mouse  Anti-His 
monoclonal  antibody  and  fluorescent  anti-mouse  IgG.  The  lack  of  a  signal  from  the 
immunoblot  could  possibly  have  been  due  to  the  sensitivity  of  the  system  being  too 
low  to  detect  the  level  of  OtrB  present.  The  control  protein,  AFAR-His  was  detected 
from  dot  blots  when  a  dilution  of  column  eluate  containing  125  ng  of  total  protein 
was  applied  to  the  membrane.  The  AFAR  eluate  showed  AFAR  as  the  only  major 
band  when  subjected  to  SDS-PAGE  (E.  Ellis  pers.  com).  Column  eluates  of  OtrB-1-lis 
preparation  contained  between  0.6  and  4.3  gg/[tl  total  protein,  meaning  that  gg 
quantities  of  protein  were  loaded  onto  the  gel.  It  is  expected  that  one  or  two  of  the 
eluates  would  contain  a  very  high  proportion  of  OtrB-His.  Initial  thoughts  as  to  the 
lack  of  detection  are  discussed  below. 
As  OtrB  is  very  hydrophobic  it  may  be  that  the  conformation  of  the  protein  in 
the  membrane  preparation  is  such  that  the  C-terminal  HisTag  is  not  presented 
appropriately  to  the  NTA-nickel  resin.  This  is  however  an  unlikely  explanation  as  the 
membrane  preparation  and  all  subsequent  steps  in  the  purification  procedure  were 
carried  out  in  denaturing  conditions  (in  the  presence  of  8M  urea).  The  OtrB-11is  may 
not  have  bound  or  may  have  only  weakly  bound  to  the  nickel  and  so  may  have  been 
removed  from  the  column  by  gravity  flow  as  the  agarose  settled  to  form  a  compact 
bed.  A  small  fraction  (I  ml)  of  this  flow-through  was  collected  for  analysis  but 
unfortunately  sample  ran  out  before  all  analyses  were  performed,  no  sample  was 
available  for  immunodetection.  As  the  binding  step  took  place  in  a  50  ml  volume,  the 
concentration  of  OtrB-His  that  may  have  been  present  in  the  sample  would  have  been 
extremely  low.  Another  possible  explanation  for  the  lack  of  detection  of  OtrB-His  is 
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that  the  protein  was  cleaved  or  degraded  by  E.  coli  cell  machinery  or  by  a  subsequent 
step  in  the  procedure.  As  the  HisTag  system  had  been  successful  in  isolating  other 
membrane  proteins  from  E.  coli  e.  g.  TetA(B)  (Aldema  et  al,  1996),  degradation  may 
seem  an  unlikely  explanation.  However,  it  must  be  remembered  that  the  TetA(B) 
protein  originates  from  E.  coli  and  that  OtrB  is  a  heterologous  protein. 
5.13  Further  sequencing  of  pJJ8 
When  no  over-expressed  band  could  be  detected  using  SDS  PAGE  it  was  suspected 
that  constructs  pJJ8  and  pJJ9  (containing  the  TGA  stop  codon  and  therefore  not 
tagged)  had  been  confused  with  each  other  resulting  in  transformation  and  expression 
of  the  control  construct.  For  this  reason  pJJ8  was  sequenced  in  from  the  vector  DNA 
using  T7-terminator  primer  (5'GCTAGTTATTGCTCAGCGG3').  The  nucletotide 
sequence  data  demonstrated  the  presence  of  a  SacI  site  but  not  an  EcoRl  site, 
therefore  the  otrBI  vectorjunction  was  presumed  intact. 
After  further  attempts  to  detect  OtrB-His  using  immunoblotting  techniques 
had  also  failed  the  construct  was  resequenced.  The  resulting  chromatograms  were  of 
much  higher  quality  and  more  bases  could  be  read.  As  a  result  of  this,  aC  residue  Z;  ' 
was  discovered  at  position  1469  which  was  assumed  to  be  a  G.  This  difference  from 
the  Reynes/  MacGregor-Pryde  sequence  was  either  due  to  a  mistake  in  both  of  these 
sequence  or  to  an  error  by  the  pfu  polymerase.  If  the  former  was  the  case  other 
differences  might  also  be  present.  To  establish  whether  this  inversion  was  the  only 
deviation  from  the  Reynes  /  MacGregor-Pryde  sequence  in  the  latter  part  of  the  gene, 
four  sequencing  primers  were  designed  against  otrB  (  primers  4-7  Fig  3.7).  These 
primers  would  sequence  the  region  of  otrB  not  previously  sequenced  using  the  ABI 
system.  The  original  copy  of  otrB  cloned  into  pJJ  I  was  used  as  the  template  in  the 
sequencing  reaction. 
5.13.1  Discussion  of  T7  terminator  primer  sequencing  results 
On  analysis  of  the  sequence  data  from  T7  terminator  primer,  the  G  to  C inversion  at 
position  1469  was  found  to  be  the  only  difference  from  the  previous  sequence, 
meaning  that  the  reading  frame  would  remain  intact 
However  upon  translation  of  the  new  sequence  into  peptide  it  was  discovered  that  no 
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polyhistidine  tail  was  present.  The  OtrB  sequence  was  intact  until  the  mutated 
tryptophan  (codon  TGG)  residue  that  replaced  the  wild-type  TGA  stop  codon. 
Sequence  downstream  of  this  position  translated  as  out  of  frame  vector  sequence, 
resulting  in  a  poly-proline  tail  (Fig  5.15).  This  was  due  to  an  error  in  the  design  of  the 
reverse  PCR  primer.  pET21a,  pET21b  and  pET21c  are  related  vectors  differing  from 
each  other  by  either  one  or  two  nucleotides  to  allow  phasing  of  the  cloned  gene.  In 
the  cloning  strategy  of  pJJ8,  a  mistake  was  made  when  designing  the  inverse  PCR 
primer  (Primer  2),  meaning  that  the  SacI  site  was  not  in  frame  with  the  HisTag- 
encoding  DNA.  In  order  to  have  built  an  expression  construct  in  frame  with  a 
polyhistidine  tag  in  pET21b,  the  primer  should  have  been  one  base  shorter,  with  the 
last  G  of  the  TGG  tryptophan  codon  being  the  first  G  of  the  GAGCTC  SacI  site. 
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i) 
Sac  I 
TGGGAGCICCGTCGACAAGCTTGCGGCCGCACTCGAGCAC 
TrpGluLeuArgArgGlnAlaCysGlyArgThrArgAlaP 
SerSerValAspLysLeuAlaAlaAlaLeuGluHis 
CACCACCACCACCACTGAGATTCGGCTGCTAA  a)  DNA  sequence 
roProProProProLeuArgSerGlyCysEnd  b)  Actual  protein  seq. 
HisHisHisHisHisEnd  c)  Expected  protein  sequence 
ii)  5'CGG  AAT  TCA  AGA  GCT  CCA  GGC  GTC  CGA  CGC  GGG  CAG 
CGG  CCC  GY 
Fiji  5.15 
1)  Sequence  of  polypeptide  tag  fused  to  OtrB,  from  pJJ8  DNA  sequenced  using  T7- 
terminator  primer. 
ii)  DNA  sequence  of  new  PCR  primer  that  will  enable  correction  of  fusion,  stop 
codon  is  shown  in  bold  type.  EcoRI  and  Sacl  sites  are  underlined 
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5.14  Future  Work 
1)  The  most  important  future  work  is  obviously  to  re-construct  pJJ8  using  a  PCR 
primer  that  results  in  translation  of  the  His-tagged  product.  The  expression  and 
purification  can  then  be  repeated  and  hopefully  OtrB  will  be  isolated. 
2)  It  would  be  interesting  to  express  the  truncated  otrB  gene  in  S.  albus  in  order  to 
assess  the  importance  of  these  two  TMH's  in  the  Streptomycetes,  as  all  MFS  proteins 
isolated  so  far  from  these  organisms  are  comprised  of  14  TMH's. 
3)  In  order  to  investigate  the  importance  of  residues  within  the  central  cytoplasmic 
loop,  mutagenesis  of  individual  residues  should  be  carried  out  to  change  the  character 
oftheloop. 
4)  The  effect  of  loop  length  should  be  investigated  by  studying  the  resistance  levels 
of  a  series  of  deletion  mutants. 
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Chapter  6 
Concluding  Remarks 
6.1  Introduction 
The  aims  of  the  work  described  in  this  thesis  were; 
1)  To  introduce  a  plasmid-born  S.  rimosus  otrB  gene  into  two  non  oxytetracycline 
producing  Streptomycetes  and  investigate  the  level  of  OTC,  CTC  and  TET  resistance 
supplied  by  the  gene. 
2)  To  express  otrB  in  E.  coli  using  a  well  characterised,  inducible  expression  system 
and  investigate  OTC  resistance  levels  conferred  on  transformed  cells. 
3)  To  construct,  express  in  E.  coli  and  isolate  a  polyhistidine-OtrB  fusion  protein. 
4)  To  produce  a  model  for  the  2-dimensional  topology  of  OtrB  using  computer 
programs  to  analyse  hydrophobicity  and  hydrophilicity. 
5)  To  express  a  mutant  OtrB  protein  from  which  the  two  central  transmembrane 
helices  had  been  deleted  in  E.  coli  and  investigate  the  potential  of  this  protein  to 
confer  OTC  resistance  upon  E.  coli. 
During  the  course  of  these  studies  it  also  became  necessary  to  determine  the 
definitive  nucleotide  sequence  of  otrB. 
6.2  Expression  of  otrB  in  Streptomyces 
Protoplasts  of  Streptomyces  rimosus  15883s  and  Streptomyces  albus,  both  non  OTC 
producers  were  transformed  with  one  of  two  plasmids,  both  carrying  S.  rintosus  DNA 
fragments  encoding  otrB.  One  of  these  plasn-dds  also  contained  DNA  encoding  part 
of  an  divergently  transcribed  upstream  gene  otrR  ,  thought  to  be  the  otrB  repressor 
gene.  The  OTC  resistance  profiles  of  transformed  strains  were  determined  by  growth 
on  solid  media  containing  increasing  levels  of  OTC.  Both  plasmids  conferred 
resistance  upon  the  hosts.  The  highest  OTC  concentration  at  which  growth  occurred 
was  observed  for  S.  rimosus  15883s  transformed  with  the  plasmid  that  did  not 
contain  DNA  encoding  the  putative  repressor  gene.  It  is  thought  that  the  absence  of 
otrR  in  this  construct  leads  to  de-regulation  of  expression.  When  the  resistance  tests 
were  repeated  using  CTC  or  TET  in  place  of  OTC,  no  growth  was  seen.  This 
indicates  that  OtrB  is  substrate  specific  in  these  organisms. 
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In  order  to  further  investigate  the  drug  resistance  conferring  properties  of  otrB  in 
Streptomycetes,  expression  studies  using  an  inducible  Streptomyces  expression 
vector  such  as  pIJ4123  (Takano  et  al  1995)  should  be  performed.  In  this  vector, 
expression  of  the  cloned  gene  is  under  control  of  the  thiostrepton-inducible  tipA 
promoter.  It  would  be  useful  to  use  this  vector  to  express  a  fusion  protein  for 
purification  by  affinity  purification.  Some  initial  attempts  to  set  up  this  system  to 
express  HisTagged  OtrB  were  carried  out  in  S.  albus,  results  indicated  that  this  is  an 
unsuitable  host.  pIJ4123  transformants  must  be  selected  for  using  kanamycin, 
unfortunately  untransformed  S.  albus  appears  to  be  resistant  to  fairly  high  levels  of 
the  drug.  In  order  to  overcome  these  difficulties  such  studies  could  be  undertaken  in  a 
different  host  background  provided  there  was  no  other  source  of  OTC  resistance. 
Alternatively  a  modified  vector  could  be  constructed,  utilising  a  more  suitable 
resistance  marker. 
6.3  Expression  of  otrB  in  E.  coli 
Expression  of  otrB  in  E.  coli  was  performed  using  expression  vectors  in  which  the 
gene  is  expressed  under  the  control  of  the  viral  T7  promoter,  expression  is  inducible 
by  IPTG.  Two  vectors  of  this  type  were  used  for  expression  studies  of  otrB,  one  of 
which  also  provided  the  means  to  construct  a  polyhistidine  fusion  to  OtrB.  Using  this 
vector,  pET2  lb  (Novagen,  UK),  transformed,  induced  cells  of  E.  coli  BL2  I  (DE3) 
and  BL2  I  (DE3)  pLysS  exhibited  high  levels  of  OTC  resistance  while  uninduced  cells 
conferred  little  or  no  resistance  on  the  host.  Expression  studies  using  the  alternative 
vector,  pT7-7  (Tabor  &  Richardson,  1985)  gave  unsatisfactory  control  of  expression 
by  the  inducer,  basal  levels  of  OTC  resistance  were  similar  to  the  levels  conferred 
when  cells  had  not  been  induced  to  express  the  gene,  maximum  levels  of  OTC 
resistance  were  also  lower  using  this  vector. 
Interestingly,  when  resistance  tests  were  performed  with  otrB  using  pET2  1  b, 
the  induced  E.  coli  displayed  a  much  less  substrate  specific  character  than  S.  albus  or 
S.  rimosus  15883s  carrying  otrB,  growing  to  some  level  when  any  of  the  three  drugs 
was  present.  Possible  causes  for  this  phenomenon  have  been  discussed  (4.5.3).  Future 
work  in  this  area  would  be  to  investigate  whether  otrB  can  confer  resistance  against  a 
wider  range  of  drugs  when  expressed  in  E.  coli  and  to  ascertain  the  mechanism  by 
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which  the  substrate  specificity  observed  in  the  natural  host  organism  is  lost  in  E.  coli. 
It  should  be  noted  at  this  point  that  otrB  shows  higher  sequence  similarity  scores  with 
multidrug  resistance  pumps  than  to  other  tetracycline/H+  antiporters. 
6.4  Construction,  expression  in  E.  coli  and  attempted  purification  of  a 
HisTagged  OtrB  fusion  protein. 
A  C-terminal  fusion  of  otrB  with  DNA  encoding  a  hexa-histidine  peptide  was 
constructed  using  pET2  I  b.  The  plasmid  was  transformed  into  E.  coli  BL2  I  (DE3),  a 
transformant  was  grown  and  induced  to  express  the  protein  by  the  addition  of  IPTG. 
Levels  of  OTC  resistance  in  this  strain  were  the  same  as  that  of  cells  expressing  non 
tagged  otrB  from  the  same  vector,  indicating  that  addition  of  the  HisTag  did  not 
interfere  with  the  function  of  the  protein.  In  contrast  to  these  results,  a  construct  in 
which  otrB  was  fused  at  the  N-terminus  to  the  HisTag  displayed  very  reduced  levels 
of  OTC  resistance,  this  was  presumed  to  be  due  to  mis-folding  of  OtrB  in  the 
membrane  directed  by  the  modified  N-terminal  end  of  the  protein. 
The  HisTag  was  added  to  OtrB  with  the  intention  of  isolating  the  fusion  0 
protein  by  the  principle  of  affinity  chromatography  using  nickel-agarose  as  a 
separation  matrix.  Purification  of  OtrB  from  membrane  fractions  of  induced  cells 
was  attempted,  and  the  column  eluates  analysed  by  SDS  PAGE.  No  bands 
characteristic  of  overrexpressed  proteins  were  observed  on  the  gel  when  stained. 
Furthermore,  no  signal  was  seen  when  gels  were  Western-blotted  and  probed  with 
AntiHis  monoclonal  antibody.  The  integrity  of  the  fusion  was  checked  by  sequencing 
of  the  expression  construct.  On  analysis  of  the  sequence  data  it  was  discovered  that 
an  error  had  been  made  when  designing  the  inverse  PCR  primer.  This  resulted  in  the 
junction  being  out  of  frame  with  the  polyhistidine-encoding  segment  of  the  vector. 
The  protein  product  therefore  contained  a  tag  that  was  made  up  largely  of  proline 
residues  and  so  did  not  bind  to  the  column  and  was  not  recognised  in  the 
immunodetection  assay. 
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6.5  Construction  and  expression  in  E.  coli  of  a  partial  deletion  of  otrB 
The  tetracyline  resistance  proteins  of  Gram-negative  organisms  consist  of  12 
transmembrane  helices  in  contrast  to  the  14  such  helices  observed  or  predicted  for 
TET  and  other  drug  exporters  of  Gram-positive  organisms.  This  observation  led  to 
the  construction  of  a  mutant  otrB  gene  that  encoded  only  the  first  six  and  the  last  six 
putative  transmembrane  helices.  The  aim  behind  the  construction  of  this  mutant  gene 
was  to  investigate  it's  expression  in  Gram-negative  E.  coli.  Would  the  deletion  of 
two  helices  of  OtrB  prevent  the  protein  from  functioning  in  Ecoli?  When  the 
construct  was  transformed  into  BL21(DE3)  pLysS,  OTC  resistance  was  observed  but 
at  a  very  low  level  compared  to  that  of  the  wild  type.  In  order  to  make  this 
experiment  more  complete,  a  similar  experiment  must  be  performed  using  a 
streptomycete  host,  this  would  give  an  indication  into  the  importance  of  the  two 
central  helices  in  Gram-positive  organisms.  Other  experiments  that  could  be 
performed  to  further  investigate  the  "preference"  of  bacteria  for  12  or  14  helix  drug 
efflux  proteins  would  be  to  attempt  to  express  a  TET  resistance  pump  from  a  Gram- 
negative  bacterium  in  a  Gram-positive  host.  For  example  to  transform  the  Tn10  tetA 
gene  which  encodes  a  12  TMH  protein  into  S.  aureus  which  is  the  host  of  TetK.  As 
well  as  going  some  way  to  investigate  the  choice  of  12  or  14  helix  tetracycline  pumps  C) 
the  experiment  performed  using  the  mutant  OtrB  indicates  that  there  are  no  residues 
absolutely  essential  for  OTC  resistance  present  in  the  deleted  region. 
6.6  Sequencing  and  protein  structure  analysis 
During  the  course  of  working  on  experiments  documented  in  this  thesis  it  became 
apparent  that  the  previous  sequences  reported  for  otrB  contained  some  errors.  In 
order  to  correctly  translate  the  gene  into  amino  acid  sequence  and  use  this  to  predict 
protein  structure,  the  correct  nucleotide  sequence  of  the  gene  was  of  importance.  The 
revised  nucleotide  sequence  was  then  used  in  TblastN  searched  to  find  closely  related 
proteins. 
The  amino  acid  sequence  was  itself  compared  against  other  proteins  from  computer 
databases  to  investigate  the  assignment  of  OtrB  to  a  specific  branch  of  the  Major 
Facilitator  Superfamily.  Once  the  correct  protein  sequence  had  been  compiled,  a 
model  of  the  membrane  topology  of  OtrB  was  drawn  up  using  computer-based 
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algorithms  that  produced  hydropathy  profiles  of  the  protein.  The  model  was  then 
used  to  decide  upon  the  exact  position  of  the  deletion  discussed  above.  Although 
computer-based  models  of  protein  structure  are  useful  they  are  not  to  be  taken  as 
absolute.  Further  experimental  work  is  needed  to  determine  the  topology  of  OtrB 
within  the  membrane.  This  can  be  done  by  fusions  of  OtrB  to  reporters  such  as  beta- 
lactamase  or  alkaline  phosphatase  or  by  protease  digestion  of  the  extruding  loops 
from  membrane  vesicles.  Future  work  to  determine  the  essential  and  important 
functional  residues  of  the  protein  would  help  to  elucidate  the  precise  mechanism  of 
resistance  of  the  protein. 
6.7  Future  Work 
It  is  most  important  that  the  HisTag  construct  be  re-made  using  the  correct  reverse 
PCR  primer  as  detailed  in  Chapter  5.  Once  this  plasmid  has  been  built  and 
transformed  into  E.  coli,  isolation  of  the  fusion  protein  by  the  NTA-  nickel  agarose 
column  method  should  be  acheivable. 
The  threat  of  drug  resistance  in  clinical  micro-organisms  is  rapidly  advancing, 
understanding  of  drug  resistance  mechanisms,  especially  those  of  producer  organisms 
is  important  when  designing  drugs  of  the  future.  Much  of  the  on-going  work  with 
Streptontyces  sp.  concerns  the  possibility  that  novel  polyketide  antibiotics  may  be 
synthesised  by  what  is  known  as  the  hybrid  genetics  approach  (Katz  &  Donadio, 
1993;  McDaniel  et  al,  1993;  Burson  et  al,  1997).  Recent  years  have  seen  the 
engineering  of  various  hybrid  polyketide  synthases  (Kramer  &  Khosla,  1998; 
Carreras  &  Khosla,  1998;  McDaniel  et  al,  1997).  It  is  envisaged  that  as 
understanding  of  the  "programming"  of  such  synthases  becomes  more  advanced, 
novel  compounds  could  be  synthesised  from  a  variety  of  genes  chosen  from  a  library 
of  polyketide  and  post-polyketide  biosynthesis  genes.  Understanding  of  the  resistance 
and  export  mechanisms  of  producer  organisms  is  critical  if  such  an  approach  is  to  be 
successful. 
188 BIBLIOGRAPHY 
Adamidis,  T.,  Champness,  W.  (1992).  Genetic  analysis  of  afsB,  a  Streptomyces 
coelicolor  locus  involved  in  global  antibiotic  regulation.  J.  Bacteriol.,  174.  pp4622- 
4628. 
Adamidis,  T.,  Riggle,  P.,  Champness,  W.  (1990).  Mutations  in  a  new  Streptomyces 
coelicolor  locus  which  globally  block  antibiotic  synthesis  but  not  sporulation.  J. 
Bacteriol.,  172.  pp2962-2969. 
Alderna,  M.  L.,  McMurray,  L.  M.,  Walmsley,  A.  R.,  Levy,  S.  B.  (1996).  Purification 
of  the  Tn1O  specified  tetracycline  efflux  antiporter  TetA  in  a  native  state  as  a 
polyhistidine  fusion  protein.  Mol.  Microbiol.  19.  ppI87-195. 
Allard,  J.  D.,  Bertrand,  K.  P  (1993).  Sequence  of  a  class  E  tetracycline  resistance 
gene  from  Escherichia  coli  and  comparison  to  related  tetracycline  efflux  proteins.  J. 
Bacteriol.,  175.  pp4554-4560. 
Allard,  J.  D.,  Gibson,  M.  L.,  Vu,  L.  H.,  Nguyen,  T.  T.,  Bertrand,  K.  P.  (1993) 
Nucleotide  sequence  of  class  D  tetracycline  resistance  genes  from  Salmonella 
ordonez.  Mol.  Gen.  Genet.,  237.  pp301-305. 
Amakasu,  H.,  Suzuki,  Y.,  Nishizawa,  M.,  Fukasawa,  T.  (1993).  Isolation  and 
characterisation  of  SGE-1;  a  yeast  gene  that  partially  suppresses  the  gall  mutation  in 
multiple  copies.  Genetics,  134.  pp675-683. 
Andersson,  H.  &  von  Heijne,  G.  (1993).  Sec  dependent  and  sec  independent 
assembly  of  E.  coli  inner  membrane  proteins:  the  topological  rules  depend  on  chain 
length.  EMBO.  J.  2.  pp683-691. 
Aukhil,  1.  Joshi,  P.,  Yan,  Y.  Erickson,  H.  P.  (1993).  Cell heparin  binding  domains  of 
hexabrachion.  J.  Biol.  Chem.  268.  pp2542-2553. 
189 Babcock,  M.  J.,  Kendrick,  K.  E.  (1990).  Transcriptional  and  translational  features  of  a 
sporulation  gene  of  Streptomyces  griseus.  Gene,  95.  pp57-63. 
Bainton,  N.  J.,  Stead,  P.,  Chhabra,  S.  R.,  Bycroft,  B.  W.,  Salmond  G.  P.  C.,  Stewart, 
G.  S.  A.  B.,  Williams,  P.  (1992).  N-(3-Oxohexanoyl)-L-homoserine  lactone  regulates 
carbapenem  antibiotic  production  in  Erwinia  carotovora.  Biochem.  J.  288.  pp997- 
1004. 
Baldwin,  S.  A.,  Henderson,  P.  J.  F.  (1989).  Homologies  between  sugar  transporters 
from  prokaryotes  and  eukaryotes.  Ann.  Rev.  Physiol.,  51.  pp459-47  1. 
Bascaran,  V.,  Sandez,  L.,  Hardisson,  C.,  Brana,  A.  F.  (1991).  Stringent  response  and 
initiation  of  secondary  metabolism  in  Streptomyces  clavuligerus.  Jnl.  Gen. 
Microbiol.,  137.  ppl625-1634. 
Benveniste,  R.  Davies,  J.  E.  (1973)  Arninoglycoside  antibiotic-inactivating  enzymes 
in  actinomycetes  similar  to  those  present  in  clinical  isolates  of  antibiotic-resistant 
bacteria.  Proc.  Nat.  Acad.  Sci.  USA.,  70.  pp2276-2280. 
Bibb,  M.  J.,  Biro,  S.,  Motamedi,  H.,  Collins,  J.  F.,  Hutchinson,  C.  R.  (1989). 
Analysis  of  the  nucleotide  sequence  of  the  Streptomyces  glaucesens  tcf?  ll  genes 
provides  key  information  about  the  enzymology  of  polyketide  antibiotic  biosynthesis. 
EMBO.  Jnl.,  8.  pp2727-2736. 
Bibb,  M.  J.,  Findlay,  P.  R.,  Johnson,  M.  W.  (1984).  The  relationship  bteween  base 
4 
composition  and  codon  usage  in  bacterial  genes  and  it's  use  for  the  simple  and 
reliable  identification  of  protein  coding  sequences.  Gene,  30.  ppl57-166. 
Bibi,  E.  &  Kaback,  H.  R.  (1990)  In  vivo  expression  of  the  IacY  gene  in  two  segments 
leads  to  functional  lactose  permease.  Proc.  Nat.  Acad.  Sci.  USA.,  87.  pp4325-4329. 
Binnie,  C.,  Warren,  M.,  Butler,  M.  J.  (1989).  Cloning  and  heterologous  expresion  in 
190 Streptomyces  lividans  of  Streptomyces  rimosus  genes  involved  in  oxytetracycline 
biosynthesis.  J.  Bacteriol.,  171.  pp887-895. 
Birnboirn,  H.  C.  &  Doly,  J.  (1979).  A  rapid  alkaline  extraction  procedure  for 
screening  recombinant  plasmid  DNA.  Nucl.  Acids.  Res.,  7.  ppI513-1523. 
Blanc,  V.,  Saleh-Bey,  K.,  Folcher,  M.,  Thompson,  C.  J.  (1995).  Molecular 
characterisation  and  transcription  analysis  of  a  multidrug  resistance  gene  cloned  from 
the  pristamycin-producing  organism,  Streptomyces  pristinaespiralis.  Mol. 
Microbiol.,  17.  pp989-999. 
Bu'Lock,  J.  D.  (1980).  Mycotoxins  as  secondary  metabolites.  In  The  biosynthesis  of 
mycotoxins:  A  study  in  secondary  metabolism.  Steyn,  P.  S.  (Ed.  )  Academic  Press. 
NY.  ppl-16. 
Burdett,  V.  (1986).  Streptococcal  tetracycline  resistance  mediated  at  the  level  of 
protein  synthesis.  J.  Bacteriol.,  165.  pp564-569. 
Burdett,  V.  (199  1).  Purification  and  characterisation  of  TetM,  a  protein  that  renders 
ribosomes  resistant  to  tetracycline.  J.  Biol.  Chem.,  266.  pp2872-2877. 
Burson,  K.  K.,  Huestis,  W.  H.,  Khosla,  C.  (1997).  Gene  shuffling  of  bacterial 
aromatic  polyketide  synthases.  Abstracts  of  papers  of  the  American  Chemical 
Society.  213.  PtI.  p83-BIOT. 
Butler,  M.  J.,  Friend,  E.  J.,  Hunter,  1.  S.,  Kaczmarek,  F.  S.,  Sugden,  D.  A.,  Warren, 
M.  (1989).  Molecular  cloning  of  resistance  genes  and  architecture  of  a  linked  cluster 
involved  in  biosynthesis  of  oxytetracycline  by  Streptontyces  rimosus.  Mol.  Gen. 
Genet.,  215.  pp231-238. 
Buttner,  M.  J.,  Chater,  K.  F.,  Bibb,  M.  J.  (1990).  Cloning  disruption  and 
transcriptional  analysis  of  three  RNA  polymerase  genes  of  Streptonzyces  coelicolor 
191 A(3)2.  Jnl  Bacteriol,  172.  pp3367-3378. 
Buttner,  M.  J.  Lewis,  C.  G.  (1992)  Construction  and  characterisation  of  Streptomyces 
coeliocolor  A(3)2  mutants  that  are  multiply  deficient  in  the  non  essential  hrd 
encoded  RNA-polymerase  sigma  factors.  J.  Bacteriol.,  174.  pp5l65-5167. 
Cabellero,  J.  L.,  Malpartida,  F.,  Hopwood,  D.  A.  (199  I)a.  Transcriptional 
organisation  and  regulation  of  an  antibiotic  export  complex  in  the  producing 
Streptomyces  culture.  Mol.  Gen.  Genet.,  278.  pp372-380. 
Cabellero,  J  L.,  Martinez,  E.,  Malpartida,  F.,  Hopwood,  D.  A.  (199  1  b).  Organisation 
and  functions  of  the  actVA  region  of  the  actinorhodin  biosynthetic  gene  cluster  of 
Streptontyces  coelicolor.  Mol.  Gen.  Genet.,  230.  pp401-412. 
Calcutt,  M.  J.  Cundliffe,  E.  (1989).  Use  of  a  fractionated  coupled  transcription 
translation  system  in  the  study  of  ribosomal  resistance  mechanisms  in  the  antibiotic 
producing  Streptomyces.  Jnl.  Gen.  Microbiol.,  135.  pp  1071-108  1. 
Campbell,  W. H.  (1992).  Expression  of  E.  coli  cytochrome  C  reductase  activity  from 
a  maize  NADH:  Nitrate  reductase  complementary  DNA.  Plant  Physiol.  99.  pp693- 
699. 
Carreras,  C.  W.,  Khosla,  C.  (1998).  Purification  and  in  vitro  reconstitution  of  the 
essential  protein  components  of  an  aromatic  polyketide  synthase.  Biochem.  37. 
pp2084-2088 
Chambers,  S.  P.,  Prior,  S.  E.,  Barstow,  D.  A.,  Minton,  N.  P.  (1988).  The  pMTL  nic 
cloning  vectors.  1.  Improved  pUC  polylinker  regions  to  facilitate  the  use  of  sonicated 
DNA  for  nucleotide  sequencing.  Gene,  68.  ppl39-149. 
Chang,  A.  C.  Y.  &  Cohen,  S.  N.  (1978).  Construction  and  characterisation  of 
amplifiable  multicopy  DNA  cloning  vehicles  derived  from  the  p15A  cryptic 
192 miniplasmid.  J.  Bacteriol.  134.  ppl  141-1156. 
Chater,  K.  F.,  Bruton,  C.  J.,  Plaskitt,  K.  A.  Buttner,  M.  J.,  Mendez,  C.  Helmann,  J.  D. 
(1989)  The  developmental  fate  of  Streptomyces  coelicolor  hyphae  depends  on  a  gene 
product  homologous  with  the  motility  sigma  factor  of  Bacillus  subtilis.  Cell,  59. 
pp133-143. 
Chater,  K.  F.  &  Merrick,  M.  J.  (1979).  In  "Developmental  Biology  ofprokaryotes"'. 
Parish,  J.  H.  (ed).  Blackwell  Scientific  Publications,  Oxford.  pp93-114. 
Charpentier,  E.,  Gerbaud,  G.,  Courvali,  P.  (1993)  Characterisation  of  a  new  class  of 
tetracycline  resistance  gene,  tet(S)  in  Listeria  monocytogenes  BM4210.  Gene,  131. 
pp27-34. 
Chopra,  1.  (1986)  Genetic  and  biochemical  basis  of  tetracycline  resistance.  Jnl. 
Antimicro.  Chemother.,  18.  No.  SC,  pp5l-56. 
Chopra,  1.  (1994)  Tetracycline  analogues  whose  primary  target  is  not  the  bacterial 
ribsome.  Antimicrob.  Agents.  Chernother.,  38.  pp637-640. 
Cline,  J.,  Braman,  J.  C.,  Hogrefe,  H.  H.  (1996).  PCR  fidelity  of  Pfu  DNA  polymerase 
and  other  thermostable  DNA  polymerases.  Nucleic  Acids  Research,  24.  pp3546- 
3551. 
Coque,  J.  J.,  Liras,  P.,  Martin,  J.  F.  (1993).  Genes  for  a  P-lactamase,  a  penicillin 
binding  protein  and  a  transmembrane  are  clustered  with  the  cephamycin  biosynthetic 
genes  in  Nocardia  lactamdurans.  EMBO  J.,  12.  pp631-639. 
Cortes,  J.,  Haydock,  S.  F.,  Roberts,  G.  A.  Bevitt,  D.  J.  Leadlay,  P.  F.  (1990).  An 
unusually  large  multifunctional  polypeptide  in  the  erythromycin  producing  polyketide 
synthetase  of  Saccharospora  erythraea.  Nature,  345.  pp  176-178. 
193 Crameri,  R.,  Davies,  J.  E.  (1986).  Increased  production  of  arninoglycosides 
associated  with  amplified  antibiotic  resistance  genes.  Jnl.  Antibiot.,  39.  pp128-135. 
Cuirale,  M.  S.,  McMurray,  L.  M.,  Levy,  S.  B.  (1984).  Intracistronic  complementation 
of  the  tetracycline  resistance  membrane  protein  of  TnIO.  J.  Bacteriol.,  157.  pp2l,  1- 
217. 
Cundliffe,  E.  (1987)  On  the  nature  of  antibiotic  binding  sites  in  ribosomes. 
Biochimie,  69.  pp863-869. 
Cundliffe,  E.  (1989).  How  antibiotic  producing  organisms  avoid  suicide.  Ann.  Rev. 
Microbiol.,  43.  pp207-233. 
Davies,  J.  E.  (1990).  What  are  antibiotics?  Archaic  functions  for  modern  activities. 
Mol.  Microbiol,  4,  ppl227-1232. 
Davies,  J.  E.,  Vonahsen,  U.,  Wank,  H.,  Schroeder,  R.  (1992).  Evolution  of  secondary 
metabolite  production  -  potential  roles  for  antibiotics  as  prebiotic  effectors  of 
catalytic  RNA  reactions.  In  "Secondary  metabolites,  theirfilliction,  and  evolution.  " 
Ciba  Foundation  Symposium.  171.  pp24-44. 
Decker,  H.,  Hutchinson,  C.  R.  (1993).  Transcriptional  analysis  of  the  Streptomyces 
glaucesens  tetracenomycin-C  biosynthesis  gene  cluster.  Jnl.  Bacteriol.,  175.  pp3887- 
3892. 
Demain,  A.  L.  (1980).  Do  antibiotics  form  in  nature?  Search,  11.  pp  148-15  1. 
Dente,  L.,  Cesareni,  G.,  Cortese,  R.  (1983).  pEMBL  -A  new  family  of  single 
stranded  plasmids.  Nucleic  Acid  Res.,  11.  ppl645-1655. 
Devereux,  J.,  Haeberli,  P.,  Smithies,  0.  (1984).  A  comprehensive  set  of  sequence 
analysis  programs  for  the  vax.  Nucleic  Acids  Res.  12.  pp387-395. 
194 Dietrich,  J.  B.,  Lorber,  B.,  Kern,  D.  (1991).  Expression  of  mammalian  tyrosine 
aminotransferase  in  Saccharomyces  cerevisiae  and  Escherichia  coli  :  purification  to 
homogeneity  and  characterisation  of  the  enzyme  overproduced  in  the  bacteria.  Eur.  J. 
Biochem.  201.  pp399-407. 
Dittrich,  W.  &  Schrempf,  H.  (1992).  The  unstable  tetracycline  resistance  gene  of 
Streptomyces  lividans  1326  encodes  a  putative  protein  with  similarities  to 
translational  elongation  factors  and  tet(M)  and  Tet(O)  proteins.  Antimicro.  Agents. 
Chemother.,  36.  pp  1119-1124. 
Distler,  J.,  Ebert,  A.,  Mansouri,  K.,  Pissowotzki,  K.,  Stockmann,  A  (1987).  Gene 
cluster  for  streptomycin  biosynthesis  in  Streptomyces  griseus:  nucleotide  sequence  of 
three  genes  and  analysis  of  transcriptional  activity.  Nucleic  acids.  Res.,  15.  pp8041- 
8056. 
Distler,  J.,  Mansouri,  K.,  Mayer,  G.,  Stockmann,  A  Piepersberg,  W.  (1992). 
Streptomycin  production  and  it's  regulation.  Gene,  115.  pp105-1  11. 
Doyle,  D.  (1987).  Ph.  D.  Thesis,  University  of  Glasgow. 
Doyle,  D.,  Butler,  M.  J.  Hunter,  1.  S.  (1988).  Molecular  analysis  of  the  oxytetracycline 
resistance  gene  otrA  of  Streptomyces  rimosus.  Heredity,  61.  pp305 
Doyle,  D.,  McDowall,  K.  J.,  Butler,  M.  J.,  Hunter,  L.  S.  (1991.  )  Characterisation  of  an 
oxytetracycline  resistance  gene  otrA  of  Streptomyces  rimosus.  Mol.  Microbiol.,  5. 
pp2923-2933. 
Durckheimer,  W.  (1975).  Tetracyclines:  chemistry,  biochemistry,  and  structure- 
activity  relations.  Angew.  Chem.  Int.  Ed.  Engl.,  14.  pp721-734. 
Eckert,  B.,  Beck,  C.  F.  (1989).  Topology  of  the  transposon  TnIO  encoded  tetracycline 
195 resistance  protein  within  the  inner  membrane  of  Escherichia  coli.  J.  Biol.  Chem., 
264.  pp  11663-11670. 
Engelman,  D.  M.  &  Steitz,  T.  A.  (1981).  The  sponaneous  insertion  of  proteins  into 
and  across  membranes  -  The  helical  hairpin  hypothesis.  Federation  Proc.  40.  pp  1557. 
Engelman,  D.  M.,  Steitz,  T.  A.,  Goldman,  A.  (1986).  Identifying  transbilayer  helices 
in  amino  acid  sequences  of  membrane  proteins.  Ann.  Rev.  Biophys.  Biophys.  Chem., 
15.  pp321-353. 
Fernandez-Moreno,  M.  A.,  Cabellero,  J.  L.  Hopwood,  D.  A.,  Malpartida,  F.  (199  1). 
The  act  cluster  contains  regulatory  and  antibiotic  export  genes,  direct  targets  for 
translational  control  by  the  bIdA  transfer  RNA  gene  of  Streptomyces.  Cell,  66. 
pp769-780. 
Fernandez-Moreno,  M.  A.,  Martinez,  E.,  Boto,  L.,  Hopwood,  D.  A.  Malpartida,  F. 
(1992a).  Nucleotide  sequence  and  deduced  functions  of  a  set  of  cotranscribed  genes 
of  Streptonzyces  coelicolor  A3(2)  including  the  polyketide  synthase  for  the  antibiotic 
actinorhodin.  J.  Biol.  Chem.,  267.  ppl9278-19290. 
Fernandez-Moreno,  M.  A.,  Martinez,  E.  Triana,  A.  J.,  Martinez,  E.,  Nierni.  J.,  Kieser, 
H.  M.,  Hopwood,  D.  A.,  Malpartida,  F.  (1992b).  abaA,  a  new  pleiotropic  locus  for 
antibiotic  production  in  Streptomyces  ceolicolor.  J.  Bacteriol,  174.  pp2958-2967. 
Flaschel,  E.  &  Friehs,  K.  (1993).  Improvement  of  downstream  processing  of 
recombinant  proteins  by  means  of  genetic  engineering  methods.  Biotech.  Adv.  11. 
pp3l-78. 
Friend,  E.  J.,  Hopwood,  D.  A.  (197  1).  The  linkage  map  of  Streptomyces  ritnosus.  Jnl. 
Gen.  Microbiol.,  68.  ppl87-197. 
Fujii,  T.,  Gramajo,  H.  C.,  Takano,  E.,  Bibb,  M.  J.  (1996).  redD  and  actll-Orf4, 
196 pathway  specific  regulatory  genes  for  antibiotic  production  in  Streptomyces 
coelicolor  A3(2),  are  transcribed  in  vitro  by  an  RNA-polymerase  holoenzyme 
containing  sigma  (HrdD).  Jnl  Bacteriol.  178.  pp3402-3405. 
Fujihara,  E.,  Kimura,  T.,  Shiina,  Y.,  Yamaguchi,  A.  (1996).  Transmembrane 
glutamic  acid  residues  play  essential  roles  in  the  metal-tetracycline/H'  antiporter  of 
Staphylococcus  aýreus.  FEBS  Lett.,  391.  pp243-246. 
Gallant,  J.  A.  (1979).  Stringent  control  in  Escherischia  coli.  Ann.  Rev.  Genet.,  13. 
pp393-415. 
Garven,  S.  (1994)  Ph.  D.  Thesis,  University  of  Glasgow. 
Ginn.  S.  L.,  Brown,  A  H.,  Skurray,  R.  A.  (1997).  Membrane  topology  of  the  metal 
tetracycline/H'  antiporter  TetA(K)  from  Staphylococus  aureus.  J.  Bacteriol.,  179. 
pp3786-3789. 
Gorman,  M.,  Chamberlin,  J.  W.,  Hammil,  R.  L.  (1968).  Monesin,  a  new  biologically 
active  compound.  V.  Compounds  related  to  monesisn.  Antimicrob.  Agents. 
Chemo.  ther.  11  pp363-368. 
Guo,  D.,  Liu,  J.,  Motlagh,  A.,  Jewell,  J.,  Miller,  K.  W.  (1996).  Efficient  insertion  of 
odd-numbered  transmembrane  segments  of  the  tetracycline  resistance  protein 
requires  even-numbered  insertion.  J.  Biol.  Chem.,  271.  pp30829-30834. 
Griffith,  J.  K.,  Baker,  M.  E.,  Rouch,  D.  A.,  Page,  M.  G.  P.,  Skurray,  R.  A.,  Paulsen,  I. 
T.,  Chater,  K.  F.,  Balwin,  S.  A.,  Henderson,  P.  J.  F.  (1992).  Membrane  transport 
proteins,  implications  of  sequence  comparisons.  Curr.  Opin.  Cell.  Biol.,  4.  pp684- 
695. 
Grimm,  A.,  Madduri,  K.,  Ali,  A.,  Hutchinson,  C.  R.  (1994).  Characterisation  of  the 
StrePtontyces  peuticus  ATCC-29050  gene  encoding  doxorubicin  polyketide  synthase. 
197 Gene,  15  1,  pp  I-  10. 
Guay,  G.  G.,  Khan,  S.  A.,  Rothstein,  D.  M.  (1993a).  The  tetK  gene  of  plasmid  pTI81 
from  Staphylococcos  aureus  encodes  an  efflux  protein  that  contains  14 
transmembrane  helices.  Plasmid,  30.  ppl63-166. 
Guay,  G.  G.,  Tuckman,  M.,  McNicholas,  P.,  Rothstein,  D.  M.  (1993b).  The  teff  gene 
from  Staphylococcus  aureus  mdiates  transport  of  potassium  in  Escherichia  coli.  Jnl. 
Bacteriol.  175.  pp4927-4929. 
Guay,  G.  G.,  Tuckman,  M.,  Rothstein,  D.  M.  (1994).  Mutations  in  the  tetA(B)  gene 
that  cause  a  change  in  the  substrate  specificity  of  the  tetracycline  efflux  pump. 
Antimicrob.  Agents.  Chernother.,  38.  pp857-860. 
Guffanti,  A.  A.,  Krulwich,  T.  A.  (1995).  Tetracycline/H+  antiport  and  Na+/H+  antiport 
catalysed  by  the  Bacillus  subtilis  TetA(L)  transporter  expressed  in  Escherichia  coli. 
J.  Bacteriol.,  177.  pp4557-4561. 
Guilfoile,  P.  G.  Hutchinson,  C.  R.  (1992).  Sequence  and  transcriptional  analysis  of 
the  Streptomyces  glaucesens  tcrnAR  tetracenomycin  resistance  and  repressor  gene 
loci.  I  Bacteriol.,  174.  pp3651-3658. 
Guthrie,  E.  P.,  Chater,  K.  F.  (1990).  The  level  of  a  transcript  required  for  the 
production  of  a  Streptomyces  coelicolor  antibiotic  is  conditionally  dependent  on  a 
tRNA  gene.  J.  Bacteriol.,  172.  pp6189-6193. 
Guthrie,  E.  P.,  Flaxman,  C.  S.,  White,  J.,  Hodgson,  D.  A.,  Bibb,  M.  J.,  Chater,  K.  F. 
(1998).  A  response-regulator-like  activator  of  antibiotic  synthesis  from  Streptontyces 
coeficolor  A3(2)  with  an  amino-terminal  domain  that  lacks  a  phosphorylation  pocket. 
Microbiology,  144.  pp727-738. 
Hahlbrock,  K.  (198  1).  Flavenoids.  In,  "The  Biochemistry  of  Plants  ".  Conn,  E.  E. 
198 (ed.  ).  Academic  Press,  Inc.,  New  York.  pp425-456. 
Hanahan,  D.  (1983).  Studies  on  the  transformation  of  Escherichia  coli  with  plasmids. 
Jnl.  Genl.  Microbiol.,  166.  pp557. 
Hansen,  L.  M.,  McMurray,  L.  M.,  Levy,  S.  B.,  Hirsh,  D.  C.  (1993).  A  new 
tetracycline  determinant,  tetH  from  Pastuerella  maltocida  specifying  active  efflux  of 
tetracycline.  Antimicrob.  Agents.  Chernother.,  37.  pp2699-2705. 
Hara,  0.  &  Beppu,  T.  (1982)  Induction  of  Streptomycin  inactivating  enzyme  by  A- 
factor  in  Streptomyces  griseus.  Jnl.  Antibiot,  35.  pp1208-1215- 
Hara,  0.,  Horinouchi,  S.,  Uozumi,  T.,  Beppu,  T.  (1983).  Genetic  analysis  of  A-factor 
synthesis  in  Streptomyces  coelicolor  A3(2)  and  Streptomyces  griseus.  Jnl.  Gen 
Microbiol.,  129.  pp2939-2944. 
Helmann,  J.  D.  Marquez,  L.  M.,  Chamberlin,  M.  J.  (1988).  Cloning,  sequencing  and 
disruption  of  the  Bacillus  subtilis  (;  28  gene.  J.  Bacteriol.  170.  ppl568-1574. 
Henderson,  P.  J.  F.  (1990).  Proton  linked  sugar  transport  systems  in  bacteria.  Jnl. 
Bioenerget.  Biomemb.,  22.  pp525-569. 
Henderson,  P.  J.  F.,  MacPherson,  A.  J.  S.  (1986).  Assay,  genetics,  proteins  and 
reconstitution  of  proton  linked  galactose,  arabinose  and  xyose  transport  systems  of 
Escherichia  coli.  Methods.  Enzymol.,  125.  pp387-429. 
Henderson,  P.  J.  F.,  Maiden,  M.  C.  J.  (1990).  Homologous  sugar  transport  proteins  in 
Escherichia  coli  and  their  relatives  in  both  prokaryotes  and  eukaryotes.  Phil.  Transac. 
Royal.  Soc.  Lond.  (B),  326.  pp391-410. 
Heukshoven,  J.  &  Dernick,  R.  (1988).  Improved  silver  staining  procedure  for  fasr 
staining  in  phastsystern  development  unit  .  1.  Staining  of  Sodium  dodecyl  sulphate 
199 gels.  Electrophoresis.  9.  pp28-32. 
Hochstein,  F.  A.,  Schach  von  Wittenau,  M.,  Tanner,  F.  W.  Jr.,  Muraki,  K.  (1960).  2 
Acetyl-2-decarboxamidooxytetracycline.  J.  Am.  Chem.  Soc.,  82.  pp5934. 
Hochuli,  E.  (1988).  Large-scale  chromatography  of  recombinant  proteins.  J. 
Chromatogr.,  444.  pp293-302. 
Hollingshead,  S.,  Vapnek,  D.  (1985).  Nucleoticle  seqUence  analysis  of  a  gene 
encoding  a  streptomycin,  spectinomycin  adenyltransferase.  Plasmid,  13.  ppl7-30. 
Hong,  S-K.,  Kito,  M.,  Beppu,  T.,  Horinouchi,  S.  (199  1.  )  Phosphorylation  of  the  afsR 
product,  a  global  regulatory  protein  for  secondary  metabolite  production  in 
Streptomyces  coelicolor  A3  (2).  J.  Bacteriol.  173.  pp23  11-23  IS. 
Hopp,  T.  P.  Prickett,  K.  S.,  Price,  V.  L.  Libby,  R.  T.  March,  C.  J.,  Ceretti,  D.  P., 
Urdal,  D.  L.,  Conlon,  P.  J.  (1989).  A  short  polypeptide  marker  sequence  useful  for 
recombinant  protein  identification  and  purification.  Bio/Technology.  6.  pp1204- 
1210. 
Hopwood,  D.  A.,  Bibb,  M.  J.,  Chater,  K.  F.,  Kieser,  T.,  Bruton,  C.  J.,  Kieser,  H.  M., 
Lydiate,  D.  J.,  Smith,  C.  P.,  Ward,  J.  M.,  Schrempf,  H.  (1985).  Genetic  manipulation 
of  Streptonzyces;  a  laboratory  manual.  The  John  Innes  Foundation,  Norwich,  UK. 
Hopwood,  D.  A.  &  Khosla,  C.  (1992)  Genes  for  polyketide  secondary  metabolic 
pathways  in  microorganisms  and  plants.  In  "  Secondary  inetabolites,  theirfiniction 
and  evolution  "  Ciba  Foundation  Symposium  17  1.  pp88-  112. 
Hopwood,  D.  A.,  Sherman,  D.  H.  (1990).  Molecular  genetics  of  polyketide  synthesis 
and  it's  comparison  to  fatty  acid  biosynthesis.  Ann.  Rev.  Genet.,  24.  pp37-66 
Hopwood,  D.  A.,  Wildermuth,  H.  Palmer,  H.  M.  (1970.  )  Mutants  of  Streptontyces 
200 ceolicolor  defective  in  sporulation.  Jnl.  Gen.  Microbiol.,  61.  pp397-408. 
Hoshino,  T.,  Ikeda,  T.,  Tornizuka,  N.,  Furukawa,  K.  (1985.  )  Nucleotide  sequence  of 
the  tetracycline  resistance  gene  of  pTHT15,  a  thermophillic  Bacillus  plasmid; 
comparison  with  staphylococcal  tetracycline  resistant  controls.  Gene,  37.  ppl3l-138. 
Horinouchi,  S.  &  Beppu,  T.  (1983).  Cloning  of  a  pleiotropic  gene  that  positively 
contols  biosynthesis  of  A-factor,  actinorhodin  and  prodigiosin  in  Streptomyces 
coelicolor  A3(2)  and  Streptomyces  lividans.  J.  Bacteriol.  155.  ppl238-1248. 
Horinouchi,  S.  &  Beppu,  T.  (1994).  A-factor  as  a  microbial  hormone  that  controls 
cellular  differentiation  and  secondary  metabolism  in  Streptomyces  griseus.  Mol. 
Microbiol.  12.  pp859-864. 
Horinouchi,  S.,  Kito,  Nishiyarna,  N.,  Furuya,  K.,  Hong,  S-K.,  Miyake,  K.,  Beppu,  T. 
(1990).  Primary  structure  of  AfsR,  a  global  regulatory  protein  for  secondary 
metabolite  formation  in  Streptomyces  coelicolor  A3(2).  Gene,  95.  pp49-56. 
Horinouchi,  S.,  Kumada,  Y.,  Beppu,  T.  (1984).  Unstable  genetic  determinant  of  A- 
factor  biosynthesis  in  streptomycin  producing  organisms:  cloning  and 
characterisation.  J.  Bacteriol.  158.  pp481-487. 
Hoshino,  T.  T.,  Ikeda,  N.,  Tornizuka,  N.,  Furukawa.  (1985).  Nucleotide  sequence  of 
the  tetracycline  resistance  gene  of  pTHT15,  a  thermophiliic  Bacillus  plasmid; 
comparison  with  staphylococcal  TCR  controls.  Gene,  37.  ppl3l-138. 
Hunter  I.  S.  &  Hill,  R.  A.  (1997).  Tetracyclines;  Chemistry  and  molecular  genetics  of 
their  formation.  In  "Biotechnology  of  Industrial  antibiotics.  "  Strohl,  W.  D.  (ed.  ) 
Marcel  Decker.  pp2ll-2i  1. 
Hunter,  1.  S.  (1985).  Gene  cloning  in  Streptomyces.  In  DNA  cloning  11;  a  practical 
approach.  Glover,  D.  M.  (ed.  )  IRL  Press.  ppl9-44. 
201 Inouye,  M.,  Arnheim,  N.,  Sternglanz,  R.  (1973).  Bacteriophage  T7  lysozyme  is  an 
acetylmuranyl  L-alanine  amidase.  J.  Biol.  Chem.  248.  pp7247-7252. 
Ishizuka,  H.,  Horinouchi,  S.,  Kieser,  H.  M.,  Hopwood,  D.  A.,  Beppu,  T.  (1992).  A 
putative  two  component  regulatory  system  involved  in  secondary  metabolism  in 
Streptomyces  species.  Jnl  Bacteriol.  174.  pp7585-7594. 
Ives,  C.  L.,  Bott,  K.  F.  (1990).  Cloned  Bacillus  subtilis  chromosomal  DNA  mediates 
tetracycline  resistance  when  present  in  multiple  copies.  J.  Bacteriol.,  171.  pp1801- 
1810. 
Jessen-Marshall,  A.  E.,  Paul,  N.  J.,  Brooker,  R.  J.  (1995).  The  conserved  motif, 
GXXX(DE)(R1K)XG[X](R1K)(R1K),  in  hydrophillic  loop2/3  of  the  lactose  permease. 
J.  Biol.  Chem.,  270.  ppl6251-16257. 
Ji,  G.  Y.,  Beavis,  R.  C.,  Novick,  R.  P.  (1995).  Cell  density  control  of  staphylococcal 
virulence  mediated  by  an  octapeptide  pheremone.  Proc.  Natl.  Acad.  Sci.  USA.  92. 
pp12055-12059 
Kanazawa,  S.  Driscoll,  M.,  Struhl,  K.  (1988).  ATR-I:  Saccharomyces  cerevisiae 
gene  encoding  a  transmembrane  required  for  aminotiazole  resistance.  Mol.  Cell. 
Biol.,  8.  pp664-673. 
Kaneko,  M.,  Yamaguchi,  A.,  Sawai,  T.  (1985).  Energetics  of  tetracycline  efflux 
encoded  by  TOO  in  Escherichia  coli.  FEBS.  Lett.,  193.  pp  194-198. 
Katz,  E.  &  Demain,  A.  L.  (1977).  The  peptide  antibiotics  of  Bacillus;  chemistry, 
biogenesis  and  possible  functions.  Bacteriol.  Rev.,  41.  pp449-474. 
Katz,  L.  &  Donadio,  S.  (1993).  Polyketide  synthesis-  Prospects  for  hybrid  antibiotics. 
Ann.  Rev.  Microbiol.  47.  pp875-912. 
202 Katz,  E.,  Thopson,  C.  J.,  Hopwood.  D.  A.  (1983).  Cloning  and  expression  of  the 
tyrosinase  gene  from  Streptomyces  antibioticus  in  Streptomyces  lividans.  J.  Gen. 
Microbiol.  129.  pp2703-2714. 
Keleman,  G.  H.,  Brown,  G.  L.,  Kormanec,  J.,  Potuckova,  L.,  Chater,  K.  F.  Buttner,  M. 
J.  (1996).  The  positions  of  the  sigma  factor  genes  whiG  and  SigF  in  the  hierarchy 
controlling  the  development  of  spore  chains  in  the  aerial  hyphae  of  Streptomyces 
coelicolor  A3(2).  Mol.  Microbiol.,  21.  pp595-603. 
Keleman,  G.  H.,  Plaskitt,  K.  A.,  Lewis,  C.  G.,  Findlay,  K.,  Buttner,  M.  J.  (1995). 
Deletion  of  DNA  lying  close  to  the  g1kA  locus  induces  ectopic  sporulation  in 
Streptonzyces  coelicolor  A3(2).  Mol.  Microbiol.,  17.  pp221-230. 
Kendrick,  E.,  Ensign,  J.  C.  (1983).  Sporulation  of  Streptomyces  griseus  in  submerged 
cluture.  J.  Bacteriol.,  155.  pp357-366 
Khokhlov,  A.  S.  (1982).  Low  molecular  weight  microbial  bioregulators  of  secondary 
metabolism.  In  Over  production  of  Microbial  product,  Krumphanzi,  V.,  Sikyta,  B& 
vanek,  Z.  (eds)  London  Academic,  UK.  pp97-109. 
Khokhlov,  A.  S.,  Tovarova,  I.  I.,  Borisova,  L.  N.,  Pliner,  S.  A.,  Shevshenko,  L.  A. 
(1967).  A  factor  responsible  for  the  biosynthesis  of  streptomycin  by  a  mutant  strain 
of  Actinomyces  streptomycinii.  Dokl.  Acad.  Nauk.  SSSR.,  177.  pp232-235. 
Khokhlov,  A.  S.,  Tovarova,  I.  I.,  Kleiner,  E.  Y.,  Kovalenko,  1.  V.  (1973).  Effect  of  A- 
factor  on  the  growth  of  asporogeneous  mutants  of  Streptonzyces  griseus  not 
producing  this  factor.  Z.  AlIg.  Mikrobiol,  13.  pp647-655. 
Khosla,  C.,  Daniel,  R.,  Ebert-Khosla,  S.,  Torres,  R.,  Sherman,  D.  H.  Bibb,  M.  J. 
Hopwood,  D.  A.  (1993).  Genetic  construction  and  functional  analysis  of  hybrid 
polyketide  synthases  containing  heterologous  acyl  carrier  proteins.  J.  Bacteriol.,  175. 
203 pp2197-2204. 
Khosla,  C.,  Ebert-Khosla,  S.,  Hopwood,  D.  A.  (1992).  Targeted  gene  replacements  in 
a  Streptomyces  polyketide  synthase  gene  cluster:  role  for  the  acyl  carrier  protein. 
Mol.  Microbiol.,  6.  pp3237-3249. 
Kitamura,  I.,  Tobe,  H.,  Yashimoto,  A.,  Oki,  T.,  Nagahawa,  H.,  Takeuchi,  T., 
Urnezawa,  H.  (1981).  Biosynthesis  of  aklavinone  and  aclacinomycins.  J.  Antibiot., 
34.  pp959-964. 
Kormanec,  J.,  Farkovski,  M.  (1983).  Differential  expression  of  principal  sigma  factor 
homologues  of  Streptomyces  aurefaciens  correlates  with  the  developmental  stage. 
Nucleic  Acids.  Res.,  21.  pp3647-3652. 
Kormanec,  J.,  Potuckova,  R.,  Rezuchkova,  B.  (1994).  The  Streptontyces  aureofaciens 
homologue  of  the  vvhiG  gene  encoding  a  putative  sigma  factor  essential  for 
sporulation.  Gene,  143.  pplOI-103. 
Kramer,  P.  J.  &  Khosla,  C.  (1998).  Enginering  of  novel  polyketicles  -  Progress  and 
prospects.  Annal.  N.  Y.  Acad.  Sci.,  799.  pp32-34. 
Kuhn,  A.  (1988).  Alterations  in  the  extracellular  domain  of  M13  procoat  protein 
make  its  membrane  insertion  dependent  on  secA  and  secY.  Eur  J  Biochem.  177. 
pp267-27  1. 
Kyte,  J.  &  Doolittle,  R.  F.  (1982).  A  simple  method  for  displaying  the  hydrophathic 
character  of  a  protein.  J.  Mol.  Biol.,  157.  ppI05-132- 
Lawlor,  E.  J.,  Baylis,  H.  A.,  Chater,  K.  F.  (1987.  )  Pleiotropic  morphological  and 
antibiotic  deficiencies  result  from  mutations  in  a  gene  encoding  a  tRNA-like  product 
of  Streptomyces  coelicolor  A3(2).  Genes.  Dev.,  2.  pp  1305-13  10. 
204 Le  Blanc,  D.  J.,  Lee.,  L.  N.,  Titmas,  B.  M.,  Smith,  C.  J.,  Tenover,  F.  C.  (1988). 
Nucleotide  sequence  analysis  of  tetracycline  resistance  gene  tetO  from  Streptomyces 
mutans  DL5.  J.  Baeteriol.,  170.  pp3618-3626. 
Leboul,  J.,  Davies,  J.  (1982).  Enzymatic  modification  of  hygromycin  B  in 
Streptomyces  hygroscopicus.  Jnl.  Antibiot.,  35.  pp527-528. 
Leskiw,  B.  K.,  Bibb,  M.  J.  Chater,  K.  F.  (199  1).  The  use  of  a  rare  codon  specifically 
during  development?  Mol  Microbiol.,  5.  p2861-2867. 
Levy,  S.  B.,  McMurray,  L.  M.,  Burdett,  V.,  Courvalin,  P.  Hillen,  W.,  Roberts,  M.  C., 
Taylor,  D.  E.  (1989).  Nonclamenture  for  tetracycline  resistance  determinants. 
Antimicro.  Agents.  Chernother.  33.  ppl373-1374. 
Lewis,  K.  (1994).  Multidrug  resistance  pumps  in  bacteria:  variations  on  a  theme. 
Trends.  Biochem.  Sci.,  19.  pp  119-123. 
Lineal,  M.  (1993)  Vesicular  transporters  join  the  major  facilitator  superfamily  (MFS). 
Trends.  Biochem.  Sci-,  18.  pp248-249. 
MacNeil,  D.  J.  (1988).  Characterisation  of  a  unique  methyl-specific  restriction 
system  in  Streptomyces  avermitilis.  Jnl.  Bacteriol.  170.  pp5607-5612. 
Maiden,  M.  C.  J.  (1987)  Ph.  D.  Thesis,  University  of  Cambridge. 
Maiden,  M.  C.  J.,  Jones-Mortimer,  M.  C.,  Henderson,  P.  J.  F.  (1988).  The  cloning, 
DNA  sequence  and  over  expression  of  the  gene  AraE  coding  for  arabinose-proton 
symport  in  Escherichia  coli  K12.  J.  Biol.  Chem.,  263.  pp8003-8010. 
Malpartida,  F.  M.,  Hopwood,  D.  A.  (1984).  Molecular  cloning  of  the  whole 
biosynthesis  pathway  of  a  Streptomyces  antibiotic  and  it's  expression  in  a 
heterologous  host.  Nature,  309.  pp462-464. 
205 Malpartida,  F.  M.,  Hopwood,  D.  A.  (1986).  Physical  and  genetic  characterisation  of 
the  gene  cluster  for  the  antibiotic  actinorhodin  in  Streptomyces  coelicolor  A3(2). 
Mol.  Gen.  Genet.,  205.  pp66-73. 
Manniatis,  T.,  Fritsch,  E.  F.,  Sambrook,  J.  (1982).  Molecular  cloning:  A  laboratory 
manual.  Cold  Spring  Harbour,  NY. 
Marger,  M.  D.,  Saier,  M.  F.  (1993).  A  major  superfamily  of  transmembrane 
facilitators  that  catalyse  uniport,  symport  and  antiport.  Trends.  Biochem.  Sci.,  18. 
ppl3-20. 
Martinez-Costa,  0.  H.,  Arias,  P.,  Romero,  N.  M.,  Parro,  V.,  Mellado,  R.  P., 
Malpartida,  F.  (1996).  A  relA/spoT  homologous  gene  from  Streptomyces  coelicolor 
A3(2)  controls  antibiotic  synthesis  genes.  J.  Biol.  Chem.,  271.  pp10627-10634. 
Martin,  P.,  Tieu-Cuot,  P.,  Courvalin,  P.  (1986).  Nucleotide  sequence  of  the  tetM 
resistance  determinant  of  the  streptococcal  conjugative  shuttle  transposon  Tn1545. 
Nuc.  Acids.  Res.,  14.  pp7047-7058. 
Matsumoto,  A.,  Hong,  S-K.,  Ishizuka,  H.,  Horinouchi,  S,  Beppu,  T.  (1994). 
Phosphorylation  of  the  AfsR  protein  involved  in  secondary  metabolism  in 
Streptomyces  species  is  by  a  eukaryotic-type  kinase.  Gene,  146.  pp47-56. 
McCormick,  J.  R.  D.,  Sjolander.  N.  0.,  Hirsch,  U.,  Jenssen,  E.  R.,  Doeschuk,  A.  P.  (1957)  A  new 
family  of  antibiotics,  the  demethyltetracyclines.  J.  Am.  Chem.  Soc.,  79.  pp456  1. 
McCormick,  J.  R.  D.  (1966).  Biosynthesis  of  the  tetracyclines,  an  integrated 
biosynthetic  scheme.  In  Antibiotics,  advances  in  research,  production  and  clinical 
use.  Herold,  M.,  Gabriel,  Z.  (ed.  's)  Czechoslovak  medical  press.  pp556-573. 
McCormick,  J.  R.  D.  (1968).  Biosynthesis  of  tetracyclines.  X.  Protetrone.  J.  Am. 
Chem.  Soc.,  90.  pp7l26-7127. 
206 Chem.  Soc.,  90.  pp7l26-7127. 
McDaniel,  R.,  Ebert-Khosla,  S.  Hopwood,  D.  A.,  Khosla,  C.  (1993).  Engineered 
biosynthesis  of  novel  polyketides.  Science,  262.  ppl546-1550. 
McDaniel,  R.,  Kao,  C.  M.,  Hwang,  S.  J.,  Khosla,  C.  (1997).  Engineered  intermodular 
and  intramodular  polyketide  synthase  fusions.  Chemistry  &  Biology.  4.  pp667-674. 
McDowall,  K.  J.,  Doyle,  D.,  Butler,  M.  J.,  Binnie,  C.,  Warren,  M.,  Hunter,  1.  S. 
(199  1).  Molecular  genetics  of  oxytetracycline  production  by  Streptomyces  rimosus. 
In  Genetics  and  Productformation  in  Streptomyces.  Baumberg,  S.  (ed)  Plenum 
Press,  NY.  pp105-116. 
MacGregor-Prycle,  S.  E.  (1995).  Ph.  D.  Thesis.  University  of  Glasgow. 
McMurray,  L.,  Levy,  S.  B.  (1995).  Decreased  function  of  the  class  B  tetracycline 
efflux  protein  TetA,  with  mutations  at  asparagine  15,  a  putative  intramembrane 
residue.  J.  Bacteriol.  174.  pp6294-6297. 
McMurray,  L.,  Petrucci,  R.  E.,  Levy,  S.  B.  (1980).  Active  efflux  of  tetracycline 
encoded  by  four  genetically  different  tetracycline  resistance  determinants  in 
Escherichia  coli.  Proc.  Nat.  Acad.  Sci.  USA.,  77.  pp3974-3977. 
McNicholas,  P.,  Chopra,  I.,  Rothstein,  D.  M.  (1992).  Genetic  analysis  of  the  letA(C) 
gene  on  plasmid  pBR322.  J.  Bacteriol.,  174.  pp7926-7933. 
McNicholas,  P.,  McGlynn,  M.,  Guay,  G.  G.,  Rothstein,  D.  M.  (1995).  Genetic 
analysis  suggests  functional  interactions  between  the  N  and  C  terminal  domains  of 
the  TetA(C)  efflux  pump  encoded  by  pBR322.  J.  Bacteriol.,  177.  pp5355-5357 
Mendez,  C.,  Chater,  K.  F.  (1987).  Cloning  of  whiG,  a  gene  critical  for  sporulation  of 
Streptomyces  coelicolor  A3(2).  Jnl.  Bacteriol,  169.  pp5715-5720. 
207 Merrick,  M.  J.  (1976).  A  morphological  and  genetic  mapping  study  of  bald  colony 
mutants  of  Streptomyces  coelicolor.  Jnl.  Gen.  Microbiol.,  96.  pp299-315. 
Metzger,  P.  A.,  Schreiber,  G.,  Aizenman,  E.,  Cashel,  M.,  Glaser,  G.  (1989). 
Characterisation  of  the  relA  I  mutation  and  a  comparison  of  relA  with  new  relA  null 
alleles  in  Escherichia  coli.  Jnl  Biol.  Chem.  264.  pp21146-21152. 
Miller,  P.  A.,  Sjolander,  N.  0.,  Nalesnyk,  S.,  Arnold,  N.,  Johnson,  S.,  Doerschuk,  A. 
D.,  McCormick,  J.  R.  D.  (1960).  Cosynthetic  factor  1,  a  factor  in  hydrogen  transfer  in 
Streptomyces  aureofaciens.  J.  Am.  Chem.  Soc.,  82.  pp5002-5003. 
Milton,  D.  L.,  Harman,  A.,  Camara,  M.,  Chhabra,  S.  R.,  Bycroft,  B.  W.,  Stewart,  G. 
S.  A.  B.,  Williams,  P.  (1997).  Quorum  sensing  in  Vibrio  anguillaruln; 
Characterisation  of  the  vanIlvanR  locus  and  identification  of  the  autoinducer  N-(3- 
Oxodecanoyl)-L-Homoserine  lactone.  J.  Bacteriol.  179.  pp3004-3012. 
Miyake,  K.,  Kuzuyama,  T.,  Horinouchi,  S.,  Beppu,  T.  (1990).  The  A-factor  binding 
protein  of  Streptomyces  griseus  negatively  controls  streptomycin  production  and 
sporulation.  J.  Bacteriol.  172.  pp3003-3008. 
Moffatt,  B.  A.  &  Studier,  F.  W.  (1987)  . 
T7  lysoszyme  inhibits  transcription  by  T7 
polymerase.  Cell  49.  pp221-227 
Muiry,  J.  A.  R.  (1989).  Ph.  D.  Thesis.  University  of  Cambridge. 
Nakano,  H.,  Matsuhashi,  Y.,  Takeuchi,  T.,  Umezawa,  H.  (1977).  Distribution  of 
chloramphenicol  acety  Itrans  fe  rase  and  chlo  ramphe  n  icol-3  -acetate  esterase  among 
Streptomyces  and  Corynebacterium.  Jnl.  Antibiot.,  30.  pp76-82. 
Neal,  R.  J.,  Chater,  K.  F.  (1987).  Nucleotide  sequence  analysis  reveals  similarities 
between  proteins  determining  methylenomycin-A  resistance  in  Streptontyces  and 
208 tetracycline  resistance  in  eubacteria.  Gene,  58.  pp229-241. 
Neal,  R.  J.  &  Chater,  K.  F.  (199  1).  Bidirectional  promoter  and  terminator  regions 
bracket  mmr,  a  resistance  gene  embedded  in  the  Streptomyces  coelicolor  A3(2)  gene 
cluster  encoding  methylenomycin  production.  Gene  100.  pp75-83. 
Needleman,  S.  B.  &  Wunsch,  C.  D.  (1970).  A  general  method  applicable  to  the 
search  for  similarities  in  the  aniino  acid  sequences  of  two  proteins.  J.  Mol.  Biol.  48. 
pp443-453. 
Nguyen,  T.  T.,  Postle,  K.,  Bertrand,  K.  P.  (1983).  Sequence  homology  between  the 
tetracycline  resistance  determinants  of  TnIO  and  pBR322.  Gene,  25.  pp83-92. 
Nikolich,  M.  P.,  Shoemaker,  N.  B.,  Salyers,  A.  A.  (1992).  A  Bacteroides  tetracycline 
resistance  gene  represents  a  new  class  of  ribosome  protection  tetracycline  resistance. 
Antimicro.  Agents.  Chernother.,  36.  ppIO05-1020. 
Noguchi,  N.,  Aoki,  M.,  Sasatsu,  M.,  Kono,  M.,  Shishido,  K.,  Ando,  T.  (1986). 
Determination  of  the  complete  nucleotide  sequence  of  pNS  1,  a  staphylococcal 
tetracycline  resistance  plasmid  propagated  in  Bacillus  subtilis.  FEMS  Lett.,  37. 
pp283-288. 
Ochi,  K.  (1985).  Sporulation  and  antibiotic  production  by  Bacillus  sublilis  mutants 
deficient  in  intracellular  proteases.  Agric.  Biol.  Chem.,  49.  pp905-907. 
Ochi,  K.  (1986a).  A  decrease  in  GTP  content  is  associated  with  aerial  mycelium 
formation  in  Streptonzyces  MA406-A-1.  Jnl.  Gen  Microbiol.,  132.  pp299-305. 
Ochi,  K.  (1986b).  Occurrence  of  the  stringent  response  in  Streptomyces  spp.  and  it's 
significance  for  the  initiation  of  morphological  and  physiological  differentiation.  Jnl- 
Gen.  Microbiol.,  132.  pp2621-263  1. 
209 Ochi,  K,  (1987a).  Changes  in  nucleotide  pools  during  sporulation  of  Streptomyces 
griseus  in  submerged  culture.  Jnl.  Gen.  Micro.,  133.  pp2787-2795. 
Ochi,  K.  (1987b).  A  rel  mutation  abolishes  an  enzyme  induction  needed  for 
actinorhodin  synthesis  by  Streptomyces  antibioticus.  Agric.  Biol.  Chem.,  51.  pp829- 
835. 
Ochi,  K.  (1990).  Streptomyces  reIC  mutants  with  an  altered  ribosomal  protein  St-L  II 
and  genentic  analysis  of  a  Streptomyces  griseus  reIC  mutant.  J.  Bacteriol.,  172. 
pp4008-4016. 
Ochi,  K.,  Oshawa,  S.  (1984).  Initiation  of  antibiotic  production  of  the  stringent 
response  of  Bacillus  subtilis  Marburg.  J.  Gen.  Microbiol.,  130.  pp2473-2482. 
Ohnuki,  T.,  Katoh,  T.,  Imanka,  T.,  Aiba,  S.  (1985).  Molecular  cloning  of  the 
tetracycline  resistance  gene  from  Streptomyces  ritnosus  in  Streptomyces  griseus  and 
characterisation  of  the  cloned  genes.  J.  B  acteriol.,  16  1.  pp  10  10-  10  16. 
Oliva,  B.,  Chopra,  1.  (1992).  Tetracycline  determinants  provide  poor  protection 
against  some  tetracyclines;  furhter  evidence  for  division  of  tetracyclines  into  two 
classes.  Anti.  Micro.  Agents.  Cherno.  36  pp876-878. 
Oliva,  B.,  Gordon,  G  G.,  McNicholas,  P.,  Ellestad,  G.,  Chopra,  1.  (1992).  Evidence 
that  tetracycline  analogues  whose  targets  are  not  the  bacterial  ribosome  cause  lysis  of 
Escherichia  coli.  Antimicro.  Agents.  Chernother.  36.  pp913-919. 
Omura,  S.  (1986).  Philosophy  of  new  drug  discovery.  Microbiol.  Rev.,  50.  pp259- 
279. 
Omura,  S.,  Tanaka,  Y.  (1984).  Biochemistry,  regulation  and  genetics  of  macrolide 
production.  In  Macrolide  antibiotics  Omura,  S.  (ed)  Chemistry,  Biology  and  practice. 
Academic  Press,  Orlando.  Fl.  US.  ppl99-229. 
210 Park,  B.  H.,  Hendricks,  M.,  Malamy,  M.  H.,  Tally,  F.  P.,  Levy,  S.  B.  (1987).  Cryptic 
tetracycline  determinant  (class  F)  from  Bacteroidesfragalis  mediates  resistance  in 
Escherichia  coli  by  actively  reducing  tetracycline  accumulation.  Anti.  Microb. 
Agents.  Chemother.,  31.  ppl739-1743. 
Park,  B.  H.,  Levy,  S.  B.  (1988).  The  cryptic  tetracycline  resistance  determinant  on 
Tn4400  mediates  tetracycline  degradation  as  well  as  tetracycline  efflux.  Anti. 
Microb.  Agents  Chemother.,  32.  ppl797-1800. 
Parker,  J.,  Watson,  R.  J.  Friesen,  J.  D.  (1976).  A  relaxed  mutant  with  an  altered 
ribosomal  protein  L  11.  Mol.  Gen.  Genet.,  144.  pp  III-  114. 
Paulsen,  1.  T.,  Brown,  M.  H.,  Skurray,  R.  A.  (1996).  Proton  dependent  multidrug 
efflux  systems.  Microb.  Rev.,  60.  pp575-608. 
Paulsen,  1.  T.,  Skurray,  A.  R.  (1993).  Topology,  evolution  and  structure  of  two 
families  of  proteins  involved  in  antibiotic  and  antiseptic  resistance  in  eukaryotes  and 
prokaryotes:  an  analysis.  Gene,  124.  pp761-768. 
Peden,  K.  W.  (1983).  Revised  sequence  of  the  tetracyc  Ii  ne-resi  stance  gene  of 
pBR322.  Gene,  22.  pp277-280. 
Pigac,  J.,  Alacevic,  M.  (1979).  Mapping  of  oxytetracycline  genes  in  Streptomyces 
rimosus.  Period.  Biol.,  81.  pp575-582. 
Potuckova,  L.,  Keleman,  G.  H.,  Lonetto,  M.  A.,  Buttner,  M.  J.,  Kormanec,  J.  (1995). 
A  new  RNA  polymerase  sigma  factor,  sigma  (F)  is  required  for  the  late  stages  of 
morphological  differentiation  in  Streptonzyces  spp. 
Mol.  Mocrobiol.,  17.  pp37-48. 
Revill,  W.  P.,  Bibb,  M.  J.,  Hopwood,  D.  A.  (1996).  Relationships  between  fatty  acid 
211 and  polyketide  synthases  from  Streptomyces  coelicolor  A3(2)  :  characterisation  of 
the  fatty  acid  synthase  acyl  carier  protein.  J.  Bacteriol.  178.  pp5560-5567 
Reynes,  J.  P.,  Calmels,  T.,  Drocourt,  D.,  Tiraby,  G.  (1988).  Cloning,  expression  in 
Escherichia  coli  and  nucleotide  sequence  of  a  tetracycline  resistance  gene  from 
Streptomyces  rimosus.  Jnl.  Gen.  Microbiol.,  134.  pp585-598. 
Rhodes,  P.  M.,  Hunter,  I.  S.,  Friend,  E.  J.  Warren,  M.  (1984).  Recombinant  DNA 
methods  for  the  oxytetracycline  producer  Streptomyces  rimosus.  Biochem.  Soc. 
Transac.,  12.  pp586-587. 
Rhodes,  P.  M.,  Winskill,  N.,  Friend,  E.  J.,  Warren,  M.  (1981).  Biochemical  and 
genetic  characterisation  of  Streptomyces  rintosus  mutants  impaired  in  oxytetracycline 
biosynthesis.  Jnl.  Gen.  Microbiol.,  124.  pp329-338. 
Roberts,  M.  C.  (1994).  Epidemiology  of  tetracycline  resistance  determinants.  Trends 
Microbiol.,  2.  pp353-357. 
Rogalsk-i,  W. (1985).  Chemical  modification  of  the  tetracyclines.  In  Handbook  of 
experimental  pharmacology.  Hvlaka,  J.  J.,  Booth,  J.  H.  (ed.  's)  vol.  78.  Springer, 
Berlin.  ppl79-316. 
Rouch,  D.  A.,  Cram,  D.  S.,  DeBerardino,  D.,  Littlejohn, T.  G.,  Skurray,  R.  A.  (1990). 
Efflux  mediated  antiseptic  resistance  gene  qacA  from  Staphylococcus  aureus; 
common  ancestry  with  tetracycline  and  sugar  transport  proteins.  Mol.  Microbiol.,  4. 
pp2051-2062. 
Rubin,  R.  A.,  Levy,  S.  B.,  Heinrikson,  R.  L.,  Kezdy,  F.  1  (1990).  Gene  duplication  in 
the  evolution  of  the  two  complementing  domains  of  Gram-negative  bacterial 
tetracycline  efflux  proteins.  Gene,  87.  pp7-13. 
Rudd,  B.  A.  M.,  Hopwood,  D.  A.  (1979).  Genetics  of  actinorhodin  biosynthesis  by 
212 Streptomyces  coelicolor  A3(2).  Jnl.  Gen.  Microbiol.  114.  pp35-43. 
Ryan,  A  J.,  Lotvin,  J.  A.,  Strathy,  N.,  Fantini,  S.  E.  (1997).  Cloning  of  the 
biosynthetic  pathway  for  chlortetracycline  and  tetracycline  formation  and  cosmids 
useful  therein.  U.  S.  Patent  5589385-A  31  -DEC-  1996. 
Saier,  M.  H.  Jr.  (1990).  Evolution  of  permease  diversity  and  energy  coupling 
mechanisms  -  an  introduction.  Res.  Microbiol.,  141.  pp281-286. 
Saiki,  R.  K.,  Gelfand,  D.  H.,  Stoffel,  S.,  Scharf,  S.  J.,  Higuchi,  R.,  Horn,  G.  T., 
Mullis,  K.  B.,  Erlich,  H.  A.  (1988).  Primer-directed  enzymatic  amplification  of  DNA 
with  a  thermostable  polymerase.  Science,  239.  pp487-49  1. 
Salyers,  A.  A.,  Speer,  B.  S.,  Shoemaker,  N.  B.  (1990).  New  perspectives  in 
tetracycline  resistance.  Mol.  Microbiol.,  4.  ppl5l-156. 
Satoh,  A.,  Ogawa,  H.,  Saomura,  Y.  (1975).  Role  and  regulation  mechanism  of 
kanamycin  actey  I  trans  ferase  in  kanamycin  biosynthesis.  Agric.  Biol.  Chem.,  39. 
pp2331-2336. 
Sarrubi,  E.,  Rudd,  K.  C.,  Xiao,  H.,  Ikehara,  K.,  Kalman,  M.,  Cashel,  M.  (1989.  The 
characterisation  of  the  spoT  gene  of  Escherichia  coli  J.  B  iol.  Chem.,  264.  pp  15074- 
15082. 
Schatz,  P.  J.  &  Beckwith,  J.  (1990).  Genetic  analysis  of  protein  export  in  Escherichia 
coli.  Annu.  Rev.  Genet.  24.  pp215-248. 
Schnappinger,  D.  Hillen,  W.  (1996).  Tetracyclines,  antibiotic  action,  uptake  and 
resistance  mechanisms.  Arch.  Microbiol.,  165.  pp359-369. 
Schuldiner,  S.  (1994).  A  molecular  glimpse  of  vesicular  monoamine  transporters.  Jnl. 
Neurochem.,  62.  pp2067-2078. 
213 Schuldiner,  S.,  Shirvan,  A.,  Lineal,  M.  (1995.  Vesicular  neurotransmitters:  from 
bacteria  to  humans.  Physiol.  Rev.,  75.  pp369-392. 
Sheridan,  R.  P.,  Chopra,  1.  (1991.  Original  tetracycline  efflux  proteins;  Conclusions 
from  nucleotide  sequence  analyses.  Mol.  Microbiol.,  5.  pp895-900. 
Sherman,  D.  H.,  Malpartida,  F.,  Bibb,  M.  J.,  Kieser,  H.  M.,  Hopwood,  D.  A.  (1989). 
Structure  and  deduced  function  of  the  granaticin  producing  polyketide  synthase  gene 
cluster  of  Streptomyces  violaceoruber  Tu22.  EMBO.  Jnl.,  8.  pp2717-2725. 
Sloan,  J.,  McMurray,  L.  M.,  Lyras,  D.,  Levy,  S.  B.,  Rood,  I.  J.  (1994).  The 
Clostridiunt  perfringens  tetP  determinant  compromises  two  overlapping  genes, 
tetA(P)  which  mediates  active  tetracycline  efflux  and  tetB(P)  which  is  related  to  the 
ribosomal  protection  family  of  resistance  determinants.  Mol.  Microbiol.,  11.  pp403- 
415. 
Someya,  Y.,  Niwa,  A.,  Sawai,  T.,  Yamaguchi,  A.  (1995).  Site-specificity  of  the 
second-site  suppressor  mutation  of  the  Asp-285-Asn  mutant  of  metal-tetracycline/  11' 
antiporter  of  Escherichia  coli  and  the  effects  of  amino  acid  substitutions  at  tile  first 
and  second  sites.  Biochemistry.  34.  pp7-12. 
Speer,  B.  S.,  Bedzyk,  L.,  Salyers,  A.  A.  (199  1).  Evidence  that  a  novel  tetracycline 
resistance  gene  found  on  two  Bacteroides  transposons  encodes  an  NADP-requiring 
oxidoreductase.  J.  Bacteriol.,  173.  pp176-183. 
Speer,  B.  S.,  Salyers,  A.  A.  (1990).  A  tetracycline  efflux  gene  on  Bacteroides 
transposon  Tn4400  does  not  contribute  to  tetracycline  resistance.  J.  Bacteriol.,  172. 
pp292-298. 
Speer,  B.  S.,  Shoemaker,  N.  B.,  Salyers,  A.  A.  (1992).  Bacteria'  resistance  to 
tetracycline;  mechanisms,  transfer  and  clinical  significance.  Clin.  Microbiol.  Rev.,  5. 
pp387-399. 
214 Stone,  M.  J.  &  Williams,  D.  H.  (1992).  On  the  evolution  of  functional  secondary 
metabolites,  natural  products.  Mol.  Microbiol.,  6,  pp29-34. 
Strauch,  E.,  Takano,  E.,  Bayliss,  H.  A  Bibb,  M.  J.  (1991).  The  stringent  response  in 
Streptomyces  coelicolor  A3(2).  Mol.  Mirobiol.,  5.  pp289-298. 
Studier,  F. W.  (1991).  Use  of  bacteriophage  T7  lysozyme  to  improve  and  inducible 
T7  expression  system.  J.  Mol.  Biol.  219.  pp37-44. 
Studier,  F.  W.  &  Moffatt,  B.  A.  (1986).  Use  of  bacteriophage  T7  RNA  polymerase  to 
direct  selective  high  level  expression  of  cloned  genes.  J.  Mol.  Biol.  189.  pp  113-130. 
Sugiyama,  M.,  Paik,  S-Y.,  Nomi,  R.  (1985.  )  Mechanism  of  self  protection  in  a 
puromycin  producing  microorganism.  Jnl.  Gen.  Microbiol.,  131.  ppl999-2005. 
Summers,  R.  G.,  Ali,  A.,  Shen,  B.,  Wessel,  W.  A.,  Hutchinson,  C.  R.  (1995). 
Malonyl  Coenzyme-A  acyl  carrier  protein  acyltransferase  of  Streptonlyces 
glaticesens,  a  possible  link  between  fatty  acid  and  polyketide  biosynthesis. 
Biochemistry,  34.  pp9389-9402. 
Swift,  S.,  Throup,  J.  P.,  Williams,  P.,  Salmond,  G.  P.,  Stewart,  G.  S.  A.  B.  (1996). 
Quorum  sensing;  a  population  density  component  in  the  determination  of  bacterial 
phenotype.  TIBS  21.  pp214-219- 
Tabor.  S.  &  Richardson,  C.  C.  (1985).  A  bacteriophage  T7  RNA 
polymerase/promoter  system  for  controlled  exclusive  expression  of  specific  genes. 
Proc.  Nat.  Acad.  Sci  (USA).  82.  pp1074-1078. 
Takano,  E.,  Gramajo,  H.  C.,  Strauch,  E.,  Andres,  N.,  White.  J.,  Bibb,  M.  J.  (1992). 
Transcriptional  regulation  of  the  redD  transcriptional  activator  gene  accounts  for 
growth  phase  dependent  production  of  the  antibiotic  undecylprodigiosin  in 
215 Streptomyces  coelicolor  A3(2).  Mol.  Microbiol.,  6.  pp2797-2804. 
Takano,  E.,  White,  J.,  Thompson,  C.  J.,  Bibb,  M.  J.  (1995)  Construction  of 
thiostrepton-  inducible,  high  copy-number  expression  vectors  for  use  in  Streptomyces 
spp.  Gene.  166.  ppl33-137. 
Tanaka,  K.,  Shiina,  T.  Takahashi,  H.  (1988).  Multiple  principal  sigma  factor 
hornologues  in  eubacteria:  Identification  of  the  "rpoD  box".  Science,  242.  pp1040- 
1042. 
Tanaka,  K.,  Shiina,  T.  Takahashi,  H.  (1991).  Nucleotide  sequence  of  genes  hrdA, 
hrdC  and  hrdD  from  Streptomyces  coelicolor  A3(2)  having  similarity  to  rpoD  genes. 
Mol.  Gen.  Genet.,  229.  pp334-340. 
Taylor,  D.  E.  (1986).  Plasmid  mediated  tetracyline  resistance  in  Canipylobacter 
jejuni-  Expression  in  Escherichia  coli  and  identification  of  homology  with 
Streptococcal  TetM  determinant.  Jnl  Bacteriol.  165.  pp1037-1039. 
Taylor,  R.  D.  (1992).  Ph.  D  Thesis,  University  of  Glasgow 
Tercero  JA,  Lacalle  RA,  Jimenez  A.  (1993).  The  pur8  gene  from  the  pur  cluster  of 
Streptontyces  alboniger  encodes  a  highly  hydrophobic  polypeptide  which  confers 
resistance  to  puromycin.  Eur.  J.  Biochem.  218.  pp963-97  1. 
Thamchaipenet,  A.  (1994).  Ph.  D.  Thesis.  University  of  Glasgow. 
Thanassi,  D.  G.,  Suh,  G.  S.  B.,  Nikaido,  H.  (1995.  Role  of  outer  membrane  barrier  in 
efflux  mediated  tetracycline  resistance  of  Escherichia  coli.  J.  Bacteriol.,  177.  pp998- 
1007. 
Thomas,  R.,  Williams,  D.  J.  (1983).  Oxytetracyline  biosynthesis:  origin  of  the 
carboxamide  substituent.  J.  Chem.  Soc.  Chem.  Commun.,  12.  pp677-679. 
216 Thompson,  J.,  Schmidt,  F.,  Cundliffe,  E.  (1982).  Site  of  action  of  a  ribosomal  RNA 
methylase  conferring  resistance  to  thiostrepton.  J.  Biol.  Chem.,  257.  pp7915-7917. 
Towbin,  H.,  Staehlin,  T.,  Godon,  J.  (1979).  Electrophoretic  transfer  of  proteins  from 
polyacrylamide  gels  to  nitrocellulose  sheets:  procedure  and  some  applications.  Proc. 
Nat.  Acad.  Sci.,  76.  pp4350-4354. 
Varela  M.  F.,  Sansom,  C.  E.,  Griffith  J.  K.  (1995).  Mutational  analysis  and  molecular 
modelling  of  an  amino  acid  sequence  motif  conserved  in  antiporters  but  not 
symporters  in  a  transporter  superfamily.  Mol.  Membr.  Biol.,  12.  pp:  313-319. 
Voet,  D  Voet  JG  (1990).  Chapter  23,  Lipid  Metabolism  in  "Biochemistry"  John 
Wiley  &  sons  (pub.  ) 
Vogtli,  M.,  Chang,  P.  C.,  Cohen,  S.  N.  (1994).  AfsR2:  a  previously  undetected  gene 
encoding  a  63  amino  acid  protein  that  stimulates  antibiotic  production  in 
Streptomyces  lividans.  Mol.  Microbiol.,  14.  pp643-653. 
Von  Heijne,  G.  (1986).  The  distribution  of  positively  charged  residues  in  bacterial 
inner  membrane  proteins  correlates  with  the  transmembrane  topology.  EMBO  Jnl.,  5. 
pp3021-3027. 
Vujaklija,  A.  D.,  Horinouchi,  S.,  Beppu,  T.  (1993).  Detection  of  an  A-factor 
responsive  protein  that  binds  to  the  upstream  activation  sequences  of  StrR,  a 
regulatory  gene  for  streptomycin  synthesis  in  Streptontyces  griseus.  J.  Bacteriol.  175. 
pp2652-266  1. 
Vujaklija,  A.  D.,  Ueda,  K.,  Hong,  S-K.,  Beppu,  T.,  Horinouchi,  S.  (199  1). 
Identification  of  an  A-factor  dependent  promoter  in  the  streptomycin  biosynthetic 
gene  cluster  of  Streptonzyces  griseus.  Mol.  Gen.  Genet.,  229.  pp  119-128. 
217 Walker,  J.  B.  &  Skorvaga,  M.  (1973a).  Phosphorylation  of  streptomycin  and 
dihydrostreptomycin  by  Streptomyces.  Enzymatic  synthesis  of  different 
diphosphorylated  derivatives.  J.  Biol  Chem.  248.  pp2435-2440. 
Walker,  J.  B.  &  Skorvaga,  M.  (1973b).  Streptomycin  biosynthesis  and  metabolism. 
Phosphate  transfer  from  dihydrostreptomycin  6-phosphate  to  inosamines, 
streptarnine,  and  2-deoxystreptamine.  J.  Biol.  Chem.  248.  pp2441-2446. 
Wang,  I.  K.,  Reeves,  C.,  Gaucher,  G.  M.  (1990).  Isolation  and  sequencing  of  a 
genornic  DNA  clone  containig  the  3'  tern-ýinus  of  the  6  methyl  salicylic  acid 
polyketide  synthetase  gene  of  Penicillium  urtiacae.  Can.  Jnl.  Micro.,  133.  pp86-95. 
Waters,  S.  H.,  Rogowsky,  P.  Grinstead,  J.,  Altenbuchner,  J.,  Schmitt,  R.  (1983).  The 
tetracycline  resistance  determinants  of  RP  I  and  TnI721;  nucleotide  sequence 
analysis.  Nucleic  Acids  Res.,  11.  pp6089-6105. 
White,  J.  &  Bibb,  A  J.  (1997).  bldA  dependence  of  undecylprodigiosin  production  in 
Streptonzyces  coelicolor  A3(2)  involves  a  pathway-specific  regulatory  cascade.  J. 
Bacteriol.  179.  pp627-633. 
Wirth,  R.,  Muscholi,  A.,  Wanner,  G.  (1996).  The  role  of  pheremones  in  bacterial 
interactions.  Trends  Microbiol.  4.  pp96-102. 
Xiao,  H.,  Kalman,  M.,  Ikehara,  K.,  Zemel,  S.  Glaser,  G.,  Cashel,  A  (199  1).  Residual 
guanosine  3'  5'  bispyrophosphate  activity  of  re1A  null  mutants  can  be  eliminated  by 
spoT  mutations.  J.  B  iol.  Chem.,  266.  pp5980-5990. 
Yamaguchi,  A.,  Inagaki,  Y.,  Sawai,  T.  (1995).  Second-site  supressor  mutations  for 
the  Asp-66-Cys  mutant  of  the  transposon  TnIO  encoded  metal-tetracycline  /  H+ 
antiporter  of  Escherichia  coli.  Biochemistry,  34.  pp  11800-11806 
Yamaguchi,  A.,  Kimura,  T.,  Sawai,  T.  (1994).  Hot  spots  for  sulfhydryl  inactivation  of 
218 cys  mutants  in  the  widely  conserved  sequence  motifs  of  the  metal-tetracycline  H' 
antiporter  of  Escherichia  coli.  Jnl.  Biochem.  115.  pp958-964 
Yamaguchi,  A.,  Kimura,  T.,  Someya,  T.,  Sawai,  T.  (1992b).  Metal  tetracycline/H  + 
antiporter  of  Escherichia  coli  encoded  by  transposon  TnIO  :  The  structural 
resemblence  and  functional  difference  in  the  role  of  the  duplicated  sequence  motif 
between  hydrophobic  segment  2  and  segment  3  and  segment  8  and  segment  9.  J. 
Biol.  Chem.,  267.  pp19155-19162. 
Yamaguchi,  A.,  Ono,  N.,  Akasaka,  T.,  Nourni,  T.,  Sawai,  T.  (1990).  Metal 
tetracycline/H'  antiporter  of  Escherichia  coli  encoded  by  transposon,  TnI0:  The  role 
of  the  conserved  dipeptide,  Ser  65 
-AsP66'  in  tetracycline  transport.  J.  Biol.  Chem.,  265. 
ppl5525-15530. 
Yamaguchi,  A.,  Ono,  N.,  Akasaka,  T.,  Sawai,  T.  (1992c)  Serine  residues  responsible 
for  tetracycline  transport  are  on  a  vertical  stripe  including  Asp-84  on  one  side  of 
transmembrane  helix  3  in  transposon  TnIO-encoded  tetracycline/  H'  antiporter  of 
Escherichia  coli.  FEBS  letters,  307.  pp229-232. 
Yamaguchi,  A.,  Someya,  Y,  Sawai,  T.  (1992a).  Metal  tetracycline/H'  antiporter  of 
Escherichia  coli  encoded  by  transposon  TOO.  The  role  of  a  conserved  sequence 
motif,  GXXXXRXGRR,  in  a  putative  cytoplasmic  loop  between  helices  2  and  3.  J. 
Biol.  Chem.,  267.  pp19155-19162. 
Yamaguchi,  A.,  Someya,  Y,  Sawai,  T.  (1993).  The  in  vivo  assembly  and  function  of 
the  N-  and  C-terminal  halves  of  the  TnIO  encoded  TetA  protein  in  Escherichia  coli. 
FEBS  letters,  324.  ppl3l-135. 
Yanish-Peron,  C.,  Viera,  J.,  Messing,  J.  (1985).  Improved  M13  phage  cloning  vectors 
and  host  strains:  Nucleotide  sequence  of  the  M  13mp  19  and  pUC  19  vectors.  Genc  33. 
pp103-119. 
219 Zen,  K.  H.,  McKenna,  E.  Bibbi,  E.,  Hardy,  D.,  Kaback,  H.  R.  (1994).  Expression  of 
lactose  permease  in  contiguous  fragments  as  a  probe  for  membrane  spanning 
domains.  Biochemistry.  33.  ppS198-8206. 
Zhao,  J.,  Aoki,  T.  (1992).  Nuceotide  sequence  analysis  of  the  class  G  tetracycline 
resistance  determinant  from  Vibrio  anguillarum.  Micrbiol.  Immunol.,  36.  pp1051- 
1060. 
w 
GLASGOW 
UNýV-ERSM 
220 